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Abstract 
The principal use of sodium monofluoroacetate (1080) in New Zealand is to control 
brushtail possums (Trichosurus vulpecula). Aerial application of baits containing 
1080 is the most common method used for large-scale control of possums. 
The use of 1080 attracts a great deal of controversy, in particular the effects on the 
environmental, non-target species, and the potential chronic effects in humans 
associated with environmental exposures. Although the nature of the acute toxicity of 
1080 has been known for more than fifty years, little is known of its effects on 
humans, in particular its chronic effects to environmental exposures. 
A benchmark dose (BMD) as an alternative to a no-observed-adverse-effect-level 
(NOAEL) approach was investigated as a means to improve current health risk 
assessment values of 1080. Both approaches were investigated for three critical 
toxicological end points, namely cardiomyopathy, testicular toxicity and teratogenic 
effects identified from the few available critical studies. The calculated BMDs and 
lower-bound confidence limits (BMDLs) for the three end points were estimated using 
the Weibull, probit and quanntal linear models. A benchmark response (BMR) of 10% 
(extra risk) was chosen and the Akaike's information criterion (AIC) was used in 
selecting the appropriate model. The BMDL estimates derived were generally slightly 
higher but comparable to the corresponding NOAEL for those same endpoints. The 
computed BMD10 and BMDL10 for cardiomyopathy and testicular effects were 0.21 
mg ki1 bw-1 and 0.10 mg kg-1bw-1, respectively. Tolerable Daily Intakes (TDis) were 
derived using the NOAEL approach and the BMD methodology and applying an 
uncertainty factor of 3000. The resulting TDI using the BMDL were generally 
consistently slightly higher than those derived using the NOAEL approach. Based on 
the best fit of modelled dose-response data, a TDI of 0.03 µg kg-1bw-1dai1 is proposed 
for human health risk assessment. 
Two sets of Provisional Maximum Acceptable Values (PMA V) were derived using the 
highest concentration of 4.0 µg L-1 1080 found in water (N=1450), and using the 
maximum allowable concentration of2.0 µg L-1 of 1080 in water for adults (0.58 µg L-
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1 and 0.94 µg L-1, respectively) and children (0.23 µg L-1 and 0.4 µg L-1, respectively). 
Parameters used in the derivation of PMA Vs were average weight, average quantity of 
water consumed, and proportion of total intake allocated to drinking water. The 
derived adult PMA V of 0.60 µg L-1 is proposed in revising the PMA V for 1080 in the 
Drinking Water Standards New Zealand. This value is 6-fold lower than the current 
PMA V of 3.5 µg L-1• Additional toxicology studies are _recommended to meet the 
definition of a "complete database" and therefore estimating a more defensible TDI, 
and consequently a PMA V for 1080. 
Risk management approaches are consistent with the Ministry of Health's current 
precautionary approach. A PMA V of 0.60 µgL- 1 in drinking water is recommended to 
consider it suitable for human consumption and that continuous monitoring be carried 
if the level of 1080 exceeds 50% of the proposed PMA V as a requirement for Priority 
2 determinands in the Drinking Water Standards. Precautionary approach appears to 
be warranted and this was supported by information provided by the Public Health 
Units (PHU) where 1080 was permitted to be dropped onto drinking water catchments. 
The PHU s exercised precautionary measures by imposing appropriate conditions to 
suit local circumstances. As 1080 may likely remain ah essential tool to contain 
tuberculosis spread by possums and to reduce possum damage to forests and crops 
until better methods of control are developed, a number of recommendations were 
proposed to protect public health. 
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Sodium monofluoroacetate ( commonly known as 1080) is a highly toxic vertebrate 
pesticide that has been proven to be effective in controlling possums, rabbits and 
wallabies (Eason 1996). However, despite its effectiveness, over several decades in 
New Zealand, its use continues to cause controversy to the general public because of 
its effects in non-target species, especially dogs, the fate of 1080 in water (Thomas 
1994), and the uncertainty associated with its potential long-term effects on human 
health (S. Gilbert pers. comm. 2000). 
In other countries, 1080 is also used, but in relatively small quantities compared with 
New Zealand. In Australia, 1080 is used in controlling the population of introduced 
European rabbits, foxes, pigs and mice, while it is used for the control of field rodents 
in Israel by aerial application or by hand. In the United States, most uses of 1080 were 
cancelled in 1972 because, in part, of deaths of non-target animals (Balcomb et al. 
1983), including endangered species (Palmateer 1989, 1990). 1080 has a very limited 
use in the USA since it is only presently registered for use in a collar designed to 
protect sheep and cattle from coyotes (Morgan and Eason 2004; Eason 2002a). 
Likewise, 1080 is mainly used in livestock protection collars for predator control ( e.g., 
wolves, coyotes, jackals) in South Africa (ERMA NZ 2006). 
New Zealand is the largest user of 1080 in the world (Parliamentary Commissioner for 
the Environment (PCE) 1994), consuming approximately 80% of the world's 
production of 1080. To illustrate, a Department of ConservatiEm EDoC) and Animal 
Health Board (AHB) report (2003) estimated the amount to be 3.2 tonnes of raw 
product in the period 1 July 2001 to 30 June 2002. The 1080 reassessment document 
prepared by Environmental Risk Management Authority New Zealand (ERMA NZ) 
(2006) suggested that DoC and AHB proposed an increase in quantity of 1080 use, i.e., 
from 1280 to 3000 kg per year and 600 to 1000 kg per year for AHB and DoC, 
respectively. 
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Although there is an extensive published database on 1080, some of the toxicological 
and metabolic data generated between 1950s and the 1970s are out of date and would 
not meet current standards. Before a new pesticide can be registered in New Zealand 
extensive toxicological data are required to meet worldwide standards (Seawright 
1994). In view of this, DoC and the AHB commissioned Landcare Research Limited 
to carry out a number of toxicology studies on 1080 to comply with current regulatory 
requirements for pesticides in New Zealand in 1998-99. Studies carried out were: 
• mutagenicity studies 
• teratology study in rats 
• 90-day feeding trial 
The majority of public concerns about possum control operations relate to the possible 
contamination of drinking water supplies with 1080 resulting from aerially sown baits 
falling into streams (Hamilton and Eason 1994). This likely contamination fuels an 
ongoing debate concerning the potential toxicological effects of the use of this 
chemical in the environment (Thomas 1994; S. Gilbert pers. comm. 2000). Interest in 
the potential toxic effects of 1080 has resurfaced as a result of the latest findings from 
the animal studies commissioned by the DoC and AHB of rats with exposures to 1080. 
Compound 1080 was found to be teratogenic, a male reproductive toxin and a 
myocardial toxin (Eason et al. 1998, 1999, 2001; Eason and Turck 2002). Older 
studies carried out in England, such as McDowell (1972a, b) and Cater and Peters 
(1961) suggested that 1080 is also a nephrotoxin in rats. 
From a public health point of view, the focus of concern recently has been the potential 
effects at low doses during long-term exposures. It should be noted that this study 
excludes exposures arising from places of work. 
1.2 Aims of the Study 
This study focuses on developing health risk assessment and health risk management 
methodologies usin_g 1080 as the model. The aims of this study are to: 
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1) Review the adequacy of the available relevant toxicological data on 1080 and 
the outcomes of studies commissioned by the Department of Conservation and 
the Animal Health Board on 1080 and its relevance to the protocols used in 
New Zealand to control possums, 
2) Investigate and carry out health risk assessment analyses of 1080 and its impact 
on public health, 
3) Develop methodologies , for the protection of sensitive segments of the 
population, specifically for children to ascertain their susceptibility to the 
adverse effects of 1080 and compare this finding with the data derived from 
adults, 
4) To use a dose-response modelling approach in deriving the Tolerable Daily 
Intake and consequently the Provisional Maximum Acceptable Value (PMA V) 
on 1080, which will form the basis for revising the PMA V for 1080 in 
Drinking Water Standards New Zealand, and 
5) Develop a risk management plan for 1080 that will: 
a) identify any problems and gaps (if any) on the current standard national 
application form and permit conditions used by the Medical Officers of 
Health, 
b) develop policy advice to assist the Medical Officers of Health in 
granting permit conditions for the use of 1080, and 
c) analyse the legal implications surrounding the use of 1080 as it affects 
public health, in particular the role of the Medical Officers of Health. 
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1.3 Scope of the study 
Chapter 1 provides a brief introduction to the project, its background, the use of 1080 
in New Zealand, natural occurrence, method of application, together with the aims and 
scope of the project. 
Chapter 2 presents the biodegradation and human exposure pathways. 
Chapter 3 discusses the identity, physical/chemical properties, stability of the C-F 
bond, toxicokinetics and metabolism in laboratory animals, and toxicodynamics. 
Chapter 4 reviews information on the toxicological hazards of 1080. 
Chapter 5 discusses the methodology and results to complete the health risk 
assessment process, which includes hazard identification, dose response assessment, 
exposure assessment, and risk characterisation used in the study. 
Chapter 6 presents the general discussion and conclusions resulting from the health 
risk assessment process. 
Chapter 7 discusses the health risk management framework, comprising the statutory 
framework of regulation of 1080, conclusions and recommendations, where 
appropriate. 
1.4 The use of 1080 in New Zealand 
Compound 1080 was first synthesised in Belgium in 1896, but its toxicity was not 
noted until 1934 (Atzert 1971). It is one of the most toxic vertebrate agents known. 
Compound 1080 was introduced into New Zealand in 1954 and its principal use has 
been to control possums (Trichosurus vulpecula), and to contain the spread of bovine 
tuberculosis to livestock such as cattle and deer herds. 
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New Zealand is the only country in the world with a "possum problem" (PCE 1994). 
Uncontrolled possum populations are a direct threat to vulnerable areas of the 
conservation estate and the diversity of New Zealand's flora and fauna (DoC and AHB 
2003). In addition, possums are the major wildlife host of bovine tuberculosis which is 
New Zealand's main animal health problem (DoC, AHB and MAF 1994; DoC and 
AHB 2003). There is a potential risk that non-tariff trade barriers could be placed on 
New Zealand's exports of beef, dairy, and deer products if other countries perceived 
that they were contaminated with tuberculosis (PCE 1994). 
A clear understanding of possible risks to the environment has been suggested by 
Parfitt et al. (1994) as being essential since more than 3.2 tonnes of 1080 are applied 
annually in New Zealand. Although 1080 has been used in New Zealand for a few 
decades now, Eason et al. (1993b) suggested that the long-term use of 1080 needs to 
be further studied because of the continuing controversy concerning its use, fate in 
water, and effects on non-target species, especially livestock and invertebrates. For 
instance, the Mangapeka Educational Trust and 1080 Action Group in Golden Bay 
have expressed concern about the teratogenic/reproductive effects of 1080. In 
addition, Takaka residents were angry and made their complaints to relevant regulatory 
authorities as 1080 was mistakenly dropped in an area where they obtain their drinking 
water and potentially contaminating their drinking water source. 
An extensive published database on the fate of 1080 in the environment and effects on 
non-target species exists. However, one of the major gaps in knowledge surrounding 
1080 is its potential long-term effects on human health. 
1.5 Natural occurrence 
Compound 1080 occurs naturally in certain plants in Western Australia and South 
Africa at concentrations similar to those used on bait for rabbit control (Twigg and 
King 1991). Approximately 40 species of plants in the genus Glastrobium occur in 
southwestern Australia and some species are abundant and contain high levels of 
fluoroacetate (Aplin 1971; Crisp and Weston 1987). Those species which occur in 
northern Australia are less toxic, i.e., Acacia georgina and G. grandiflorum (Twigg 
and King 1991). 
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Plant species of the genus Glastrobium can produce more than 2,000 mg ki1 in leaves 
(Twigg 1994). The concentration of fluoroacetate in these plants varies between 
species, region, soil type, and season. As fluoroacetate had been an integral part of the 
Australian environment some animals have developed varying degrees of tolerance to 
fluoroacetate. This tolerance has not yet been quantified scientifically in New 
Zealand. The biochemical mechanism responsible for tolerance is poorly understood 
(Twigg 1994). Of the Australian seed-eating animals the emu Dromaius 
novaehollandiae has by far. the greatest tolerance to fluoroacetate with an LD50 of 102-
200 mg ki1 (Twigg et al. 1988). This example illustrates that animals in areas where 
fluoroacetate has been part of their natural environment can tolerate high 
concentrations of the compound, compared with animals living in areas where 
fluoroacetate was not an integral component of their natural habitat. Such animals, 
e.g., dogs, with an LD50 of 0.06 mg ki
1 bw (body weight), are extremely sensitive to 
fluoroacetate. 
The plant Dichapetalum cymosum (Gitblaar) was the first to be found to contain 
fluoroacetate in Africa. Several other species of Dichapetalum have also been shown 
to produce fluoroacetate (Vickery et al. 1973; Vickery and Vickery 1975). 
Fluoroacetate has also been isolated from Palicourea marcgravii, a South American 
species known to be poisonous (de Oliviera 1963). It has also been established that 
Acacia georgina contains fluoroacetate, producing a syndrome characterised by 
sudden death (Bell et al. 1955). 
It can be assumed that because 1080 is not naturally present in the New Zealand 
environment, animals may be more susceptible to it as they would not have developed 
tolerance as opposed to their Australian counterparts. However, the tolerance 
exhibited by some Australian animals only relates to the lethal effects based on the fact 
that most publications in this field focussed on acute toxicity. However some studies 
have reported sub-lethal effects of 1080, such as elevation in blood/tissue citrate, such 
as that of Twigg et al. (1986) which may likely to precede pathological effects and it is 
also possible and likely that chronic toxicological effects might be less in resistant 
species (Twigg et al. 1994). Because of the widespread use and potential for long-
term low-level exposure of sensitive species, it seems possible that chronic effects may 
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occur. Since the focus of this thesis is on the use of 1080 in New Zealand, i.e., 
synthetic 1080, no further work has been done on this topic. Naturally occurring 1080 
was only mentioned in this thesis to put in context the toxicity of 1080. 
1.6 Method of application 
Compound 1080 is applied by aerial drops and ground-baiting operations, the latter 
utilising a range of control techniques including bait stations, bait on spits, and hand 
broadcasting. It may be applied using a variety of natural and manufactured baits. It is 
available as a 20% w/v stock solution for use on boiled oats, or for spraying onto diced 
carrots. It can be incorporated into manufactured cereal baits, apple based paste or a 
gel. Registered 1080 concentrations are available at 0.02, 0.04, 0.06, 0.08 and 0.15%. 
In aerial poisoning for possum control, 1080 is coated on carrot baits or mixed into 
cereal baits. Aerial application of baits containing 1080 has been demonstrated to be 
very successful in controlling possums in up to 95% of the population. This method of 
application has eradicated possums over areas of up to 20,000 ha, as reported by 
Thomas (1994) and PCE (1994). 
The Digital Global Positioning System (DGPS) uses satellites as reference points for 
establishing position and has been proven to be generally an effective tool in targeting 
the possum population (Morgan et al. 1996). DoC (1994) and DoC and AHB (2003) 
considered that aerial baiting of 1080 is the only available method of application that 




Biological degradation and exposure pathways 
2.1 Biodegradation 
Biological degradation of 1080 may occur in the toxic bait, in the poisoned animal, and 
in the soil and waterways where it is finally deposited (Rammel and Flemming 1978). 
Environmental research shows biodegradation occurs in microbes, invertebrates, 
plants, and animals. Under wet mild conditions, 1080 residues will usually disappear 
within 1 to 2 weeks. However, l 080 may persist in bait, soil, or in carcasses for 
several weeks or even months in cold or dry conditions (Eason et al. 1993a; Parfitt et 
al. 1994; Morgan and Eason 2004). A study carried out by Bowen et al. (1995) 
suggested that carrot baits were highly water resistant and showed no decline in 1080 
concentration after 200 mm of rain while the pellet form was less resistant. Table 1 
illustrates the time required for the biodegradation of 1080 in various conditions. In 
general, the bait may disintegrate during wet and warm conditions and takes longer 
under dry and cold conditions because there will be little biological activity to 
breakdown the structure of the bait. Bait breakdown is also dependent on the amount 
of rainfall and the nature of the bait. 
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Table 1 
Time required for biodegradation of 1080 in various conditions 
Source Conditions Change or effect Time 
measured 
Eason et al. 1993b Laboratory, 20°C 1080 no longer 
detected 
Field - aquaria in water After 2 days 
- plants in water After 7 days 
elimination of 1080 
traces in wetas and 2-8 weeks 
cockroaches 
King et al. 1994 Laboratory, 15-28°C, 1080 reduction m 6 days 
11 % soil moisture soil-50% 
-up to 87% 23 days 
Parfitt et al. 1994 Laboratory, 23°C Time for 50% 10 days (none after 
reduction of 1080 in 27 days) 
At l0°C soil (Kaitoke Silt 30 days (traces after 
Loam), and level 120 days) 
At5°C remaining at end of 80 days (traces after 
experiment 120 days) 
Laboratory, 21 ° C Elimination of l 080 
in water 2-6 days 
Gooneratne et al. Laboratory, warm 1080 in 1080-killed 1080 still present 
1994 rabbit after 3 weeks 
Wong et al. 1991 Laboratory, warm, Loss of 1080 from 
moist baits 
- oat baits, 4 weeks 
71 % loss 
- meat baits, 4 weeks 
14% loss 
Legal case* Field, winter Sheep killed by baits Still toxic at 6 weeks 
1987 
Fleming and Parker Field, winter Loss of 1080 from 
1991 meat baits-75% 7 weeks 
-85% 32 weeks 
David and Gardiner Laboratory, warm, Loss of toxicity to 
1966 moist aphids feeding on 
plants 111 1080-
treated soil 
-at 10 ppm 1080 2 weeks 
-at 50 pm 1080 11 weeks 
Modified from Office of the Parliamentary Commissioner for the Environment 1994. 




Compound 1080 is dissolved easily in water, so generally it is washed out of baits by 
rainfall. Once it is washed into the soil, common soil bacteria and fungi break it down 
(Walker and Bong 1981; Wong et al. 1991). Degradation of 1080 treated baits 
depends upon climatic conditions. Breakdown is most rapid at higher temperatures 
(Chenoweth 1949) and wet conditions and slower in cold and dry environments 
(Hamilton and Eason 1994; Batcheler 1978). To illustrate, on average the toxicity in 
carrot baits is reduced to about 10% or less of the original concentration when exposed 
to about 100 mm of rain (Livingstone and Nelson 1994). However, this study appears 
not to support the finding by Bowen et al. (1995) where it was reported that no decline 
in 1080 concentration after 200 mm was observed in carrot baits. Given the fact that 
the aerial application of 1080 is generally done during winter months, it is likely that 
1080 could persist in cold water streams for some time because it might survive 
without breakdown long enough to be carried quite a considerable distance 
downstream. 
Field water monitoring programmes for aerially sown 1080 baits undertaken between 
1990 to 1997 demonstrated that generally, trace amounts of 1080 found close to the 
limit of detection (0.0003 mg C 1) were in 5.8% of the 761 water samples tested (Eason 
1997). Highest concentrations of 1080 found in some locations ranged between 0.2 µg 
L-1 to 3.5 µg L-1 One hundred tonnes of 0.08% 1080 cereal-based baits were aerially 
applied over 17 000 ha of forest in the Waipoua Forest Sanctuary and streams and 
rivers were monitored for 4 months. Similarly, Rangitoto Island was aerially sown 
with 20 tonnes of 0.08% 1080 cereal-based baits over 2 300 ha. There was no 1080 
detected in any of the water samples tested (detection limit of 0.0003 mg L-1) (Eason et 
al. 1992). Blackstone Hill was aerially treated with 0.023% 1080 carrot baits and 
streams and rivers were monitored for 4 weeks after the operation. Measurable 
amounts of 1080 occurred within 48 hours of the operation in two samples (0.0003 and 
0.0006 mg L-1) and no detectable levels of 1080 (detection limit of 0.0003 mg L-1) was 
measured after the 48 hour period (Hamilton and Eason 1994). 
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In Taranaki, the possum control operation involved 11 000 ha of Egmont National 
Park, 1 900 of rateable bush and 4 090 ha of pastoral land. Variable traces of 1080 
(<0.003 mg L-1) were found in some samples (detection limit of 0.0003 mg L-1) (Parfitt 
et al. 1994). Water analysis after major operations from 1990 to 2002 is shown in 
Appendix 1. In contrast, 1080 solutions prepared in distilled water and stored at room 
temperature for 10 years showed no significant breakdown. Additionally, 1080 in 
stagnant algal-laden water did not lose biocidal properties during 12 months (Mcilroy 
1981a). Eisler (1995) suggested that more research would be required to determine the 
persistence of 1080 in aquatic environments. 
A recent study carried out by the National Institute of Water and Atmospheric (NIWA) 
Research Ltd. suggested that the water sampling programmes to date (see Appendix 1) 
showed a large number of "zero" detection levels of 1080 and its non-detection may 
reflect the absence of baits within streams ( detection limits of 0.0003 mg L-1 and 
0.0001 mg L-1). Evidence to support this view is that both the Lewis Pass and Moana-
Ruru streams 1080 drops had no baits in them (Suren and Lambert 2004). The fate of 
baits in moving water and the rate that 1080 leached from the baits were evaluated by 
laboratory experiments. 
Suren and Lambert (2004) claimed that although the actual baits (Wanganui No.7) 
were expected to remain in a stream for up to 72 - 84 h before they disintegrated, 
examination of 1080 concentration in the baits showed that over 50% of this 
compound had leached from baits within the first 8 - 12 h after being submerged. By 
24 h, the baits contained only 0.019% 1080, a loss of over 90% of the original 1080 in 
the baits (0.15%). Hence, the same authors concluded that water samples should be 
collected within 8-12 hours after 1080 operation but not after 24 hours to determine the 
presence of 1080. However, the 'over' 90% loss reported by Suren and Lambert was 
not factually correct as the loss only equated to 87% loss. 
2.1.2 Soil 
The fate of 1080 in soil has been studied extensively. It is water-soluble and residues 
from uneaten baits leach into the soil. Compound 1080 is degraded to non-toxic 
metabolites such as glycolate by soil microorganisms, usually through cleavage of the 
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C-F bond (Walker and Bong 1981; Wong et al. 1992b; Eason et al. 1993b). The soil 
microorganisms that can detoxify 1080 appear to be ubiquitous in the environment. In 
New Zealand soils, where the toxin does not occur naturally, several species of 
bacteria (Pseudomonas and Nocardia), fungi, and algae degraded fluoroacetate by 
defluorination (Kelly 1965; Batcheler 1978; Bong et al. 1979). Soil microorganisms 
capable of defluorinating 1080 include Aspergillus fumigatus, Fusarium oxysporum, at 
least 3 species of Pseudomonas acidovorans, Pseudomonas jluorescens, an 
unidentified Pseudomonas sp., Nocardia spp., Penicillum purpurescens and Penicillum 
restrictum. The most effective defluorinaters in solution and in soils were certain 
strains of Pseudomonas, Fusarium, and Penicillium (Wong et al. 1991, 1992a; Walker 
1994) and in moist soils by the Nocardia groups (Batcheler 1978). 
Compound 1080 was unlikely to be persistent in the environment for long periods of 
time. Biodegradation of 1080 depended on factors such as temperature, moisture, 
species of microorganisms present, availability of nutrients and the toxin to the 
microorganisms, and under some conditions may take several weeks or months. Parfitt 
et al. (1994) found that 1080 persists in bait, the soil, or in carcasses for several weeks 
or even months in cold or dry conditions. 
Biodefluorination of 1080 by soil bacteria was maximal under conditions of neutral to 
alkaline pH and at soil moisture contents of 8-15% and temperatures ranging from 15-
300C. Biodefluorination of 1080 by soil fungi was maximal at pH 5 (Wong et al. 
1992b ). The defluorination of 1080 was low when 1080 was the sole carbon source. 
However, it was enhanced in the presence of an alternative source such as peptone-
meat extract (Wong et al. 1991; Bong et al. 1979). 
2.2 Exposure pathways 
2.2.1 Secondary poisoning 
Compound 1080 has posed a high degree of secondary hazard to humans and other 
susceptible species, both during and after the intended control operations. Secondary 
poisoning can occur when a predator or scavenger eats poisoned animal or poisoned 
baits (Calver and King 1986). Compound 1080 in carcasses can create a secondary 
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poisoning hazard to carnivorous predators (Bell 1972). Because of the vegetable 
origin of the baits, they may be eaten by other herbivores, such as sheep, cattle, or 
various species of native wildlife. This may then lead to both primary poisoning (i.e., 
the toxic bait was ingested directly) and secondary poisoning of non-target animals 
(Mcllroy 1982). The potential risk of primary and secondary hazards from 1080 
baiting depends upon many factors including the susceptibility of the target and non-
target species, concentration in the bait, amount of bait applied, the number of 
consumed poisoned animals, the amounts of different consumed tissues or organs, and 
the time of year the bait is applied (Mcllroy 1981a; Hegdal et al. 1986; Mcllroy and 
Gifford 1992). 
Although laboratory studies have suggested that theoretically 1080 poses hazards to 
non-target species through both primary and secondary poisoning, field data are 
available to assess the effects of 1080 on non-target populations, such as that of 
Powlesland et al. 2003, Powlesland et al. 2005. Secondary poisoning has been 
recorded in New Zealand for dogs, stoats, ferrets, cats, and harrier hawks (Batcheler 
1978). Dogs are highly susceptible to 1080, and thus are at greater risk of toxicity 
(Rammel and Flemming 1978). Dogs generally die as a result of secondary poisoning 
after eating the carcasses of poisoned animals that have undigested 1080 baits in their 
stomachs (Livingstone 1994; DoC, AHB and MAF 1994; Meenken and Booth 1997), 
eating a single cereal pellet, or by licking some 1080 paste (Livingstone 1994; 
Livingstone and Nelson 1994). 
Previous studies have shown that mink are among the more sensitive species to 1080 
(Hornshaw et al. 1986) suggesting that mink might be a good model for studying 
secondary toxicity of 1080. However, when the gastrointestinal tract of the 1080 
poisoned rabbit had been removed from the carcass, no mink died when fed with the 
poisoned rabbit, suggesting that secondary toxicity from 1080 may heprimarily due to 
consumption of the unmetabolised compound from the gut of prey species and not 
from the muscle tissue (Aulerich et al. 1987). 
A study by Mcllroy and Gifford (1992) suggested that foxes, dingoes, dogs and cats 
appeared to be at greater risk of secondary poisoning than native birds and mammals, 
particularly from eating the muscle tissue from poisoned rabbits containing 1080 
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ranging from 0.01 to 4.88 mg of 1080 per rabbit. This is expected because muscles 
generally contained the highest amount of 1080 given their high proportion of total 
body weight. Secondary poisoning in man caused by eating venison, hearts or liver 
was regarded as unlikely, as is chronic poisoning from daily ingestion of tissues 
containing up to 9.2 ppm (Clarke et al. 1981). In New Zealand, the Maximum Residue 
Limits (MRL) for 1080 in food was specified as 0.001 mg kg-1 (default value) or at 
about the limits of detection. This value was estimated to be 9000 fold lower than 9 .2 
ppm mentioned by Clarke et al. (1981). 
The concentration of 1080 used in baits and the amounts of bait eaten by different 
animals may also affect the risk that carrion-eaters face from secondary poisoning 
(Mcllroy and Gifford 1992). Domestic cats may also be poisoned by eating rodents 
and birds killed by 1080-poisoned bait (Gosselin et al. 1984). Ground squirrel control 
with 1080 baits has caused secondary poisoning of dogs, cats, coyotes, bobcats, 
skunks, and kit foxes (Hegdal et al. 1986) and domestic ferrets that ate 1080-poisoned 
white-footed mice (Peromyscus leucopus) (Hudson et al. 1984). Similarly coyotes 
died after ingestion of 1080-poisoned ground squirrels (Casper et al. 1986; Marsh et 
al. 1987). However, ·there is no evidence of secondary poisoning seen in coyotes, 
domestic dogs, striped skunks (Mephitis mephitis), and black-billed magpies fed with 
dead coyotes poisoned by 1080 (Burns etal. 1986). Similarly, secondary poisoning in 
Virginia possums (Didelphis virginiana), and striped skunks was not observed after 
ingesting dead coyotes (Eastland and Beasom 1986; Burns et al. 1991). The risk of 
secondary poisoning to predators was minimal in the consumption of tissues of 1080-
killed black-tailed prairie dogs ( Cynomys ludovicianus) because of the very low level 
of 1080 in their tissues (Huggins et al. 1988). 
Vomitus containing 1080 has been potentially hazardous to non-target animals that eat 
it (O'Brien et al. 1986). Because 1080 exerts an emetic action especially in coyotes 
and feral pigs, non-target animals were at risk of primary poisoning from eating the 
vomitus (Atzert 1971; Mcllroy 1983; Rathore 1985; O'Brien et al. 1986, 1988). Pigs 
commonly vomit after ingesting 1080 (Mcllroy 1983) and vomiting was an obvious 
and consistent early sign of 1080 intoxication in feral pigs, occurring as little as 10 
minutes after ingestion. However, vomiting in no way assured survival. It has 
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occurred in all animals dying from 1080 intoxication and 94% of those that lived 
(O'Brien 1988). It has been suggested that this may enhance the survival of some pigs 
but increase the chance of killing other non-target species which eat the vomitus 
(O'Brien at al. 1986). Its main importance was its risk of secondary poisoning to non-
target animals. 
2.2.2 Human exposure 
2.2.2.1 Drinking water 
Under the Pesticides (Vertebrate Pest Control) Regulations 1983 (now repealed by the 
Hazardous Substances and New Organisms (HSNO) Act 1996), the Medical Officer of 
Health may grant a permit to apply 1080 in any water catchment area from which 
water was drawn for human consumption. The granting of a permit was mandatory 
provided the Health Act 1956 and the Pesticides (Vertebrate Pest Control) Regulations 
were not contravened. In granting permits, conditions may be imposed as the Medical 
Officer of Health has considered fit to meet local needs. Information provided by the 
local Public Health Units (PHUs) showed that all PHUs have granted permits to· 
aerially apply 1080 on to drinking water catchments (see Chapter 7 and Appendix 7 
relating to preliminary information collected by the author (NF) through the assistance 
of the PHUs). The HSNO Act also provides that designated authorities may grant 
permits to apply 1080 in a catchment area from which water is drawn for human 
consumption. Details of the current role of the Medical Officers of Health are 
provided in Chapter 7. 
In a poisoning operation some of the 1080 may enter a water source and pollute a 
potable water supply. This could happen by rain that may leach the 1080 from bait 
lying on the ground; or the bait may be inadvertently dropped directly into the water 
supply; or a poisoned carcass may enter a water supply (Rammel and Flemming 1978). 
As 1080 is highly water-soluble and may be leached by rainfall from toxic baits into 
the environment, this source of contamination has generated major public concern, 
particularly after aerial application of 1080 baits (Thomas 1994). 
15 
The rapidity with which 1080 is leached out of baits by rainfall will depend on a 
number of factors including the amount of rainfall, what kind of bait it is, the exposed 
surface area of the bait in relation to its mass, and on the strength of the absorption 
sites within the bait. Therefore, thinner pieces of bait will leach 1080 faster than 
thicker pieces of bait (Rammel and Flemming 1978). Wheeler and Oliver (1978) 
suggested that following moderate rainfall nearly all of the 1080 is lost from the oats 
baits. As a general rule, 5 mm of rain will reduce the chemical toxicity by up to 20%, 
10 mm by up to 70% and 20 mm of rain by up to 80% of toxicity (type of bait 
unspecified) (Taranaki Regional Council 1993). Thus, treated baits falling into a 
drinking water catchment could represent a significant source of contamination. 
Compound 1080 is prone to dilution because it is water-soluble. Landcare Research 
Ltd (Wright 2007) has prepared a set of guidelines for water sample collection and 
handling to assist DoC and the regional councils in their 1080 operations activities. 
The analytical techniques for 1080-water residue analysis which can detect 1080 at 
extremely low concentrations in water were developed by Landcare Research based on 
the work of Ozawa and Tsukioka (1987). Testing is carried out using a gas 
chromatography method. The water sample is acidified with hydrochloric acid and 
1080 is converted to the dichloroaniline derivative by using N,N' -dicyclohexyl 
carbodiimide and 2,4-dichloroaniline. The derivative is cleaned on a silica cartridge, 
eluted with toluene, and quantified by gas chromatography with electron-capture 
detection. 
Ground and surface water after aerial-1080 operations m Waipoua, Rangitoto, 
Taranaki, Central Otago and Wairarapa were analysed for 1080 residues. The great 
majority of samples from poisoned catchments showed no traces of 1080 at the 
detection limit of 0.3 µg L-1 (Eason et al. 1992). However, Taranaki and Central 
Otago samples showed trace levels (Meenken 1993). Single water samples were taken 
at different intervals, i.e., immediately after the application of the bait, after the first 
major rainfall, and during the first six weeks after the operation. According to several 
authors, such as that of Booth et al. 1997; Meenken and Eason 1995 and Parfitt et al. 
1994 there was no evidence of significant or prolonged 1080 contamination in surface 
and ground water. In addition, no detectable levels of 1080 were present in reticulated 
water. It should be noted that the water analysis for detecting the presence of 1080 has 
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become three times more sensitive since this report was published and is now 0.1 µg L-
I (0.1 ppb) in a 50 ml water sample (Wright 2007). 
Between 1990 and 2003, there were 1450 water samples tested (Fisher and Eason 
2003). The water samples were collected following aerial application of 1080 baits in 
large-scale possum operations and one rabbit control operation. Approximately 5% of 
the water samples tested showed detectable levels of 1080 (Fisher and Eason 2003; 
Eason and Wright 2001)). Eason (2002a) concluded that significant contamination of 
waterways following aerial application of 1080 baits is unlikely. The highest 
concentrations of 1080 in areas where it was found to be present range from 0.2 to 9.0 
µg L-I (see Appendix 1). However, Eason (2002b) reported that the water sample with 
9.0 µg L-I was collected by a worker with 1080 dust on his overalls and hands. 
2.2.2.2 Food 
The general public is more likely to encounter 1080 exposure through ingestion of 
trace amounts in food such as meat or milk. There were incidents reported to the 
Ministry of Health relating to feral meat and milk 1080 contamination exceeding the 
maximum residue limit (MRL) in foods of 0.001 mg kg-I (J. Simpers. comm. 1998). 
It was reported that 1080 had killed nine dairy cows after 1080 application in baits. 
The estimates showed that milk taken from surviving animals within the first 48 hours 
of the poisoning incident contained 1080 four times the allowable MRL in any food of 
0.001 mg kg-I even after the massive dilution within the silo milk. However, test 
results showed no detectable 1080 in the dry product or in the reconstituted milk (J. 
Sim pers. comm. 1998). The Ministry of Health issued a public statement that the 
dairy products were fit for human consumption. However, it would be of particular 
health concern if the milk taken directly from the cows was consumed by the public 
since it may contain unacceptable levels of 1080. 
From July 2002, responsibility for all food safety and quality issues was transferred 
from the Ministry of Health to the New Zealand Food Safety Authority (NZFSA) (see 
section 7.2.4). NZFSA considers meat from wild animals containing toxic residues as 
unsafe. It does not guarantee the safety or fitness of wild animals' meat as fit for 
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human consumption because recreational catch meat has not been subjected to any 
hygiene or processing standards, control or inspections. Recreational hunting is not 
regulated and there is no established testing regime in place (NZFSA 2005b ). 
Rammell and Fleming (1978) estimated that a human would have to eat 750 g of meat 
from a deer killed by 1080 before any toxic effect would occur and 10 kg before death 
was likely. This estimate was based on seven deer (LD50 0.5 mgkt
1
) that died from 
1080 poisoning. This is a large amount and it is unlikely that an adult human would be 
able to consume this in one sitting. Temple and Edwards (1985) estimated that a 70 kg 
man would have to eat 25 kg of meat from ducks killed with 14 mg kt1 doses of 1080 
to receive a lethal dose. This calculation would equate to 5 mg kg-1 which is 
consistent with the conclusion made by Gosselin et al. (1984) that 5 mg kg-1 is 
probably the best single estimated lethal dose value for humans although the same 
authors estimated that the mean lethal dose in humans ranges from 2 to 10 mg kg-1• 
Chenoweth (1949) reported a lower mean lethal dose (2 to 5 mg kg-1). It would appear 
that the lower bound on the lethal dose is 2 mg kg - l. 
The risk to humans from eating meat of domestic animals accidentally poisoned with 
high sub lethal concentrations appears to be minimal to low because 1080 is cleared 
rapidly from domestic animals, usually within a few days (Eason et al. 1994b). Using 
residue data from sheep, Eason (1993) and Rammell (1993) estimated that even in a 
worse case scenario, a 30 kg child would have to eat 500 g of meat from a sheep that 
had eaten one or two toxic baits within the previous 2-3 hours to receive a near-lethal 
dose of 1080. It is apparent that the older literature focussed on the lethal effect of 
1080, as has been highlighted by the author (NF). 1080 decomposes at 200°C 
(Sunshine 1969). This temperature however is very high and would basically bum 
meat to a crisp; 
In 1999, the Ministry of Health received a report that feral meat was contaminated with 
1080. The highest concentration of 1080 found in meat was 0.028 mg kg-1 which well 
exceeded the MRL of 0.001 mg kg-1 (default value). This incident has highlighted 
some human health implications. The Ministry of Health estimated that the "safe" 
human exposure level for 1080 was 0.1 µg kg-1bw dai1 (Durham 1998a). Estimation 
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of a "safe" human exposure level was calculated by using the NOAEL from the 
teratology study (Eason et al. 1998, 1999) of 0.1 mg ki1 dai1 /1000. 
Meat consumptions of 5 g, 150 g, and 624 g are shown below to demonstrate the likely 
exposure from eating contaminated meat. A 60 kg pregnant woman who had 
consumed 5 g of meat day-1 (consumption data from Food Standards Australia New 
Zealand then Australia New Zealand Food Authority), contaminated with 0.028 mg kg-
1 (highest level found in meat) will receive a dose of 0.0023 µg ki1 dai1 (5g * 0.028 
mg kg-1/60). This figure is 2.3% of the provisional "safe" human dose estimated at 0.1 
µg kg-1 bw day-1 (with built in 1000 UF). 
However, 5 g is a very tiny amount and 150 g of meat may be a more realistic figure. 
Therefore, a 60 kg pregnant woman who consumes 150 g of contaminated meat 
approaches a value of 0.07 µg kg-1 dai1 (150 g * 0.028 mg ki1/60 kg), which is still 
below an exposure of concern. 
An estimate using an upper consumption limit of 624 g of beef (this value was used as 
a surrogate for deer consumption) demonstrated that a woman consuming this large 
quantity of contaminated meat will receive a dose of 0.29 µg ki1 (624 g * 0.028 mg 
kg-1/60 kg) (Durham 1998a) which is approximately 3 fold above the "safe" dose and 
should be further studied as it might be of particular health concern. These estimates 
were calculated prior to the 90-day subchronic study. 
2.2.2.3 Air borne dust 
Aerial 1080 poisoning operations are usually applied in areas away from home and 
dust from poisoned baits may travel in the atmosphere especially during windy days. 
The public have raised concerns that this could be a potential route of 1080 exposure. 
An air-sampling programme was carried out during a 1080 aerial bait application 
(1080 bait concentration not specified) in the Tararua Ranges in the vicinity of 
Featherston, to ascertain whether 1080 dust was being carried in the atmosphere onto 
land bordering the drop zone. Bromley (1996) reported that three air samplers were 
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used for this purpose. Two samplers were placed at the edge of the drop zone and the 
third sampler was used to measure background levels. It was not reported whether 
dust formation is likely but the fibreglass filters were taken before, during and after 
1080 aerial application and the presence of 1080 was measured. Bromley (1996) 
reported the levels of 1080 to be below the limit of detection of 0.01 µg on the filter. 
The Ministry of Health concluded that airborne dust does not appear to represent a 
significant exposure (Durham 1998a). 
2.2.2.4 Baits 
The exposure to · 1080 baits is to a limited degree either through accidental or 
intentional ingestion of 1080 (Pelfrene 1991 ). Bait exposures were excluded from the 
exposure assessment (see Chapter 6) because they were not relevant for the purposes 
of developing a TDI for 1080. Relevant exposure scenarios used in developing TDis 
were drinking water, food, air, and soil intakes. Should there be any suspected 
exposure of the public to 1080 baits, the actual exposure ( and risk) would be estimated 
separately as the need arises. 
2.2.2.5 Exposure of children at home 
Children form a unique subgroup within the population. They have higher exposures 
and some higher susceptibilities that are quite different from those of adults. As with 
adults, the potential for exposure to 1080 for infants and young children is through 
ingestion, inhalation, and percutaneous absorption. A detailed discussion of child 
exposure is provided in Chapter 5. 
2.2.2.6 Others 
Occupational exposure 
Biological monitoring of occupationally exposed individuals was conducted in New 
Zealand, such as by O'Connor et al. (2000, 2001). Some urine results indicate an 
exposure higher than the Biological Exposure Index (BEI) set by the Department of 
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Labour (Workplace Services). It has been highlighted earlier that occupational 
exposures are outside the scope of this study and will not be discussed further. This 
information is mentioned here to illustrate that 1080 was detected while workers were 
engaged in 1080 related activities (see Appendix 8a carried out by this author (NF) 
with respect to 1080 worker's postal survey). 
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Chapter 3 
Physical, Chemical, Toxicokinetics and Toxicodynamics 
3.1 Identity, physical and chemical properties 
Sodium monofluoroacetate is also known as Compound 1080 or ten eighty (1080). 
This name is derived from: a labor:;1tory testing number used for the chemical in early 
USA experiments. The empirical formula for sodium monofluoroacetate is 
C2H3FNa02 with CAS number 62-74-8. It is a colourless, odourless, tasteless, highly 
water soluble salt that decomposes at about 200°C (Pelfrene 1991) and should not be 
heated above 110°C (Egekeze and Oehme 1979). 
It is hygroscopic when exposed to air, highly soluble in water, but relatively insoluble 
in organic solvents such as kerosene, alcohol or acetone or in animal and vegetable fats 
and oils. In general, 1080 is chemically stable due to the strength of the carbon-
fluorine bond. 
Its common name, Compound 1080 or 1080, will be used entirely throughout the text 
for simplicity. 
3.2 Stability of C-F bond and carbon-fluorine compounds 
The toxicity of 1080 depends on the stability of the C-F bond (Pelfrene 1991 ). Peters 
(1957) suggested that the C-F bond in fluoroacetic acid is very stable. The carbon-
fluorine compounds are not toxic themselves but become toxic due to "lethal 
synthesis". 
A defluorination system which cleaves the C-F bond of 1080 may serve as a protective 
mechanism in reducing the amount of fluoroacetate available for biotransformation to 
fluorocitrate (Kostyniak 1979). Kostyniak et al. (1978) have shown that defluorination 
in vivo may lead to a toxic response, but it is also possible that defluorination may 
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prevent the toxic effect and could minimise the production of fluorocitrate and the 
characteristic toxic response. The involvement of glutathione in the in vivo 
defluorination of 1080 in the rat liver has been verified by Kostyniak (1979) and the 
liver has been confirmed as the main site for defluorination of fluoroacetate (Twigg 
1994). Twigg et al. (1986) and Twigg and King (1991) stated that once glutathione 
levels were low, fluoroacetate was no longer effectively detoxified and the inhibition 
of aconitate hydratase and/or citrate transport in mitochondria is increased. It was 
further stated that low levels of fluoroacetate remained present in the plasma of skinks 
under study, despite extensive defluorination, for at least 96 hours. The liver 
glutathione levels remained low for up to 14 days (Twigg 1986). It is likely, therefore, 
that individuals with low glutathione levels, or who are unable to rapidly restore 
diminished glutathione, may be more susceptible to the toxic effects of fluoroacetate as 
glutathione plays a major role in the detoxification process of the toxic metabolite. 
However, this has not been confirmed by the author (NF) and there do not appear to be 
any cases to support this. 
The C-F bond was once assumed to be impregnable to biological attack. However, a 
number of reports offer evidence that the C-F bond may be relatively unstable (Gal et 
al. 1961) and the biological systems can defluorinate some of these compounds 
(Egekeze and Oehme 1979). For example, rats administered 5 ppm of 1080 in the 
drinking water for four months deposited as much fluoride in bone as did rats receiving 
5 ppm of fluoride as sodium fluoride (Smith et al. 1977). This suggested an in vivo 
defluorination reaction of 1080 or one of its metabolites (Egekeze and Oehme 1979). 
However, the biochemical mechanism of the C-F bond break is unclear (Gal et al. 
1961). 
It is not well known what happens to degradation products of 1080, particularly 
fluorocitrate, which is the active toxic agent synthesised from 1080 by organisms and 
likely to be present in the bodies of animals poisoned by 1080. Various micro-
organisms have the ability to catalyse the cleavage of the C-F bond of fluoroacetate, 
degrading fluoroacetate to glycolate and fluoride ions. This has been demonstrated by 
a number of researchers such as Goldman (1965), Goldman et al. (1968), Bong et al. 
(1979), and Wong et al. (1992a). Fluorocitrate is therefore assumed to be unstable in 
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the environment (Booth et al. 1999). Another study revealed a certain degree of 
instability of the C-F bond of the fluoroacetate administered to rats (Gal et al. 1961). 
Carbon-fluorine compounds are potentially very toxic and toxicity must be clearly 
distinguished from fluorides. Poisoning with 1080 is totally different from that 
produced by fluoride ion. In fluoroacetate, the fluorine is tightly bound in a fluorine-
carbon linkage, which can be split only by harsh treatment (Gajdusek and Luther 
1950). This statement is inconsistent with the findings of Egekeze and Oehme (1979) 
because the in vivo enzymatic reactions which produced the free fluoride should not be 
considered as harsh treatment. 
Fluorides are toxic when present in excessive amounts in soil and water. They can 
induce malformations of bone, fluorotic teeth in humans and other disorders in cattle. 
Skeletal fluorosis and an increased risk of bone fractures occurred at a total intake of 
14 mg fluoride/day and an increased risk of bone effects at total intakes above about 6 
mg fluoride/day. The lethal dose to the average adult has been estimated to be 
between 5 and 10g (32-64 mg fluoride per kilogram body weight) (IPCS 2002). Their 
action is different from that of the carbon-fluorine compounds such as 1080. The 
Drinking Water Standards New Zealand (2005) provides 1.5 mg/L Maximum 
Acceptable Value (MAV) for fluoride. For oral reasons, the Ministry of Health 
recommends that the fluoride content for drinking water be in the range of 0.7-1.0 
mg/L (this is not a MAV). 
3.3 Toxicokinetics and metabolism in laboratory animals 
Compound 1080 is absorbed through the gastrointestinal tract, open wounds, mucous 
membranes, and the pulmonary epithelium. It is not readily absorbed through the 
intact skin (Atzert 1971). It is quickly distributed to tissues. Oral dosages were found 
to have similar toxicity to subcutaneous, intramuscular, intravenous, and 
intraperitoneal dosages (Gajdusek and Luther 1950; Mcllroy 1981a, 1983). 
The required time for elimination of 1080 from tissues varied among species. Dogs 
required 2-3 days, rats 36 hours, and sheep as long as 1 month (Mcllroy 1981a). In 
another study (Eason and Gooneratne 1993b) rabbits, sheep, and goats were dosed 
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orally with 0.1 mg kg-1 1080 (approximately one-quarter the LD50). The plasma 
elimination half-life in rabbits, mice, goats and sheep was 1, 2, 5, and 11 hours, 
respectively, and tissue concentrations were consistently lower than plasma 
concentrations. This is consistent with the findings of Egekeze and Oehme (1979) Gal 
et al. (1961), Eason et al. (1993b) and Sykes et al. (1987) in that higher concentrations 
of 1080 were found in plasma than in major organs or tissues. Various species given 
0.1 mg kg-1 of 1080 demonstrated rapid elimination from plasma (within 18 hours, 24 
hours and 96 hours in goats, possums, and sheep respectively), and also from tissues 
(within 1-4 days in goats). Traces of 1080 detected amounted to less than 0.002 µg g-1 
(Eason et al. 1994a). It would appear that elimination in small animals, such as rabbits 
and mice, is faster than in larger animals, such as sheep, goats, or possums (Eason et 
al. 1994a). It would, therefore, not unreasonable to think that the half-life would be 
even longer in humans. 
Eason et al. (1994a) reported that the initial clearance of 1080 in urine in sheep dosed 
via a gastric cannula with an aqueous solution of 1080 at a dose of 0.1 mg ki1 
coincided with the decrease in 1080 plasma concentration during the first 48 hours. 
This suggests that approximately 70% of the dose is broken down in the 
gastrointestinal tract or metabolised in vivo (Eason et al. 1994b). 
Rammell (1993) suggested that 1080 concentrations in the muscle from sheep dosed 
orally at 200 µg kg-1 reached a maximum of about 110 ppb in 4 hours and decayed 
exponentially thereafter, with an elimination half-life of about 12 hours. In the liver, 
the maximum concentration of about 40 ppb was found at 2 hours, with an exponential 
decay thereafter, and an elimination half-life of about 3 hours. Elimination half-life in 
the liver appears to be about four times faster than that in the muscle, presumably 
because it is metabolised there. For ease of comparison, the elimination half-lives of 
mammals are summarised in Table 2. 
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Table 2 
Elimination half-life in plasma and muscle for sheep, goat, possum, 
rabbit, and mouse* 
Species Sample Route of Dose, Elimination 










* Eason et al. 1994b 
n.d. = not determined 
a Eason et al. 1993b 
b Rammel 1993 
c Gooneratne et al. 1994 
d Sykes et al. 1987 
3.4 Toxicodynamics 
administration mg kg-1 half-life 
(hours) 
oral 0.1 11.0 a 
oral 0.2 12.0 D 
oral 0.1 5.5 a 
n.d. 
oral 0.1 9.0 a 
n.d. 
oral 0.1 1.1 C 
oral 0.1 0.4 C 
iv injection 0.4 2.0 ° 
iv injection 0.4 1.7 Q 
Compound 1080 is a highly vertebrate toxic agent whose biochemical mode of action 
in vertebrates is known. The fluorine in 1080 is strongly bound to the co- carbon atom 
in the substituted acetic acid (Figure 1, adopted from Ramm.el and Fleming 1978). The 
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Figure 1 
Relationship of 1080 and acetic acid 
1080 disrupts the tricarboxylic acid (TCA) cycle (also known as the Krebs or the citric 
acid cycle), which is a complex metabolic pathway common to most organisms 
(Rammel and Fleming 1978; Peters and Wakelin 1953). The enzymes responsible for 
the reactions of the TCA cycle are all found in the mitochondrial fraction of the cell, 
mostly in the matrix, in proximity to the enzymes of the respiratory chain (Fruton 
1972). 1080 reacts with coenzyme A (CoA) in the presence of adenosine-5'-
triphosphate (ATP) to form fluoroacetyl CoA (Walker 1994). Fluoroacetyl CoA then 
combines with oxaloacetate to give fluorocitrate which in tum leads to aconitase 
inhibition which creates increased fluorocitrate and citrate. (In the normal TCA cycle, 
acetate condenses as acetyl-CoA with oxaloacetate to form citrate.). Figure 2 depicts 
the accepted view of biosynthesis of fluoroacetic acid to fluorocitrate ( adopted from 
Egekeze and Oehme 1979). 
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Figure2 
Accepted view of the biosynthesis of flu-0roacetate to fluorocitrate in the animal 
cell and the block of the TCA cycle at the citric stage caused by fluorocitrate 
Synthesis of fluorocitrate occurs in the mitochondria and the fluorocitrate formed 
inhibits mitochondrial aconitrate hydratase (aconitase) responsible for catalysing the 
conversion of citrate to isocitrate (Timbrell 2000) but does not appear to affect the 
cytoplasmic isozyme in vivo (Buffa et al. 1973). The inhibition arises from the fact 
that the aconitase is able to bind fluorocitrate but cannot carry out the dehydration to 
cis-aconitate as the carbon-fluorine bond is stronger than the carbon-hydrogen bond 
(Timbrell 2000). The aconitase inhibition leads to characteristic large citrate 
accumulation in certain tissues and is primarily responsible for the toxicity of 1080 
(Peters 1952, 1957). 
The accumulation of citric acid has been converted in vivo into fluorocitrate (Clarke et 
al. 1981; Fawaz and Fawaz 1953; Peters and Wak:elin 1953). Fluorocitrate, a 
metabolite produced in 1080 synthesis, is believed to be the active toxicant and is 
specific in its blocking action on aconitase (Peters 1963). Peters (1952) coined the 
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term "lethal synthesis" to emphasise that the actual toxicant 1s fluorocitrate, a 
metabolite of 1080 (Figure 3 ). 
Fluoroacetate 
Fluorocitric acid 
Inhibition of aconitase 
J, 
TCA cycle block 
Figure 3 
"Lethal synthesis" 
Fluorocitrate competitively inhibits the TCA cycle enzyme, aconitrate hydratase 
(aconitase) (Carrell et al. 1970) and blocks the TCA cycle at the citrate stage 
(Morrison and Peters 1954). With disruption of the TCA cycle, energy production, in 
the form of adenosine triphosphate, falls. Citrate and other breakdown products of fats 
and carbohydrates accumulate and cell functions are severely impaired. Death may 
result from: (a) respiratory arrest following severe convulsions, (b) gradual cardiac 
failure or ventricular fibrillation; or ( c) progressive depression of the central nervous 
system with either respiratory or cardiac failure as the terminal event (Peters 1957; 
Buffa et al. 1973; Twigg 1986; Chenoweth 1949). 
Peters (1963) suggested that no mammalian enzyme has been found that was inhibited 
by fluoroacetate in vitro. However, in vivo, the ion undergoes synthesis to form 
fluorocitrate and this inhibits mitochondrial aconitase. Since the citrate synthetase 
continues to work, citrate accumulates in the tissues. The accumulation of citric acid is 
the best evidence available that the Krebs cycle functions while the animal is still alive 
(Buffa and Peters 1950). 
Poisoning by fluoroacetate causes large increases in the citrate concentrations in mice 
and death occurs 24 hours after exposure to 1080 (Matsumura and O'Brien 1963). 
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Whereas Williamson et al. (1964) agreed that the initial effect of fluoroacetate is to 
produce fluorocitrate, they considered that the secondary inhibition of 
phosphofructokinase by the accumulated citrate was actually lethal because it deprived 
the cell of pyruvate, which would eventually overcome the inhibition of aconitase 
(Williamson et al. 1964). In addition, Buffa and Peters (1950) demonstrated that rats 
injected intraperitoneally with 5-10 mg kg-1 of 1080 produced large accumulations of 
citrate in most tissues within 1 h. 
The actual mechanism by which 1080 causes the death of an animal is not fully 
understood despite the fact that considerable information is available into the 
biochemistry of 1080 intoxication (Buffa et al. 1973). A study conducted by Lauble et 
al. (1996) was unable to answer whether or not the inhibition of aconitase by 4-
hydroxy-trans-aconitate (HTn) accounts for neurotoxic effects of 
fluoroacetate/fluorocitrate compounds despite the fact that HTn has been shown to be 
an extremely tight binding inhibitor of aconitase. 
Fluorocitrate was found to be at least 100 times more toxic than fluoroacetate when 
injected directly into the brain under various experimental conditi_ons. An intracerebral 
dose of 0.115 µg did not cause convulsions and failed to kill rats weighing about 250 
g, while doses of 0.287 µg or greater caused convulsions and killed almost all the rats 
(Morselli et al. 1968). A dosage of 40-60 mg kg-1 is necessary to kill by the ip route, 
and an oral dosage of 40 mg constitutes an LD50. The great difference was attributed 
to failure of fluorocitrate to reach aconitase within critical cells of the brain and the 
heart (Peters and Shorthouse 1971). 
Research conducted by Gal et al. (1961) showed that rats metabolise 1080 to non-toxic 
metabolites and can excrete monofluoroacetate as well as its toxic metabolite, 
fluorocitrate, in the urine (Atzert 1971). Gal et al. (1961) demonstrated that during the 
four-day exposure period after ip administration of 1. 77 mg kg -l of radioactive 1080 
into rats, 30-35% of a dose of 1080 administered to rats was excreted unchanged in the 
urine, and by the fifth day less than 0.2% was excreted. Furthermore, these authors 
concluded that there were unidentified metabolites present other than fluoroacetate and 
fluorocitrate. Urinary fluoroacetate sharply decreased after 48 hours while that of 
fluorocitrate reached maximum in 24 hours. The toxic metabolite fluorocitrate in the 
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urine represented only 3% of the total fluoroacetate-2-C14 administered. The same 
authors reported that the liver displayed no citrate accumulation, which may provide 
evidence that the conversion of fluoroacetate into fluorocitrate must be a minor 
pathway of fluoroacetate metabolism in the liver consistent with the findings of Buffa 
and Peters (1950). 
Kostyniak (1979) stated that administration of 375 mg diethylmaleate enhanced the 
toxicity of fluoroacetate in rats injected intraperitoneally with 1, 1.5, 2.5, 3.5, 4, 4.5, or 
5.5 mg kg-1 1080 due to a decrease in activity of the liver glutathione-dependent 
defluorinating system. Twigg (1986) reported that 15% depletion of glutathione levels 
in the rat was associated with a significantly greater elevation of plasma citrate levels 
in animals dosed with 1.5 mg kg-1 of 1080. Reduced glutathione plays a significant 
role during fluoroacetate poisoning. Glutathione is involved in the defluorination 
mechanism and also partially protects aconitase from the harmful effects of 
fluorocitrate (Twigg 1986; Mead et al. 1979). Mead et al. (1985) reported that 
fluorocitrate exerts its toxic action by covalently binding two glutathione-dependent 
enzymes which are located in the inner membrane of mitochondria. These enzymes 
are responsible for transporting citrate into and out of this organelle. 
The fluoroacetate defluorinating activity of several organs of the Swiss mouse was 
investigated by Soiefer and Kostyniak (1983). The liver contained the highest 
fluoroacetate defluorinating activity followed by kidney, lung, heart and testes with no 
activity detected in the brain. This result is consistent with the findings that the heart 
(Whittem and Murray 1963) and testes (Sullivan et al. 1979) are the critical organs to 
the toxic effects of 1080 demonstrating the least defuorination activity compared with 
other organs, such as the kidney and the liver. Fluoroacetate is metabolised in animals 
and undergoes defluorination by liver enzymes in the presence of glutathione. 
It was also demonstrated that the tolerance of emu to the toxic effects of 1080 could be 
largely attributed to emu's considerable capacity to detoxify fluoroacetate by 
defluorination via an enzymatic glutathione-dependent mechanism or to low 
susceptibility of aconitate hydratase to the fluorocitrate produced (Twigg et al. 1988). 
The detoxification process resulted to low citrate accumulation in the plasma (Twigg 
1986). 
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Adult rats administered with single doses of 1080 at 5.8, 3.3., and 1.8 mg kg-1 bw by 
stomach tube were sacrificed and the level of 1080 in their tissues analysed. Fasted 
rats given a total dose of 49.1 mg (equivalent to 5.8 mg kg-1 bw) and sacrificed at the 
end of five hours estimated 1.5 mg kg-1 1080 in the liver and 6.4 mg/kg in the heart. In 
urine and faeces, 0.23 mg kg-1 and 0.30 mg/kg were recovered, respectively. 
Surviving animals dosed with a single oral dose of 3.3 mg ki1 bw and sacrificed at the 
end of 24 hours showed levels of 1080 two-fold lower in sacrificed than dead animals 
which implied that animals continued to metabolise 1080 while still alive (Hagan et al. 
1950). Hagan et al. (1950) also found that animals given a total dose of 1.4 mg 1080 
and sacrificed at 48 h found O .14 mg kg-1 in the entire animal ( excluding skin) and O .17 
mg kg-1 was excreted in urine and faeces. This study suggested that among the target 
organs tested, the least amount of 1080 was always found in the liver consistent with 
previous studies presumably because of the role of the liver in detoxifying 
fluoroacetate. 
Male albino rats and male albino mice were administered either ip or orally with 
fluoroacetate but only ip to mice. Teele and Casida (1989) concluded in their study 
that the metabolic defluorination of fluoroacetate is attributable to both conjugation of 
fluoroacetate with glutathione and conversion to (-)-erythra-fluorocitrate, which is 
both an inhibitor of and a substrate for aconitase. The urine of rats and mice 
administered with fluoroacetate or (-)-erythra-fluorocitrate showed elevated levels of 
citrate and glucose and diminished urea consistent with disruption in the TCA cycle 
and ammonia metabolism. 
The metabolism of fluoroacetate in the skink (Tiliqua rugosa) and the rat (Rattus · 
norvegicus) was investigated by Twigg et al. (1986). Rats administered ip with 3 mg 
kg-1 bw in aqueous solution produced a five-fold increase in plasma citrate levels 
within 4 hours whereas skinks administered with 100 mg/kg bw showed a 3-4 fold 
increase in plasma citrate levels 48 hours after dosing. 
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3.4.1 Variation in susceptibility 
The sensitivity and exposure of animals to 1080 has formed the basis for assessing the 
potential risk of non-target animals being killed by the poison during pest control 
programmes. In many cases, measurements of sensitivity can provide this function, 
indicating which species are particularly tolerant and likely to survive ingestion of 
poison baits or other poisoned animals. 
Very young animals, such as the pouch young of marsupials, can be more sensitive to 
1080 than other members of their population, either by eating baits directly or 
indirectly by ingesting 1080 in their mother's milk (Mcllroy 1981b). The body weight 
is also important. Obviously the larger the body size of an animal is, the more 1080 it 
will have to ingest to receive a lethal dose (Mcllroy 1982). 
Compound 1080 exerts variable toxicity in different species. To illustrate, the LD50 
varies from 0.06 mg kt1 in the dog to over 500 mg kt1 in the South African toad, 
Xenopus laevis (Chenoweth 1949). Amphibians and reptiles are more resistant to 1080 
than mammals and birds because of their greater ability to detoxify fluoroacetate by 
defluorination, a reduced ability to convert fluoroacetate to fluorocitrate, and an 
aconitase hydratase enzyme that is comparatively insensitive to fluorocitrate inhibition. 
In reptiles, the LD50 value was greater than 54 mg kt
1 body weight (bw) while in 
amphibians the LD50 value was greater than 44 mg kt
1 bw (Eisler 1995). 
Warm-blooded species varied considerably in their response to 1080. A study of 
species sensitivity showed that among the warm-blooded species, primates and all 
types of birds were generally the least susceptible to 1080 poisoning, whereas the 
camivora and wild rodents appeared to be particularly sensitive (Chenoweth 1949). 
Among the 171 species of mammals for which there are data, variability was 
considerable in the time until signs of poisoning became apparent (0.1 hour to greater 
than 7 days), the time to death (0.1 hour to greater than 21 days), and the time until 
animals began to show signs of recovery (2 hours to 18 days) (Mcllroy 1986). 
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Mammals with low metabolic rates such as marsupial carnivores seemed to be more 
tolerant than mammals with higher metabolism such as eutharian carnivores to a 
poison such as 1080 that interferes with metabolism (Mcllroy 1981a, 1981b). 
Likewise, amphibians and reptiles, which have lower metabolic rates than birds and 
mammals, are less sensitive to 1080, while non-passerine birds, which mostly have 
lower metabolic rates than passerine birds, often seem to be more sensitive to 1080 
(Mcllroy 1984). The differences in sensitivity to 1080 appeared to be caused by 
species-specific metabolism, but it is not clear what exactly was involved (Mcllroy 
1984). 
The toxic effects vary amongst different animals. In some, it affected the heart while it 
caused tonic convulsions in others (Peters 1963). Among herbivores, 1080-induced 
deaths were due primarily to cardiac disorders; among carnivores, deaths were from 
central nervous system (CNS) disorders; and among omnivores, deaths were from both 
cardiac and CNS disorders (Atzert 1971). Some mammals also displayed 
parasympathetic nervous system effects including increased salivation, urination, and 
defecation and eventual cardiac failure (Hudson et al. 1984). There remain 
unexplained species differences in fatal 1080 poisonings. Dogs died from convulsions 
or respiratory paralysis, but monkeys, horses, and rabbits died from ventricular 
fibrillation (Murphy 1986). 
Compound 1080 acts mainly on the central nervous system and the heart. It seems that 
there are species in which fluoroacetate affected chiefly the heart, such as the rabbit, 
the goat, and the horse, and others in which only the central nervous system was 
affected, such as the dog, the guinea pig, and the frog. In the cat, the rhesus monkey, 
domestic pig, and birds, both systems are involved (Pelfrene 1991). 
In rats treated with 3mg ki1 of fluoroacetate, a five-fold elevation in serum citrate and 
15-fold increase in heart citrate accumulation were observed. In contrast, citrate 
accumulation in dogs was less pronounced exhibiting a 2-3 fold increase in the heart 
and serum (Bosakoswki and Levin 1986). Correlations were demonstrated between 
serum citrate levels and various biochemical changes in rats and dogs intoxicated with 
fluoroacetate. For dogs, serum citrate correlated well with heart citrate accumulation, 
elevated serum glucose, and depressed serum total calcium. For rats, serum citrate was 
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well correlated with heart citrate accumulation, heart ATP depletion, and elevated 
serum glucose (Bosakoswki and Levin 1986). Heart ATP depletion in dogs was not 
significantly affected in contrast to rats. Death is believed to result from repeated and 
prolonged convulsions and respiratory arrest, and not from cardiac changes 
(Chenoweth 1949). Dogs showed a longer latent period than for rat, even though dogs 
displayed a higher susceptibility to fluoroacetate. Although species differences were 
noted, serious clinical signs and death were always associated with highly elevated 
serum citrate levels. 
Signs of 1080 intoxication, such as nausea, vomiting, and heart or respiratory failure 
occurred in most species within 0.5 to 2 hours after ingestion (Eason et al. 1994b ). 
Most of the deaths in mammals generally occurred between 8 and 48 hours after 
ingestion of a lethal dose (Eason et al. 1994b ). 
3.4.2 Latent period 
A characteristic feature of fluoroacetate poisoning is the latent period, which usually 
ranges from 30 minutes to 2 hours before the onset of symptoms (Pattison and Peters 
1959; Atzert 1971; Twigg 1994). The length of the delay or latent period until signs of 
1080 poisoning appear has been accounted for by the time necessary for its metabolism 
and biochemical mode of action (Chenoweth 1949; Atzert 1971; Mcllroy 1982; 
Pelfrene 1991 ). Fluoroacetate metabolism was generally rather slow in most animals 
(Mcllroy 1981a), Hence, the latent period following the administration of 1080 and 
response via any route was unusually long and variable. This has been demonstrated 
in numerous studies (Chenoweth 1949; Atzert 1971; Hudson et al. 1984; Mcllroy 
1986; Batcheler 1978). Rabbits, mice, goats and sheep that received small sub-lethal 
doses of 1080 showed clinical signs, metabolised and excreted 1080 within 1-4 days, 
and then recovered (Eason et al. 1994b ). In general, herbivores such as possums 
exhibited signs of cardiac failure after ingestion of a lethal dose. In contrast, 
carnivores experienced predominantly central nervous system disturbances and 
convulsions with death due to respiratory failure (Egekeze and Oehme 1979). 
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3.4.3 Tolerance to sub-lethal doses 
Tolerance to 1080 is a time related phenomenon and exposure to repeated sub-lethal 
doses of 1080 has increased the tolerance of some species to the toxic effects of 1080 
(Atzert 1971). Kalmbach (1945) noted that laboratory white rats appeared to have 
acquired tolerance to 1080 by the ingestion of sub lethal doses for a period of 5-14 
days. Cessation of dosing for 7 days caused a loss of tolerance. Miller and Phillips 
(1955) found that a dietary level of 20 mg kg-1 (20 ppm) in rats inhibited the growth 
rate sharply during the first week. Rats gained tolerance to 1080 for less than two 
weeks and their growth rate gradually became normal within 3 to 4 weeks. Rats that 
had adjusted to 1080 showed a second retardation of growth when returned to a dietary 
level of 20 ppm after two weeks on a normal diet. It was also noted that rats 
conditioned to a dietary level of 20 ppm were then able to adapt to a dietary level of 40 
ppm. The amount of food given to test animals was not specified although the report 
mentioned that the dose was greater than the single LD50 dose per day. 
Mink and ferrets may also acquire some tolerance for 1080 (Hornshaw et al. 1986). 
This was evident when animals were given lower concentrations of 1080 in their diets 
during the first two weeks of the test. The same animals were able to tolerate greater 
concentrations of 1080 during the third and fourth weeks of the exposure period. 
Animals have developed tolerance to fluoroacetate in places, such as Australia and 
South Africa, where indigenous plants produce fluoroacetate. However, the 





4.1 Effects on Laboratory Animals and in vitro systems 
Beasley (1996) highlighted that there have been many studies conducted on the acute 
toxicity of 1080, in particular studies characterising the lethal dose. Although acute 
toxicity is outside the scope of this project, an overview has been provided in this 
chapter, as it has contributed to the greater understanding of the toxicological hazards 
of 1080. Only studies containing information that may assist in the human health risk 
assessment have been reviewed in detail. 
Studies on the possible toxic effects from repeated exposures are limited, and the few 
chronic studies available have employed relatively high doses, and/or unusual routes of 
administration, such as intraperitoneal injection. The results therefore may not be 
applicable to human exposures, since relevant exposures are by ingestion, inl).alation or 
dermal absorption. However, Chenoweth (1949) suggested that it appeared that there 
was no striking difference between non-percutaneous routes of exposures on the 
resulting toxic effects of 1080, i.e., whether it is administered orally, subcutaneously, 
intramuscularly, intraperitoneally or intravenously. Chenoweth (1949) further said that 
this phenomenon was uncommon in the field of pharmacology. This could probably 
due to the long latent period before symptoms can be produced, which allows time for 
absorption. Hence, all studies which are relevant to human exposures mentioned 
earlier have been considered for health risk assessment purposes. 
4.1.1 Acute toxicity 
Acute toxicity for purposes of this discussion is expressed as the median lethal dose 
(LD50), which is defined as the statistically derived single dose of a chemical that can 
be expected to cause death in 50% of a given population of organisms under a defined 
set of experimental conditions (IPCS 2000a) unless otherwise specified. 
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Acute oral toxicity 
Compound 1080 lacks one of the properties desirable in an ideal vertebrate toxic agent. 
It is a potent poison for all mammals, including humans. Compound 1080 is highly 
toxic to a wide range of animals by all common routes of administration. Most 
unadapted mammals have been fatally poisoned by less than 2 mg ki1 (Atzert 1971). 
Estimates of the mean lethal dose in humans range from 2 to 10 mg ki1 (Gajdusek and 
Luther 1950; Harrison et al. 1952). A lethal dose of 1080 in humans caused· either 
nervous system (e.g., convulsions) or cardiac effects after a latent period (Harrison et 
al. 1952). Symptoms of 1080 intoxication included laboured breathing, vomiting, 
lethargy, muscular incoordination, weakness, and tremors (Chenoweth 1949; Atzert 
1971; Hudson et al. 1984; Murphy 1986; Eason and Frampton 1991). 
Mammals were the least resistant tested group against 1080 but a wide difference in 
the LD50 between mammals was also noted. Individuals of sensitive species died after 
receiving a single dose of 0.05-0.2 mg kg-1 bw. The difference in sensitivity by a 
number of species including the route of administration is illustrated in Table 3. 
38 
Table 3 
Acute toxicity after single administration of 1080* 
Species Route LDso (mg kg -1) 
Rat Oral 0.22 
Rat Oral 2.5 
Rat Oral 1-2 
Rat Intraperitoneal 3-5 
Mouse Subcutaneous 19.3 
Mouse Subcutaneous 17.0 
Mouse Intraperitoneal 10.0 
Mouse m,.traperitoneal 16.5 
Mouse Intraperitoneal 14.7 
Guinea pig. Oral 0.4 
Guinea pig Intra peritoneal 0.37 
Rabbit Subcutaneous 0.28 
Dog Oral 0.06 
Cow Oral 0.39 
Calf Oral 0.22 
Possum Oral 0.79 
Mallard duck Oral 4.8 
South African clawed toad Oral 500 
(Xenopus laevis) 
* Source: Pelfrene 1991 
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Acute dermal toxicity 
Four dose levels of 1080 paste (vehicle unspecified) were dermally applied to rabbits 
and the estimated LD50 was 324 mg kg-
1 for females and 277 mg kt1 for males. Based 
on these data, 1080 was classified as a dermal toxicant (Fagerstone et al. 1994). Atzert 
(1971) suggested that 1080 is poorly absorbed ih intact skin. However, the results 
from this study demonstrate that the oral toxicity is 200 times more than the dermal 
. toxicity and this implies that less than 1 % absorption occurs. 
a. Primary dermal irritation test 
One percent 1080 (vehicle unspecified) was kept in contact with the skin of rabbits for 
4 hours. The compound did not cause significant erythema and oedema and mild or 
slight dermal irritation was observed at 72 hours (Fagerstone et al. 1994). 
b. Primary eye irritation test in rabbit 
One percent 1080 solution (vehicle and volume not stated) was applied to the 
conjunctiva! sac of the eye, causing slight conjunctiva! irritation and no corneal opacity 
or iritis (Fagerstone et al. 1994). 
4.1.2 Single/Repeated exposure 
a. Reproductive toxicity 
Effects on testes 
Reduction in plasma testosterone concentrations and degeneration of seminiferous 
tubules were observed in lizards exposed to repeated sub lethal doses equivalent to 100 
and 200 mg kg-1 daf1 for 15 days (Twigg et al. 1988). Savarie (1984) also observed 
that 1080 exposures resulted in testicular damage and elevated concentrations of citrate 
after the 15-day exposure period (Twigg et al. 1986). Degeneration of seminiferous 
tubules was observed in testes from some of the lizards treated at a single dose of 100 
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or 250 mg kt1• Some lizards received multiple doses of 5 (5x), 20 (5x), or 50 mg kg-1 
day-1 (5x) for 15 days. The lowest dose in the study was 5 mg kt1 which was 20-fold 
higher than the highest dose used in the pivotal study exhibiting overt signs of 
testicular toxicity in rats. Sullivan et al. (1979) considered that the testis was the organ 
most vulnerable to 1080 poisoning. Overt signs of toxicity were observed in rats 
weighing 165-180 g after 7 days exposure to 1080 at concentrations of 6.6 ppm 
(ingested a daily average of 0.037 mg rat -I or 0.18 mg kg-1) or 20 ppm (ingested a 
daily average of 0.14 mg rat -I or 0.71 mg ki\ Six rats per group were euthanised 
daily during the 7-day treatment and others at 3, 7, 14 and 21 days after the end of each 
treatment period. These effects included decreased testicular weight, morphological 
damage to the testes, degeneration of seminiferous tubules, and altered 
spermatogenesis. Regeneration started to occur on the ih day of treatment and 
spermatogenesis was still abnormal by day 21 after treatment. Testicular changes in 
rats exposed to 2.2 ppm 1080 (ingested a daily average of 0.016 mg rat-1 or 0.078 mg 
kg-1) were not as widespread as those exposed at higher concentrations of 1080 and all 
testes were histologically normal 7 days after treatment. Because of the short exposure 
time, this study is not comparable to the 90-day study of Eason et al. (2001) and Eason 
and Turck (2002) where the rats under study did not recover during the 56-day 
recovery period. 
Five Sprague-Dawley rats weighing 400-450 g were administered 20 ppm 
fluoroacetate in drinking water for 7 days. There were sharp decreases in sperm counts 
during treatment, but the sperm counts of all animals, after treatment, were practically 
zero in approximately 3 weeks. Sixty-five days after treatment, partial sperm count 
recovery was observed in two of these rats. The five treated rats all showed advanced 
patchy degeneration changes, primarily sloughing and aggregation of spermatozoa, 
which fused to form striking multinucleated forms. Several tubules also showed an 
intermediate coagulative necrosis. In all five rats, both epididymides contained 
luminal cellular necrosis (Al-Juburi et al. 1989). Al-Juburi et al. (1989) claimed that 
the rats were treated with doses of fluoroacetate similar to those used by Sullivan and 
co-workers (1979) and that the results were similar. However, direct comparison 
cannot be made because Al-Juburi et al. (1989) only provided the concentration of 
1080 while the water intake was actually measured by Sullivan et al. (1979), which 
permitted estimates of fluoroacetate ingested by animals. 
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In another study, laboratory rats exposed for a period of approximately four months to 
26 ppm of 1080 in drinking water ( consumption volumes not specified) showed severe 
damage of the testes, characterised by massive disorganisation of the seminiferous 
tubules, nearly total loss of functional cells, absence of sperm, and damage to the 
Sertoli cells (Smith et al. 1977). Regressive modifications of the semi.niferous tubules 
were observed by Mazzanti et al. (1965) in the testes of albino rats. No NOAEL1 was 
established from this old.er study. The main objective was·ascertaining the presence of 
fluoride ,in the skeletal system .. This study was written in Italian and only a very short 
summary was provided in English, describing only the testicular effects of 1080. 
Eisler (1995) noted that sublethal effects of 1080 included testicular damage in rats 
after exposure to 0.07-0.71 mg ki1 drinking water for 7 days. This study 
demonstrated that .testicular effects of 1080 were · manifested after a relatively short 
.period of time and consistently at high levels of exposures. 
A dose-response relationship was observed in minks and ferrets after dietary exposure 
to 1080. Minks suffered severe impaired reproduction presumed to be due to oligo- or 
aspermia, or spermatopathy after dietary exposure to 0.80 ppm of 1080 for two months 
(Hornshaw et al. 1986) .. Animals were fed with diets containing 0.05, 0.20 or 0.80 
ppm of 1080, resulting in estimated average dose of 0.01, 0.045, and 0.165 mg daf1, 
respectively based on their daily food consumption. No NOEL/NOAEL was reported 
from this study. In the same study, young ferrets were exposed to 1.08, 1.94, and 3.50 
ppm of 1080, resulting in an estimated average dose of 0.26, 0.40, and 0.60 mg day-1, 
respectively based on their daily food consumption. Reduction in testes weights was 
observed at 1.94 and 3.50 ppm of 1080 (significantly different from control, p::;;0.05). 
In comparison, adult ferrets were exposed to 4.76, 8.56, and 15.40 ppm of 1080, 
resulting in estimated average doses of 0.66, 0.84, and 0.80 mg day-1, respectively, 
based on their daily food consumption. Testes weights, although reduced, were not 
significantly different from the control. This illustrates that young ferrets were more 
1 NOAEL is the highest exposure level at which there are no biologically significant increases in the 
frequency or severity of adverse effect between the exposed population and its appropriate control; some 
effects may be produced at this level, but they are not considered adverse or precursors of adverse effects 
(IPCS 2000a)). . 
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susceptible to the toxic effects of 1080 than adults with regard to testes weight because 
their food consumption is almost twice than the adults, i.e., cumulative food intake for 
4 weeks is 6,937 g vs 3,528 g. 
In another study (Shinoda et al. 2000), single oral doses of 1080, either 0.5 or 1.0 mg 
kg-1 was administered for a short period of time. Sprague-Dawley rats showed signs of 
testicular toxicity after a single oral dose of 1.0 mg kg-1 and were sacrificed 6 to 72 
hours later. Necrosis in spermatids, probably resulting from rapid and severe 
adenosine triphosphate (ATP) depletion, and apoptosis in spermatogonia from gradual 
and partial ATP depletion, was observed. At a later stage, it was noted that 1080 
inhibited spontaneous spermatogonial apoptosis. 
In an investigation carried out by Wolfe (1988) to evaluate the subchronic toxicity of 
1080, Sprague-Dawley rats were dosed by oral gavage with 0.05, 0.20, and 0.50 mg 
kg-1day-1 1080 for a period of 13 weeks. Treatment-related findings included 
decreased testes/epididymides weights, testicular changes and immature/abnormal and 
reduced number of sperms in the epididymal ducts and epididymides. A NOEL of 
0.05 mg ki1daf1 was ·reported in this study. In another study (Eason et al. 2001; 
Eason and Turck 2002), Sprague-Dawley rats, about 6 weeks of age, were dosed with 
1080-treated water at 0.025, 0.075, and 0.25 mg ki1daf1 by oral gavage for 90 days. 
Findings at necroscopy ( date of terminal sacrifice not specified) included severe 
hypospermia of the epididymis and severe degeneration of the seminiferous tubules of 
the testes in male rats dosed with 0.25 mg kg-1daf1• It was confirmed that recovery 
from testicular damage did not occur even after 56 days without treatment. The 
NOAEL for rats administered with 1080 via oral gavage for 90 days was 0.075 mg 
ki1daf1• The spacing between doses in these two studies is relatively close with one 
another, therefore the LOAELS and NOAELS should not be considered significantly 
different. 
b. Myocardial toxicity 
Rammel (1993) and Eason et al. (1994b) claimed that cumulative damage to the heart 
or other organs from repeated exposure to large sublethal doses of 1080 can occur in 
sheep (Ovis aries). Smaller doses of 1080 given at regular intervals produced 
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cumulative effects (Annison et al. 1960) and resulted in myocardial damage in sheep, 
probably due to increased accumulation of citrate in the heart. The cumulative effect 
of 1080 has been noted in other species, such as the rat. This has been attributed 
largely to the slowness of the kidney in clearing fluoroacetate in the body (Chenoweth 
1949). Sheep were affected differently from rats in that further doses following the 
initial administration of 1080 proved to be fatal. Rats were able to tolerate non-fatal 
dose of 1080 for the next 24 to 36 hours following further administration of 1080. 
This finding appeared to suggest that larger animals are affected differently than 
smaller animals. However, there has been little reliable information on 1080's action 
and toxicity in the larger domestic animals (Annison et al. 1960) and therefore the 
observed differences could not be directly compared. Whether or not elimination 
mechanisms in larger animals, such as sheep, are relevant to humans has remained 
unknown. 
It has been suggested that 1080 was rapidly eliminated in all species tested, hence it is 
not cumulative (Rammell 1993), but repeated exposure to sublethal doses of 1080 can 
result in cumulative damage to the heart or other organs (Peters 1963; Annison et al. 
1960). Inflammation of the heart occurred in rats exposed to 1080 at dosages of 0.05, 
0.20, and 0.50 mg ki1dai1 for 13 weeks by oral gavage (Wolfe 1988). 
Merino sheep treated with a single high dose of 0.5-1.0 mg ki1 bw 1080 dosed by 
stomach tube on Lucerne hay exhibited myocardial lesions which were sometimes 
inconspicuous. Multifocal areas of necrosis in various stages of development were 
observed in animals subacutely and chronically treated ( over 167 days in one sheep) at 
a lower dose range of 0.05-0.1 mg kg-1dai1 (Schultz et al. 1982). This latter 
experiment was conducted at various duration of exposures, e.g., 41, 66, 33 days. 
The citrate content of hearts of rats injected intraperitoneally with 20 mg kg-1 bw was 
examined, and citrate accumulation was observed in 1080-poisoned tissues 
(Williamson et al. 1964). The 1080 treatment was given 30 minutes before the hearts 
were removed. The results suggested that although the initial effect of fluoroacetate is 
to give rise to fluorocitrate and disrupt the TCA cycle, the secondary inhibition of 
phosphofructokinase by the accumulated citrate was lethal. This was due to the cell's 
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deprivation of pyruvate which would eventually overcome aconitase inhibition 
(Williamson et al. 1964). 
Acute multifocal injury to the myocardium, after 1080 doses as low as 0.11 mg 
kg-1daf1 for 3-7 days, was observed in several research studies carried out in Australia 
(Eason et al. 1994b). Whittem and Murray (1963) demonstrated mild but 
characteristic cardiac histopathology in sheep dosed with 0.055 mg kg-1daf1 of 
fluoroacetate by stomach tube, and typical cardiac histopathology at 0.11 mg ki1 
day-1. However, the duration of this study was not specified. The same authors 
compared the poisoning arising from the gidea plant (Acacia georginae) and potassium 
fluoroacetate poisoning in sheep, One group of sheep was fed with powdered gidea 
and another with purified potassium fluoroacetate at similar dose rates, i.e., 0.22 mg 
potassium fluoroacetate kg-1 daf1 equivalent to 7.3 g powdered gidea leaf ki1 daf1. 
This comparison was made based on the assumption that all organically bound fluorine 
in gidea was as toxic as potassium fluoroacetate, for an unspecified period of exposure. 
Because palatability became a problem, sheep were fed by stomach tube with either a 
watery suspension or various extracts of finely hammer-milled gidea leaves. Similar 
symptoms, such as sudden collapse, spasmodic breathing, and typical cardiac 
histopathology, such as acute myocardial damage were observed in animals fed gidea 
which suggested that fluoroacetate in gidea was as toxic as potassium fluoroacetate. In 
the same study, similar acute myocardial lesions were found in the hearts of sheep and 
guinea pigs treated with potassium fluoroacetate. Whittem and Murray (1963) 
suggested that the most susceptible target organ is the myocardium as revealed by the 
pathologic lesions. 
Peters et al. (1972) and Savarie (1984) suggested that fluorocitrate was present in 
smaller amounts than fluoroacetate and it was not as toxic as fluoroacetate after oral 
ingestion or parenteral administration. These authors further concluded that the 
decreased fluorocitrate toxicity was apparently due to its larger molecular size, which 
would not be so readily absorbed through tissues. The toxic principle in gidea was 
identified as the fluoroacetate ion by conversion to the butyl ester and the use of gas 
chromatography. Infra-red absorption spectra confirmed the identification of 
fluoroacetate (Oelrichs and McEwan 1961). 
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Eason et al. (2001) and Eason and Turck (2002) noted increases in heart weight in both 
male and female Sprague-Dawley rats, about 6 weeks of age, when compared with 
controls. The test animals were treated with 1080 in drinking water at doses of 0.025, 
0.075, and 0.25 mg ki1dai1 by the oral route for a period of 90 days. No effects were 
noted in the lower dose groups. Cardiomyopathy was only seen in 50% (10/20) of 
males dosed with 1080 at 0.25 mg kg-1dai1 and 5% (1/20) female rat, suggesting a 
gender difference. The NOAEL for rats was reported to be 0.075 mg kg-1dai1 by the 
same authors. 
c. Developmental toxicity (teratogenic effects)) 
Spielmann et al. (1973) found no macroscopically visible malformations in female rat 
embryos after exposure to single doses of 1 mg kg-1 1080 on days 9, 10, or 11 of 
pregnancy and killed at day 20. No abnormalities were detected by examination of 
skeletons stained to detect abnormalities (stain not stated) and retardation of 
ossification. The authors concluded that 1080 was not teratogenic. However, this 
conclusion was in contrast to the findings of De Meyer and De Plaen (1964) who 
found that 1080 administered intraperitoneally on the 9th day of pregnancy in rats at a 
dose of 600 µg had caused eye anomalies, syndactylia and evisceration. The authors 
did not provide further details about the teratogenic study and the teratogenic effects 
reported were only mentioned in the introduction of their paper. 
A more recent study by Eason et al. (1998, 1999) confirmed that 1080 caused 
developmental defects in rats when pregnant females were exposed to 0.10, 0.33 and 
0.75 mg kg-1day-1 of 1080 diet by the oral route on a daily basis during the period of 
organogenesis (from days 6 through to 17 of gestation). The highest dose (0.75 mg kg-
1dai1) showed irreversible limb abnormalities and the next highest dose (0.33 mg kg-
1dai1) showed reversible rib defects. A NOAEL was reported at 0.10 mg ki1 
dai1• Although Spielmann et al. (1973) used a higher dose than that used by Eason et 
al. (1998, 1999), the two studies cannot be directly compared since only a single dose 
was used by Spielmann et al. (1973) as opposed to the multiple doses used by Eason et 
al. (1998, 1999). De Meyer and De Plaen (1964) also confirmed positive teratogenic 
effects although no further information was provided, as mentioned earlier. 
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The Ministry of Health considered that this teratology study demonstrated that 1080 
was a teratogen in the rat strain in that it caused irreversible abnormality in offspring at 
exposure levels (in the dams) which were below those that caused maternal toxicity 
(Durham 1998a). 
d. Renal toxicity 
An earlier study by Cater and Peters (1961) investigated acute 1080 poisoning in rats 
and reported swelling and blockage of the proximal convoluted tubules and distension 
of the Bowmans capsule. · High doses of 1080 administered intraperitoneally were 
applied in this case, i.e., 60 or 80 mg kg-1 causing death in some animals within about 
2 hours. Rats subjected to multiple doses of fluorocitrate totalling 150 mg ki1 (15 mg 
kg-1 on day 0, 10 mg on day 1, 5 mg/day on day 2 and 3, 10 mg on day 4, 15 mg on 
day 7, 60 mg on day.9 and 30 mg on day 10) in 10 days, showed changes similar to 
those found in the kidneys of patients dying with lipid nephrosis, i.e., fatty 
degeneration in the walls of the arcuate, interlobular and glomerular arteries (Cater and 
Peters 1961 ). The exact period of exposure was not stated and the expression "in 
about" was used consistently in the report. As acknowledged by the authors, the single 
doses used were lethal and multiple doses were consistently very high. The doses 
applied were several fold higher than the maximum dose used by Eason et al. (2001) 
and Eason and Turck (2002) of 0.1 mg kg-1• 
Single intraperitoneal injection of large doses of 1080 (15 or 60 mg kg-1 bw) in rats 
resulted in swelling of the proximal convoluted tubules of the kidney at 15 mg kg-1. 
This change persisted in the distal segments and involved widespread necrosis at 60 
mg kg-1• The extent of the damage was dose dependent and cellular damage was 
reversible at 15 mg kg-1 (McDowell 1972a). In another study, McDowell (1972b) 
demonstrated that administration of 1080 at 3.5, 20 and 60 mg ki1 bw by 
intraperitoneal injection caused swelling of the proximal convoluted tubules of the 
kidney and the change was reversible at 3.5 mg kg-1. Compound 1080 also damaged 
the proximal convoluted tubules of the rat kidney but the effect was not dose-
dependent. 
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An investigation of the 1080 effects on the rat testis by Sullivan et al. (1979) included 
examining its effects on the kidney. Exposure concentrations used were 2.2 (0.016 mg 
raf1 or 0.07 mg kg-1), 6.6 (0.037 mg raf1 or 0.18 mg kg-1), and 20 ppm (0.14 mg raf1 
or 0.71 mg kg-1) in drinking water for a period of 7 days. Results showed normal 
organ weights, ATP concentrations, and histological appearances. A significant 
accumulation of citrate was noted in kidneys of rats exposed to 20 ppm of 1080. 
It is evident from studies that have been analysed that the kidney responded to the 
overt effects of 1080 only when rats were exposed to high doses. Later repeated-dose 
studies at lower doses, such as that of Eason .et al. (2001) and Eason and Turck (2002), 
did not report the kidney as a target organ. No publishe_d article has claimed that .the 
kidney was a critical organ to the adverse effects of 1080. Supporting this notion were 
observations made by Chenoweth (1949) and Chung (1984) that the kidney tissue was 
observed to be very sensitive in vitro but the renal dynamics did not seem to be 
affected to any significant extent in vivo. This may explain why the kidney appears 
not to be a critical organ for toxic effects of 1080. 
4.1.3 Genotoxicity 
Eason et al. (1999) showed that 1080 was not mutagenic using three complementary 
cell mutation and chromosomal aberration tests (Ames assay, mouse lymphoma assay 
and the micronucleus test). The results comprised negative results and hence there is 
good (but not conclusive) evidence that 1080 is not genotoxic. Genotoxicity testing 
only provides information about possible genotoxic potential, and substances with this 
potential are suspected of being carcinogenic. However, the final proof can only be 
determined from long term animal exposure (Kroes 1995). 
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4.2 Effects on humans 
Human data 
No epidemiological studies have been identified to date designed to ascertain the 
chronic effects of 1080 following long-term exposure in humans. However, there have 
been some reported cases on acute 1080 poisoning which may provide an 
understanding of the toxic effects of 1080 in humans. The symptoms observed were 
limited to cases of acute poisonings. 
The main symptoms of acute poisoning in humans were vomiting, CNS disorders 
including convulsions, heart failure, and death. Typically, symptoms first appeared 1 
to 2 hours after ingesting the 1080, although the onset of symptoms depended upon the 
dose received (Rammel and Flemming 1978). Both the heart and the CNS were 
affected, death usually resulting from respiratory failure during convulsions, and 
occasionally due to ventricular fibrillation (Trabes et al. 1983). The high levels of 
fluoroacetate in the urine indicated rapid urinary excretion. This was significant 
because in spite of gastric lavage, death usually ensued by about 17 hours after 
ingestion of the poison (Harrison et al. 1952). Of particular interest, however, is the 
case of a 17-year old boy who lived for five days after ingesting 1080 (Brockmann et 
al. 1955). 
According to Reigart et al. (1975), the CNS effects were agitation, depressed 
consciousness, seizures, and eventually coma. The cardiovascular effects, which often 
resulted in death, may be ventricular tachycardia and fibrillation. Children appeared to 
be more prone to myocardial failure than to ventricular fibrillation. After successful 
resuscitation from cardiac arrest, a poisoned child was left with severe neurologic 
impairment (McTaggart 1970). The response in adults to 1080 may be identical to that 
of the rhesus monkey (Chenoweth 1949), with death usually due to ventricular 
fibrillation (Murphy 1986). 
Based on fatal or near fatal cases of human poisonings, the dangerous dose for humans 
was estimated to be 0.5 - 2.0 mg ki1 bw (Chenoweth 1949; Rammel and Flemming 
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1978). Human poisoning with 1080 further illustrates differences in the clinical 
picture observed among mammals. Cardiac and CNS effects were both important, the 
CNS effects predominating. The clinical picture was somewhat similar to that 
observed in the cat, pig and rhesus monkey, but most close to that of the cat (Gajdusek 
and Luther 1950). 
There were two 1080 poisoning incidents related to occupational exposures. The first 
report of chronic poisoning by 1080 concerned a New Zealand rabitter (Parkin et al. 
1977; Gosselin et al. 1984). However, the alleged chronic 1080 poisoning was 
disputed by Peters (1977), Rammel et al. (1977), and Ramsay (1977) as there was no 
evidence that 1080 was involved. These authors claimed that analysis of fluorine in 
urine was not a validated indicator of 1080 exposure. It was noteworthy that the 
autopsy revealed petechial haemorrhages and congestion of the organs that included 
diffuse tubular degeneration of the kidneys (Pel:frene 1991). In the second case, 
neurologic, liver, kidney, and thyroid dysfunction was observed in an exterminator 
who was repeatedly exposed to 1080 during a 10-year period (Parkin et al.1977). 
In an unusual case of occupational -exposure, a gust of wind blew 1080 powder into a 
worker's face, and some was inhaled. Symptoms observed were immediate tingling 
sensation around comers of the mouth and in nasal passages, salivation, loss of speech, 
numbness of the entire face, and blurred vision. Although paraesthesia spread to arms 
and legs and violent convulsions and coma followed, the worker recovered completely 
(Grant 1986). 
From 1971 to 1981, the National Poisons Centre of Israel collected 111 cases of 
accidental or unintentional poisoning with 1080. These cases included three cases of 
death and one case of mass accidental poisoning affecting 30 children. A small 
number of wheat grain baits impregnated with 1080 were involved and those affected 
did not suffer from clinical symptoms of poisoning (Roy et al. 1982 2, as cited by 
Pelfrene 1991 ). In addition, there were five cases of acute 1080 poisoning collected 
between 1975 and 1981 in Taiwan. Acute reversible renal failure or frank uraemia was 
2 The original is published in Hebrew. 
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observed in cases where large amounts of 1080 ( close to the estimated human LD50 of 
5 mg kg-1 bw) ingested (Chung 1984). 
At least 16 fatalities have been reported from high acute exposure by Pattison and 
Peters (1959). One child following ingestion of wheat impregnated with 1080 was left 
with severe neurologic impairment after successful resuscitation from cardiac arrest 
(McTaggart 1970). There were also reported cases of visual impairment in patients, 
but the nature and basis of blurring of vision have not been established either clinically 
or experimentally (Grant 1986). 
A boy aged 2 years was accidentally poisoned by licking the 1080 crystals from the 
screw top of a 1080 poison bottle. Six hours after exposure, the boy exhibited signs of 
poisoning that included both central nervous signs ( tonic convulsions) and cardiac 
signs. The dose received was unknown (Gajdusek and Luther 1950). Another case 
report described CNS abnormalities in a 15-year-old female intentionally ingested 
1080. Immediate clinical features of intoxication were tachycardia, grand mal 
seizures, psychomotor agitation, and deterioration of consciousness. Neurological 
examination established dysfunction and moderate diffuse brain atrophy (Trabes et al. 
1983). 
In New Zealand, the only documented human fatality from 1080 was an apparent 
suicide. Twelve non-fatal human poisonings from 1080 have also been reported. 
However, no additional information is available relating to these events, as the 
database is incomplete (PCB 1994). Human poisonings from indirect sources, such as 
contaminated water or dead animals, have not been documented in New Zealand or 
overseas (PCB 1994). 
4.3 Human Health Effect Toxicity End Points 
This thesis is focussed specifically on the health effect toxicity end points needed to 
complete the health risk assessment and health risk management processes in order to 
address the public health implications of 1080 in relation to its continued use. These 
were repeated dose toxicity, genetic toxicity, and reproductive and developmental 
toxicity. The description for repeated dose toxicity was taken from the Organisation 
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for Economic Co-operation and Development's (OECD) Manual for Investigation of 
High Production Volume Chemicals (2004). Other terms are defined as prescribed in 
the Harmonised Integrated Hazard Classification System for Human Health and 
Environmental Effects of Chemical Substances (1998). It is important that these 
terminologies be defined to avoid varying interpretations. 
Acute toxicity provides information on adverse health effects likely to arise from short-
term exposure to a relatively high dose of chemical. It can be expressed as: Acute oral 
toxicity when the adverse effects occur within a short time of oral administration of a 
single dose of a substance or multiple doses given within 24 hours; Acute dermal 
toxicity when the adverse effects occur within a short time of dermal application of a 
single dose of a test substance; and Acute inhalation toxicity when the total of adverse 
effects is caused by a substance following a single uninterrupted exposure by 
inhalation over a short period of time (24 hours or less) to a substance capable of being 
inhaled. 
Repeated dose toxicity ( or subchronic toxicity) includes the adverse health outcomes 
resulting from a repeated dose of a chemical with duration of administration generally 
lasting for 14, 28, or 90 days. 
Reproductive toxicity includes adverse effects on sexual function and fertility in adult 
males and females, as well as developmental toxicity in the offspring. 
Developmental toxicity includes any effect which interferes with normal development 
of the conceptus, either before or after birth, and resulting from exposure of either 
parent prior to conception, or exposure of the developing offspring during prenatal 
development, or postnatally, up to the time of sexual maturation. The major 
manifestations of developmental toxicity include death of the developing organism, 
structural abnormalities, altered growth and functional deficiencies. Developmental 
toxicity can be considered a component of reproductive toxicity, and often it is 
difficult to distinguish between effects mediated through the parents and direct 
interaction with developmental processes. 
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Genetic toxicity applies to processes which alter the structure, information content, or 
segregation of deoxyribonucleic acid (DNA), including those which cause DNA 
damage by interfering with normal replication processes, or which in a non-
physiological manner (temporarily) alters its replication. 
Chronic toxicity includes adverse effects resulting from exposure over the animal's 
lifetime, or a major fraction thereof. The duration of the chronic study has been under 
debate for many years and different requirements exist in different countries (from 6-
24 months). It also varies with species and parameters being studied. 
4.4 Criteria in reviewing adequacy of toxicological data 
4.4.1 Repeated-dose toxicity 
In the area of repeated-dose toxicity, it is important to distinguish the following: 
Short-term repeated dose study is performed to obtain information on the toxicity of a 
chemical· after repeated administration and as an aid to establish doses for subchronic 
studies. It is obviously of shorter duration than a subchronic toxicity study. The 
duration is generally 14 or 28 days with the compound administered daily. As in the 
subchronic study, a dose range and number of doses should be chosen to allow 
demonstration of a No-Observed-Adverse-Effect-Level (NOAEL) or Lowest-
Observed-Adverse-Effect-Level (LOAEL)3• 
Subchronic repeated dose study can last for different periods of time, but 90 days is the 
most common test duration. The animals must be given sufficiently high doses to 
elicit relevant toxic effects, and examined or tested in such a way as to document the 
toxic effects. 
Subchronic studies for pesticide registration are usually conducted in two species, one 
of which is a rodent, by the route of most likely exposure (usually oral). The test is not 
3 The LOAEL is the lowest concentration or amount of a substance, which causes an adverse alteration of 
morphology, functional capacity, growth, development or life span of the target organism distinguishable 
from normal ( control) organisms of the same species and strain under the same defined conditions. 
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capable of determining those effects that have a long latency period for development 
because the study duration is not necessarily sufficiently long to reveal delayed or 
chronic effects. 
4.4.2 Chronic study 
Long-term or chronic exposure studies are performed similarly to subchronic studies 
except that the period of exposure is longer than three months. In rodents, chronic 
exposures are usually for six months to two years. Chronic studies in non-rodent 
species are usually for one year but may be longer. 
4.4.3 Reproductive study 
Reproductive toxicity includes adverse effects on fertility in males and females. It 
covers any effect interfering with normal development both before and after birth, 
from conception to sexual maturity. The oral route is preferred. The highest dose 
should produce toxicity but not mortality in parents, and the lowest dose should not 
produce toxicity. It should include a NOAEL or a LOAEL. Two generations of 
animals with one litter per generation are generally utilised as the minimum 
reproductive study. 
4.4.4 Developmental study 
Developmental studies are intended to detect the potential for substances to produce 
embryotoxicity and birth defects. A properly conducted teratogenicity study should 
provide a satisfactory estimation of a NOAEL or a LOAEL as well as an obvious 
effect level for maternal toxicity. Embryotoxicity or teratogenicity occurring only at 
maternally toxic dose levels have less relevance than similar effects produced by doses 
that have no adverse effects on the dams. 
The selection of species 1s particularly important because there may be wide 
differences in sensitivity as evidenced by the lack of teratogenicity of thalidomide in 
rats. It is generally considered essential that a second non-rodent species be studied 
and the rabbit is the most commonly used second species. 
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Chapter 5 
Health Risk Assessment 
5.1 Health risk assessment 
Risk is described as the likelihood that an adverse outcome will occur when a person 
or group is exposed to a particular concentration or dose of a substance for a specific 
period of time (Paustenbach 1989; IPCS 2000b ). Risk therefore can be expressed as 
risk (R) equals toxicity (T) times exposure (E), or R = T * E. 
Risk assessment puts the concepts of toxicity, hazard, and risk into a consistent 
framework (Y osie 1987). Risk is determined by the combined relationship between 
exposure and toxicity, specifically in determining whether adequate exposure 
benchmarks exist to compare with toxicologically acceptable levels or levels of 
concern, which needs urgent attention (Covello and Merkhofer 1993). The classic 
pesticide risk assessment paradigm is a four-step procedure consisting of hazard 
identification, dose response, exposure assessment, and risk characterisation (NRC 
1983). 
It is recognised that in the absence of risk assessment, policies and actions will 
generally be based on an approach that is likely to be less rigorous and more limited 
than risk assessment. Alternatively, a policy that is dictated purely by evidence alone, 
as in the case of traditional epidemiological approaches, may take decades to form. 
Furthermore, risk assessment is used as a tool by decision makers to help in: 
• identifying research needs and setting research priorities aimed at reducing 
important scientific uncertainties, and 
• providing a framework for analysing the potential adverse consequences of 
alternative risk management policies or actions (Covello and Merkhofer 1993). 
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Purchase (1986, page 55) has characterised the importance of toxicological risk 
assessment by saying that: 
"Toxicology is one of the few scientific disciplines that can have an immediate and 
enormous effect on public policy. It is difficult to think of any other scientific 
discipline that, from the simplest result, can create major policy impacts." 
In the process of health risk assessment, toxicology data from animal studies and 
human epidemiology and clinical studies, · if· available, are evaluated. The dose 
response relationship at low doses is predicted using mathematical formulae. In 
addition, the information on the degree of exposure is used to predict quantitatively the 
likelihood that a particular adverse response will be seen in a specific human 
population (Paustenbach 1995). Risk assessment has received broad acceptance 
among regulatory agencies, in particular the United States (Paustenbach 1989), and 
among members of the public. Its use has been increasingly vital to providing 
information for developing environmental health policy and also assisting decision 
makers by providing estimates of the health effects associated with local 
environmental exposures and their potential distribution in the population (Privalova et 
al. 2001). 
Silbergeld (1993) stated that the usefulness and effectiveness of risk assessment have 
been debated because data and scientific understanding were often insufficient. It 
could also be considered as an admission that a certain amount of risk is acceptable. 
However, it should be remembered that health risk assessment is not an exact science. 
For many aspects of risk assessment, reliable information may or may not be available 
and scientific uncertainty is a fact of life. Therefore, it is important to understand the 
strengths and limitations of each assessment and to communicate this information to 
those involved and the public (Ohanian 2000). Because of the many uncertainties 
about exposure and effects, risk assessment is as much a policy-driven as a science-
based process (NRC 1994). In this sense, science informs, but policy decides (NRC 
1994). 
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A basic premise of risk assessment is that chemicals that can cause a specific toxic 
effect in animals can cause similar effects in humans (Eaton and Klaassen 2001). To 
put this statement into perspective, the International Agency for Research on Cancer 
(IARC) stated that all human carcinogens that have been adequately tested in animals 
produce positive results in at least one animal model (IARC 1994, 2000). This 
association cannot establish that all agents and mixtures that cause cancer in 
experimental animals also cause cancer in humans. Nevertheless, in the absence of 
adequate data on humans, it is biologically plausible and prudent to regard agents and 
mixtures for which there is sufficient evidence of carcinogenicity in experimental 
animals as if they presented a carcinogenic risk to humans (IARC 1994). 
Rats have been predominantly employed in predictive toxicological evaluation because 
they are relatively cheap, available in large numbers, and no other animal model, in a 
general sense, uniformly simulates the responses of humans to foreign substances 
(Calabrese 1991). On the other hand, there is no absolute certainty that a substance 
that has not been found to produce any adverse effects in animal models, i.e., rodents 
or primates will also be safe for humans. 
In this context, the assessment of human health hazards associated with 1080 
exposures presents interesting challenges. While animal experiments at relatively high 
doses have been carried out, the public health impacts of long term, low dose 1080 
exposures are still unknown and health risk assessment should be treated with caution. 
The primary aim of this health risk assessment is assessing the relevance to humans of 
the possible risk associated with a particular level of 1080 exposure. 
5.1.1 Process 
The first step is to identify the possible hazards that may be presented by the chemical. 
Hazard is an intrinsic property of the chemical. The dose response relationship helps 
to describe the hazardous properties of the chemical under different exposure 
conditions. In order to assess hazard, animal studies are conducted with different 
exposure levels, or doses, as well as varying durations of exposure. 
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In the case of compound 1080, possible hazards are assessed by determining whether 
1080 produces adverse effects, and identifying the nature of those effects. Any 
adverse effects are identified through a thorough review of toxicological literature 
(Paustenbach 1995). This is crucial to answering the question of whether exposure to 
1080 could ( at any dose) cause an increase in the incidence of adverse health effects 
(e.g., birth defect, etc.) in humans. One of the primary objectives of hazard 
identification is the choice of the most appropriate end point/s for further dose-
response assessment. 
Determining the dose-response relationship of the substance is the second step. Dose-
response evaluations define the relationship between the experimental dose of 1080 
and the probability of a specific adverse effect in laboratory animals. In this context, 
the specific adverse effect at the lowest dose is referred to as the critical effect, and its 
highest concentration or dose that will not cause an effect is the NOAEL (Haber et al. 
2001; Paustenbach 1995). 
The third step is to determine the exposure by quantifying the available dose of the 
chemical received by humans by the oral, inhalation, and dermal routes of exposure ( or 
a combination of such exposures). The concentration of the chemical that humans are 
likely to be exposed to is estimated (Paustenbach 1995), for instance during the period 
of pregnancy or over a lifetime. 
Characterising the risk constitutes the final step of the process. In risk characterisation, 
the important risk conclusions and related uncertainties are identified and highlighted. 
Apparent thresholds are discussed, and potencies are described. A discussion of 
uncertainty includes comment on issues such as the quality and quantity of available 
data, use of default assumptions, incomplete understanding of the general biologic 
phenomena, and scientific judgements or science policy positions that were employed 
to bridge information gaps. In many cases, this is achieved by providing estimates of 
the type and magnitude of health effects associated with environmental exposures and 
their potential distribution in the population (Privalova et al. 2001). 
Risk characterisation is the starting point for risk management considerations and the 
formulation of regulatory decision-making (Paustenbach 1995). It is described as a 
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bridge between science and policy (Hertz-Picciotto 1995). Furthermore, it is 
considered an essential tool in helping decision makers to develop policies and actions 
to inform decisions about the extent to which a potential risk needs to be managed or 
regulated (Covello and Merkhofer 1993; Silbergeld 1987, 1993). Characterisation of 
risk is consistently the weakest component of a risk assessment as numerous aspects of 
science and regulatory policy appropriately describing whether a significant human 
health hazard exists in a specific setting are illustrated (Paustenbach 1989). 
5.1.1.1 Health hazard identification 
A major component of the hazard identification process is the use of animal bioassay 
data. Animal models have been used to predict the responses of humans to chemical 
and physical agents for hundreds of years (Calabrese 1991). The purpose of hazard 
identification is to evaluate the weight of evidence for adverse effects in humans based 
on assessment of all available data on toxicity and mode of action. It is intended in 
this thesis to address (a) whether 1080 may pose a health hazard to humans, and (b) 
under what circumstances an identified hazard may be expressed. The result is a 
scientific judgement as to whether 1080 can cause an adverse effect in humans. As 
noted by Kimmel (1990), determining a hazard is often dependent on whether or not a 
dose,.response relationship is present. 
There is convincing evidence that the toxicity of 1080 is mediated principally through 
its metabolite, fluorocitrate as described by Peters (1963). However, it is thought that 
1080 toxicity is not due primarily to the accumulation of citrate per se but to the 
blockage of energy metabolism (Pelfrene 1991 ). Although some aspects of 1080 
metabolism such as the conversion to fluorocitrate are clear, the overall fate of 1080 in 
animals is unknown (Rammel and Fleming 1978). Uncertainties exist regarding 
whether or not the likely pathways involved in the metabolism of 1080 in animals are 
qualitatively and quantitatively similar in humans. 
Selection and adequacy of pivotal study 
In general, human exposure data for prediction of human response to 1080 are quite 
limited. Hence, animal bioassay data have served as the primary basis for most 
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quantitative risk assessments. Traditionally, threshold approaches have been applied 
to the assessment of noncancer endpoints (Ecobichon 2001). 
The toxicity and adverse health effects of 1080 have been analysed in Chapter 4. In 
principle, human data are preferred for risk assessment, although some authors 
disagree with this statement. The use of acceptable human studies avoids the problems 
of interspecies extrapolation and, therefore, confidence in the estimate is often greater 
(Paustenbach 1995). However, there are no known human studies available to date to 
evaluate the potential public health implications of 1080. Therefore, data from well-
conducted animal studies have had to be used. Animal test results often represent the 
only means by which toxicity in humans can be effectively predicted. In some cases, it 
may not be possible to use the most desirable animal for testing because of animal 
welfare or cost considerations (Calabrese 1991). For example, use of monkeys is 
restricted to special cases, even though they represent the species that may react in a 
manner most closely to humans. Hence, in the absence of data from a more relevant 
species, data from the most sensitive animal species tested, are generally used. In 
addition, the route of administration must be considered when choosing the critical 
study from among quality toxicity tests. In general, the preferred exposure route is that 
which is considered most relevant to environmental exposure. 
For risk assessment, the most sensitive endpoint from the most appropriate or sensitive 
species forms the basis for selecting the pivotal study. For 1080, the most sensitive 
endpoints of toxicity in animals identified were testicular and myocardial toxicity, and 
teratogenicity. These, then, are the critical effects of 1080. 
A review of the relevant animal data revealed that the studies of Eason et al. (1998, 
1999, 2001) and Eason and Turck (2002) provide the most appropriate studies for 
health risk assessment as they are more recent, of good scientific quality, followed 
standard guidelines, used recognised Good Laboratory Practice (GLP) and were able to 
establish NOAELs for critical effects in sensitive target organs. Therefore these 
studies were chosen as the pivotal studies. The pivotal study is the study from which 
the NOAEL was derived. The importance of using GLP was that this ensured that the 
study report/s accurately stated what was done and what the results were (Lu 1996). 
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GLP was also applied to all studies conducted to satisfy guideline requirements for 
product registration with the US EPA (1979) and OECD (1989). 
There were no available chronic exposure studies by any route of exposure. Therefore 
potential tolerable concentrations for exposures were calculated using the subchronic 
studies with application of appropriate uncertainty factors. 
Critical endpoint/s and critical effects 
The critical end point used in dose response assessment is the effect occurring at the 
lowest exposure dose (Barnes and Dourson 1988). Available data suggested that the 
studies reported by Eason et al. (2001) and Eason and Turck (2002) could be 
considered for health risk assessment, as they were most recent and complied with the 
GLP procedures. The toxicological end points for which the dose response 
relationship was best characterised were the developmental (Eason et al. 1998, 1999) 
reproductive and myocardial toxicities observed in the subchronic study in rats by 
Eason et al. (2001) and Eason and Turck (2002). Whittem and Murray (1963) drew a 
similar conclusion that the heart was the most susceptible organ to pathologic lesions, 
while Sullivan et al. (1979) considered the testis as the organ most vulnerable to the 
toxic effects of 1080. 
Table 4 shows the critical effects, the NOAELs, and experimental doses of 1080 in 
animals tested for the critical toxicity end points. This author (NF) considers the 
critical effects to be "adverse", hence the use of the term NOAEL rather than NOEL 
used by Eason and Turck (2002) and Eason et al. (2001). 
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Table4 
Summary of critical toxicity end points and effects arising from 
1080 exposure in rats 
Critical Endpoint · Parameter Experimental dose Critical Effect 




,. LOAEL 0.33 mg/kg bw/day development 
Testicular toxicity 2 .. · NOAEL 0.075 mg/kg bw/day Severe hypospermia 
in epididymis, 
'·· ·' severe degeneration 
., 0.25 mg/kg bw/day of seminiferous 
LOAEL tubules of the testes 
Myocardial toxicity :i. NOAEL 0.075 mg/kg bw/day 
,· Cardiomyopathy 
0.25 mg/kg bw/day 
LOAEL 
1 Eason et al. (1998, 1999) 
2 Eason et al. (2001 ); Eason and Turck (2002) 
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5.1.1.2 Dose-response assessment 
The dose-response relationship is a fundamental and essential concept in the practice 
of toxicology (Barnes and Dourson 1988). The response to toxic effects generally 
increases as the dosage of the toxicant is increased. In considering toxic effects at 
various dose levels, the dose range of interest is generally the low-dose. For health 
risk assessments, dose response relationships are frequently based on animal studies. 
Doses are usually presented per unit body-weight ( e.g., mg ki1 daf1) (IPCS 1999) . 
. Previous sections of this thesis have focussed on the characterisation of hazards to 
1080 (Chapter 4) and potential sources of human exposures to 1080 (section 2.2.2). In 
order to bring these issues together and provide an adequate characterisation of risk, 
the relationships of exposure to dose and ultimately, to response are evaluated. The 
dose-response relationship provides a basis to infer a point of departure for 
extrapolation for noncancer risks. Similarly, these relationships provide insight into 
the shape of the dose-response below the point of departure, which can help inform 
choices for extrapolation models (IPCS 1999). 
Suitable data that describe a dose response relationship for 1080 in animals are quite 
limited. Available studies included acute and subchronic exposures in animals and 
some information on acute poisonings in humans. 
Characterisation of threshold 
Systemic (non-cancer) toxicity is usually assumed to have thresholds below which no 
effects occur (IPCS 2000a). For these toxicities, safety assessments are carried out 
with establishment of TDis, which are seen as doses below these thresholds. The 
threshold concept led to the logical conclusion that exposure to substances at doses 
below the threshold was safe and therefore acceptable. From this concept, guidelines 
were derived and standards designed to protect public health. 
The derived TDI usually includes an uncertainty factor (UF). The derived UF is 
generally based on the adequacy of the pivotal study, an assumed degree of inter-and 
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intraspecies variation, the adequacy of the overall database, and the nature (severity) of 
toxicity (Gephart et al. 2001). 
For toxic effects, other than heritable mutations and genotoxic carcinogenicity, 
considered to have a threshold, a number of different estimates may be used as an 
approximation of the threshold (NRC 1983). The non-cancer endpoints are 
distinguished from carcinogenic and mutagenic endpoints, which are often treated as 
non-threshold processes. 
The threshold concept is considered important in the regulatory context. The 
individual threshold hypothesis states that a range of exposures from zero to some 
finite value could be tolerated by the organism with essentially no chance of 
expression of the toxic effect (NRC 1983). Further, it is often prudent to focus on the 
most sensitive members of the population. Therefore, regulatory efforts are generally 
made to keep exposures below the population threshold, which was defined as· the 
lowest thresholds of the individuals within a population. 
Quantitative response analysis included determining · a NOEL/NOAEL and/or 
LOEL/LOAEL for each toxicity end point under study (Hayes 2001). 
No-observed-adverse-effect-level (NOAEL) vs No-observed- effect-level (NOEL) 
The regulatory focus for the NOAEL is normally on the highest dosage which causes 
no effects. The NOAEL for the critical toxic effect was sometimes referred to simply 
as the NOEL, i.e., the term NOEL has been used to mean the equivalent of a NOAEL. 
However, the use of NOEL is ambiguous in that there may be observable effects that 
are not of toxicological significance, i.e., they were not "adverse". Scientists within 
the US EPA's Office of Pesticide Programs (OPP) traditionally defined NOEL as the 
dose that did not cause an adverse effect and there was no distinction made between 
NOEL and NOAEL (M. Dourson pers. comm. 2005). In 1980, other U.S. EPA 
scientists introduced the term NOAEL to distinguish it from NOEL. The distinction 
between the two terms only relates to the term "adverse''. It is also considered 
important to determine whether adverse effects are seen for chemicals with Rills based 
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on NOELs, rather than NOAELs, if NOELs are to be used to developing Rills (M. 
Dourson pers. comm. 2005). 
Although a NOAEL is an experiment's subthreshold (whereas the LOAEL is the 
experiment's threshold dose) the NOAEL is sometimes incorrectly viewed as a level 
that is always without adverse effects (Gaylor 1992). However, the true risk of 
exposure at the NOAEL can vary from zero to >20%, depending on the background of 
variability of end points, spacing of doses, and numbers of animals used, or 
alternatively it could be many-fold lower than a true population threshold (Leisenring 
and Ryan 1992; Gaylor 1992; Renwick and Walker 1993). This could particularly be 
the case if the effect modelled was an adaptive change and not necessarily adverse. 
Therefore, the NOAEL is not the same as the biological threshold and may 
underestimate or overestimate the true no-effect level (Renwick and Walker 1993). 
The dose-response data are used to identify either an NOAEL or LOAEL for the 
critical effect. Approaches for characterising threshold dose-response relationships 
include the identification of NOAELs or LOAELs. Traditionally, the use of the 
NOAEL from the pivotal study is the primary basis for the scientific evaluation of the 
risk posed to humans from systemic toxicity (Barnes and Dourson 1988). The 
NOAEL approach identifies the greatest experimental dose not associated with a 
statistically significant increase above background in the most sensitive adverse 
effects, and then UFs and modifying factors are applied to derive the TDI (Allen et al. 
1996). 
Dose-response modelling 
Benchmark Dose (BMD) methodology 
It has been suggested by Crump (1984) that dose-response modelling, i.e., the 
benchmark dose (BMD) methodology, rather than the traditional NOAEL approach, 
should be generally applied to systemic toxicity. Dose-response modelling is a 
commonly accepted method of estimating the response associated with a given 
exposure. Dose-response models are expressed as functions of dose possibly 
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covariates and set of constants (parameters) that govern the details of the shape of the 
resulting curve (details are presented in the following sections). 
A variety of dose-response models are available for calculating a benchmark dose. 
However, not all human observations (if available) or animal experiments are 
amenable to dose-response modelling (Crump 1995): for instance, if there is a 
biologically significant increase in a rare malformation where it was found to be not 
statistically significant. 
The US EPA BMDS 1.3 software (US EPA 2001) was developed as a tool to facilitate 
the application of BMD methods. It was employed in the dose-response modelling for 
the purposes of this study. The minimum data set for calculating a BMD should at 
least show a significant dose-related trend in the selected critical end point/s. It is 
preferable to have a study or studies with one or more doses near the level of 
Benchmark Response (BMR) to give a better estimate of the BMD, and thus, a shorter 
confidence interval. The BMR is a response level, generally expressed as in excess of 
a background used to define a BMD. A study or studies in which all the dose levels 
show changes compared with the control values (i.e., when there is no NOAEL) can be 
utilised in BMD analyses, unless the lowest response level was much higher than the 
BMR. 
The BMDS software does not analyse statistical power (J. Zhao pers. comm. 2006). In 
the benchmark analysis, smaller studies tend to result in smaller BMDLs, whereas the 
opposite is true for NOAELs. The NOAEL has an undesirable property in that the 
fewer animals used, the lower the statistical power to detect effects, therefore resulting 
in higher NOAEL values all other factors being equal (Gaylor 1996). The BMD 
method resolves the less statistical power issue by providing a lower BMDL (R. Howd 
pers. comm. 2006). 
In the BMD methodology, the selection of a BMR can also be based on the statistical 
power provided by the data. For example, Gaylor and Aylward (2004) concluded that 
with a sample size of five animals per group the NOAEL would be at the risk-based 
BMD10 while the NOAEL would be near the risk-based BMD05 with a sample size of 
ten animals per group. The BMD method is not specifically designed for conducting 
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meta-analyses and it does not allow the data to be stratified in the data modelling in 
order to distinguish the difference between studies (J. Zhao pers. comm. 2006). 
Benchmark Dose 
The BMD is the dose (Barnes et al. 1995) calculated to be associated with an increase 
in the response (called the Benchmark Response, BMR) (Gaylor 1992) for a given 
incidence ( e.g., 5 or 10% incidence) of effect estimated from all toxicity data on that 
effect within the study (Crump 1984, 1995). The use of the BMDL has encouraged 
better experiments to be conducted to obtain tighter confidence limits, resulting in 
higher TDI values (Gaylor 1996) and is therefore more accurate which makes 
subsequent health risk management decisions better. 
Benchmark dose (BMD) vs No-observed-adverse-effect level (NOAEL) 
The BMD approach is considered to be an alternative method of providing a more 
quantitative dose-response evaluation (Hayes 2001). The NOAEL approach has been 
criticised in several ways, as it does not consider all of the dose-response data, is 
highly dependent on the number of animals used, and it may be inconsistent from 
study to study because a NOAEL is constrained to one of the experimental doses 
(Allen et al. 1996; Gaylor 1996; Castorina and Woodruff 2003). Similarly, studies 
which have utilised more reliable exposure measures or more sensitive end points, are 
likely to achieve a lower NOAEL (Jacobson et al. 2002), thus potentially discouraging 
well-designed studies. An example of a more reliable exposure measure is measuring 
the amount of feed consumed rather than assuming that everything has been ingested, 
especially when the chemical in feed causes a taste aversion in the dose groups versus 
just measuring the animal body weight. 
It is well known that the NOAEL does not necessarily show that there is a zero risk 
below a threshold dose. Gaylor (1992) showed, for example, in a review of 
developmental toxicity studies, that the estimated risk of stillborn or resorbed or 
malformed fetuses ranged from O to 4.5% at the NOAEL. 
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The BMD approach has been used in recent years as an alternative approach for 
calculating TDis to avoid the shortcomings associated with the NOAEL (Crump 
1984). It has gained wide acceptance in carrying out health risk assessment and has 
been frequently used by various regulatory agencies, such as the US EPA and the 
WHO (Fowles et al. 1999). 
The BMD approach uses all of the experimental data to fit one or more dose-response 
curves. These curves are used in tum to estimate a BMD corresponding to a specified 
level of risk. The selected level of risk is typically set at the lower end of the range of 
responses that can be detected experimentally (e.g., the 1, 5, or 10% risk level for 
quanta! responses). In using the NOAEL approach to calculate a TDI, the only data 
point used is the NOAEL (Gaylor et al. 1998). The BMD approach is not restricted to 
experimental NOAELs/LOAELs but also makes use of dose response data and sample 
size. 
Two types of quantitative toxicological data 
The quantitative toxicological data used in this study were basically of two types: 
quanta! and continuous. Quanta! data consist of "yes-no" information specifying 
whether or not a subject had an abnormal response (Crump 1995). It also specifies the 
number of animals affected, but does not give a measure of the magnitude of the effect 
(Gephart et al. 2001). It provides the simplest case for estimating BMDs (Gaylor et al. 
1998). On the other hand, with continuous data, the effects are measured on a 
continuum (Crump 1984), such as sperm count and body weight. Modelling for 
continuous data has been recognised to be complicated (Barnes et al. 1995). One 
difficulty identified is differentiating between normal variation and an adverse effect, 
and another is modelling the change in the mean versus proportion of individuals 
outside the normal range. Tables 5 and 6 summarise the data used for the quanta! and 
continuous models, including the species, route of exposure, dose levels, and the 
effects at each dose. 
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Table5 
Toxicological studies and quantal critical end points 
Doses, Study Sample Number Critical end points, dictating NOAEL Species and Route of 
mg/kg/bw size affected sex exposure 
0.0 Short term 1 26 0 Malformations - irreversible forelimb Female rats Diet 
malformations 
0.10 26 0 
0.33 26 1 
0.75 26 11 
0.0 Subchronic 1. 20 0 (T); 1 (E) Severe hypospermia in epididymis, severe Male rats Drinking water 
degeneration of the seminiferous tubules 
of the testes 
0.025 10 0 (T); 0 (E) 
0.075 10 0 (T); 2 (E) 
0.25 20 10 (T); 10 (E) 
0.0 Subchronic 1. 20 0 (M); 1 (F) Cardiomyopathy Male and Drinking water 
female rats 
0.025 10 0 (M); 0 (F) 
0.075 10 0 (M); 0 (F) 
0.25 20 10 (M); 1 (F) 
1 Eason et al. (1998, 1999) 
2 Eason et al. (2001) Eason and Turck (2002) 
M ::: male; F ::: female; T = testicular; E = epididymis 
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Table 6 
Toxicological studies and .continuous critical end ·points 
Doses, Study Sample Critical end Mean values Species and sex Route of exposure 
mg/kg/bw size points 
0.0 Short term 1 25 (M); 25 (F) Fetal weight 4.1 (M); 3.9 (F) Male and female rats Diet 
0.10 26 (M); 26 (F) 4.0 (M); 3.9 (F) 
0.33 25 (M); 25 (F) 3.9 (M); 3.8 (F) 
0.75 25 <M); 25 (F) 3.5 (M); 3.3 (F) 
0.0 Subchronic 2 20 Sperm count 8.76 Male rats Drinking water 
(no. x 108/g) 
0.025 10 8.66 
0.075 10 7.89 
0.25 20 2.22 




0.25 10 1.57. 
1 Eason et al. (1998, 1999) 
2 Eason et al. (2001); Eason and Turck (2002) 
M = male; F = female · 
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Benchmark dose models 
For the data investigated in this study, three models for each of the quantal and 
continuous data sets were investigated to determine which of the three models best fit 
the data. The models were used to calculate the BMDLs for the quantal and 
continuous response variables at the 95% lower confidence limit and 10% level of 
extra risk. These models are summarised with their respective mathematical equation 
below as adopted from the US EPA (1995). 




P(d) = c + (1-c)*{l-exp[-ql*d]} 
P(d) = c + (1-c)*{l-exp[-ql*cf]} 
P(d) =·c + (1-c)*F(a + b*ln(d)), 
where F(x) is the cumulative normal density function, 
F(x) = 1/i[l +erf(x/sqrt(2))] 
(b) Continuous data BMD models 
Power m(d}= c+q1(d-da/ 
Polynomial m(d}= c+q1(d-do}+ ... +qk(d-da/ 
Linear m(d}= c+qJ(d-da) 
where P(d) is the probability response at the dosed; c is background at zero dose, m(d) 
is the mean response at the dosed, c and qi, ... , qk are parameters estimated from the 
data, do is the threshold dose, erf (.) is the error function. 
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Measurement variables 
a. Quanta! variables 
Data on quanta! variables are commonly presented as a fraction or percent of 
individuals that exhibited the given condition at a given dose or exposure level. For 
such data, probability density models such as probit, Weibull, logistic, quanta! linear, 
etc., are selected. These models give predictions that lie between zero and one for any 
possible dose, including zero. For the purposes of this study, Weibull, probit and 
quantal · linear models were used to calculate the BMD for the quantal response 
variables based on their model performances. 
b. Continuous variables 
Data for continuous variables are often presented as means and standard deviations or 
standard errors, but may also be presented as a percent of control or some other 
standard. Continuous m0dels, namely power, polynomial and linear, were used in this 
study in calculating the BMDs for the continuous response variables at a 10% effect 
level. 
Test of goodness-of-fit 
Goodness-of-fit tests evaluate the hypothesis that a particular model fits the data 
effectively (Golden 2000). The Pearson x2 test (US EPA 1995) is used to assess the fit 
of the models to the observed dose-response data. It statistically measures the 
dispersion of data about a dose-response curve in order to provide a test for rejection of 
a model due to lack of an adequate fit, e.g., a P-value of 0.1 (US EPA 2001). 
Observed and expected numbers of affected test animals were determined in each dose 
group and the observed and expected number of affected animals would be relatively 
close if a model fits well. The Chi-square residuals for each dose group were also 
specified. 
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The purpose of using a goodness-of-fit value from the BMD calculation was different 
from that of the p-value routinely used in statistical analysis. In conventional 
statistical analysis, a null hypothesis of no difference between the treated group and the 
control is tested by determining the probability of getting the results that one did if 
indeed there was truly no difference in the population whence samples came. In this 
case, the objective is to make a "yes" and "no" decision about the result with a 
stringent criterion, which is usually 0.05 or 0.01 for model acceptance. 
In BMD modelling the null hypothesis is that the data are adequately represented by 
the BMD model chosen. In this case, the US EPA (2003) recommends a minimum 
goodness of fit p value of p=0.1 be used instead of the conventional values of 0.05 or 
0.01 for model acceptance since it would be particularly important that the value be 
adequately modelled for BMD calculation. Therefore the higher the p-value, the better 
the model is deemed to fits the data. 
P-values only identify those models that are consistent with the experimental results. 
For the assessment of fit, degrees of freedom for the test statistics were determined as 
n-p, where n is the number of dose groups while p is the number of model parameters 
estimated from the data. BMDs do not assign degrees of freedom to parameters related 
to a constraint, so that a model usually has only 2 degrees of freedom, while the 
models with unconstrained parameters have 3 (US EPA 2000). 
For the purposes of this study, a p-value from the chi squared test of< 0.1 was set as 
the rejection level to test the hypothesis of adequate modelling. P-values from the chi-
squared test for each model (Table 7) were obtained using the US EPA BMDS 1.3 
software (USEP A 2001 ). Models that met the default statistical criteria for adequacy 
and visually fit the data were retained in determining the BMDLs. 
All models met the X2 test criterion except for the Weibull model for the 
cardiomyopathy in female rats (unable to run the data which suggested that this model 
does not fit the data) (Table 7), power and linear models for the sperm count post 56-
day recovery period and the linear model for the female fetal weight. A p-value of 1 
was obtained for the polynomial model while a p-value <0.0001 for the power and 
linear models for the sperm count post 56-day recovery period was obtained (Table 7). 
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It should be noted that there were only two data points for this end point, i.e., the 
control group and the top dose level. The two mid ranges were not examined as there 
were only 20 rats allocated to recovery groups, 10 to the control group and 10 to the 
top dose group. Gaylor (1992) cautioned that data should contain two nonzero 
response levels; if not, nearly any curve can be drawn through a single effect point and 
a control value. In this regard, the BMD modelling required at least two treated dose 
groups in addition to a control group for the minimum model (E. Hack pers. comm. 
2004). Hence, the sperm count after the 56-day recovery period was not included in 
this analysis· as the data were not appropriate for BMD modelling. The linear model 
for the female fetal weight was rejected for not meeting the statistical criterion, p'?:.0. l. 
74 
Table7 
Goodness-of-fit tests for quantal and continuous models for various toxicity end 
points at 95% confidence limit with BMR of 10% 
Quantal models P-value• 
Toxicity end point Probit Quantal linear 
Epididymis '- 0.5211 0.5495 
Testicular i 1.0 0.4105 
Cardiomyopathy 2 
Male 1.0 -. 0.4105 
Female 0.5929 0.5971 
Teratogenic effects 1 0.9337 0.1297 
§ eliminated due to calculation failure 
Continuous models P-value• 
Toxicity end point Polynomial Power 
Sperm count 2 0.896 0.957 
Sperm count post 56 1.0 <.00001• 
days 2 
Fetal weight, 1 
Male 0.526 0.212 
Female 0.967 0.315 
a P-value from chi-squared test at <0.1 is the rejection level 
• rejected model 
1 Eason et al. (1998, 1999) 













Benchmark response rate (BMR) 
The BMR is a response level used to define a BMD, the lower limit of which is used as 
the point of departure (BMDL). For compounds with BMD values based on quantal 
data, the BMR is expressed in terms of a percent increase in risk of adverse outcome 
compared with background. The upper confidence limit (UCL) of this BMR can be 
used to determine the lower limit of the BMD, which is used as the point of departure 
and is referred to as the BMDL (Crump 1995). The UCL refers to the upper limit of 
the slope of the dose response curve at the BMR. Thus, if the BMR is 10%, then the 
UCL refers to the upper limit of the slope at 10%. This upper limit will be above the 
10%, of course, but when extrapolated downward in dose, will eventually cross the 
10% response line. The dose where this crossing occurs is the BMDL. 
A TDI is most often developed from the BMDL. The BMR is typically set at the 
lower end of the range of responses ( e.g., 10% or 5% change) that can be detected 
experimentally. Use of this approach can help avoid uncertainties associated with low-
dose extrapolation using models that result in widely differe~t values that may not 
reflect biologic realities (Crump 1995). 
Since the BMDs at the 1 % risk level are often not precisely estimated, Auton (1994) 
suggested using a BMD corresponding to a 5% risk for teratology data, showing that 
the BMDL will be comparable to the NOAEL for most datasets. Similarly, Gaylor 
(1992) concluded that the BMD at the 5% effect level was similar to the NOAEL 
determined by statistical tests of trend. Currently, there is no scientific rationale for 
preferring a 5% or 10% effect level, and it appears that selection of one over the other 
would have minimal effect on the derived TDI in most cases (Barnes et al. 1995). For 
the purposes of this study, a BMR of 10% was used in calculating the BMD. This 
10% value is consistent with the 10% BMR recommended by the U.S. EPA (2003). In 
most cancer and some non-cancer bioassays, the 10% response is at or near the limit of 
sensitivity (US EPA 2003). 
For compounds with BMD based on continuous data, the BMR may be expressed as a 
percent change in mean response compared with control or in terms of standard 
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deviations from the control mean response (US EPA 2003). For continuous end 
points, a BMR of 10% increase in risk was used for the purposes of this study as 
recommended by the US EPA. 
Model Performance 
The goodness of fit of the model to the data is a statistical procedure that provides a 
measure of the goodness of fit of a dose response model to a set of data (US EPA 
2001). The degree of fit is an indication of how well the model reflects the data. 
Akaike's information criterion (AIC) is used for comparison between models and 
selection of the model for BMDL calculations. The AIC values were obtained using 
the US EPA BMDS software (US EPA 2001). 
AIC can be calculated using the equation 
AIC = - 2 logl +2p, 
where L is the value of the likelihood function at the maximum likelihood estimates 
(MLE) for the parameters, and p is the number of parameters estimated in the model 
(Sand et al. 2002). Although the AIC does not reach a conclusion about "statistical 
significance" and does not "reject" any model, it determines how well the data support 
each model. Lower AIC values were preferred according to this procedure for 
estimating the BMD and the BMDL (Sand et al. 2002). The model with the smallest 
AIC was selected among all plausible models and this criterion was used for final 
model selection. 
The AIC values for the dose-response models used in the study are listed in Table 8. 
Analysing the overall model performance of various models, the model with the lowest 
AIC was chosen to estimate the BMD. If the BMDL estimates were within a factor of 
3, they were considered indistinguishable, and the model with the lowest AIC was 
selected to provide the BMDL (US EPA 2003). Since the BMD was chosen within or 
near the experimental dose range, it was relatively insensitive to the choice of the dose-
response model. In addition, an adequate fit to most of the experimental data was 
achieved with all the models (Gaylor et al. 1998). 
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The three quantal models gave comparable AIC values. However, the probit model 
was used in deriving the BMDs for all the quantal end points except for the teratogenic 
effects, where the Weibull model was chosen using the AIC criterion. For both 
models, the power and background parameters were estimated by the maximum 
likelihood estimates. For the continuous end points, the linear model gave the lowest 
AIC for sperm count and the power model had the lowest AIC for male and female 
fetal weights. The power, background, and intercept parameters and slope, 
background, and power parameters were used for the power and polynomial models, 
respectively. Details of the AICs are shown in Table 8. 
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Table 8 
Model performance for quantal and continuous models for various toxicity end 
points 
Quantal models 
Akaike's Information Criterion (AIC) 1 
· Toxicity end point · Probit Quantal linear 
Epididymis j 51.5434 51.773 
Testicular 3 · 31.7259 34.6013 
Cardiomyopathy j 
Male 31.7259 34.6013 
Female 21.4352 21.4528 
Teratogenic effects :1. 48.125 53.3508 
Continuous models 
Akaike's Information Criterion (AIC) 1 
Toxicity end point Polynomial Power 
Sperm count J 118.47 120.59 
Fetal weight, 2 
Male -124.96 -122.80 
Female -138.11 -136.10 
• rejected model 
1 AIC is the statistical measure of how well the model fit the data 
2 Eason et al. (1998, 1999) 












Calculation of BMDs and BMDLs 
As starting points for estimating safe exposure levels, there has been a recent 
movement to use BMDs instead ofNOAELs and LOAELs (Bailer et al. 1999). One of 
the suggested advantages of the BMD method is that it could be applicable in 
situations when NOAELs do not exist (Sand et al. 2002). Like the NOAEL and 
LOAEL, BMD values can be interpreted to correspond to negligible or very low risk 
levels, rather than to precise numerical values. A BMDL has been proposed as a 
replacement for the NOAEL in setting acceptable human exposure levels (Crump 
1995). The exposure levels that result from reducing NOAELs and LOAELs (or 
BMDs) by uncertainty factors may simply be expected to provide adequate safety and 
no specific risk connotations are necessarily attached to them (Bailer et al. 1999). 
The dose associated with the BMR is determined using the dose-response curve. The 
dose corresponding to a given BMR is considered the BMD. The BMD or BMDL is 
then used in place of a NOAEL to derive the TDI. 
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Illustration of a benchmark dose (BMD) approach 
Figure 4 shows a BMD calculated using a 5 or 10 percent BMR (the horizontal dashed 
lines) and a 95% lower confidence bound on dose. The probits are the proportions of 
abnormal responses. The BMDL1o ( corresponding to a lower confidence limit on the 
dose resulting in the BMR of 10% increase in risk) is used as an alternative to the 
NOAEL value for TDI calculations and· used for the purposes of this study. In 
benchmark analysis the BMDL, defined as the lower bound of the 95% confidence 
interval for the BMD, is used as the principal criterion for regulatory purposes. The 
BMDL was used instead of the BMD to provide a margin of safety and at least to 
ensure that the most sensitive individuals in the population are protected (Jacobson et 
al. 2002). This statement is correct when the standard BMR of 10% is chosen as the 
basis of the extrapolation. The use of a BMDL in experimental animals does not 
impact the choice of uncertainty factor for within human variability. Note also that the 
use of a BMDL from a human study, similarly does not impact the choice of an 
uncertainty factor for within human variability. However, if a BMR of something less 
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than 10% is used, an argument could be made that a different choice of an uncertainty 
factor for within human variability needs to be made. Analyses have been made with 
BMDs, BMDLs, NOAELs and LOAELs. A 5 or 10% choice represents either a 
NOAEL or perhaps LOAEL (M Dourson pers. comm. 2007), and thus is consistent . 
with the standard NOAEL/100 approach. 
a. Quantal end points 
Calculation of the BMDs followed the framewo:t;k given by Crump (1995). A brief 
. . . 
outline is presented here. 
Quantal data are modelled using. a mathematical expression for the probability P(d) 
that an individual subjected to a dose dhas an abnormal response (Crump 1995). The 
BMD can be defined as the dose that results in a prescribed additional or extra risk 
which are the two common ways of expressing risk (Gaylor and Slikker 1990). If the 
proportions responding in the control and treated groups are P(O) and P(d), the 
additional risk is: 
Additional risk (AR) is defined as: 
AR(d) = P(d) - P(O) 
The extra risk (ER) may be interpreted as the probability of a response at dose (d) 
conditional on the fact that no response would have resulted from dose zero. In the 
absence of background risk {P(O)=O, additional and extra risk are identical (Crump and 
Howe 1985). Therefore, the extra risk is defined as: 
ER(d) = [P(d) -P(0)]/[1- P(O)] 
where P(d) is the probability ofresponse at dose (d), andP(O) is the probability of 
response in the absence of exposure or the background exposure (d = 0). 
Extra risk was used in estimating the BMD for the purposes of this study. 
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The BMDs and the BMDLs were estimated using the US EPA BMDS version 1.3 
software (US EPA 2001) for the corresponding models chosen according to the criteria 
adopted for the purposes of this study. BMDLs were calculated using the maximum 
likelihood method. As can be seen, the BMDs were typically only slightly higher than 
the BMDLs (Table 9). For the purposes of this study, the point of departure for BMD 
modelling for quanta! end points is the BMDL associated with 10% BMR. Figures 5 
to 8 demonstrate the dose-response curves for 1080 and the models chosen to fit the 
data on various quanta! end points. The error bars indicate 95% confidence intervals 
for the fraction affected. The fraction of animals affected in each dose group is 
indicated by circles. The BMR was an extra risk of 10%. The dose labelled BMDL 
corresponds to the lower end of a one-sided 95% confidence interval for the BMD. 
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Teratogenic effects (Weibull model) 
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Table 9 
Modelling results with quantal endpoints at a 10% response rate (BMD) and its 
lower 95% confidence limit (BMDL) 
Critical end point BMD BMDL 
mg/kg mg/kg 
Weibull Quanta! Probit Weibull Quanta! Probit 
Linear Linear 
Forelimb 0.45 0.23 0.48 . 0.30 0.15 0.36 
malformations 1 
Testicular effects z 0.22 0.05 0.21 0.07 0.03 0.11 
Epididymis z 0.07 0.04 0.09 0.03 0.03 0.06 
Cardiomyopathy '-
Male ·. 0.22 0.05 0.21 0.07 0.03 0.10 
Female • 1.83 0.89 • 0.20 0.21 
• rejected model 
1 Eason et al. (1998, 1999) 
2 Eason et al. (2001); Eason and Turck (2002) 
The BMD approach generates a slope term, which is a new parameter not available in 
the NOAEL approach. The BMD and the BMDL are derived from the slope of the 
dose-response curve at the BMD (Gaylor 1992). It has been recognised that the slope 
could provide significant information to the assessor. Most likely the threshold is 
more quickly approached with steep dose response curves than shallow slopes, all 
other items being equal. 
For the purposes of this study, the slope was taken to be the slope term ql, where the 
x-axis is the dose and the y-axis corresponds to the number of animals responding 
adversely. . A dose-response curve is fitted to the experimental data and the lower 
confidence limit on the dose corresponding to the BMR is obtained. This dose 
represents the estimate of the dose that produces a 10% increase in risk in the context 
of this paper. Thus, the BMDL10 is the lower confidence limit of the dose that gives a 
10% excess in abnormal responses above the spontaneous background level. 
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The NOAELs and LOAELs, and BMDs and BMDLs slopes for various critical quantal 
end points are shown in Table 10. The probit model was used in deriving the BMDs 
and the BMDLs for testicular, epididymis, male and female cardiomyopathy and the 
Weibull model for teratogenicity based on AIC criteria. 
Table 10 
N'OAEL and LOAEL values and dose-response slopes with corresponding BMD 
and BMDL values from various quantal end points 
T6xicity end point·. NOAEL LOAEL ql Slope BMD BMDL BMD 
.. mg kg-1 mgkg-1 term mg/kg/ mg kg-1 Model 
(best fit) 
Epididymis ~ 0.075 0.25 6.83 0.09 0.06 Probit 
Testicular ~ 0.075 0.25 . 31.73 0.21 0.11 Probit 
Cardiomyopathy, 2 0.075 0.25 31.73 0.21 0.10 Probit 
male 
Cardiomyopathy, 2 0.075 0.25 0.88 0.89 0.21 Probit 
female 
Teratogenicity 1 0.10 0.33 1.42 0.45 0.30 Weibull 
1 Eason et al. (1998, 1999) 
2 Eason et al. (2001); Eason and Turck (2002) 
The BMDs and BMDLs calculated for each model were compared to one another and 
to the NOAELs (Table 10). The BMDLs for all quantal end points, using the best fit 
models, were about three times higher than the NOAELs for teratogenicity and female 
cardiomyopathy; and almost the same for the other end points (Foronda et al. 2007a, 
see published article in Appendix 2). Given that the BMDL estimates from the three 
models were within a factor of 3, except for the epididymis which had the lowest 
BMDL, they were considered to show no appreciable model dependence and were 
considered to be indistinguishable in the context of the precision of the methods. The 
results were consistent with that of Gaylor et al. (1998). 
The probit model demonstrated steeper slopes for testicular and male cardiomyopathy 
while a shallower slope was observed for female cardiomyopathy and epididymal 
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pathology. Shallower slopes were observed for teratogenicity using the Weibull 
model. 
b. Continuous end points 
The general method for determining continuous end points, the framework given by 
Crump (1995), was followed in calculating the BMDs. A brief outline of this 
framework is summarised as follows: 
For a given dose d, there is a resulting continuous response X governed by a 
distribution function F. One of the parameters of F, 8(d), depends upon d, and the 
remaining parameters, represented by a (slope), do not. Given the distribution 
function F and the background response value po, a cut off response x0 can be 
· calculated with responses more extreme than x0 considered abnormal. Using the above 
notation when larger responses are more adverse, the probability of having an 
abnormal response given a subject's dosed is given by 
P(d) = I -F[xo; 8(d), a,], 
IfBMD corresponds to an extra risk of 0.10 (BMR), then,p(BMD) is the proportion of 
affected animals at the BMD, and p(O) is the proportion in the control group, BMR is 
defined to be: 
BMR = [p(BMD)- p(0)]/[1-p(O)] 
This equation can be rearranged to yield 
p(BMD) = p(O) + [1-p(O)]BMR) 
While the primary focus on BMD methodology in the literature has been on quantal 
end points, a few investigators have explored applications to continuous variables 
(Kavlock et al. 1995). The application of the BMD approach to continuous data is 
more complex as some judgement is required about the magnitude of an effect that one 
would consider to be "abnormal" or "adverse" (Barnes et al. 1995). 
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Generally, with continuous data there is not a clear demarcation between normal and 
adverse measurements (Gaylor et al. 1998). Continuous data can be quantised but 
Gaylor et al. (1998) recommend analysing the continuous data instead of converting 
them to quantal data. Gaylor's recommendation was adopted for the purposes of this 
study. 
There were two continuous end points investigated in this study. These were the fetal 
weights· for male and female rats under study and the sperm count for male rats. A 
summary of the modelling results using power, polynomial and linear models is 
presented in Table 11. The BMD values were higher than the BMDLs, the difference 
ranging from I.I to 2-fold higher. The dose response curves for the sperm count and 
male and female cardiomyopathy are presented in Figures 9 to 11 . 
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Male fetal weight (Power model) 
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Table 11 
Modelling results with continuous endpoints at the lower 95% confidence limit 
and 10% reduction in sperm count and fetal weights 
Critical end BMD 
point mg kg-1 
v· Power Polynomial 
Sperm count L. 0.10 0:08 
Fetal weight, 1 0.58 0.58 
male 
Fetal weight, 1 0.61 0.61 
female 
1 Bas~~ et al. (1998, 1999) 
2 Eason et al. (2001); Eason and Turck (2002) 
• rejected model 
BMDL 
mg kg-1 
Linear Power Polynomial Linear 
0,10 0.09 0.04 0.09 
0.52 0.44 0.41 0.43 
• 0.49 0.50 • 
The BMDs calculated for the chosen model were compared to the defined NOAELs 
(Table 12). The BMDLs were similar to the NOAELs for all the end points. 
The continuous linear model gave a steeper slope for sperm count while shallower 
slopes were observed using the power models for the fetal weights (Table 12). The 
same slopes were noted for both the female and male fetal weights but a slight 
difference is present in the BMDs and BMDLs. This could be due to a difference in 
background and power parameters. 
91 
Table 12 
NOAEL and LOAEL values and dose-response slopes with corresponding BMD 
and BMDL values from various continuous end points 
Toxicity end NOAEL LOAEL ql BMD BMDL BMD 
point mg kg-1 mgkg-1 Slope mgkg-1 mg kg-1 Model 
term (best fit) 
Sperm count i 0.075: 0.25 -8.70 0:10 0.09 Linear 
Fetal weight; 1 0.33 0.75 -0.57 0.58 0.44 · Power 
male 
Fetal weight, 1 0·.33 0.75 -0.57 0.61 0.49 Power 
female 
1 Eason et al. (1998, 1999) 
2 Eason et al. (2001); Eason and Turck (2002b) 
The use of uncertainty factors 
Uncertainty in health risk assessment results from the lack of certainty with respect to 
exposure dose, dose-response relationship, and individual susceptibility for a 
substance. In most cases, the data are inadequate to draw precise conclusions with 
respect to the range of variability in human responses. Because of this uncertainty and 
the desire to provide protection to the high-risk segments of the population, the 
concept of an uncertainty factor (UF) has evolved (Clarke et a/.1981). 
An UF is a mathematical expression of uncertainty that is used to protect populations 
from hazards which cannot be assessed with high precision (IPCS 1992). Dourson et 
al. (1996) argued that the use of the UF approach in risk assessment was justified· on 
the rationale that low dose risks remain largely unknown for both carcinogens and non-
carcinogens. The application of the UFs is also seen as a combination of scientific 
judgments about low-dose exposures and risks. 
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Applying UFs to the NOAEL is the primary approach used in threshold-based risk 
assessments. It is used in the extrapolation of results of standard toxicity tests to the 
human situation. The choice for these UFs is based on limited toxicological data. 
Typically, UFs range in value from 1 to 10 (IPCS 2000b). Implicit in the use ofUFs is 
the assumption that true conversion factors for the various types of extrapolation are 
random independent variables. Furthermore, it is assumed explicitly that the value of 
each individual factor used ( e.g., 10) is large enough to capture a high percentage of 
· the range over which that factor varies (Kodell and Gaylor 1999). 
The uncertainties inherent in health risk assessment are especially evident in the 
assessment of chronic health effects due to low level of exposures to toxic chemicals. 
In health risk assessment, selection of assumptions is taken into policy considerations 
because of these uncertainties (Covello 1989). When uncertainty is great, health risk 
assessment can produce a false sense of accuracy. However, when uncertainties are 
fully documented, they can be extremely large, which may lead to a conclusion that the 
health risk assessment results are so imprecise as to be nearly useless (Covello and 
Merkhofer 1993). 
a. Inter- and intraspecies extrapolation 
Traditionally, toxicological data from high-dose animal experiments have been 
extrapolated to low-dose human exposure using UFs. The application of a 100-fold 
UF to NOAEL results from long-term animal studies is a long-standing practice. It has 
been interpreted as resulting from the product of two 10-fold safety factors: one factor 
to account for animal-to-human differences, and another factor of 10 to extrapolate 
from average humans to potentially sensitive human subpopulations (Dourson and 
Stara 1983; Lehman and Fitzhugh 1954; Klaassen and Doull 1980; Weil 1972). It was 
founded on a public health based rationale that assumes that an average group of 
humans may be as much as 10-fold more susceptible than the average group of animals 
under study (Calabrese et al. 1992). The value of 10 is considered a health-protective 
value and is generally used as the UF for standard setting by the US EPA and the 
California Office of Environmental Health Hazard Assessment (Alexeeff et al. 2002). 
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Although humans are qualitatively similar to other animals with respect to many health 
outcomes following chemical exposures, an UF of 10 has been used to compensate for 
the uncertainties surrounding interspecies differences (Pohl and Abadin 1995). 
Dourson and Stara (1983) supported the use of this UF based on empirical evidence in 
the literature suggesting that a 10-fold reduction in animal dose is sufficient to 
extrapolate to a practical human threshold dose (e.g., a NOAEL). Calabrese (1985) 
concluded that the commonly used UF of 10 seemed to provide protection for 80 to 
95% of the human population. On the other hand, some investigators considered that 
although humans are frequently more sensitive than animals in terms of milligrams per 
kilogram of body weight (Dourson and Stara 1983; Lu 1983), this is not always the 
case. Digression from the default UF of 10 may be warranted in some cases (Pohl and 
Abadin 1995). 
A study conducted by Dourson et al. (2001) found that where there was a 10-fold UF 
for experimental animal to human extrapolation. Although the number of comparisons 
was only 22, 5 (23%) of R:IDs or RfCs calculated from experimental animal data were 
higher than the US EPA's human based values. Based from this observation it would 
be reasonable to argue that the 10-fold UF was sufficient to protect human health for 
those R:IDs and RfCs derived only from experimental animal data. However, 
exceptions often occur and thus results from experimental animals should always been 
reviewed against human information when available. 
Variability between the genetically similar animals is small compared to the variability 
within the heterogenetic human population (Barnes et al. 1995). This rationale 
justified retaining the default UF of 10 for intraspecies differences between estimating 
a TDI on a BMD from animal data. In addition, the Barnes et al. (1995) report 
supported the view that UFs used to compensate for the use of subchronic studies 
rather than chronic studies, the lack of database completeness, for example should be 
retained when estimating a TDI based on a BMD. 
Kalberlah and Schneider (1998) suggested that a factor of 10 might not be sufficient to 
cover sensitive subpopulations under all circumstances as the conventional default 
factor of 10 is not based on a large set of valid data for human variability. Main 
contributors to inter-individual susceptibility differences to chemicals include age, 
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illness, pregnancy, sex, and genetic predisposition. Human studies showed that further 
analysis is necessary to gauge the extent to which the variability of responses are 
representative for the general population and potentially vulnerable subgroups (Hattis 
et al. 1999a, b; 2001). Uncertainties associated with intraspecies extrapolation factors 
result from limited knowledge of the variability among humans for toxicokinetics and 
toxicodynamics, insufficient data on the susceptibility of special subpopulations and 
the mutual dependencies of these factors. 
b. Duration of exposure 
An up to 10-fold UF is generally used to extrapolate from a subchronic exposure to a 
chronic exposure. This factor is: used for studies that involve less than lifetime 
exposure and is based on the assumption that if the chemical were given over lifetime 
of the animal rather than over a fraction of the lifetime, a smaller amount of chemical 
would result in the same effect. Based on this rationale, Dourson and Stara (1983) 
concluded that it seems reasonable to employ a 10-fold UF to account for differences 
between subchronic and chronic effect levels. Beck et al. (2001) concurred that 
extrapolation of subchronic to chronic exposures is generally accompanied by an UF 
of 10 for non-cancer effects with the assumption that an effect observed with a 
subchronic exposure is not likely to occur at less than one-tenth of that dose for a 
chronic exposure. The Food and Drug Administration (FDA) recommends an 
additional 10-fold factor where subchronic animal NOELs or NOAELs were available 
in two species due to the added uncertainty when estimating an ADI from adequate 
shorter-term toxicity data (Kokoski 1976 as cited by Dourson and Stara 1983.) 
However, Shibko4 (1981, as cited by Dourson and Stara 1983) has a slightly more 
conservative view as it was recommended that if subchronic data were available for 
only one species, an extra 2-fold UF is to be used as it seemed likely that the extra 
margin of uncertainty would probably include the range of sensitivity of two species 
which is normally required for toxicological evaluation. The logic for a 2-fold extra 
factor, i.e., a combined UF of2000 instead of 1000, is for the database UF as discussed 
in subclause ( c) on page 96 (M. Dourson pers. comm. 2005). 
4 Memorandum to Dr M. Dourson. 
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The European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) 
proposed a value of 2-3 as default for extrapolation from subchronic to chronic 
exposure while other organisations favour a value of 10, such as the US EPA, the 
Agency for Toxic Substances and Disease Registry (ATSDR), and the German 
European Aerosol Federation (EAF) (Kalberlah et al. 2003). It was explained that the 
differences are due to differences in protection levels, where ECETOC aims at central 
estimates, while the US EPA or the German EAF tend to include higher percentiles of 
cases or substances in their extrapolations. 
c. Completeness of overall database 
An extra factor of 10 would be appropriate where major deficiencies in the data exist 
with respect to quality, quantity or omission, such as a lack of chronic toxicity studies 
(Dourson et al. 1992; IPCS 1994). In one review, more than a third of the substances 
(3 8 and 3 7%) had no appropriate chronic study to validate the RtD/T AD (Kalberlah et 
al. 2003). 
Beck et al. (2001) suggested that when the database is limited, there is uncertainty as 
to whether the identified NOAEL might be significantly lower if other studies were 
performed, or whether a different NOAEL might have been identified if additional 
health endpoints had been evaluated. Beck et al. (2001) defines a complete database 
as having: 
• two systemic toxicity mammalian studies in different species; 
• one mammalian multigeneration reproductive study; and 
• two mammalian developmental toxicity studies in different species. 
d. Protection of children 
The US Food Quality and Protection Act 1996 (FQPA) provides a new extra IO-fold 
safety factor to be added after the determination of the TDI to ensure that infants and 
children are protected (US EPA 1996). The additional safety factor under the FQP A is 
largely policy-based and not driven by scientific findings (Scheuplein et al. 2002). It 
has been recognised by both the US EPA and others (US EPA 2002; Fenner-Crisp 
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2001; Dourson et al. 2002), that the toxicity component of this safety factor overlaps 
with the database uncertainty factor discussed earlier, and that when the database 
factor is employed properly, no need exists for the toxicity component of the FQP A 
factor. Based on this rationale, no additional safety factor is proposed to be 
incorporated for children's increased susceptibility beyond that already incorporated to 
account for human variability. 
e. Justification of UFs applied in estimating the tolerable daily intakes. 
Uncertainty factors 
• A default factor of 10 (U A) is used to take into account the interspecies 
variation. For example, the toxicokinetics and toxicodynamics differences 
between humans and rats (the test species used in the pivotal study) are not 
known as no relevant data exist for 1080 in humans, although based on lethal 
effects, rodents might be as sensitive, or perhaps more sensitive, than other 
mammals such as humans. 
• An uncertainty factor of 10 (UH) is used to account for intraspecies differences 
(i.e., human variability) in response to toxic chemicals. This UF was 
introduced to protect sensitive individuals within a population. Age, sex, 
genetic composition, nutritional status, and pre-existing diseases may all alter 
susceptibility to toxic chemicals. To be assigned a factor of less than 10, a 
chemical must have more than just an adequate, peer reviewed human database 
(Abernathy et al. 2003). Information on toxicokinetics and toxicodynamics 
variability in humans would also be useful for considering an uncertainty factor 
other than the default value of 10. 
• An UF of 10 (Us) was used to account for the use of data from a subchronic 
study as a surrogate for results from a chronic study. This UF appears to be 
warranted based, for instance on the evidence that prolonged exposure (21 to 
126 days) to 1080 in the drinking water of laboratory rats caused depletion of 
spermatids, formation of spermatid and spermatocyte giant cells, and 
seminiferous tubule atrophy (Smith et al. 1977). Exposure to 1080 for two 
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months severely impaired the reproduction of mink, which was presumed to be 
due to oligo- or aspermia (Hornshaw et al. 1986). 
In addition, subchronic 90-day tests still have their limitations with regard to 
human health hazard assessment since exposure takes place only for a certain 
period (approximately 10% of the lifetime (Kroes 1997)). The length of this 
period may not necessarily be sufficiently long enough to reveal chronic 
effects, since the substance may produce different toxic responses when 
administered repeatedly over a long period of time, and the ageing process may 
alter tissue sensitivity, metabolism or physiological capability. Moreover, 
spontaneously occurring diseases may also influence the degree and nature of 
the effect of the substance. 
Database uncertainty factor (Un) 
• In relation to completeness of the overall database, the Beck et al. (2001) 
definition of a "complete database" was applied. If these five studies are 
available, and if clear thresholds can be identified from them, then there is a 
high degree of confidence that one has approximated an appropriate point of 
departure. Unfortunately, there is no mammalian multigeneration reproductive 
toxicity study to date on 1080. There is only one species tested (rats), with 
regard to teratogenicity, whereas two species are normally required for 
toxicological evaluation. In case of this factor, professional judgment is 
required to determine the appropriate value, taking into account the scientific 
uncertainties of the studies and the overall database. 
A U0 of 3 is proposed, considering the definition for a "complete database". A U0 of 
3 is judged to be reasonable based on the availability of part of, but not the "complete 
database". The use of a 3-fold factor here, instead of a default value of 10 is also 
consistent with current practice (Dourson 1994) in that the use of more than 3 areas of 
uncertainty with default values of 10 leads to overly conservative estimates of TDI (or 
Rills). The common practice is to use only a 3-fold factor for the 4th area of 
uncertainty and an additional 3-fold factor for a 5th area of uncertainty. Alternatively, 
the uncertainty factors other than for interspecies and intraspecies variability can be 
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viewed as all related to general database deficiencies and the overall factor for this area 
is between 1 and 100-fold (IPCS 1994). 
Combined, the overall UFs and U0 that are proposed to be used in deriving the TDI for 
1080 is 3000 (i.e., 10*10*10*3). The US EPA is currently using a cumulative 
maximum of 3000 UF in its risk assessments (Kodell and Gaylor 1999; US EPA 
2002). 
The IPCS (1994) has recognised the imprecision of the cumulative default factors and 
in order to maintain credibility of the risk assessment process, IPCS has suggested that 
the total default UF should not exceed 10 000. If the risk assessment leads to a higher 
factor, then the resulting TDI would be so imprecise as to lack meaning. 
f Use of statistically derived UF 
Kodell and Gaylor (1999) have proposed using an estimate of the upper percentile, 
such as for instance 95th or 99th of the distribution of the product, UH* UA * Us* UD, 
of UFs as a statistically valid way of combining UFs, that will be sufficiently 
protective of the general population but not overly conservative. It has been 
demonstrated that several of these UFs behave as random variables and that their 
probability distributions may be approximately by the log-normal distribution 
(Dourson et al. 1996; Hartis 1998). 
The upper percentiles of the distribution of the product as a combined UF were derived 
from the estimates of means and standard deviations of the approximately log-normal 
distributions of individual UFs. These values are used to replace the conventional 
product of default factors (Kodell and Gaylor 1999). In obtaining the representative 
mean (median) estimates, the expression m1n cu1) = ln (U 1, o.s) is applied (U 1, o.s = 
observed median of the distribution of uncertainty factor U1 (1 = L, S, A, or HJ). 
Estimates for representative standard deviations are solved for s10 (Ul) in the following 
expression 
m1n(Ul + ZaS Jn(Ul) = ln (U1, 1-a), 
99 
where Za is the 100(1 - a) th percentile of the standard normal distribution and U 1, 1 _ a 
is the observed 100(1 - a) th percentile of the distribution of uncertainty factor U 1. 
Kodell and Gaylor (1999) has used the data of Swartout (1996) in reaching to their 
conclusion that the estimated mean (median) ofln (US) is m1n (US)= ln (2) = 0.69, while 
the estimated standard deviation, s1n (US), is found to be 1.30 by using the following 
formula 
0.69 + zo.osSJn(US) = ln(l 7), 
where 17 was the observed 95th percentile of the distribution of subchronic to chronic 
dose ratios. For both ln(UA) and ln(UH), the estimated mean (median) is ln(l) = 0. 
The data of Dourson and Stara (1983) showed that 92% of 490 chemicals evaluated in 
acute lethality studies had interspecies adjustment factor values of at most 10. An 
estimated value of 1.64 was obtained for s1n (UH) from the expression: 
0 + zo.osSJn(UH) = ln(lO). 
The expression 
U (95) = exp {min (U) + zo.osS1n(u)} 
can be used to standardise the various factors in estimating the upper 95th percentiles, 
U(95). 
Table 13 presents the point estimates for the 95th and the 99th percentiles for each 
individual UF, and the combination of three and four factors compiled from 
information in Kodell and Gaylor (1999) with some unknown and/or unspecified 
rationale for the distribution function. A point estimate for the upper percentile, e.g., 
95th percentile of the combined range of uncertainty can be obtained from 
UHASL (95) = exp { min (UH) + min (UA) + m,n (US)+ min (UL) 
+ 1.645 [S21n(UH)+ S21n(UA) + S21n(US) + S21n(UL)] Yi}. 
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Table 13 
Estimated upper percentiles of distributions of uncertainty factors 
Uncertainty 95th Percentile 99th Percentile Product of Default 
Factor Point Estimate Point Estimate Factors 
Us 17 41 10 
UA 15 48 10 
UH 15 45 10 
UHA 46 228 100D 
UHAs 161 998a 1 oooc 
UHAsL 4067 
1000 X 3 = 3000° 
998 X 3 = 2994e 
a Maximum value for three uncertainty factors [with some unknown and/or unspecified rationale for the 
distribution function.] Kodell and G~ylor 1999 · 
b Maximum conventional value for two uncertainty factors 
0 Maximum conventional value for three uncertainty factors . 
d Maximum conventional value for four uncertainty factors as suggested by the US EPA 
e UF derived in section 6.1.1.2 based on Kodell and Gaylor 1999 
The formula for UHAS gives a combined UF that is less conservative (but almost 
similar) than the conventional NOAEL approach of simply multiplying together a set 
ofUFs. Kodell and Gaylor (1999) stated that it is appropriate to use a larger percentile 
than the 95th percentile, but to still use a point estimate. Due to the limited information · 
available, in particular the relevance of severe toxic end-points to humans, a more 
conservative approach appears to be warranted. Hence, the 99th percentile is proposed 
forthe purposes of this study. 
As can be seen in Table 13, the default maximum factor of 3000 recommended by the 
US BP A for four factors approaches the estimated 99th percentile. There were three 
UFs (UHAs = 998) in this study plus an extra factor of 3 to take into account the 
incompleteness of the database. Since Kodell and Gaylor (1999) did not include 
database uncertainty factors in their analysis, UHAs will simply be multiplied by the U0 
. of 3, bringing the total UF to 2994. 
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g. Use of human data 
The presence of human data obviates extrapolating from animals to humans. 
Therefore, human studies, when available, are given first priority, with animal toxicity 
studies serving to complement them (Barnes and Dourson 1988). However, using 
human data in this context requires that the human study should be at least of 
comparable quality to an animal study that might be used to determine a risk value. 
Human data that are not directly useful as the basis of the NOAEL value may be 
compared with animal data to determine the most appropriate interspecies uncertainty 
factor, rather than a default factor of 10 (Dourson et al. 1996). 
The principal strength of epidemiological studies is that they yield data for humans. 
They provide the strongest possible direct scientific evidence of risk to humans. 
Epidemiological studies also eliminate many of the problems encountered in 
conducting animal studies, especially those arising from the need to extrapolate from 
one species to another. However, it is known that well documented human 
toxicological data occur rarely. Kalberlah et al. (2003) have summarised that in two 
separate studies 92% and 83% of the substances have to use animal data to derive an 
oral RID or tolerable absorbed dose (TAD). Even in cases where suitable human data 
could be found for RfD/T AD derivation, intraspecies extrapolation had to be 
performed (100 and 96%, respectively) as no data on sensitive subpopulations existed. 
An important limitation of epidemiological studies is the difficulty in detecting adverse 
health effects at low exposure levels. Furthermore, if such studies are available, they 
often lack quantitative information on the concentrations to which the people have 
been exposed or to what else the populations have been simultaneously exposed 
(Ministry of Health 1995a). As in laboratory animal studies, observed associations are 
usually less pronounced at low levels of exposure, which make the data difficult to 
assess due to chance, errors, biases, or confounding factors. As suggested by Covello 
and Merkhoffer (1993), epidemiological studies are not controlled laboratory 
experiments. The epidemiologist does not control exposure to the risk agent and 
generally the study is limited to exposures and diseases that occur naturally or 
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accidentally. Also, one needs to consider the ethical, practical, and legal restrictions 
associated with experiments involving humans. 
Rall (1979) was strongly of the view to place primary reliance on laboratory test 
results, as human epidemiological studies cannot be used to predict or assure safety for 
several reasons. Epidemiology cannot demonstrate what effects a substance will have 
until after humans have been exposed to it and perhaps become ill. Also, it may be 
impossible to assess the effects of a substance, if exposure has been ubiquitous, 
because there is no unexposed control group. Furthermore, it is usually difficult to 
determine doses in human exposures and to identify small changes in common effects, 
which can be important if the population is large. 
As both animal and human data have advantages and disadvantages, both types of data 
should be analysed when conducting health risk assessments to minimise the 
uncertainties. 
Tolerable Daily Intake (TDI) 
A TDI is defined as an estimate of the intake of a substance over a lifetime considered 
to be without appreciable health risk. Toxicological risk assessments for non-
carcinogenic health effects usually result in point estimates for human limit values, 
such as "Acceptable Daily Intake", "Tolerable Intake" or Tolerable Daily Intake. 
These terminologies were developed by the World Health Organization (WHO) while 
"Reference Dose" (RID) or "Reference Concentration" (RfC) are used by the US EPA 
(Kalberlah et al. 2003). The International Programme on Chemical Safety (IPCS) 
stated that the TDI is similar in definition and intent to terms such as the RID and RfC 
and acceptable daily intake (IPCS 1994). An RID or RfC is intended to be a level of 
exposure for the human population that is likely to be without appreciable risk of 
causing adverse effects for a lifetime (IPCS 1994). 
Barnes and Dourson (1988) pointed out that the concept of the "acceptable daily 
intake" has been used in the field of regulatory toxicology for many years. However, 
the health significance of exposures to non-carcinogenic substances has received 
considerable scrutiny, resulting in the introduction of the concept of the term 
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"reference dose" in order to avoid the use of judgmental terms such as "safety" and 
"acceptable". 
Although the scope of this study is in connection with potential long term exposures to 
1080, a "tolerable intake" based on short-term exposure was estimated (see page 127). 
It needs to be borne in mind, however, that TD Is are based on assumption of lifetime 
daily exposure, which is the standard method of estimating standard limits, such as the 
ADis or Rills, and therefore is conservative when exposure is only for a short period 
of time. 
For the purpose of this study, the TDI for 1080 was estimated to be 0.03 µg kt1 bw 
dai1. (see section 5.1.1.5). The estimated TDI is compared with the estimated 
exposure. If the calculated TDI is greater than the estimated exposure, the likelihood 
of an adverse effect occurring in an exposed population is very small. 
The term tolerable daily intake (TDI) is used throughout the text except when citing 
research studies, where the original terminology was retained, e.g., RID. 
5.1.1.3 Exposure Assessment 
Exposure assessment determines the degree of contact a person has with a chemical 
and estimates the magnitude of the absorbed dose (CAAHEAP 1991). Several factors 
need to be considered when estimating the absorbed dose, including factors such as 
exposure duration and exposure route. By definition, "duration" is the "period of time 
over which the person is exposed" (CAAHEAP 1991). 
For many health risk assessments, exposure assessment is the most difficult task as it 
often depends on factors that are hard to estimate and for which there are few data 
(Covello and Merkhoffer 1993). Critical information on the conditions of exposure is 
often lacking. This statement is particularly relevant in the case of 1080, as data on 
conditions of exposure are scant, which makes health risk assessment difficult to 
quantify. Default assumptions were generally used as the basis for the purposes of this 
study. It is also known that exposures to the general population are less well 
documented than occupational exposures (Covello and Merkhoffer 1993). This may 
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be due to greater uncertainty associated with the activities of the general population. It 
is known that occupational activity is easier to characterise. As noted by the National 
Research Council (1994), despite the presence of uncertainty, decision makers may be 
forced to face the reality that exposures have been either overestimated or 
underestimated for every member of the exposed population. 
When risk is a function of time of exposure, exposure or dose profiles can be very 
useful. In these profiles, the exposure concentration or dose is plotted as a function of 
time (Aylward et al. 1996). Such profiles are important for use in health risk 
assessment where the severity of the effect depends on the pattern by which exposure 
occurs, rather than on the total exposure. For example, 1080, a developmental 
toxicant, may only produce effects if exposure occurs during a particular stage of 
development, i.e., the period of organogenesis. During the period of organogenesis, 
the embryo is most susceptible to the effects of teratogens, such as 1080. This period 
generally ends some time from the 10th to the 14th day in rodents and in the 14th week 
of the gestation period in humans. For example, Lu (1996) pointed out that a brief 
exposure of a rodent to a teratogen on the 10th day of gestation is expected to induce a 
variety of malformations. Similarly, a single acute exposure to a very high dose may 
induce adverse effects, even if the average dose is much lower than apparent no-effect 
levels (Paustenbach 2000). 
It is important to identify and evaluate those populations, subpopulations and 
individuals that are potentially at greater risk of exposure and susceptibility, so that if 
warranted appropriate mitigation can be implemented. Individuals and groups are 
deemed to be at potentially higher risk if they are likely to be exposed to high 
concentrations of 1080, such as drinking water that has been highly contaminated with 
1080. Inherent genetic variability, age, gender, pre-existing disease, environmental or 
lifestyle factors may, among other things, have enhanced the susceptibility (IPCS 
2000a) to the toxic effects of 1080. Some subgroups may be especially susceptible to 
adverse health effects, such as pregnant women, the very young, the elderly, and 
persons with impaired health (Covello and Merkhoffer 1993). 
Since children form a unique subgroup within the population, a separate risk analysis 
was carried out as a component of this study. Children have vulnerabilities to 
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chemicals that are quite distinct from those of adults (Morford et al. 2004). Children 
eat three to four times more food per kg of body weight than adults. The air intake of a 
resting infant is twice that of an adult on a body weight basis. Because of these 
interactions with their environment, children are easily exposed to more pollutants per 
kg of body weight than are adults (Fabian 1998; Wigle 2003). Children have 
immature metabolic pathways compared with those of adults. Therefore, the ability of 
the child to detoxify or activate and excrete certain toxins would be different from that 
of adults because of this biochemical immaturity. In addition, children's delicate 
developmental processes are easily disrupted as· they undergo rapid growth and 
development (Bailer et al. 1999; IPCS 1986). Organs such as the kidneys and liver are 
not functionally developed enough to properly metabolise and excrete toxic chemicals 
which may lead to additional damage. Furthermore, some systems ( e.g., 
immunological and neurological) are not fully developed and are easy targets for 
chemical injury (Pohl and Abadin 1995). As with adults, the potential for exposure to 
1080 for infants and young children is through ingestion, inhalation, and percutaneous 
absorption. 
The special vulnerability of the young becomes evident when the young and the adult 
experience the same dose. For example, many substances that can be used with 
relative safety by the pregnant mother can be quite harmful to her developing child, 
such as alcohol and tobacco (Kopecky and Koren 1998). The developing fetus may 
encounter 1080 in utero by the placental route - this has been demonstrated in animal 
studies, where it showed that 1080 was capable of causing malformations in rats 
(Eason et al. 1999). However, whether this occurs in humans is unknown. 
Young children may be at risk if milk contaminated with 1080 is a major component 
of their diet. Cow's milk and those other domestic animals, for example, may also be 
contaminated with 1080. Although this rarely happens, the accidental contamination 
of milk has occurred in the past in New Zealand (J. Simpers. comm. 1998). 
The US National Research Council (NRC 1993) report "Pesticides in the Diets of 
Infants and Children" raised concerns that at least in some cases, children may not be 
protected adequately by then-current US regulatory policies. However, the relevant 
question is not whether children are inherently more sensitive than adults but whether 
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they are at greater risk (Scheuplein et al. 2002). If the exposure is greater in a child, 
then the risk should be greater, whether or not it is judged to be above the toxic effect 
threshold. Zero risk and absolute safety can hardly be achieved or proven but exposure 
to very low levels provides negligible or tolerable risk. 
Very limited information is available on children's exposure to environmental 
toxicants. The primary routes of exposure to chemicals in the environment are 
ingestion of contaminated drinking water, food, inhalation of dusts, and dermal contact 
(Paustenbach 1995). These exposure pathways may also be relevant to 1080. 
Children's exposure to lead is an example where a number of studies have been 
documented. For example, children's exposure to lead is primarily through ingestion. 
Towards the end of the first year of life, oral exploration is common and it could be 
accompanied by ingestion of substances not normally regarded as food, a condition 
called pica (Murgueytion et al. 1996). Exposure from hand-to-mouth activity (e.g., 
surface dust and soil) is well documented in several studies such as WHO (1995) and 
Ruppel (1995). Atmospheric entry of soil into houses and soil brought indoors by 
animals or human beings ( on bodies, clothes, shoes) are also possible sources of 
exposure. Calabrese and Stanek (1992) determined that approximately 30 percent of 
household dust was derived from outdoor soil and that the remaining 70 percent came 
from other household sources such as deteriorating lead paint. 
Hand-to-mouth behaviour, such as putting toys and other objects in their mouths and 
eating food which has been on the floor are relevant, especially in children aged six to 
72 months. Mouthing and pica are recognised to diminish with continuing 
development after the first year of life, however hand to mouth activity persists 
(Barltrop 1966). These factors result in eating less foreign matter by the age of four 
(WHO 1995). Accidental ingestion may also occur in early childhood as a 
consequence of increasing mobility and diminishing supervision. 
5.1.1.3.1 Quantification of exposure levels 
There are no adequate data to accurately quantify the various exposure scenarios for 
1080. Estimating the magnitude of the potential dose of 1080 from drinking water 
requires knowledge of the amount of water ingested, the 1080 concentrations in the 
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water, and the body weight of the individual concerned. The amount of water ingested 
per day may vary with each person. When little is known about the specifics of 
exposure, a value of 2 litres per day for adults, 1 litre per day for children and 0.75 
litres per day for infants are used as the default values (Beck et al. 2001; U.S. EPA 
1992). The DWS NZ also employs 2 litres per day for adults as the default value. 
It is important to note that intake is not equivalent to the absorbed dose (IPCS 2000b ). 
Bioavailability data are important in the process of exposure risk assessment. Owen 
(1990) suggested that organisations such as the US Department of Health and Human 
Services assume 100% absorption ifthere is no valid evidence to the contrary. For the 
purposes of this study, 100% absorption was used as the default value unless 
appropriate data were available to the contrary. Notwithstanding the high water 
solubility of 1080 and its metabolite, it is probable that 100% is an overestimate. 
Adult exposure based on actual concentrations of 1080 in various media 
Humans can be exposed to 1080 through various routes of exposure. Exposure 
scenarios considered relevant for the -purposes of this study, are drinking water, food 
intake, and inhalation of dust from 1080 baits during aerial spraying programme. The 
values used in the exposure estimate are the highest concentrations of 1080 found in 
various media ( excluding milk, tea, air and soil) (Table 14). A separate estimate is 
presented in Table 15 using the maximal allowable concentrations of 1080 in food and 
drinking water except for dermal and inhalation intakes where no standards are 
available. Hence, actual 1080 concentrations in air and soil were used. 
The following exposure estimates are calculated as: 
a. Intake from food 
The methodology for estimating uptake via ingestion must account for the quantity of 
food ingested each day, the concentration of contaminant in the ingested material, and 
the body weight (kg) of the individual. In this instance, the most likely relevant 
sources would be contaminated meat (e.g., contaminated feral meat) and contaminated 
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milk. The recommended intake from the Healthy Eating for Adult New Zealanders 
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(Ministry of Health 2000) of about 200 g daf1 meat (surrogate value used for 
contaminated feral meat) and 500 ml daf1 of milk were used for the purposes of this 
study. The highest 1080 concentration found in contaminated meat was 0.028 mg ki1, 
resulting to a likely intake of 5.6 µg 1080 daf1• In milk, the reported value was 0.004 
mg kg-1 giving an estimated intake of 2 µg 1080 daf1 (Table 14). Based on a 70 kg 
body weight, which is the representative body weight for adult New Zealander equates 
to 0.08 µg kg-1 bw 
day-1 for meat and 0.028 µg ki1 bw daf 1 for milk. 
It has been shown that 1080 is naturally present in tea. Twigg et al. (1996) have 
shown that a normal cup of tea contains about 0.001 nanograms mr1 (0.001 µg/L) of 
1080. An adult may consume an estimate of 450 ml of tea per day; this calculates to 
0.00045 µg from tea (Table 14) or 0.0000006 µg/kg bw/day, based on a 70 kg adult. 
This estimate would be below the TDI. 
b. Intake from drinking water 
The responsibility for ensuring that drinking water used for human consumption 
conforms to the DWS NZ is within the purview of the Ministry of Health. The highest 
concentration of 1080 found in drinking water catchments was 4.0 ppb (this excludes 
the 9 ppb found in water samples apparently due to contamination by a worker with 
1080 dust on his overalls and hands). It should be noted that 4 ppb is only slightly 
higher than the current PMA V of 3.5 ppb. The rationale in using 4 ppb is discussed in 
detail in section 7 .11.2. Based on a 70 kg body weight (Ministry of Health 2005), the 
estimated intake from drinking water is 2 * 4 = 8.0 µg daf 1adulf 1 or 0.11 µg kg-1 bw 
day-1 (Table 14). 
b(i) Water supply contamination 
Assumptions: 
Treated 1080 baits are spread at the rate of3 kg of 0.15 % per ha. This is equivalent to 
4.5 g of 1080. This amount is used in all three exposure scenarios to demonstrate the 
amount of contaminated drinking water needed to be consumed to reach the TDI of 
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0.03 µg kg-I bw daf I. The exposure scenarios set out on page 110 are illustrative and 
intended as examples only. It should be borne in mind that contamination may vary 
from one locality to another depending on the hydrology in the area and parameters 
used in various 1080 applications. 
1) Scenario a 
A house roof water supply is contained in a tank 0.75 min radius (r), 3kg of bait is 
accidentally dropped onto the roof. Rain fell overnight, and all of the 1080 (4.5g) is 
leached out and drains into the tank. The depth of water in the tank is 0.8 m (d). The 
volume of water in the tank is: 
rcr2d 
= 3.14 X (0.75 X 0.75) X 0.8 m3 
= 1.41 m3 or 1400 litres. 
Therefore: The concentration of 1080 in the tank water is 4500 mg 1080/1400 L = 
3.21 mg/Lor 3214 µg/L. 
A 70 kg adult with a dose rate of 0.03 µg kiI bw daf I would be exposed to 2.1 µg 
1080 day-I. An adult weighing 70 kg would need to consume only 0.00065 L (0.65 
ml) of the tank water in order to reach the TDI of 0.03 µg kiI bw day-I. 
2) Scenario b 
The application rate described above was sown to one hectare of water catchment and 
the entire toxic load was leached from the baits directly into a stream by 25 mm 
rainfall. The volume of water is 250 m3 or 250,000 litres. 
Therefore: The concentration of 1080 in the water entering the stream is 4 500 mg 
1080/250, 000 L = 0.018 mg/Lor 18 µg/L. 
A 70 kg with a dose rate of 0.03 µg kg-I bw daf I would be exposed to 2.1 µg 1080 
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day-1. An adult weighing 70 kg would need to consume 0.12 L (120 ml) of this water 
to reach the TDI of 0.03 µg ki1 bw daf1. 
3) Scenario c 
Similar parameters were used as in "scenario b" but a 100 mm rainfall was used 
instead of25 mm. The volume of water is 1000 m3 or 1,000,000 litres. 
Therefore: 4 500 mg 1080/1, 000, 000 L = 0.0045 mg/Lor 4.5 µg/L. 
A 70 kg with a dose rate of 0.03 µg ki1 bw daf1 would be exposed to 2.1 µg 1080 
day-1. An adult weighing 70 kg would need to consume 0.46 L ( 466 ml) to reach the 
TDI of 0.03 µg ki1 bw daf 1. 
After the rain runoff enters the stream, the concentration of 1080 will be further diluted 
depending on the size and flow rate of the stream. 
c. Intake from air 
The Wellington City Council (WCC) carried out a study (Bromley 1996) to determine 
the level of 1080 in air addressing the concerns raised by members of the public that 
aerial application was causing significant 1080 dust in to the atmosphere. The 
Ministry of Health estimated, based from the WCC study, that airborne dust from 1080 
was in the level of 0.0008 µg/m3 (Durham 1998b ). The US EPA (2002) has reported 
that an adult's intake of air is 20 m3daf1. Therefore, the estimated intake for an adult -
would equate to 0.0008 * 20 = 0.016 µg daf 1adulf 1 or 0.0002 µg kg-1 bw day-1. 
d. Dermal intake 
The parameters used in estimating the soil dermal absorption were taken from the 
Ministry for the Environment (MfE) and Ministry of Health (MoH) (MfE and MoH 
1997) guidelines. The estimated intake arising from soil that has been contaminated 
with 1080 was calculated to be 4700 (skin contact area)* 0.5 (soil adherence) * 0.009 
(1080 soil content) * 0.10 (dermal absorption) = 0.002 µg. Soil samples were tested 
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after three aerial applications using 0.15% 1080 cereal (pellet type unspecified) bait. 
Mean 1080 residues of 1080 in soil was estimated to be 0.009 ppm (Wright et al. 
2002). The 10% dermal absorption was based on animal data that exists showing 
lower dermal toxicity. 
Table 14 presents the potential 1080 exposure in food, water, air and soil. 
Table 14 
~ummary of highest recorded** estimates arising from 1080 exposure in adult 
· 1080 intake Parameters used Estimated daily intake 
Intake from meat · Meat iritake, 200 g/day taJ 200 g * 0.028mg/kg 
1080 content, 0.028 mg/kg (b) = 5.6 µg 
Intake from milk Milk intake, 500 ml w 500 ml * 0.004 mg/kg 
1080 content, 0.004 mg/kg(b> =2.0 µg 
Intake from tea Tea intake, 450ml 450ml * 0.001 µg/L 
1080 content, 0.001 µg/L Cd) =0.00045 µg 
Intake from drinking Water intake, 2 L/day; lCJ 2 * 4.0 µg/J, 
water 1080 content, 4.0 µg/L/day (e) = 8.0 µg 
Intake from air 1080 in air, 0.0008 µg/m3 Ct) 0.0008 * 20 m~ 
Air intake, 20 m3/day (g) = 0.016 µg 
Dermal absorption Skin contact area, 4 700 cm:t tnJ 4700 * 0.5 * 0.009 * 10% = 
Soil adherence, 0.5 mg/cm2 Ci) 0.002 µg 
1080 content, 0.009 mg/kg Ci) 
Bioavailability, 10% 
Total daily 1080 intake = 5.6 + 2.0 + 0.00045 + 8.0 + 0.016 + 0.002 = 15.62 µg 70 kg 
adult"1 or 0.22 µg kg -l bw/day .-1 
** excluding milk, tea, air, soil 
a - Ministry of Health (2000) 
b -J. Sims pers. comm. (1998) 
0-Ministry of Health (2005) 
d - Twigg et al. 1996 
0 - Eason (2002) 
f-Durham (1998b) 
g - US EPA (2002) 
h - MfE and MoH (1997) 
i_ US EPA (1989) 
j - Wright et al. (2002) 
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Adult exposure based on maximum allowable 1080 in various media 
a. Intake from food 
Using the default 0.001 mg kt1 maximum residue limit specified in the New Zealand 
(Maximum Residue Limits of Agricultural Compounds) Food Standards 2004, the 
maximum likely intake was estimated to be 0.2 µg 1080 daf 1 from meat (200g * 
0.001) and 0.45 µg 1080 day-1 from milk (450 ml* 0.001) (Table 15). Using a 70 kg 
body weight gives an estimated intake of0.003 µg kt1 bw daf1 for meat and 0.006 µg 
kt1 bw day-1 for milk.· The same parameters were used for tea (450 ml* 0.001 = 0.45 
µg or 0.006 µg kg-1 bw day-1 based on a 70 kg adult). 
b. Intake from drinking water 
It has been assumed by' DoC, ABB and RCs that the Ministry of Health has reduced 
the Provisional Maximum Acceptable Value (PMA V) for 1080 in drinking water 
supplies as a response to the research findings by Eason et al. (1998, 1999, 2001) and 
Eason and Turck (2002). This is not the case. The PMA V in the DWS NZ (Ministry 
of Health 2005) has remained unchanged at 3.5 µg L-1• The DWS NZ requires that 
where the concentration of a Priority 2 determinand5 · such as 1080 exceeds 50% of the 
· maximum acceptable value (MA V) of 3.5 µg L-1, then it should be continuously 
monitored until such time that the concentration falls to 2 µg L-1• The MA Vis defined 
in the DWS NZ as the concentration of a determinandbelow which the presence of the 
determinand does not result in any significant risk to a consumer over a lifetime of 
consumption. 
The Ministry of Health developed a policy in 1998, as an interim measure, that only 
drinking water containing 2 µg L-1 1080 or less would be acceptable for human 
consumption (Durham 1998b). The 2 µg L"1 was taken as an approximation to 50 
percent of the PMA V in the DWS NZ (Ministry of Health 2005). Based on a 70 kg 
5 Priority 2 determinand is a constituent of the water that is present in a specific supply or distribution zone, 
usually a concentration that exceed 50% of the MA V (MoH 1995). 
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body weight, the maximum intake from drinking water was estimated to be 2 * 2= 4 
µg day-1 adult or 0.057 µg kt1 bw daf1 based on a 70 kg adult (Table 15). 
c. Intake from air 
The same parameters were used as in Table 14 because there is no standard for 1080 in 
air. The estimated intake for an adult equates to 0.0008 * 20 = 0.016 µg daf1adulf1 or 
0.0002 µg kt1 bw daf 1. 
d. Dermal intake 
Similarly, the parameters used in Table 14 were adapted. The estimated intake arising 
from soil that has been contaminated with 1080 was calculated to be 4700 (skin 
'contact area) * 0.5 (soil adherence) * 0.009 (1080 soil content) * 0.10 (dermal 
absorption)= 0.002 µg. 




Summary of maximal possible exposures, under current acceptable limits, arising 
from 1080 exposure in adult 
1080 intake Parameters used Estimated daily intake 
Intake from meat Meat intake, 200 g/day w 200 g * O.OOlmg/kg 
1080 content, 0.001 mgikg (b) =0.2 µg 
Intake from milk Milk intake, 500 ml w 500 ml * 0.001 mg/kg 
1080 content, 0.001 mg/kg(b> = 0.50 µg 
Intake from tea , Tea intake, 450mllaJ 450ml * 0.001 mg/kg 
1080 content, 0.001 mg/kg (b) = 0.45 µg 
. .Intake from drinking Water intake, 2 L/day; lcJ 2 * 2.0 µg/L 
water 1080 content, 2.0 µg/L/day (d) =4.0 µg 
Intake from air OJ 1080 in air, 0.0008 µg/m3 <t> 0.0008 * 20 m3• 
Air intake, 20 m3/day <t> =0.016 µg 
Dermal absorption o, Skin contact area, 4 700 cm" w 4700 * 0.5 * 0.009 * 10% = 
Soil adherence, 0.5 rng/cm2 (h) 0.002 µg 
1080 content, 0.009 mg/kg (i) 
Bioavailability, 10% 
Total daily 1080 intake = 0.2 + 0.50 + 0.45 + 4.0 + 0.016 + 0.002 = 5.17 µg 70 kg adult"1 or 
0.07 µg kg -l bw/day -1 
a - Ministry of Health (2000) 
b - New Zealand (Maximum Residue Limits of Agricultural Compounds) Food Standards 2004 
0- Ministry of Health (2005) 
d-Durham (1998b) 
e-Durham (1998b) 
r - US EPA (2002) 
g - MfE and MoH (1997) 
h_ US EPA (1989) 
i - Wright et al. (2002) 
j actual concentrations of 1080; no standards set in air and soil 
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Child exposure 
Infants and children, particularly the former, are groups whose risks may differ 
qualitatively and quantitatively from those of adults. Infants and children differ from 
adults in their exposure both qualitatively and quantitatively, in part because they 
consume more food, drink more water and breathe more air per unit of body weight 
than adults do (IPCS 2000a). Traditional health risk assessments are carried out using 
adult data and have not examined the special vulnerabilities of infants and children. 
Adding an appropriate Utt, e.g., 10 is being used in lieu of such an examination. A 
default value of 10 is incorporated in most risk assessments. 
Standards do not usually contain separate information for children. In this particular 
situation, there were no data for children, as values derived were all intended for 
adults. Young children aged 3 to 5 years old have a high food intake relative to their 
body weight and their mouthing behaviour makes them the highest exposed subgroups 
of the child population (Bailer et al. 1999). For the purposes of this study, exposure 
esti1:1ates target this particular age group. 
Child exposure based on actual concentrations of 1080 in various media 
The values used in the exposure estimate are the highest concentrations of 1080 found 
in various media ( excluding milk, air and soil) (Table 16). Table 17 presents the 
exposure estimates using the maximal allowable concentrations of 1080 in food and 
drinking water except for dermal and inhalation intakes where no standards are 
available. Hence, actual 1080 concentrations in air and soil were used. 
The following exposure estimates are made based on the following factors: 
a. Intake from food 
Ingestion of contaminated food is a potential pathway of exposure to 1080 among 
children. Contaminated meat and milk were the exposure pathways used in this 
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exposure estimate. It is known that children's exposure from food ingestion may differ 
from that of adults because of differences in the type and amounts of food eaten. 
The same 1080 concentrations used in estimating adult exposures of 0.028 mg kg-1, 
and the recommended intake from the Ministry of Health's Eating for Healthy 
Children Aged 2 to 12 (Ministry of Health 2002) of about 100 g was consumed= 2.8 
µg of 1080. In case of recommended intake of milk of 500 ml, it would equate to 2 µg 
of 1080 (500 ml* 0.004 mg kg-1). Tea has been excluded because it is not a beverage 
that children would normally consume. 
b. Intake from drinking water· 
Water intake in a child aged 3-5 years has been estimated to be 0.87 L dafI (US EPA 
1997). Using the same parameters, the maximum intake from drinking water was 
estimated to be 0.87 * 4 = 3.48 µg day-1child-I or 0.20 µg kg-I bw day-1 for a 15 kg 
child. 
c. Intake from air 
Children are generally vulnerable to outdoor pollution because they often engage in 
physical activities or play outdoors. Also, they have relatively high air intake 
compared to adults (Wigle 2003). Based from the WCC study discussed earlier 
(Bromley 1996), the Ministry of Health estimated in 1998 that the 1080 airborne dust 
was around 0.0008 µg m3-1 (Durham 1998b). The US EPA (2002) has reported that a 
child's (3-5 years) intake of air was 8.7 m3dafI. Therefore, the child's intake of 1080 
from air would equate to 0.0008 * 8.7 = 0.007 µg dafI child-I or 0.0005 µg ktI bw 
day-1• 
d. Intake from soil 
The ingestion of soil is particularly relevant for young children because of their 
mouthing behaviour. The mean soil ingestion rate for children recommended by the 
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EPA for risk assessment is 100 mg daf1 or 200 mg daf1 as conservative estimates 
(US EPA 1997). 
A study by Wright et al. (2002) showed that the average 1080 residues from soil 
samples after bait application was 0.009 µg g-1• Using a soil intake of 100 mg daf1 
soil this would yield a yalue 0.0009 µg daf 1, assuming 100% bioavailability. 
e. Dermal intake 
Children may be more highly exposed to 1080 through dermal routes than adults as 
they often play and crawl on contaminated surfaces and are more likely to wear less 
clothing than do adults. In addition, children have a higher body surface area relative 
to body weight. 
The parameters used in estimating the soil dermal absorption were taken from the MfE 
and MoH (1997) report. The maximum dermal intake arising from soil that has been 
contaminated with 1080 was estimated to be 2625 (skin contact area) * 0.5 (soil 
adherence)* 0.009 (1080 in soil)* 0.10 (dermal absorption)= 0.0012 µg. 
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Table 16 
Summary of highest recorded** estimates arising from 1080 exposures in 
children (3-5 years) 
1080 intake · Parameters used Estimated daily intake 
· Intake from meat Meat intake, 100 g/day (aJ 100 g * 0.028mg/k.g 
1080 content, 0.028 mg/kg (b) =2.8 µg 
Intake from milk Milk intake, 500 ml laJ 500ml * 0.004 mg/kg 
1080 content, 0.004 mg/kg (b) =2µg 
Intake from drinking Water intake, 0.87L/day; l0J 0.87 * 4.0 µg/L 
water 1080 content, 4.0 µg/L/day <e> = 3.5 µg 
Intake from air 1080 in air, 0.0008 µg/m3 (f) 0.0008 * 8.73 
Air intake, 8.73 m3/day (g) =0.007 µg 
Intake from soil Soil intake, 100 mg/d l0J 0.009 * 100 * 100% = 0.0009 
1080 in soil, 0.009 µgig soil 3 (h) µg 
Assuming 100% bioavailability 
Dermal absorption Skin contact area, 2625 cm:l llJ v, 2625 * 0.5 * 0.009 * 10% 
Soil adherence, 0.5 mg/cm2 <i> =0.0012µg 
1080 in soil, 0.009 µgig soil <3>(h> 
Bioavailability, 10% 
Total 1080 intake = 2.8 µg + 2 µg + 3.48 +0.007 µg + 0.0009 µg + 0.0012 µg = 8.3 µg 1080 
15 kg child"1 or 0.55 µg kg·1 bw day1 15 kg child"1 
** excluding milk, air, soil 
a -Ministry of Health 2002 
b -J. Sims pers. comm. (1998) 
d_ US EPA 1997 
e - Eason 2002 
r-Durham 1998b 
g _ US EPA 2002 
h - Wright et al. 2002 
i - MfE and MoH 1997 
i_ US EPA 1989 
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Child exposure based on maximum allowable 1080 in various media 
The following exposure estimates are made based on the following factors: 
a. Intake from food 
Meat and milk complying with the New Zealand (Maximum Residue Limits of 
Agricultural Compounds) Food Standards 2004 will have a maximum residues limit of 
0.001 mg kt1. Assuming the recommended intake from the Ministry of Health's 
Eating for Healthy Children Aged 2 to 12 years (Ministry of Health 2002) of about 100 
g was consumed, this would equate to 0.1 µg of 1080. In the case of the recommended 
intake of milk of 500 ml, it would equate to 0.5 µg of 1080 (500 ml * 0.001 mg kg-1). 
Tea has been excluded because it is not a beverage that children would normally 
consume. 
b. Intake from drinking water 
Water intake in a child aged 3-5 years has been estimated to be 0.87 L d-1 (US EPA 
1997). Using the same parameters, the maximum intake from drinking water was 
estimated to be 0.87 * 2 = 1.74 µg daf1child-1 or 0.116 µg kt1 bw daf1 for a 15 kg 
child. 
c. Intake from air 
Using the same parameters as in Table 16, the child's intake of 1080 from air would 
equate to 0.0008 * 8. 7 = 0.007 µg daf 1 child-1 or 0.0005 µg kt1 bw daf 1. 
d. Intake from soil 
Similarly, using a soil intake of 100 mg daf1 soil and 0.009 µg g-1 1080 concentration 
in soil would yield a value 0.0009 µg daf1, assuming 100% bioavailability. 
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e. Dermal intake 
The parameters used in estimating the soil dermal absorption were taken from the MfE 
and MoH ( 1997) report. The maximum dermal intake arising from soil that has been 
contaminated with 1080 was estimated to be 2625 (skin contact area) * 0.5 (soil 
adherence)* 0.0009 (1080 in soil)* 0.10 (dermal absorption)= 0.0012 µg. 
The maximum acceptable potential 1080 exposure in food, water, air and soil 1s 
presented in Table 17. 
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Table 17 
Summary of maximal possible exposures, under current acceptable limits, arising 
from 1080 exposures in children (3-5 years). 
1080 intake Parameters used Estimated daily intake 
Intake from meat Meat intake, 100 glday ta) 100 g * O.OOlmg/kg 
1080 content, 0.001 mg/kg (b) = 0.1 µg 
Intake from milk Mille intake, 500 ml (aJ 500ml * 0.001 mg/kg 
1080 content, 0.001 mg/kg Cb> =0.5 µg 
Intake from drinking Water intake, 0.87L/day; (<1J 0.87 *2.0 µg/L 
water 1080 content, 2.0 µg/L/day <e> =1.74 µg 
Intake from air 1080 in air, 0.0008 µglm3 <t> 0.0008 * 8. 73 
Air intake, 8.73 m3/day (g) =0.007 µg 
Intake from soil · Soil intake, 100 mgld (<IJ 0.009 * 100 * 100% = 0.0009 
1080 in soil, 0.009 µgig soil 3 (h) µg 
Assuming· 100% bioavailability 
Dermal absorption Skin contact area, 2625 cm"' tiJ w 2625 * 0.5 * 0.009 * 10% 
Soil adherence, 0.5 mglcm2 Ci> =0.0012µg 
1080 in soil, 0.009 µgig soil <3> Ch> 
. Bioavailability, 10% 
Total 1080 intake= 0.1 µg + 0.5 µg + 1.74 µg + 0.007 µg + 0.0009 µg + 0.0012 µg = 2.35 
µg 1080 15 kg child"1 or 0.16µg kg"1 bw day·1 15 kg child"1 
a - Ministry of Health 2002 
b - New Zealand (Maximum Residue Limits of Agricultural Compounds) Food Standards 2004 
d_ US EPA 1997 
e - Durham 1998b 
r-Durham 1998b 
f · US EPA 2002 
- Wright et al. 2002 
; - MfE and MoH 1997 
j_ US EPA 1989 
* actual concentration of 1080; no standards set in air and soil 
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5.1.1.4 Derivation of Tolerable Daily Intakes (TD Is) 
In general, TDis are used to provide information on potential long-term toxic effects of 
the substance in question (Bender 2002). Toxicity risk assessment currently relies on 
the estimation ofTDis based on the use of the NOAELs or BMDLs divided by the UFs 
(Allen et al. 1994). However, the TDI value does not guarantee an absolute certainty 
as there is a low probability that adverse effects might occur and the absence of all risk 
to all people cannot be assured at this level (Barnes and Dourson 1988). The existence 
of different TD Is need not imply that any one of them is more "wrong" or "right" than 
the rest. It is more a reflection of the difference in scientific judgement of risk 
assessors (Barnes and Dourson 1988). 
The TDI can be derived using either the NOAEL or the BMDL divided by UFs, for 
instance, by Dourson and Stara (1983) and Dourson and DeRosa (1991). The 
calculation of a TDI by applying a UF to a NOAEL will be referred to as a 'NOAEL 
approach' since the point of departure was the NOAEL for the critical adverse effects. 
The estimation ofTDis based on the use of the BMDL based on these same effects and 
divided by UFs will be called the 'BMD approach'. 
For the purposes of this study, the assessments and calculations of TDI were 
undertaken according to the WHO recommendations as described in the International 
Programme on Chemical Safety's "Environmental Health Criteria 104, Principles for 
the Toxicological Assessment of Pesticide Residues in Food" (IPCS 1990). 
It should not be categorically concluded that all doses below the TDis are "acceptable" 
(or will be risk free) and that all doses in excess of the TDis are ''unacceptable" or will 
result in adverse effect (Barnes and Dourson 1988). It is important to note that TDis 
resulting from the use of large uncertainty factors are quite imprecise, at least 3 fold or 
down. Any value within this approximately 10-fold range is the same number (M 
Dourson pers comm. 2007). 
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To derive the TDI, this can be represented mathematically using the following formula 
(UFs are used multiplicatively): 
Tolerable Daily Intake (TDI) = NOAEL or BMDL/ (U A *UH*Us * Uo* UL) 
where: 
NOAEL = no-observed-adverse-effect level (mg/kg/day) 
BMDL = benchmark dose's lower bound confidence limit (mg/kg/day) 
U A = interspecies extrapolation 
UH= intraspecies extrapolation 
Us = using subchronic data 
U0 = using incomplete database 
UL= extrapolation from LOAEL to NOAEL (if needed), not used with BMDL 
The following information shows the steps in deriving the TDI. 
Step 1. Identify the pivotal study from the toxicity studies conducted for 1080. There 
are two pivotal studies chosen: (1) subacute teratology study in rat with a NOAEL of 
0.10 mg kg-1 bw day-1 and (2) the 90-day study in rat with a NOAEL of 0.075 mg kg-1 
bw daf 1. For the purposes of this study, the NOAEL for testicular and myocardial 
effects from the subchronic study (Eason et al. 2001; Eason and Turck 2002) was used 
in calculating the TDI, i.e., 0.075 mg ki1 bw daf 1. 
Step 2. Determine the appropriate UFs. 
Step 3: Calculate the TD Is for 1080 by dividing the NOAEL or BMDL by the 
appropriate UFs. 
The calculated TDis from an aggregate exposure to 1080 from all possible combined 
sources are shown in Tables 16. The aggregate TDis include combined exposure from 
food (i.e., meat and milk), drinking water, dermal contact and inhalation exposures. In 
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the case of children, non-dietary (residential/public) exposure may be more of 
relevance. 
TDI calculations for various scenarios. 
(1) Derive the TDI based on NOAEL of0.075 mg ki1 bw day-1• 






Therefore: TDI = 0.025 µg/kg bw/day 
EPA recommends an UF of 3000 should be the maximum used for risk assessment to 
be meaningful (Kodell and Gaylor 1999). 
Therefore: TDI = 0.025 µg ki1 bw day-1 according to US EPA methods. 
For the purposes of this study, the statistically derived 99th percentile point estimate of 
2994 (see Table 13) was chosen as the UF in estimating the TDI to protect the general 
population. Rounding off to 3000, the TDI derived gave the same value as the TDI 
applying the US EPA 3000 UP which equates to 0.025 µg ki1 bw daf 1. 
TDivalues 
Comparative TDis from the NOAEL and BMDL values are shown in Table 18. 
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Table 18 
Comparative TD1s from NOAEL and BMDL values using various UFs 
Quantal NOAEL TDI, µg/kg bw/day BMDL TDI, µg/kg bw/day 
Toxicity endpoint 
UF 3000 a 2994 D 3000 a 2994 D 
Epididymis 0.025 0.025 0.010 0.010 
Testicular 0.025 0.025 0.037 0.037 
Cardiomyopathy, 0.025 0.025 0.033 0.033 
Male 
. Cardiomyopathy, . 0.025 0.025 0.070 0.070 
Female 
Teratogenic 0.033 0.033 0.10 0.10 
Continuous NOAEL TDI, µg/kg bw/day BMDL TDI, µg/kg bw/day 
Toxicity endpoint 
UF 3000 a 2994 D 3000a 2994 D 
Sperm count 0.025 0.025 0.03 0.03 
Fetal weight, 0.11 0.11 0.15 0.15 
Male 
Fetal weight, 0.11 0.11 0.16 0.16 
Female 
a Maximum conventional value for four uncertainty factors as suggested by the USEP A 
b Maximum value for four uncertainty factors as derived in section 5.1.1.2 
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Thus, comparing the NOAEL and the BMDL TDI derived values using the two UFs 
(Table 18), demonstrated that the TDis for both approaches gave consistently similar 
values, with the TDis derived from the BMDLs resulting in slightly higher values for 
all aspects except for the epididymal effects. Rounding off, the TD Is were the same or 
very similar using the 3000 UF and the 2294 UF. 
Several BMDLs could be used to establish the TDI. The BMDL computed for male 
cardiomyopathy (0.10 mg kg-1 bw day -1) and for testicular effects (0.11 mg kg-1 bw 
daf1) were chosen as these effects were considered to be the most sensitive end points 
(Foronda et al. 2007a, see published article in Appendix 2) as discussed in earlier 
sections of this thesis, for instance by Sullivan et al (1979), Eason et al (2001), Eason 
and Turck (2002), Whittem and Murray (1963), and Wolfe (1988). Rounding off, a 
TDI for 1080 was established using the BMDL of 0.10 mg ki1 bw day -l divided by 
the appropriate UF. Because 2994 is not meaningfully different from 3000, 2994 was 
rounded to 3000 in the final calculation. 
Thus, the TDI would be 
TDI = 0.10 mg kg-1 bw day -l /3000 
= 0.033 ug ki1 bw day -l 
For the purposes of this study, the TDI used in this study in estimating the risks from 
1080 exposures is 0.03 ug kg- 1 bw day-1 (Foronda et al. 2007b, see published article in 
Appendix 3). This value may be considered as conservative (i.e., protective) and errs 
on the side of caution due to the incomplete information currently available, as 
discussed earlier. 
Acute/short-term exposure 
Although acute exposure is outside the scope of this study, it is recognised that humans 
may be exposed to 1080 for only a short period of time. In this context, a "tolerable 
intake" was estimated using the NOAEL of 0.10 mg ki1 bw day-1 derived from the 
teratogenic study conducted by Eason et al. (1998; 1999) (see Table 10). Applying an 
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UF of 300 (i.e., 10 for intraspecies variability, 10 for interspecies differences and 3 for 
incomplete database), the "tolerable intake" was estimated to be 0.33 ug kg-1 bw day-1. 
This value was ten-fold higher than the TDI derived earlier of 0.03 ug kg-1 bw day-1 
and could be used for health risk assessment purposes when appropriate. 
5.1.1.5 Derivation of Provisional Maximum Acceptable Value (PMA V) 
As a basic rule, unless there were good reasons to believe the contrary, the WHO 
Guidelines are usually accepted or adopted as MA Vs in the DWS NZ (M. Taylor pers. 
comm. 2003). The current PMAV in the DWS NZ for 1080 is 0.0035 mg L-1 (3.5 
ppb ). The MA V is established for adults and to a limited extent for children ( e.g., for 
DDT) and assumes that exposure occurs over the en(~re lifetime. 
The WHO recommends that the standard human body weight of 60 kg be used in the 
calculation. However, a study conducted by the Ministry of Health concluded that the 
average human body weight in the New Zealand population is 75 kg (M. Turley pers. 
comm. 2004). The use of a 75 kg bw would not be appropriate for women as they 
generally weigh less than 75 kg. For the purposes of this study, 70 kg was used as the 
standard adult human body weight consistent with the DWS NZ 2005. 
There were two calculations made: 
"Scenario a" using 50% as the proportion of total daily intake allocatable to drinking 
water, if based on maximum concentrations so far found in various media (excluding 
milk, tea, air and soil) (Table 14); and 
"Scenario b" using 80% as the proportion of total intake allocatable to drinking water, 
if based on the maximum allowable concentrations in various media, including the 
Ministry of Health's interim policy measure of2 ppb for drinking water (Table 15). 
The finally proposed PMA V was based on adults and via "scenario a" as derived using 
the formula: 
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Adult PMA V = (BMDL/UF * bw * proportion)/daily intake of drinking water 
(a) PMAV = (0.10/3000) * 70 * 0.5)/2 
= 0.00058 mg/Lor 0.58 µg L-1 
(b) = (0.10/3000) * 70 * 0.8)/2 
= 0.00094 mg/L or 0.94 µg L-1 
where: average weight of adult = 70 kg 
average quantity of water consumed by an adult = 2 L daf1 
proportion of total intake allocated to dri~ing water = 0.50 for "scenario a" 
and 0.80 for "scenario b" 
uncertainty factor = 3000 (for inter and intraspecies variation, subchronic 
study, and incompleteness of database) 
It is common practice to use the data first, and then the relative source contribution 
defaults second (M. Dourson pers. comm. 2005). The data suggest 50% comes from 
drinking water, hence 50% was used as the proportion of total intake (refer Table 14). 
The maximal allowable 1080 concentrations (refer Table 15) in drinking water has 
accounted for 80% of the total intake. The difference was due to meat and milk 
contributing a significant proportion of the total intake, therefore reducing the 
proportion of drinking water in 50% of the total daily intake. It is acknowledged that 
contamination of meat and milk are considered to be rare incidents. In meat, the 
highest concentration was used while the concentration of 1080 after considerable 
dilution within the silo was used in milk (see 2.2.2.2). 
The derived value of 0.58 µg L-1 (rounding off to 0.60 µg L-1) is 6 fold lower than the 
current PMA V of 3.5 µg L-1 in drinking water for 1080. Using the maximal allowable 
concentration of2 ppb, the derived PMAV of 0.94 µg L-1 is about 4 fold lower than the 
current PMA V. It should be noted that the analytical limit of detection for 1080 is 0.1 
µg/L (Wright 2007). 
129 
P MA V using child parameter: 
Child PMA V = (BMDL/UF * bw * proportion)/daily intake of drinking water 
The proportion of total intake allocated was based on 4 ppb 1080 concentration present 
in drinking water in "scenario a" (refer Table 16) while the maximum allowable 
concentration of 1080 of2 ppb (Ministry of Health's interim policy measure) was used 
in "scenario b" (refer Table 17). 
Scenario a 
PMA V = (0.10/3000) * 15 * 0.4)/0.87 
= 0.00023 mg L"1 or 0.23 µg L"1 
Scenario b 
PMAV = (0.10/3000) * 15 * 0.7)/0.87 
= 0.0004 mg L"1 or 0.4 µg L"1 
where: average weight of child = 15 kg 
average quantity of water consumed by a child = 0.87 L day"1 
proportion of total daily intake allocated to drinking water = 0.4 for "scenario 
a" (refer Table 16) and 0. 7 for "scenario b" (refer Table 17) 
uncertainty factor = 3000 (for inter and intraspecies variation, subchronic 
study, and incompleteness of database) 
Table 19 
Provisional Maximum Acceptable Value (PMA V) for 1080 
Scenario a, µg L-1 Scenario b, µg L"1 
Adult, 70 kg 0.58 0.94 
Child, 15 kg 0.23 0.40 
The child PMA V of 0.23 µg L-1 is about 15 fold lower than the current PMA V of 3.5 
µg L-1 in drinking water for 1080 using 4 ppb of 1080 and about 9 fold lower (PMA V 
130 
of 0.4 µg L-1) when 2 ppb of 1080 was used as the concentration of 1080 in drinking 
water (Table 19). However, the use of a TDI for a child's exposure scenario is 
conservative unless the critical effect is based on toxicity in the young. This is because 
most critical effects occur after longer exposures, which exceed the childhood portion 
of the lifecycle. 
WHO assigns an arbitrary ( default) value of 10 % for drinking water when data are not 
available concerning the proportion of total intake ingested in drinking water in the 
derivation of WHO guideline values. This default value is, in most cases, sufficient to 
account for additional routes of intake (i.e., inhalation and dermal absorption) of 
contaminants in water (Ministry of Health 1995a). A value of 20% was assigned as 
the proportion of 1080 intake in the DWS NZ (Ministry of Health 1995). This value 
was subsequently revised to 50% in the DWS NZ 2005 (Ministry of Health 2005). 
The Drinking Water Standards and Health Advisories published by the US EPA (2002) 
do not include 1080 on their list. The USA may not need a reference value for 1080 as 
it has limited use in that country, i.e., used only in livestock protection collars designed 
to kill coyotes when they bite the neck of a lamb or kid goat (Fagerstone et al. 1994), 
and the situation in New Zealand is extremely different from that of the USA. 
Similarly the WHO guidelines have no MA V for 1080 in drinking water (D. Ogilvie 
pers. comm. 2004). 
5.1.1.6 Risk characterisation 
Risk characterisation takes into account the quantitative considerations in risk 
assessment including dose-response assessment, exposure assessment (Beasley 1996), 
and uncertainty (Eaton and Klaassen 2001). The risk characterisation should convey 
that the risk assessment process is subject to scientific uncertainty and disagreement 
(Paustenbach 1995). Uncertainty can be defined as a lack of precise knowledge about 
the state of nature (Bailer et al. 1999). This creates practical problems in determining 
how to assess and deal with the uncertainty itself, and also in estimating the risk 
associated with 1080 exposure. It includes a policy based on science that underlies 
decisions throughout the risk assessment process (Ohanian et al. 1997) and discussion 
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of data gaps together with recommendations for improving the accuracy of the 
assessment (Barnard 1994). 
The risks posed by exposure are primarily determined by the quantity used and types 
of 1080 exposure. In this case, the risk may be higher as opposed to other chemicals 
used in the environment because it is aerially applied. Compound 1080 is released to 
the environment from ground application but more particularly during aerial 
application. Estimating the likely absorbed dose of 1080 is a challenging task, 
especially if one considers all the potential sources of exposure such as food, water, 
and air. Available data upon which to base estimates of human exposure to 1080 are 
limited. However, based on exposure estimates drinking water is likely to be the 
principal source of exposure (Tables 14 and 16). 
Exposure from other media, such as air and dermal absorption, appears to be negligible 
in comparison with that from drinking water. However, 1080 in contaminated feral 
meat and milk has contributed a significant proportion of 1080 intake because the 
concentrations of 1080 found in these media were well above the maximum residue 
limit in food. Since food contamination was considered to be a rare event, the focus of 
the human health risk characterisation is on the potential exposure of the general 
population to 1080 contaminated drinking water. Compound 1080 can be legally 
aerially applied to drinking water catchments provided permits have been obtained 
from relevant regulatory authorities. Hence, contamination of drinking water 
catchments cannot be ruled out (see Chapters 1 and 7). Tables 15 and 17 provide the 
maximal acceptable limits of 1080 in various media, with drinking water providing the 
likely principal source of exposure. 
The primary concern is about the potential toxic effects in humans associated with 
possible exposures to 1080 long term and at low level of exposures. The magnitude, 
frequency, and duration of exposure may vary considerably in different situations. 
Modem toxicology contributes specifically to the assessment of human hazard from 
exposure to 1080. Ideally, laboratory and epidemiology studies are utilised. However, 
in this particular case the only information that is available is from laboratory animals 
and the challenge in health risk assessment lies in predicting what effects will occur in 
human. Also, the target area in the health risk assessment process is usually the risk at 
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low levels of exposure. This is where there is lack of data and where projections of 
effects and risks are most needed (Bailer et al. 1999). 
Animal studies have demonstrated the adverse effects of 1080. Critical effects 
identified from the pivotal studies were testicular, teratogenic effects and 
cardiomyopathy. Since there are no human studies on the subchronic or long-term 
effects of 1080 in humans, the subchronic toxicity information is limited to laboratory 
animals. Whether or not the critical effects identified are relevant to humans is 
unknown. However, it would be prudent from a public health standpoint that with no 
valid reason to believe the contrary, it is reasonable to assume that these effects also 
occur in humans. 
Noncancer risk assessment is currently based on the assumption that a biologic 
threshold dose must be exceeded before exposure to a chemical causes effects. Under 
this view, if a person is exposed to a dose below their threshold of response, no effect 
is experienced and thus no risk is involved. However, there is variability in the 
sensitivity of individuals to chemicals and in order. to assess population risks, 
responses of sensitive individuals must be taken into account. Unfortunately, human 
environmental epidemiological data are rare and, even when available, the data may be 
inadequate to determine with any precision the threshold for particularly sensitive 
individuals. Hence, the human threshold dose is usually extrapolated from animal 
data. Animal test data provide an estimate of the subthreshold dose, or NOAEL. 
Because the true relationship between this animal threshold dose and the human 
threshold remains unknown, uncertainty is inherent in the extrapolation. 
Two systemic toxicity mammalian studies in different species, one mammalian 
multigeneration reproductive study, and two mammalian developmental toxicity 
studies in different species comprise the criteria used to define a "complete database". 
There is a lack of toxicology studies relating to 1080 chronic exposure studies, and this 
hinders the determination of appropriate TDI for long-term exposure. Special attention 
is given to studies involving low-dose chronic exposures, since such exposures can 
elicit effects that may be considered of health concern. 
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In general, other studies did not meet these criteria, resulting in a higher UF with 
respect to the completeness of the database. The UFs can be reduced if additional 
studies are carried out to generate a "complete database" and better understanding of 
the interspecies and intraspecies variability of 1080. Testing in the past has focussed 
mostly on acute effects rather than long-term effects (Horrigan et al. 2002) and 
employing large doses of 1080 to elicit its toxic effects. In addition, it is difficult to 
interpret older studies they tended to not comply with current GLP standards. Risk 
assessors should be better placed to adjust UFs once the data gaps are resolved through 
the conducting of additional studies. 
In reality, the majority of risk assessments are based on "imperfect or incomplete" 
data. An attempt to estimate population threshold for humans is fraught with 
uncertainty because toxicokinetics and toxicodynamics between the test species and 
humans have not been studied adequately, and because of the heterogeneity in these 
processes among human populations. In addition, the paucity of information with 
respect to toxicokinetics of 1080 in humans highlights the need to carefully limit and 
monitor occupational and environmental exposures to achieve a better understanding 
and management of human toxicity (Temple and Edwards 1985). Thus, estimates of 
the human population threshold will always involve uncertainty (Baird et al. 1996). 
Since there are no reported adequate long term feeding studies on 1080, any TDI needs 
to be derived from subchronic studies and the utilisation of higher UFs than would be 
used when a full toxicology database is available and used in the estimation of the 
TDI. This short-term exposure scenario may, however, reasonably represent the 
picture in the case of some feral animals that have been exposed to 1080 entering the 
human food chain, as human dietary exposure is likely to be very different than 
average lifetime exposure. Estimating the risk to humans following chronic exposure 
to low doses can be particularly difficult since laboratory animals are usually exposed 
to concentrations which approach toxic levels, while humans are normally exposed to 
concentrations 1/1001h to 1/10001h the NOEL in rodent bioassays (Paustenbach 1989). 
For all critical end points a dose response trend was observed. The probit slope for 
testicular and cardiomyopathy were both steeper than the epididymis. The q 1 slope for 
cardiomyopathy was much steeper for males than the females. The q 1 slope for the 
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teratogenic end point was shallower compared with the other toxic effects (see Table 
10). 
A major difference was also observed with regard to the susceptibility of males and 
females to the myocardial toxicity of 1080, males being more susceptible. This was 
evident as 50% of males were affected at 0.25 mg/kg as opposed to 5% in females (see 
Table 5). Male rats are well known for their greater capacity to detoxify certain 
compound because of their higher activity of cytochrome P450-dependent 
monooxygenases. Therefore, they may demonstrate less toxicity to some compounds 
than females. However, if the metabolic product is more toxic than the parent 
compound, they may demonstrate higher sensitivity than females (Hodgson et al. 
2001). The male specific cytochrome P450s in rat are CYP2A2, CYP2Cll, 
CYP2C13, CYP3A2, CYP3A18 and CYP4A2 while the female specific cytochrome 
P450 is CYP2C12 (Waxman and Chang 2005). It might be predicted that the 
differences in the susceptibility of male and female rats to the toxic effects of 1080 
could be associated to a large degree with differences in their liver miscrosomal 
enzymes. 
In the case of continuous end points, a statistically significant (p :S:0.01) 15% decrease 
in fetal weight between animals receiving the highest dose vs control group was 
observed for both males and females (Table 6). In relation to sperm concentration, the 
BMDL was defined as the lower 95% confidence limit on the dose that produced a 
mean sperm count in exposed animals that was 10% less than the mean sperm count in 
control animals (Pease et al. 1991 ). The sperm concentration was severely affected by 
this compound, producing a 74% reduction when exposed at 0.25 mg/kg (2.22 * 108 g-
1) (Table 6) and significantly different from the control group (P <0.01). 
The pivotal studies utilised that established NOAELs were more recently conducted 
and complied with GLP standards. The NOAELs established for critical end points 
were 0.075 mg ki1 bw daf1 for the testicular and cardiomyopathy and 0.10 mg ki1 
bw day-1 for teratogenicity. Six different mathematical models (i.e., three each for 
quantal and continuous end points) were considered. The BMD was defined as a 10% 
increase in risk response. The BMDL of 0.10 mg ki1 bw daf1 was utilised to 
estimate the TDI for 1080. 
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Characterisation of the risk of human exposure to 1080 focussed on the levels of 
exposure that might occur in the general population with 1080 contamination of 
environmental media including food and drinking water. The total estimated 1080 
intake from various sources of exposure pathways (Table 14 and Table 16) under these 
conditions was compared with the estimated TDI of 0.03 µg ki1 bw day-1• T~e 
estimated total potential intake from 1080 sources was 0.22 µg kg-1 bw daf1 or 16 µg 
70 kg-1 adult and 0.55 µg kg-1 bw daf1 or 8.3 µg 15 ki1 child. These values are seven 
and 18 times the estimated TDI of 0.03 µg kg-1 bw day-1 for adults and children, 
respectively. The exposure assessments were based on an estimate of daily 
consumption of 2 Land 0.87 L for adults and children, respectively of drinking water 
contaminated with 4 ppb of 1080 that is likely to be without appreciable risk of 
deleterious effects occurring during a lifetime. 
The emphasis on the so-called "worst case scenarios" appears to be the ma3or 
shortcoming of exposure assessments, although such an approach may be a reasonable 
"screening assessment" used to dismiss insignificant hazards (Paustenbach 1989). 
Predictably, worst-case assessments will usually not describe the bulk of the exposed 
population and will often overestimate even the most exposed person. Hence, 
exposure assessment was also provided using maximum acceptable limits of 1080 
content in relevant media (Tables 15 and 17). The value of 0.07 µg kg -I bw/day-1 is 
over twice the estimated TDI of 0.03 µg ki1 bw daf1. In children, 0.16 µg kg -I 
bw/day -l is five times the estimated TDI of 0.03 µg kg-1 bw day-1. The exposure 
assessments were based on daily consumption of 2 L and 0.87 L of drinking water 
contaminated with 2 ppb of 1080 for adults and children, respectively that is likely to 
be without appreciable risk of deleterious effects during a lifetime. 
For the purposes of this study, exposure of the general population has been estimated 
based on 4 µg L-1 (the value is just over the DWS NZ PMA V of 3.5 µg L-1). 
Assuming that adult humans drink on average 2 L of water each day, the exposure 
would be 8 µg 70 kg-1 adult daf 1 or about 0.11 µg ki1 bw day-1 for a 70 kg adult. 
This exposure level is almost four times the TDI of 0.03 µg kg-1 bw day-1 which 
demonstrates that it may be possible for a person who consumes drinking water that 
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has been contaminated with 4 µg L-I to receive an exposure dose above the estimated 
TDI. 
Assuming that adult humans drink on average 2 L of water each day and applying the 
Ministry of Health's interim recommendation of 2 µg L-I in drinking water (Durham 
1998b), the exposure would be 4 µg 7Q kg-I adult daiI or about 0.06 µg kiI bw daiI 
for a 70 kg adult. This exposure level is twice the TDI of 0.03 µg kg-I bw daiI which 
demonstrates that it may be possible for a person who consumes drinking water that 
meets the Ministry of Health's recommendation of 2 µg L-I in the DWS NZ to exceed 
the TDI, Le., the PMA V is not adequately protective of public health6 • Also, this 
estimate represents intake of only less than 1 L of water per day so as not to 
exceed the estimated TDI of 0.03 µg kg-1 bw day·1. This demonstrates that more 
· than 1 L daily water consumption might be a health concern. 
· Estimating the. child intake using 1080 concentration of 4 µg L-1, the exposure would· 
be 3.5 µg 15 kg child day-I (4 * 0.87 L) or 0.23 µg kg-I bw daiI for a 15 kg child. 
This value is about eight times higher than the TDI of 0.03 µg kg-I bw daiI. For the 
purpose of the child intake estimate using the maximum acceptable 1080 intake is 15 
kg* 0.03 µg kg-I bw daiI/2 µg L-I = 0.22 L. Therefore, if 1080 in drinking water was 
at the maximum acceptable level (in terms of the Ministry of Health's interim 
recommendation of 2 µg L-1), a child weighing 15 kg would need to be limited to no 
more than 0.22 L (220 ml) of water per day, if the TDI is not to be exceeded. This 
volume is almost four fold less than the drinking water intake allocated to this 
particular age group. This estimate shows that a child weighing 15 kg gets the same 
dose of 1080, on a body weight basis, with one-fourth the water intake of a 70 kg 
adult. This is clearly a small amount of drinking water and is likely to represent a 
health concern, illustrating that children are likely to be at greater risk of being 
exposed to toxic effects of 1080 than adults. 
6 The exposure assessment was based on an estimate of daily consumption of 2 L of drinking water 
contaminated with 2 ppb of 1080 that is likely to be without appreciable risk of deleterious effects during a 
lifetime of exposure. 
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Estimates made on various contaminated drinking water scenarios indicated that: 
• Scenario a - 1,400 L of water contaminated with 4.5 g of 1080 would only 
need 0.65 ml of drinking water to reach the TDI of 0.03 µg ki1 bw day-1• 
• Scenario b - 250,000 L of water contaminated with 4.5 g of 1080 would only 
need 120 ml of drinking water to reach the TDI of 0.03 µg kg-1 bw day-1• 
• Scenario c - 1,000,000 L of water contaminated with 4.5 g of 1080 would only 
need 466 ml of drinking water to reach the TDI of 0.03 µg ki1 bw d~y-1• . 
Comparing all the expo~ure scenarios modelled, it appears that those who $ource their 
drinking water from a tank according to "scenario a" was considered likely to be at 
most risk from the overt effects of 1080. In the eve:nt of such contamination occurring, 
exposure of the general public becomes a public health issue. 
The concentrations of 1080 estimated in the three scenarios modelled w~ compared 
with the proposed PMA V of 0.60 µg L-1 and the current Ministry of Health's interim 
policy measure of2 µg L-1 (Table 20). To summarise: 
Table 20 
Comparisons of various Provisional Maximum Acceptable Values (PMAVs) 
Scenario a* Scenario b * Scenario c * 
Proposed PMAV of 0.60 5357 30 7.5 
µg/L 
MoH interim policy of 2 1607 9 2.25 
µg/L 
* X fold higher than PMA V 
The estimates made showed that the volume of water was a significant contributing 
factor in lowering the level of 1080 present because of the water dilution factor 
involved. 
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As there have been isolated cases in the past concerning 1080 contamination of milk 
and meat, the following analysis illustrates the risk that may arise from these sources. 
Assuming the recommended amount of milk consumed by an adult ( 500 ml equivalent 
to 2 standard glasses) and 1080 content in the contaminated milk was 0.004 mg kt1 (J. 
Simpers. comm. 1998), this exposure was estimated to be 2 µg 1080 or 0.03 mg 
kg-1bw daf 1 in a 70 kg person. The highest concentration of 1080 found m 
contaminated feral meat from samples that have been taken for testing was 0.028 mg 
kt1 (J. Simpers. comm. 1998). The recommended intake for adults is about 200 g = 
5.6 µg 1080 or equivalent to 0.08 mg kg- 1bw daf1 in a 70 kg person. Comparing these 
exposure estimates with the TDI of2 µgin a 70 kg adult, 1080 intake via contaminated 
meat intake is almost three fold higher than the TDL Therefore, it is possible for an 
adult eating highly contaminated feral meat to be affected and this could be of public 
health significance. 
As shown earlier, children have a greater potential for exposure to 1080. The exposure 
estimate for milk was 2 µg 1080115kg = 0.13 µg kg -l bw. This value is four fold 
higher than the TDI. Meat intake is 2.8 µg 1080/15 kg= 0.18 µg kg-lbw, which is 
six fold higher than the TDI. Exposures to contaminated meat and milk only 
constituted minor pathways for 1080 exposure when maximum residue limits were 
employed in risk assessment. However, when these media were highly contaminated, 
such as in these scenarios, a single exposure to these sources may likely be of health 
concern, particularly in children. 
Owing to the high biodegradability of 1080, exposures to high concentrations of 1080 
over long periods of time appear to be unlikely. However, short-term exposures at 
high concentrations cannot be ruled out and is particularly relevant in case of women 
of child-bearing age exposed during the vulnerable periods of organogenesis. These 
fmdings have implications for humans exposed to 1080, particularly during the 
susceptible periods of early development. Approximately 3% of newborn children 
have one or more significant congenital malformations at birth, and by the end of the 
first postnatal year about 3% more are recognised to have serious developmental 
effects (Bracken and Holford 1981 ). Of these, it is estimated that 20% are of known 
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genetic transmission, 10% are attributable to known environmental factors, and the 
' 
remaining 70% result from unknown causes (Wilson 1977). Furthermore, the study of 
Eisler (1995) demonstrated that it is possible to elicit toxic effects of 1080 even with a 
relatively short exposure period. A "tolerable intake" based on short-term exposure 
was estimated, although outside the scope of this study, and could be used as 
appropriate (see page 127). 
The margin of exposure (MOE) is the ratio of the NOAEL or BMDL determined in 
animals and expressed as mg kg-1 daf1to the calculated human exposure (Faustmann 
and Omen 2001; US EPA 2003). Therefore, 0.10 mg kt1 bw daf1/0.22 µg kt1 bw 
day-1= 454 (adult MOE) (see 5.1.1.3.1 and Table 14) while the MOE for a 15 kg child 
= 0.1 mg kg-1 bw day-1/0.S5 µg kt1 bw daf1= 180 (see section 5.1.1.3.1 and Table 
16). Using maximum acceptable values would yield an MOE of 1430 for adults (0.10 
mg kt1 bw day-1/ 0.07 µg kg-1 bw daf1) (see 5.1.1.3.1 and Table 15) and for children, 
the estimated MOE was 625 (0.10 mg kg-1 bw day-1/0.16 µg kt1 bw day-1) (see 
5.1.1.3.1 and Table 17). Table 21 summarises the MOEs for the four scenanos 
described above for easy reference. 
Table 21 
Margin of exposure (MOE) at various exposure scenarios 
Highest concentration 
Adult, 70 kg* 454 
Child, 15 kg** 180 
* highest concentration, excluding milk, tea, soil, air 
** highest concentration, excluding milk, soil and air 
Maximum acceptable limits 
1430 
625 
Low values of MOE indicate that the human levels of exposure are close to levels for 
the NOAEL or BMDL in animals. There is usually no factor included in this 
calculation for differences in human or animal susceptibility or animal-to-human 
extrapolation. Based on a NOAEL determined in laboratory animals, MOEs greater 
than 100 would generally be considered adequate for protection against the potential 
toxicity of a chemical that has a complete toxicity database (Dourson and Stara 1983; 
Davidson et al. 1986; Burin and Saunders 1999). The assumption that an MOE of 100 
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or more is acceptable assumes that humans could be 10 times more sensitive to a 
chemical than the most sensitive laboratory animal tested, and some individuals could 
be 10 times more sensitive than others within the human population. In this case since 
the MO Es for both adults and children are higher than 100, these would represent 
lower levels of risk. However, the toxicity database is not complete for 1080 and thus 
a MOE higher than 100 is needed for appropriate comparisons of safety. 
Although it was acknowledged that 1080 is highly biodegradable, evidence showed 
that smaller doses of 1080 given at regular intervals produced cumulative effects, such 
as myocardial damage in sheep (Annison et al. 1960). Whether this finding is relevant 
to humans is unknown. It appears, therefore, that low doses may produce adverse 
effects and would be of public health concern. The key questions here are whether 
humans are susceptible to the toxic effects of 1080 at low doses, and if so, at what 




6.1.1 Key findings 
The primary concern of this investigation is to develop a model for assessing the 
public health risk using 1080 as an example. Based on a comprehensive review of the 
literature considered to be relevant to human health risk assessment, this study found 
that the critical effects of 1080 exposure in animal experiments were teratogenicity, 
testicular/epididymis and myocardial toxicity. The BMD approach utilised in the 
study demonstrated that the BMDLs for both the quantal and continuous end points 
were generally slightly higher (but comparable) to the corresponding NOAELs for 
those same endpoints. The pursuit of an appropriate UF was also investigated, which 
resulted in a statistically derived UF in preference to the use of a conventional default 
set ofUFs. 
This study also showed that the most likely source of 1080 exposure would be from 
contaminated drinking water. Hence, this route of exposure was the main focus of risk 
characterisation. The proposed PMAV of 0.60 µg L-1 for 1080 in drinking water is 
six-fold lower than the current PMAV of 3.5 µg L-1 in the DWS NZ. The current 
PMAV of 3.5 µg L-1 may not be protective of public health, particularly in areas where 
their drinking water sources are collected from small water supplies or from personal 
reservoirs where the water dilution would not be so great (see exposure scenarios in 
5.1.1.3.1). These findings suggest that the PMAV for 1080 in the DWS NZ estimated 
based on an adult human being would be of particular health concern if this amount 
was taken by a 15 kg child. 
6.2 Health hazards 
There is little reliable information on 1080's action and toxicity in larger animals 
(Annison et al. 1960). The acute health effects of 1080 are well studied in animals, 
particularly by the oral route, but there is a paucity of data in humans by any route of 
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exposure. Information on the oral toxicity of 1080 in humans is limited to acute 
symptoms in a few reported cases of individuals who ingested a single dose of the 
compound. As pointed out by Bailer et al. (1999), there is generally a lack of human 
data at low levels of exposure. Unfortunately, many substances of toxicological 
concern do not have human exposure data available. Therefore, in this particular 
instance only animal model studies were utilised to predict potential human responses. 
In so far as the availability of data is concerned, rats were the test animals used in the 
pivotal studies and were therefore used in carrying out the health risk assessment. 
The potential health risks of 1080 reflect the identification of the critical end points of 
toxicity as being reproductive and myocardial toxicity and teratogenicity. The studies 
commissioned by the DoC and AHB regarding the short term developmental 
(teratogenesis) and the 90-day sub chronic studies were not robust enough due to lack 
of, for example, another species for the teratogenic testing and the absence of a chronic 
study. However, these have been the most useful studies that have been carried out on 
the potential adverse effects of 1080. Frequently, older studies do not meet current 
protocol standards. In the case of 1080, older studies were found not to be suitable for 
the purposes of this study as test animals were subjected to a single lethal dose or only 
a single duration of exposure. The likely chronic effects of 1080 cannot be accurately 
ascertained from the test animals as only subchronic studies have been conducted so 
far. For the critical end points identified (other than the teratogenic effects), the 
absence of chronic studies is a critical weakness in the health risk assessment of 1080. 
Some may argue that a chronic study may not be necessary as 1080 is not likely to be 
carcinogenic, since genotoxic studies are negative. However, authors such as Kroes 
(1995) supported the concept that subchronic 90-day rodent tests have limitations with 
regard to human health hazard assessment since exposure takes place for only 
approximately 10% of the lifetime. Hence, the substance may produce different toxic 
responses when repeatedly administered over a long period of time, as the time frame 
may not be long enough to reveal chronic effects. Moreover, the ageing process may 
alter sensitivity, metabolism or physiological capability. This study, therefore, agrees 
with Beck and co-workers' (2001) definition on what would constitute a "complete 
database", where a chronic study is a main component. 
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The absence of human exposure information constitutes a critical source of uncertainty 
for risk-based regulatory decision making. In the absence of 1080 human exposure 
data, policy makers, regulators, risk assessors, and others must rely on estimates. This 
approach is limited in identifying health risks because it relies on assumptions about 
potential 1080 exposures, thus introducing uncertainty in the risk estimates and 
ensuing policies necessary to protect public health. 
Values derived from human studies are preferred, if available, for comparison with 
estimates of exposure to characterise risk, despite the uncertainties in using 
epidemiological data (Paustenbach 1995). However, human studies should be at least 
of comparable quality to an animal study that might be used to determine a risk value 
(Dourson et al. 1996). [Quality here refers to the quality of the study for the purposes 
of conducting a human risk assessment. Obviously, a well conducted study that 
monitors an effect in rats that has no counterpart in humans would not be a high 
quality study for a human risk assessment]. The concept of using human data was not 
supported by Rall (1979), however, as epidemiological studies are difficult to use to 
predict or assure safety for several reasons, such as the difficulty of detecting adverse 
health effects at low exposure levels. 
6.3 Toxicokinetics 
Metabolism is an important source of species differences in toxicokinetics (IPCS 
2000b ). Small animals tend to metabolise chemicals more rapidly than humans 
because their relative liver weight is generally greater, liver perfusion is higher, and the 
activity of most mammalian hepatic metabolising enzymes, for instance, cytochrome 
P-450, increases relatively with decreasing body weight (IPCS 2000b ). This implies 
that humans may metabolise 1080 at a much slower rate than rats due to the difference 
in body size, and therefore may be at greater risk from the toxicological effects of 
1080. Schaefer and Machleidt (1971) suggested that fluorocitrate was found in small 
amounts (as little as 2.5% of 14C fluoroacetate was converted to fluorocitrate) and it is 
not as toxic as 1080 after oral ingestion in mouse. This finding was supported by Gal 
et al. (1961) who reported that after administration of 14C labelled fluoroacetate, 
fluorocitrate only accounted for 3% radioactivity in rats. This finding appears to 
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indicate that fluoroacetate may be more of concern than its metabolite fluorocitrate. 
Therefore, a slower metabolism may not necessarily to be beneficial. 
There is no toxicokinetic and toxicodynamic information suggesting that rat and 
human metabolism is very similar for 1080, but in the absence of information to the 
contrary, the assumption should be made that 1080 may manifest the same adverse 
toxic effects in other species, including humans. 
The toxicity of many chemicals requires metabolic activation to reactive compounds, 
which can cause adverse effects. The major metabolic pathways of 1080 result in a 
metabolite that is of high toxicity and appears to be readily excreted. Human acute 
toxicity data were estimated based on only a few observations (Chenoweth 1949). 
Among the larger animals tested, sheep and human have similar acute toxicities and 
these were also based on few observations (Chenoweth 1949). As there are no human 
data to determine the nature or dose-response pattern of the critical effects, it is not 
possible to determine how 1080 behaves in the body. Whether it is comparable to 
sheep is unknown. 
Incorporation of biological half-life data into risk assessments can have substantial 
benefits for improving the understanding on potential exposures and risks (Travis et al. 
1983) associated with 1080 exposures. As shown in Table 2, the elimination half-lives 
of the different species tested vary (Eason et al. 1994b ). The results showed that in 
sheep both the plasma and the muscle elimination half-lives were longer than those of 
other animal species tested. This may explain the difference in the overall toxicity of 
1080 to various animal species investigated. It was also noted that based on their 
LDsos, rats were more susceptible to the toxic effects of 1080 than mice (Table 3). 
However, whether their rate of elimination is the same is not known, as there were no 
specific data for rats. 
On the assumption that the elimination half-life of the rats is similar to that of the 
mouse could be a possible reason why sheep continue to exhibit myocardial toxicity, 
because their rate of elimination could be longer than the rats. Therefore, it is likely 
that they are exposed longer to the toxic effects of 1080 due to slow elimination rate. 
Oral gavage was the route of administration used in both studies. A direct comparison 
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cannot be made as the dosing regimes were different but it can be assumed that toxic 
effects may be likely to occur at doses below the 0.075 mg ki1 bw daf1 NOAEL 
derived from Eason et al. (2001) and Eason and Turck (2002). Wolfe (1988) obtained 
a slightly lower NOEL of 0.05 mg ki1 bw daf1 for the heart, testes/epididymides and 
spleen effects. Rats were the test animals used and oral gavage was the route of 
administration chosen. 
In an investigation carried out by Whittem and Murray (1963) in sheep, the 
myocardium was affected even at the lowest dose of 0.055 mg ki1daf1 applied. 
Sheep were exposed to multiple doses (0.055, 0.11, 0.22 mg kg-1day-I) of 1080. The 
findings from this study concur with those of Eason et al. (2001) and Eason and Turck 
(2002) which demonstrated that the heart is a critical organ affected by the toxic 
effects of 1080. The dose of 0.055 mg kg-1daf 1 was clearly below the NOAEL 
established by Eason et al. (2001) and Eason and Turck (2002) of 0.075 mg kiI bw 
day-1 and similar to that of Wolfe (1988). It appears that the true lowest effect level 
may possibly be even lower than 0.05 mg kg-I bw-I day-I. 
In an experiment carried out by Annison et al. (1960), administration of 0.4 mg kg-I 
bw of 1080 intravenously to sheep proved lethal within 4 to 6 hours of exposure. 
However, it was observed that doses of 0.2 to 0.3 mg kiI bw demonstrated only slight 
hypersensitivity reactions, irrespective of the route of administration. Interestingly, 
after recovery from a sublethal dose the animals showed an increased susceptibility to 
1080. This finding demonstrated that despite the high biodegradability of 1080, a 
cumulative effect may still occur. The opposite is true in rats where a non-fatal dose 
seems to provide a protective effect towards further doses for 24 to 36 hours 
(Chenoweth 1949) which demonstrated that rats are more tolerant to the adverse 
effects of 1080 at lower levels of exposure than sheep even though they were exposed 
for a relatively short period of time. Supporting this notion was the statement made by 
Eason (2002) that while 1080 itself does not accumulate in the body, repeated 
exposure to large sub-lethal doses may result in cumulative damage to the heart. 
Fluoroacetate has also the ability to cause a reduction in the levels of reduced 
glutathione in the liver necessary for detoxification as demonstrated by the reduction 
of liver glutathione levels in skinks exposed for up to 14 days (Twigg 1986). It would 
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appear therefore that depletion of glutathione may enhance susceptibility to the overt 
toxic effects of 1080. Whether this finding is relevant to humans is unknown. 
6.4 Interspecies variability 
Examination of the toxicology data suggested that there were differences between 
species in susceptibility to the mortality and subchronic toxicity of 1080. Compound 
1080 is not selective and it could be toxic to all mammals that ingest the 1080 baits. 
Dogs are particularly susceptible to both the primary poisoning ( direct ingestion of 
bait) and secondary poisoning ( consumption of an animal killed by primary poisoning 
(Rammel and Fleming 1978)). Development of a tolerance is not a characteristic 
feature of 1080's action in dogs (Chenoweth 1949). They eventually die when 
exposed to minute quantities of 1080 (LDso = 0.06 mg kg-1 or LD100 = 0.10 mg kg-1). 
Fish, amphibians, and reptiles were usually less sensitive to 1080 than warm-blooded 
animals (Atzert 1971; Twigg et al. 1986). 
6.5 NOAEL and BMD approaches 
It is well known that the NOAEL does not necessarily identify a zero risk below a 
threshold dose (Gaylor et al. 1998). In this study, the BMD approach, which involves 
fitting a mathematical model to toxicological dose-response data, was examined as an 
alternative to the use of a NOAEL. In the pivotal studies, test animals were exposed 
via the oral route and NOAELs were established for all the critical toxicity end points. 
All of the studies have at least one dose level above the NOAEL. Model performance 
(Table 8) was analysed and the AIC values obtained for the three models were 
comparable. 
Gephart et al. (2001) suggested that the strength of the BMD methodology is that 
different models that properly fit the data should give similar BMD estimates for the 
same data set. The findings from this study generally concur with this notion, as the 
choice of dose response model had little effect on the estimated BMD. There was a 
little difference in BMD results between models with a similar fit. Furthermore, the 
same authors claimed that if models were of equally good fit, then different models 
should give similar BMD estimates for both the continuous and quantal data. Again, 
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this notion was supported by this study (Tables 9 and 11 ). In this sense, the results of 
this investigation support the argument made by Crump (1984) that model choice is 
not a critical factor for BMD estimation because model-based extrapolation to low 
doses is not required. 
In comparing the three quantal models (Table 7), all models passed the goodness of fit 
test although in most cases the Weibull and probit models generally provided a better 
fit to the data. A difference noted between the first two models and that of quantal 
linear was with the latter usually producing the more conservative BMD/BMDL, i.e., 
two to four fold lower in all end points investigated. The probit model provided the 
best fit to testicular and male cardiomyopathy data and was chosen in estimating the 
BMDL for the determination of TDI. The quantal linear model was not chosen, 
although it provided the lowest BMDL, because it provided the worst fit among the 
models tested (Table 9). The epididymal effects provided the lowest BMDL but this 
value was not chosen as the point of departure because relevant research studies have 
concluded that the most critical effects arising from 1080 exposures were the testicular 
and myocardial effects. In addition, testicular effects and male cardiomyopathy have 
lower AIC values than epididymal effects (Table 8) and p-values of 1.0 and 0.3213 
were observed (Table 7), respectively. All continuous dose response models provided 
reasonable fits to all of the data except for the female fetal weight using the linear 
model (Table 7). The BMDs for the three continuous models were consistently similar 
(Table 12), supporting Crump's principle (1984) regarding model choice. 
Gaylor et al. (1998) pointed out that when no clear dose response is obtained and/or 
the BMD is calculated to be above the highest experimental dose level, use of the 
NOAEL might be more appropriate for setting a TDI. The BMD for female 
cardiomyopathy was higher than the LOAEL, 0.89 mg kg-1 bw and 0.25 mg kg-1 bw, 
respectively so it may be more appropriate to use the NOAEL as a point of departure 
in this particular situation (Table 10). Fowles et al. (1999) and Gaylor (1996) 
suggested that the BMD should be below the observable LOAEL if it is to represent a 
point of departure for health risk assessment. The BMDL was 0.21 mg kg-1 bw which 
is lower than the LOAEL. The BMD for teratogenicity (0.45 mg ki1 bw) was higher 
than the LOAEL in the study (0.33 mg kg-1 bw) (Table 10). Although the BMD 
exceeds the LOAEL for female cardiomyopathy, the BMDLs are consistently below 
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the LOAELs for the other toxic end points, and the BMDL is recommended in 
deriving the TDI for health risk assessment. Also, Barnes et al. (1995) suggested that 
it was not realistic to assume that implementation of the BMD approach would end the 
use of the NOAEL approach because there will always data sets that cannot be 
evaluated using the BMD approach. Hence, the NOAEL approach should be used 
where appropriate. 
For effects that have the same NOAEL, the effect with the steeper dose-response will 
have a higher BMD (Gephart et al. 2001) is generally true for slopes of dose response 
curves for populations because such slopes reflect population variability, by definition. 
Thus, steeper slopes indicate more homogeneity in the population and higher BMDLs, 
other items being equal. Given that the data have the same NOAEL and different 
slopes, the BMD is likely smallest with shallower slope (M. Dourson pers. comm. 
2005). This statement is particularly true in relation to effects on the epididymis, 
exhibiting a shallower slope and a lower BMD compared with testicular effects and 
male cardiomyopathy with steeper slopes and higher BMDs (Table 10). 
However, the statement conflicts with the observation that the slopes of the dose-
response curves for cardiomyopathy in females are shallower than that of 
cardiomyopathy in males and testicular effects, but the BMDs for cardiomyopathy in 
males and testicular effects are smaller than those for cardiomyopathy in females. The 
reason for this apparent discrepancy is that the relationship between the slopes and 
BMDs for different effects with similar NOAELs depends on the location of the BMR. 
If the BMR is below the response at the LOAELs, then the effect with the steepest 
slope will likely have a higher BMD, while if the BMR is above the response at the 
LOAEL, the shallower slope will likely yield a higher BMD. 
Fetal weight changes are often a very sensitive measure of effect of developmental 
toxicity studies, thus making it an important endpoint in the risk assessment process. 
Female and male fetal weights have the same slopes but they have different BMDs 
(Table 12) which could be due to difference in background and power parameters. 
This was consistent with the suggestion made by Gephart et al. (2001). The NOAEL 
for this end point was at 0.33 mg kg-1 and, compared with sperm count, was less 
affected by 1080 toxicity exhibiting 15% reduction in fetal weight (Table 6). 
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Compared with many other species, human males produce fewer sperm relative to the 
number of sperm required for fertility. Since most test animal species produce many 
more sperm than do humans, negative results in an animal study that is limited to 
fertility endpoint do not prove that the compound poses no reproductive hazard for 
men (Obasanjo and Hughes 1997). Therefore men may be at risk of reproductive 
effects of 1080 and this could be of public health concern. Environmental effects on 
male fecundity have been reported in a few studies (Mattison et al. 1990; Kaur 1988; 
Stachel et al. 1989; Thomas 1981). However, whether these examples are relevant in 
case of 1080 exposures is unknown. 
A gender-related difference was observed in myocardial toxicity, in which male 
animals were found to be more susceptible than the females at 0.25 mg kg-1 bw-1 (50% 
vs 5% of the animals tested, respectively) (Table 5). 
6.6 Uncertainty factor 
It is known that there is variability in the sensitivity of individuals to chemicals and 
thus in order to assess population risks the responses of sensitive individuals must be 
taken into account. Unfortunately, human environmental epidemiologic data are very 
rare, and even when they are available, the data may be inadequate to determine with 
any precision the threshold for particularly sensitive individuals. Epidemiological 
studies are less often available and are sometimes of reduced value because of the lack 
of quantitative information on the concentrations to which the people have been 
exposed or to what else the populations have been simultaneously exposed (Ministry 
of Health 1995a). Hence, the human threshold dose is typically extrapolated from 
animal data. Animal test data provide an estimate of the- subthreshold dose, or 
NOAEL. Because we do not know the true relationship between this animal threshold 
dose and the human threshold, uncertainty is inherent in the extrapolation. 
The derivation of the TDI for 1080 was based on subchronic studies due to the absence 
of chronic studies. Higher UFs were utilised to take into account the uncertainties 
involved in the inter and intraspecies differences, the use of subchronic studies and the 
incompleteness of the overall database. In addition, critical information on the 
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conditions of human exposure is lacking. Exposures to the general population are less 
well documented than occupational exposures due to limited availability of systems 
capable of measuring the exposures to specific risk agents actually experienced by 
people (Covello and Merkhoffer 1993). 
6.7 Derivation of TDI 
The statistically derived UF of 2994 (rounded to 3000 in the final calculation) 
proposed in this study represents a viable alternative to the use of a product of default 
factors to establish the TDI. The UF provides a known level of confidence in health 
protection, without unnecessarily compounding the conservatism built into each 
individual factor. The same UF of 2994 was used for the BMD approach to make the 
resulting TDis comparable, on average, to those calculated using the NOAEL 
approach. The BMD can provide a more consistent approach that avoids the extreme 
behaviour of the NOAEL, such as it does not use all of the dose response data; highly 
dependent on the number of animals used; and constrained to one of the experimental 
dose (Gaylor et al. 1998). 
The NOAEL of 0.075 mg ki1 bw day-1 for testicular and cardiomyopathy from Eason 
et al. (2001) and Eason and Turck (2002) might provide the most appropriate and 
relevant basis for 1080 TDI. A complementary study was also carried out with a 
NOAEL of 0.10 mg kg-1 bw dai1 based on malformations as the toxic end point 
(Eason et al. 1998, 1999). 
Six different mathematical models (i.e., three each for quanta! and continuous end 
points) were considered at 95% confidence limit at 10% risk response. However, the 
BMDLs generated by the probit models arising from the most critical end points, i.e., 
male cardiomyopathy and testicular effects of 0.10 mg kg-1 bw day -l was ultimately 
chosen to estimate the TDI, because the use of these models was able to capture more 
of the available data. TDI of 0.03 ug kg-1 bw day -l is proposed to be used for 1080 
health risk assessment until additional studies are carried out since these studies may 
likely reduce the UF in deriving the TDI and thereby likely raise the value of the TDI. 
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The exposure estimate may be considered conservative, as the general population may 
not be exposed to 1080 throughout their entire life. However, it can be argued that 
most risk estimates are based on lifetime exposure possibly due to difficulties in 
estimating the frequency and length of time an individual has been exposed. This 
methodology has been widely used to develop TDis based on the assumption that the 
general population may be exposed to the chemical in question for lifetime. The 
PMA V has also been estimated using a similar concept (Ministry of Health 2005). 
The health risk assessment carried out in this study was based on this rationale. 
6.8 Risk characterisation 
In characterising the risk for 1080, the potential total intake from 1080 sources was 
estimated to be 15.62 µg 70 kg adulf1 or 0.22 µg kg -l bw/day-1 (Table 14). As can be 
seen, this value is seven-fold the estimated TDI of0.03 µgki 1 bw dai1• 
In 1998, the Ministry of Health recommended an interim level of 1080 in drinking 
water of 2 µg L-1 to be acceptable for human consumption (Durham 1998b ). However, 
the results from this study demonstrated that 4 µg 1080 (2 L * 2 µg L-1) which equates 
to 0.057 µg kg-1 bw daf 1 for a 70 kg adult is almost two-fold higher than the derived 
TDI of 0;03 µg kg-1 bw day-1• It appears, therefore, that it may be possible for an adult 
person who consumes 2 L of contaminated drinking water at this level to exceed the 
TDL This may pose a health risk to the general population. 
By convention, risk assessments are based on adults weighing 70 kg. However, results 
from this study show that children are likely to be more susceptible than adults to the 
adverse affects of 1080 based on the parameters used in this study. Children have been 
shown to be more at risk than adults as the recommended drinking water intake of 
0.87L equates to 3.48 µg 1080 (0.87 L * 4 µg L-1) or 0.232 µg kg-1 bw dai1 for a 15 
kg child which is about eight fold higher than the derived TDI of 0.03 µg kg-1 bw dai 
1
• Using the Ministry of Health's interim recommendation of 2 µg L-1 equates to 1.74 
µg 1080 (0.87 L * 2 µg L-1) or 0.12 µg kg-1 bw dai1, which is four fold higher than the 
derived TDI of 0.03 µg kg-1 bw day-1. Based on this health risk assessment, children 
would only need 220 ml of drinking water per day in order to reach the TDL A 15 kg 
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child drinking 1 L of water with 2 ppb of 1080 receives 2.2 times the dose per kg 
bodyweight of a 70 kg adult drinking 2 L of water day-1• Also, children of all ages are 
still developing so they may be at greater risk than of adults (Scheuplein et al. 2002). 
In general, early life exposures in some instances can lead to adverse health outcomes 
later in life (Needham 2005). Low level environmental exposures do not cause 
obvious or immediate illness and their impacts on the society receives less attention. 
There is a paucity of child exposure information for most chemicals (Hubal et al. 2000; 
Morford et al. 2004). 
In considering toxic effects at various dose levels, the dose range of interest is 
generally the low dose range, since it usually reflects the human exposure situation. 
However, in most cases data for dose responses are available for high doses only and 
are often derived from animal experiments only. Therefore, the uncertainty in dose 
response assessment is large. Gavage exposures are expected to result in significant 
effects since laboratory animals are exposed to higher doses of the chemical 
administered and the overt effects are seen at short periods of exposure as opposed to 
continuous low level of exposures where the harmful effects may only manifest over a 
relatively long period oftime. This additional uncertainty justifies a conservative TDI. 
The use of the UF for within-human variability (IO-fold) and incomplete database (3-
fold) which together represent a 30-fold reduction in the TDI to account for sensitivity 
or the lack of a two generation study that monitored younger animals justified the 
application of a higher UF. Proponents of the theory that children are at higher risk of 
adverse effects following exposure to environmental chemicals, including pesticides, 
advocate an increase for children in the margin of safety that is used when setting 
exposure limits. In practice, this means an additional safety factor for children that 
would translate into smaller permissible exposures to children. In considering this 
point, the NAS panel recommended that an additional UF up to the 10-fold factor 
should be considered when there is evidence of postnatal developmental toxicity and 
when data from toxicity testing to children are incomplete. 
The additional factor under the FQP A is largely policy-based and not driven by 
scientific reason (Scheuplein 2000). Furthermore, technical evaluation of the 
uncertainty factors for both human variability and database completeness show that 
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these two factors are sufficient to address any children's sensitivity issues (Dourson et 
al. 2002). Based on this rationale, no additional UF was incorporated for children's 
potential increased susceptibility, but it was incorporated within human variability as 
discussed earlier (and a separate assessment was made for children, which 
incorporated the higher exposure considerations). 
The environmental fate of a chemical can dramatically influence the degree of human 
exposure (Paustenbach 1995). Davis et al. (1993) has also supported the importance 
of incorporating information on the fate of chemicals in the environment in their 
exposure estimates, whenever possible. This is particularly relevant in the case of 
1080 as it tends to degrade rapidly. Influencing factors include soil and water 
microbes, weather and temperature. The resultant change may alter the exposure 
assessment. If exposure occurs through a water source, then exposure assessment must 
consider how 1080 is altered over time as 1080 generally becomes diluted and 
degrades after release. This was the main reason why the interim level recommended 
by the Ministry of Health of 2 ppb was also used in this risk assessment. In addition, a 
separate health risk assessment was carried out using the actual concentrations of 1080 
found in drinking water. 
As 1080 is rapidly biodegraded, it is unlikely that the general population exposed to 
detectable concentrations of 1080 over relatively long periods of time. However, 
women of childbearing age may be exposed for short periods of time and it is possible 
that this may occur during the vulnerable developmental periods and could be of public 
health significance. In risk assessment, the appropriate application of UF is 
complicated in the case of teratogenic effects because of the assumption that a single 
exposure during development may produce an effect, and the recognition that multiple 
exposures may result in effects at lower doses in many cases (US EPA 1991 ). 
Compound 1080 is an established teratogenic agent in rats. The period of 
organogenesis (from day 18 through about day 40 postconception in the human) is the 
period of greatest sensitivity to teratogenic insults and the period when most gross 
anatomic malformations can be induced. Most major malformations occur before the 
36th day of gestation in human (Scialli and Colie 1997). For exposures of limited 
duration, the time-in-life during which the exposure occurred may be more critically 
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important in determining whether exposure occurred while the child was developing in 
utero and possibly on which days of gestation. This is particularly important to 
women of child-bearing age who may be pregnant, and may be exposed to 1080. 
The question posed for the present investigation is whether the adverse toxic effects 
found in laboratory test animals are relevant to the human population. The 
establishment of the TDI is complicated by the fact that there are no chronic studies, 
multigeneration toxicity studies or relevant human data available to help in 
ascertaining the toxic effects of 1080. A further complicating factor is the lack of 
information on the amount of 1080 to which the public may be exposed. A low dose 
extrapolation was required to the dose range most relevant to the general public. 
However, it should be noted that the degree to which the dose may be below the 
population threshold is unknown (Dourson et al. 2001). 
No scientific evidence is presently available on the long-term effects of 1080. 
However, this is probably due to low occupational and environmental exposures, 
which has never made the collection of data on 1080 of enough relevance to elicit 
epidemiological studies. 
When limited data are available, and in the absence of empirical data to the contrary, it 
is generally assumed that a chemical will be absorbed in humans to approximately the 
same extent as it occurs in laboratory animals. This should take into account that the 
same conditions of exposure were applied and recognising the differences between 
species, such as dermal exposure where absorption is often lower in humans than in 
the common laboratory species (IPCS 2000b ). 
It is recognised that well documented human data with respect to environmental 
exposures occur rarely. Intraspecies extrapolation must be performed when no data on 
sensitive human subpopulations exist (Kalberlah et al. 2003). To evaluate critically 
the adverse effects of 1080, it is necessary to compare data derived from experiments 
with laboratory animals, the results of epidemiological studies (if any), as well as the 
effects observed in acute human exposures. These factors are critically important to 
minimise the uncertainties identified in conducting the risk assessment process. 
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6.9 Conclusion 
The use of BMD methodology to provide a more quantitative dose response evaluation 
from all available data was investigated with the aim of improving human health risk 
assessment and compared with the traditional NOAEL approach. Generally, for both 
the quantal and continuous end points, the BMDLs generated were generally slightly 
higher but comparable point of departure to the NOAEL approach. The BMD 
approach has the advantage of using all the data points, resulting in better 
quantification of the effect level. This study has provided evidence that the BMD 
approach is useful for improving the scientific basis of the human health risk 
assessment for 1080. 
Available data upon which to base estimates of human exposure to 1080 are limited. 
However drinking water is likely to be the principal source of exposure (Tables 14 and 
16). This statement was supported by Eason (1995) who concluded that the most 
significant potential exposure route for the general public is likely to be the 
contamination of surface water in water supply catchments. Exposure from other 
media, such as air and dermal absorption appears to be negligible in comparison with 
that from drinking water. Based on exposure estimates derived using the highest 
recorded concentrations of 1080 in meat and drinking water ( excluding milk, air and 
soil) and the acceptable limits of 1080 in various exposure pathways, intake for the 
general population would be primarily from drinking water. The focus of the human 
health risk characterisation is, therefore, the general population exposed to 
contaminated drinking water. 
The adult PMA V derived from the study was found to be much lower than the current 
PMA V in the DWS NZ (Table 19), suggesting the value may need to be reviewed in 
light of the findings from this study. At present, the maximum acceptable value is 
categorised as 'provisional', as it is acknowledged that relevant studies are still 
missing for the purposes of human health risk assessment. The PMA V can be 
reviewed and revised when adequate additional information becomes available. 
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Although not a common practice in setting standards in New Zealand, the increased 
exposure potential of children may need to be examined with a view to setting a 
standard that is protective of all the population. It is well recognised that children are 
more susceptible to the toxic effects of many environmental pollutants. This has been 
acknowledged in developed countries, such as the USA, where special legislation for 
the US FDA and US EPA was drawn up to specifically monitor whether existing 
measures were adequate to protect children. That said, specific examples of standards 
that have been revised to accommodate extra susceptibility of infants or children are 
not yet available. 
It is worth exploring the option of having additional toxicology and epidemiology 
studies (if possible) conducted to increase the confidence in the TDI, as this would 
have significant health policy implications and health risk management approaches. 
The recommended PMA V was based on findings from this study. It is up to the 
relevant regulatory authority to make the final decision on what guideline value should 
be set in New Zealand. The following chapter discusses health risk management 
approaches relevant to this study which may serve as the basis in developing policy 
options taking into account political, cost-benefit analyses, and so on. 
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Chapter 7 
Health Risk Management 
7.1 Health Risk management 
Health risk management deals with associated health risks so as to protect public 
health from the .. toxic potential of 1080 including the management of public health 
concerns and relevant processes. For the purposes of this study, risk management 
generally focuses on public health. For simplicity, the term risk management was used 
throughout this document. 
Before health risks can be managed, they have to be assessed and characterised (see 
Chapter 5). · Once risk characterisation has been completed, the focus turns to risk 
management (van Leeuwen 1995). In reality, health risk assessment and risk 
management are inextricably linked as shown by the overlapping circles in Figure 12. 
Risk characterisation (see sections 5.1.1.6 and 6.8), the last step in. health risk 
assessment, is the starting point for risk management considerations (Paustenbach 
1995). The risk characterisation showed that drinking water is likely to be the 
principal source of exposure (Tables 14 and 16). Hence, the risk management for the 
purposes of this study focuses mainly on drinking water. 
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Relationship between health risk assessment and health risk management 
Risk management refers to the process of reducing the risks to a level deemed to be 
tolerable by society and to assure control, monitoring, and public communication 
(Morgan 1990). It also includes decisions concerning the need for regulatory schemes 
and the type of scheme that should be implemented. Such schemes may include 
specifying the PMAV of 1080 in the DWS NZ or setting a TDI. These are called 
'intake' standards, i.e., concentration standards based on measurements on ambient 
medium from which absorption takes place, such as in drinking water or food (Illing 
2001). Toxicologists are often concerned with defining the highest amount that can be 
present in the body without significant ill-health occurring. 
Done well, risk management is inherently precautionary in the sense that it should 
make use of effective health risk assessment to predict, anticipate, and prevent harm, 
rather than merely reacting when harm arises (Hrudey and Leiss 2003). The book 
Silent Spring (Carson 1962) had a profound effect on the way in which pesticides were 
viewed by the general public (Wilkinson 1990). This book found a voice in the 
political and legislative realm (Stark et al. 2004). For instance, the Food Quality and 
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Protection Act in the USA was enacted restricting the use of many pesticides in a wide 
range of uses. This piece of legislation particularly protects the consumers, especially 
children, illustrating the increasing public concern about the dangers of environmental 
contaminants to public health. 
Regulation is perhaps the most visible aspect of risk management (Hood et al. 1992). 
7.2 Statutory framework relating to the use of 1080 
There are a number of legislative frameworks relevant to the use of 1080 in New 
Zealand. These are summarised below: 
7.2.1 Hazardous Substances and New Organisms Act 1996 (HSNO Act) 
The Hazardous Substances and New Organisms Act 1996 aims to protect the 
environment, and the health and safety of people and communities by preventing or 
managing the adverse effects of hazardous substances and new organisms. Section 97 
of the HSNO Act sets out the responsibilities for enforcement of the Act and 
associated regulations. Under this Act, the Director-General ( Chief Executive) of the 
Ministry of Health must ensure that the provisions of this Act are enforced where it is 
necessary to protect public health which covers all locations in which public health is 
put at risk. 
The HSNO Act repealed a number of statutes in New Zealand, including the Pesticides 
Act 1979 and the Toxic Substances Act 1979 which were relevant to the use of 1080. 
The hazardous substances part of the HSNO Act came into force on 2 July 2001. The 
Pesticides (Vertebrate Pest Control) Regulations 1983 (Pesticides (VPC) Regulations) 
and the Toxic Substances Regulations 1983 continued in force as transitional HSNO 
regulations by virtue of section 174 of the HSNO Act. The effect of section 174(4) 
and ( 5) of the HSNO Act was to preserve the powers of the functions exercised by the 
Medical Officers of Health under these regulations and continued until 30 June 2005. 
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The HSNO transfer process involved the assessment of the intrinsic hazardous 
properties of 1080 and assignment or a classification to it that was based on the criteria 
specified in the Hazardous Substances (Classification) Regulations 2001 make the 
treatment of 1080 consistent with the regulations of other vertebrate toxic agents, such 
as cyanide. The Hazardous Substances (Sodium Fluoroacetate) Gazette Notice 2005 
came into effect on 1 July 2005 and completed the transfer of the risk management of 
1080 to the HSNO regime. As a consequence, 1080 is now subject to the HSNO suite 
of controls which cover the full life cycle of 1080 from import or manufacture through 
to final disposal. Labelling, packaging, emergency management, tracking and disposal 
are also covered in the HSNO controls. Under the HSNO Act, all hazardous properties 
of 1080 are considered and controls are assigned by the Environmental Risk 
Management Authority (ERMA) in accordance with the appropriate hazard 
classifications. The default controls may be varied by the ERMA so as to maintain the 
existing requirements under the previous legislation. The HSNO Act is administered 
by the MfE and the ERMA. 
7.2.2 Resource Management Act 1991 (RMA) 
The MfE administers the RMA. There are requirements under the RMA that provide 
restrictions on discharges of contaminants into the environment. These include 
discharges to soil, water and air where actual or potential 1080 contamination may 
occur. In cases where regional plans have classified water as for human uses, 
discharge of "contaminants" to water either requires a consent or it must be a permitted 
activity (an activity that is allowed by a plan without a resource consent if it complies 
in all respects with any conditions specified in the plan) under the RMA. 
"Contaminant" is defined under the RMA as includes any substance ... 
(a) when discharged into water, changes or is likely to change the 
physical, chemical or biological condition of water: or 
(b) when discharged onto or into land or into air, changes or is likely to 
change the physical, chemical, or biological condition of the land or in 
air onto or into which it is discharged. 
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Discharges to air may largely be determined by the nature of the discharge activities, 
such as where 1080 is discharged to air as dust. A resource consent is required for any 
discharge activities that have actual or potential effects on the environment. Discharge 
of 1080 to land such as in ground bait applications or for baits that dropped aerially 
onto land would only require a discharge permit if the activity is restricted by rules or 
plans. It should be noted that the requirement to obtain a resource consent is only one 
of the approvals that are required before 1080 aerial operation can be undertaken. 
7.2.3 Health Act 1956 
The administration of the Health Act falls within the responsibility of the Ministry of 
Health. The purpose of the Health Act is to improve, promote and protect public 
health. Local authorities are empowered under the Act to abate nuisances which are 
offensive or likely to be injurious to health. The functions and powers of Medical 
Officers of Health, such as the protection of water supplies are set out in this Act. 
The nuisance provisions of the Health Act can be used to protect public health. 
''Nuisance" entails either damage to private property or infringement of a public right 
which causes "injury" to the public. However, because this provision can only be 
applied once a nuisance has already occurred, not before its occurrence, it may not be 
useful in most respects. The Ministry of Health is currently reviewing the Health Act. 
In 2001, Cabinet approved proposals for the Public Health Bill (CAB Min (01) 29/15). 
7.2.4 Food Act 1979 
The New Zealand Food Safety Authority (NZFSA) administers the Food Act 1979. 
All food produced for sale in New Zealand must comply with the New Zealand 
(Maximum Residue Limits of Agricultural Compounds) Food Standards 2004. These 
standards are mandatory standards under the Food Act. The MRL for 1080 is 0.001 
mg kg -I ( default value) or at about the limits of detection. 
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7.2.5 Agricultural Compounds and Veterinary Medicines Act 1996 (ACVM Act) 
The NZFSA is accountable for the implementation of the ACVM Act. The purpose of 
the Act is to prevent or manage the risk associated with the use of agricultural 
compounds and veterinary medicines (formerly called animal remedies under the 
repealed Pesticides Act), such as risks associated with 1080 to the trade in primary 
produce, animal welfare, and domestic food standards . 
. 7.2.6 Health and Safety in Employment Act 1992 (HSE Act) 
The HSE Act is administered by the Department of Labour (Workplace Services). The 
purpose of the Act relates to the health and safety of employees, and other people at 
work or affected by the work of other people. The minimisation of worker's exposure 
to the use of 1080 is covered by the requirements of the HSE Act. 
7.2.7 Drinking Water Standards for New Zealand 2005 (DWS NZ 2005) 
The Ministry of Health sets the quality standards for drinking water in New Zealand. 
The DWS NZ 2005 (Ministry of Health 2005) provides a yardstick for assessing how 
safe the water is to drink. The DWS NZ is considered to be a safety or quality 
standard, which is another approach to 1080 control. Such a standard is set with the 
intention to protect human health. 
The DWS NZ specifies the Maximum Acceptable Value (MAV) for drinking-water 
constituents or properties ( determinands) of concern to public health. The MA V in 
drinking water represents the concentration of a determinand which, on the basis of 
present knowledge, is not considered to cause a significant risk to the health of the 
consumer over a lifetime of consumption of water. The current Provisional Maximum 
Acceptable Value (PMAV) for 1080 is 0.0035 mg L-1 (3.5 ppb). It is a requirement 
under the DWS NZ for Priority 2 determinands, such as 1080, that monitoring be 
carried out if the level of 1080 in drinking-water exceeds 50 % of the PMA V as 
discussed in sections 5 .1.1.3 .1 and 5 .1.1.5. 
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7 .3 1080 reassessment 
The DoC and the Animal Health Board (AHB) are the main users of 1080 for possum 
control. These two government agencies have applied for reassessment of 1080 in the 
light of updated scientific research information into the adverse effects of 1080 and the 
benefits and risks of its use. The ERMA has decided that there are grounds for 
reassessment of 1080 as new significant information has become available relating to 
the toxic effects of 1080 since it was initially registered under the Pesticides Act in 
1964, and that there is information relating to a significant change in the quantity of 
substance used (ERMA New Zealand 2002). 
The initial target date for reassessment of 1080 in 2002 was postponed due to the 
inability of the HSNO Act to deal with local issues, such as addressing the need to 
impose additional conditions to suit local needs. In particular, DoC and the AHB were 
concerned about whether the new legislation enabled the Medical Officers of Health to 
retain their former role under the Pesticides (VPC) Regulations which enabled them to 
impose additional controls on 1080 operations in order to address local needs. These 
two agencies recognised the concerns raised by the general public being driven by the 
potential human health risks that may arise from the use of 1080 and they saw the role 
of the Medical Officer of Health as critical in addressing these public health concerns 
(N. Hancox pers. comm. 2002). The action taken by the two agencies has 
acknowledged the importance of public health specialists in dealing with such issues. 
It is worth noting that the Ministry of Health has raised similar concerns to ERMA on 
how local issues should be dealt with when 1080 is applied in areas where public 
health may likely be at risk (S. Gilbert pers. comm. 2002). 
The HSNO Act was later amended (Hazardous Substances and New Organisms 
(Transitional Provisions and Controls) Amendment Act 2004) to give the ERMA the 
power to delegate the decision for any application for any permits or revocation as 
specified in the legislation. The power may be delegated to individuals, such as the 
Medical Officer of Health, or a HSNO enforcement officer, or an employee of the 
Ministry of Health (see section 5.4). This has been a great improvement to the 
workability of the HSNO Act in so far as addressing local issues in a similar manner to 
the previous legislative regime. 
164 
On 13 August 2007, the ERMA has announced that the reassessment for 1080 has 
been completed and highlighted the fact that tighter management regime on the use of 
1080 is to be imposed. From 1 January 2008 all aerial operations using 1080 will be 
actively monitored by the ERMA New Zealand (ERMA NZ 2007). 
7.4 Implications for the Medical Officers of Health 
Prior to the HSNO Act coming into force, the approval and method of application of 
1080 was governed by the Pesticides (VPC) Regulations 1983 (now repealed). 
Permission from a number· of authorities, including the Medical Officer of Health at 
the local public health unit was required prior to 1080 being used. The role of the 
Medical Officer of Health is to ensure that public health is not at risk. If the Medical 
Officer of Health is satisfied that the application or use 1080 to which it relates will not 
contravene the Health Act and the Pesticides (VPC) Regulations, the regulations 
require that the Medical Officer of Health give permission to the use or application of 
1080. The legislative power to grant 1080 permits is mandatory provided the relevant 
legislation is not contravened. The Medical Officer of Health may, however, impose 
additional conditions as he/she thinks fit to protect public health consistent with local 
needs. 
To promote national consistency in setting any such conditions, the Ministry of Health 
published the Model Permit Conditions for the Use of Sodium Monofluoroacetate 
(1080) (Ministry of Health 1995b, see Appendix 6) to assist Medical Officers of 
Health to identify and develop conditions for 1080 use. The Medical Officers of 
Health use their discretion in applying additional conditions to 1080 permits on a case-
by-case basis in light of the toxicology findings. 
Under the Pesticides (VPC) Regulations, the Medical Officer of Health may grant a 
permit to apply 1080 in restricted areas specified in the regulations including on a 
public road, in any other place to which the public are entitled to have access, within a 
certain distance of any such road or place, or in any catchment area from which water 
is drawn for human consumption. 
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The Hazardous Substances (Sodium Fluoroacetate) Transfer Notice 2005 provides that 
a permit to use 1080 is required from a person who has been delegated for the purpose 
by the ERMA. The ERMA has delegated specific functions to Medical Officers of 
Health and Health Protection Officers (the delegated officers) who are warranted 
HSNO-enforcement officers and who have obtained a Certificate of Completion of a 
Ministry of Health risk management course or Health Impact Assessment course, any 
University of Otago summer school course on risk management or attendance at other 
Ministry of Health training such as professional development, resource management 
and emergency management, a Diploma in Public Health, or a Master in Public Health. 
The delegation under the HSNO Act includes the power to decide an application for a 
permission; and/or to add, delete or otherwise vary any condition on a permission; 
and/or to revoke a permission for the use of 1080 in a catchment area from which 
water is drawn for human consumption or in any other area where a risk to public 
health may be created by such application. 
The Medical Officer of Health's role in ensuring that public health is not compromised 
during 1080 operations is illustrated in the following example (M. Broughton-Webb 
pers. comm. 1998). In April 1998, residents of Wairarapa expressed concerns about a 
proposed 1080 drop in the catchment of the Waihora stream due to the low rainfall and 
the Wellington Regional Council (WRC) decided to postpone the operation until 
normal rainfall returned. When the Medical Officer of Health met with the local 
residents, it was agreed that if the operation were to continue during the abnormally 
dry weather then WRC would be required to provide the local residents with 
alternative drinking water. The provision of the drinking water would need to continue 
until testing showed that the Waihora stream was not contaminated with 1080. 
Because of the abnormally dry weather and the minimal flow in the Waihora stream, 
the Medical Officer of Health agreed that the WRC would need to consult with and 
obtain the agreement of all users of drinking water drawn from the Waihora stream as 
to when the testing of the stream would take place. As a result of this meeting, the 
WRC indicated that they did not intend to proceed with the operation until rainfall 
occurred and the flow of the Waihora stream returned. 
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7.5 Model 1080 permit conditions 
The Ministry of Health's model permit conditions (Ministry of Health 1995b) provide 
guidance to Medical Officers of Health. These model permit conditions (Appendix 6) 
are the Ministry's expectations but are only best practice guidelines in that they have 
no statutory status. However, the conditions become legal requirements if they are 
included by the Medical Officer of Health as part of their permit conditions. 
The model 1080 permit conditions were developed by the Ministry of Health after 
rigorous consultation with affected parties. The model conditions were finalised 
taking into consideration the views expressed by the District Health Boards ( then 
Crown Health Enterprises), regional councils, DoC, Ministry of Agriculture and 
Fisheries (MAF), PCE, National Pest Control Agencies (NPCA) and the National 
Beekeepers Association. Furthermore, considerable discussion took place between 
relevant agencies, such as DoC, AHB, NPCA, and representatives from the regional 
councils, in particular on whether the additional conditions were achievable and 
reasonable prior to finalising and printing the model permit conditions (M. Taylor pers. 
comm. 1995). 
The Medical Officer of Health has the statutory authority to apply the conditions to the 
permits for the 1080 applications, but may vary the conditions from the Ministry of 
Health's model permit conditions in some circumstances to meet local needs. For 
instance, the requirement for water sampling may be waived if historical results are 
available from the same area and have demonstrated that 1080 concentration in the 
water will be less than 2 ppb of 1080 and the same conditions are proposed with the 
application, such as the strength and rate of application. However, these would be at 
the discretion of the Medical Officer of Health and additional precautions may be 
required due to unforeseen circumstances and may compromise public health. 
Special emphasis was given in relation to drinking water catchments because of the 
controversy over this area. For the purposes of the permission required from the 
Medical Officer of Health, the restriction applies to any drinking-water catchment 
from which water is drawn for human consumption. As a guideline to the Medical 
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Officer of Health, the Ministry of Health has defined this to mean that a "catchment 
area from which water is drawn for human consumption", is simply "a water 
catchment that is used as a source of human drinking water". However, there were 
difficulties encountered in the above definition, in particular, Northland where over 
90% of the area is probably a water catchment (J. Jarman pers. comm. 1996). The 
definition was revised by the Ministry of Health in 1998 for the purposes of regulation 
12(1)(f) of the Pesticides (VPC) Regulations (now repealed) only as "Any area from 
which rainfall flows into a body of water, that is proximate enough to an abstraction 
point which supplies water for human consumption, such that it can be said that the 
water is drawn from that area.".(Durham 1998c). 
Drinking water catchment is not defined in the HSNO Act. The same definition was 
adopted for the purposes of Hazardous Substances (Sodium Fluoroacetate) Gazette 
Notice 2005 only and this .definition was included in the approved application form 
(Appendix 4).· However; this is not a statutory definition and should be applied 
cautiously. It is considered essential to take into account the potential threat to human 
health of application/use of 1080 in relation to the abstraction point supplying water 
for human consumption. 
7.6 Concerns/problems surrounding the 1080 national application form and 
permit conditions 
In 2000, the Medical· Officers of Health agreed to use standard application and 
permission forms for the use of 1080 taking into account the model permit conditions 
and incorporating the ability to carry out a health impact·assessment. The forms were 
formally adopted by the Medical Officers of Health in November 2000 but it was 
acknowledged that the individual Medical Officer of Health may adapt and vary the 
forms as they think . fit. The revised application and permission forms were 
subsequently amended to take into account the HSNO requirements and the comments 
from all public health units. The forms were then approved by the ERMA for use by a 
delegated person7 from 1 July 2005. These forms were subsequently amended and 
approved by the ERMA New Zealand in June 2007 and required to be used from 1 
7 Person acting under a delegation from the ERMA. 
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July 2007 (Appendices 2 and 3). It should be noted that the delegated persons have no 
power to modify the application form but it can be amended if a new approval is 
obtained from the ERMA New Zealand. However the conditions set in the permit 
form may be modified or waived by the delegated person as she/he sees fit to suit local 
circumstances. The permit form also specified the fact that the HSNO requirements 
are minimum requirements and that stricter conditions may be imposed by the 
delegated person. 
The health impact assessment component of the application form should be carried out 
by the agency conducting the operation and that any potential public health risks that 
have been identified and the proposed measures in mitigating those risks should be 
advised to delegated persons. In this way, delegated persons would be in a better 
position to set conditions in 1080 permits. There is also some confusion as to what 
would constitute a "drinking water catchment". A definition was provided in the 
application form for the purposes of the Hazardous Substances (Fluoroacetate) Gazette 
Notice only (see section 7.5 and Appendix 4) 
Because most of the 1080 operations are now being contracted out, the agency 
conducting the operation is considered to be "responsible" for all poisoning operations 
where permits have been granted under their names because in most cases delegated 
persons would not even know the contractors and/ or subcontractors. 
The need for a shorter version of the application form was also raised by users of 1080 
to PHUs when the application form was initially reviewed in 2005 because others 
found the form too complex from a user's point of view. On balance, this was found 
to be acceptable by others as contractors would only need to mark any item "not 
applicable" if it was not relevant to their application. 
It is known that risk can never be entirely eliminated from life, and risk reductions 
come at a price (Zeckhauser and Viscusi 1990). To put this statement in the context of 
using 1080, in 1999 the Wellington Regional Council (WRC) raised concerns with the 
then Minister of Health regarding the burden that tighter controls on 1080 use placed 
on them in terms of the financial impact and the potential alarm these additional 
conditions may raise in the general public (G. Durham pers. comm. 1999). For 
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instance, the WRC raised concerns in 1999 about the "excessive" water sampling 
regime and cost with additional water sampling costs around $25,000 for a period of 
six months. In addition, it was claimed that testing increases public concern generated 
by the requirement to notify affected households of the application of 1080 in their 
drinking water catchment and providing alternative drinking-water (G. Durham pers. 
comm. 1999). WRC stated that the concerns outlined in their letter to the Minister of 
Health were a reflection of national concerns and were not confined to the Wellington 
reg10n. 
However, the Ministry of Health does not view this cost of water sampling and 
monitoring to be excessive, when considered within the overall Council budget of $5 
million for pest control operations. For example, New Zealand spent over $30 million 
in 1993/94 (since increased) and $14 million has been allocated for possum research in 
1995 (G. Durham pers. comm. 1999). The price indicated by the WRC was indeed not 
onerous and the findings from this study have shown that water monitoring is crucial 
in 1080 operations. 
WRC advised that other councils were canvassed about their concerns, and asked what 
permit conditions were applied in their regions, and whether they were consistent. 
Regional councils were seeking consistency in the approach and procedures of Medical 
Officers' of Health nationally. Fundamental inconsistencies identified were the 
Medical Officers of Health interpretation of risks with water supplies, application of 
ground laying and interpretation of regulations to territorial authorities. 
The MAF have also expressed concerns about the effect any restrictions on 1080 use 
may have in jeopardising the existing possum control programme and subsequent 
impact this may have on the incidence of bovine tuberculosis, export markets and 
I 
viability of agriculture (G. Durham pers. comm. 1999). Addressing the concerns 
raised by MAF, the permit conditions do not restrict the use of 1080 per se, but merely 
ensure that adequate monitoring of environmental conditions and quality control 
standards are followed. In addition, it should be noted that excessive levels of 1080 in 
dairy milk, as occurred in Carterton where nine dairy cows died (J. Simpers. comm. 
1998), may be of concern from the perspectives of both consumers and damage to 
export markets. 
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Despite these two major issues, the permit conditions have been applied throughout the 
country because the conditions can be modified to suit local needs. 
7.7 Tolerable level of risk 
Zero risk and absolute safety is unlikely to be achieved or proven. Hence, the major 
question is the tolerability. A good approach to risk management should achieve a 
tolerable risk. The terms "tolerable" and "acceptable" have the same intent (similar to 
ADI and TDI as discussed in section 5.1.1.2) but the term "tolerable" is chosen, for the 
purposes of this study, because it connotes a level of intake that could be tolerated by 
an individual. It does not imply acceptability of that level in any other sense. The 
term "acceptable" is retained if the original author has used this word on the original 
text. 
What constitutes a tolerable risk is an important decision that will vary according to a 
large number of circumstances. It is basically a policy decision that must carefully 
weigh a number of factors. It should be noted that what is tolerable for risk assessors 
may not necessarily be tolerable to communities who are susceptible to threats. 
For carcinogens, the DWS NZ presents concentrations in drinking water that are 
equivalent to lifetime cancer risks of one in 10 000 (10-4) to one in a 100 000 (10-5). 
Risk estimates are determined by employing a cancer potency (unit risk) value together 
with assumptions for lifetime exposure through drinking water. This provides a low-
dose estimate cancer risk to humans that are considered unlikely to pose a carcinogenic 
risk in excess of the stated values (US EPA 1989). 
For non-carcinogenic pesticides such as 1080, a common way to derive an equivalent 
value is with the MOE. It should be noted, however, that this is not actually a measure 
of risk but an exposure. However, the MOE has been used as a surrogate for an 
acceptable risk level (R. Howd pers. comm. 2005). 
With the BMD modelling approach, the actual level of risk at low dose levels can be 
extrapolated. This is frequently achieved using the 5% effect level (an effect in 5% of 
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the population) (R. Howd pers. comm. 2005). For the purposes of this study, the 
probit model was employed and the same parameters were applied as in deriving the 
BMDL10 for 1080 (see Chapter 5) but the 5% effect level was used instead of the 10% 
effect level. The BMDLos for 1080 for male cardiomyopathy and testicular effects 
were estimated to be 0.07 mg ki1 bw-1 day-1 and the statistically derived UF of 2994 
(rounded to 3000) was used in deriving the tolerable level of risk. The tolerable risk 
level was estimated to be 0.024 µg ki1 bw-1 day-1• 
7.8 Policy involvement 
Attempts to estimate population threshold for humans based on studies of toxicity in 
laboratory animals are fraught with uncertainty. The uncertainty is compounded by the 
absence of chronic animal studies and availability of information on the incidence of 
adverse chronic health effects in humans. The sensible approach is to use the best 
scientific understanding of relevant risks and adopting sensible default assumptions in 
the face of uncertainty (Ellman and Sunstein 2004). Any approach for deriving, for 
instance, a TDI or PMA V, inherently involves both scientific assessment and policy 
judgement. This mixture of science and policy causes difficulty for decision-makers 
because the relative impacts of scientific assessment and policy judgment, respectively 
are not readily evident. 
When there is substantial scientific uncertainty about the risks, policy decisions should 
be made that err on the side of caution with respect to the health of the public (Kriebel 
et al. 2001 ). Existing 1080 data do not permit comprehensive health risk assessments 
of all possible exposure situations. Therefore, a certain amount of scientific 
uncertainty is by necessity inherent in most situations (Johnston and Simmons 1990). 
Risks cannot be evaluated solely on the basis of scientific considerations alone, but 
evaluation involves a decision on what risk is 'tolerable'. What constitutes 'tolerable' 
is a societal judgement and depended on how the public perceives the risk (Illing 
2001). This would also include taking into account residual risks, such as those not 
evaluated because they have not been identified. Providing that the health risk has 
been fully assessed, the residual risk remaining after implementation of the appropriate 
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management procedures should be at least 'tolerable'. The maJor question 1s 
ascertaining what is 'tolerable'. This area is where policy decisions are made. 
I Data I 1 >I Corpus I 2 ~ Policy 
\ t 3 
. Figure 13 
Use of scientific data for policy purposes 
Figure · 13 illustrates the use of scientific data for policy purposes (Hansson 2002). 
Data originating in toxicological experiments and other observations give rise to 
scientific corpus of information, e.g., complete database for 1080 (arrow 1). In 
developing policy, sufficient scientific corpus of information is normally used (arrow 
2). In the context of protecting public health, however, exclusive reliance on suf~cient 
scientific information may have unwanted consequences. The thalidomide incident is 
a classic example, in which several thousand children were born with serious birth 
defects. When thalidomide was initially tested, no teratogenic effects in rats and mice 
at 4,000 mg/kg were observed. Due to the negative finding, thalidomide was allowed 
to be continuously taken by pregnant women. It was later discovered that limb 
malformations could be produced in certain strains of white rabbits if they were 
exposed during the 8th-16th days of gestation. Several strains of monkeys were also 
found -to be susceptible and gave similar malformations to those seen in humans 
(Timbrell 2000). 
In this study, due to incomplete data currently available on 1080, the evidence would 
not be sufficient to warrant its use solely for the purpose of influencing policies in the 
"standard" way (arrows 1 and 2). However, if toxicological evidence suggests that a 
precautionary approach is warranted, a direct route from scientific data to policies 
(arrow 3) should be applied (called a science-based precaution by Hansson and Ruden 
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2002). This precautionary approach was adopted for the purposes of this study. The 
National Radiological Protection Board (2004) defines "precautionary approach" as a 
scientific term used to describe the cautious process that scientists use when converting 
experimental data into advice on acceptable levels of public exposure to any agent. 
Where data cannot provide a reliable estimate, it is customary to use the most 
conservative estimate of the risk when setting standards. 
The scientific research community and policy decision makers have viewed responses 
to the uncertainty of risk estimations, and its consequences differently (McMichael 
1989). Determining an "acceptable" level of risk entails a complex interaction of 
science, perceptions, values and priorities of different social interests (Steensberg 
1989). "Acceptability" varies with time and place. This can be demonstrated by the 
following scenarios: 
• What was tolerable in the past may no longer be tolerable in the future or vice 
versa. In 1995, the PMAV for 1080 in the DWS NZ was 5 ppb but this was 
subsequently reduced to 3.5 ppb in the 2000 and 2005 editions of the DWS NZ 
· in light of the results from the latest teratology study commissioned by DoC 
andAHB. 
• What may be acceptable in one country may be totally unacceptable in another. 
In the USA, the use of 1080 is limited to livestock protection collars while it is 
legally allowed to be aerially applied in New Zealand. Use of 1080 is restricted 
in many countries, such as the USA because of its effects on native mammals 
and predators during poisoning operations. However possums have no natural 
predators in New Zealand and there are only two native mammals (both bats) 
(NPCA 1994). 
7.8.1 Recommendations made by the Ministry of Health 
The Ministry of Health has encouraged health officials to adopt a precautionary 
approach and use tighter controls on permit conditions governing the use of 1080 
(Durham 1998a, 1998b ). This was as a result of toxicology studies commissioned by 
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the DoC and the ARB which indicated that potential risks from exposure to 1080 were 
higher than previously thought, as discussed in previous chapters. 
This precautionary approach included recommending to Medical Officers of Health 
that they apply the specific model permit conditions relating to drinking-water supplies 
when granting permits for 1080 use in drinking water catchment areas. In addition, the 
Ministry advised Medical Officers of Health to require water sampling for 1080 in 
those affected areas to ensure that contamination levels were below 50% of the PMA V 
set in the . DWS NZ. The Ministry of Health has further advised that 1080 
concentrations above 50% of the' PMA V (i.e., 2 ppb) should not be recommended as 
permissible for human consumption (Durham 1998b ). 
The Ministry of Health has made two recommendations to the Medical Officers of 
Health that could be applied to water catchments used for drinking water. These were 
for alternative situations, to be part of the permit conditions as a precautionary measure 
and that the following conditions given below be part of a 1080 permit. However, 
these conditions were not applied consistently in all localities because they were at the 
discretion of the local Medical Officer of Health (Durham 1998b). 
• A permit exemption should not be granted when applying 1080 in any 
catchment area from which water is drawn for human consumption, 
unless it is possible to avoid use of water from that catchment until the 
chemical analysis of the water demonstrates a level of less than 2 ppb 
and for affected residents to be provided with an alternative drinking 
water source. For example, if there are multiple sources of water 
supply, one source could be segregated from 1080 applications and 
used until the level of 1080 in the water source affected by the 1080 
application is less than 2 ppb. 
• If 1080 is applied in a catchment area which is the only source of 
drinking water, mandatory monitoring of the water supply, to the 
satisfaction of the Medical Officers of Health, is required until tests 
show that the concentration is below 2 ppb. Depending on the 
circumstances ( e.g., the extent to which water from the treated water 
catchment is diluted by other sources), health officials may require that 
an alternative temporary drinking-water supply be available, such as 
bottled water or storage of uncontaminated water by households. This 
could involve notices being issued by regional councils to the 
households in the area prior to 1080 being laid so that water can be 
stored and the public make informed choices. 
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7.8.2 Proposed actions 
The preliminary collection of information provided by the public health units on the 
way 1080 was used in their region (see Appendix 7) demonstrated that all public health 
units grant permits to drop 1080 onto drinking water catchments and appropriate 
conditions are imposed when such permits are granted. In addition, there were 
occasions where 1080 baits were inadvertently dropped onto drinking water 
catchments. Key 1080 issues/incidents brought to the attention of the Ministry of 
Health by the local PHU that were of public health significance are summarised below: 
• The anti-1080 lobby have attempted to provide evidence of the biological 
plausibility validating the linkage between the alleged cluster of miscarriages 
and the aerial application of 1080 in the Tararua ranges. They implied that 
exposure to trace levels of 1080 in drinking water below the detectable limit or 
to 1080 dust led to miscarriages and malformed babies. 
• A 1080 mishap had occurred sometime in 2001. 1080 baits accidentally 
dropped in an area where Takaka residents sourced their drinking water supply, 
resulting in residents being very concerned about the possible contamination of 
their drinking water supply. The 1080 baits were discovered by chance after a 
resident had gone for a walk. 
• An off-target drop of 1080 near Westport was reported to the Ministry of 
Health in 2001. The target area was near Westport but the actual drop occurred 
within the Westport drinking water catchment. Calculations of the worst-case 
scenario suggested that the maximum number of pellets which may have 
entered the water supply was less than 20. Monitoring of the water supply was 
immediately undertaken. In this particular scenario, the results showed no 
detectable levels of 1080 in the water supply as the dilution may have been too 
great for the concentration of 1080 to be analytically measured, i.e., below the 
limit of detection. 
In view of the likely contamination of drinking water, adequate precautionary 
measures should be taken to ensure that health of the general public would not be put 
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at risk. The proposed conditions are similar to those previously recommended (see 
section 7.7.1) and support the precautionary approach adopted by the Ministry of 
Health. The only difference is the suggested maximum allowable concentration of 
1080, i.e., from 2 to 0.60 µgL- 1. The conditions proposed will be at the discretion of 
the delegated person as he/she sees fit to meet local needs. 
In some circumstances, it may be appropriate for the delegated person to apply 
discretion and have less stringent requirements. This could depend, for instance, on, 
• the extent to which drinking-water source area in the catchment has 
been diluted by other sources; 
• the distance between the treatment area and the draw-off point for the 
water supply; 
• water test results from previous operations covering the same catchment 
at the same or greater application rate; 
• method of application of 1080 (ground laying and the use of bait 
stations are likely to involve lower risk of contamination of surface 
water than aerial application). 
7.8.3 Ground application 
1080 aerial application has been a focus of controversy and has been recognised as 
posing greater risk than ground application because the latter is likely to involve lower 
risk of contamination because of the better control of the location of the bait drops. 
There are limited data to assess the effect of ground based 1080 poisoning application. 
WRC (2000) has concluded in its report that following hand broadcasting of 1080 
baits, water samples contained no detectable levels of 1080 and therefore ground-based 
application appears not to have a measurable effect on the quality of drinking water. 
This may likely be due to less quantities of bait entering water courses and thus, less 
stringent requirements may be required for ground application than for aerial 
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application. For example, if a locality has a 1080 water monitoring data available from 
previous treatments, this information could be used to ascertain whether or not the 
level of 1080 may be likely to exceed the proposed PMA V of 0.60 µgL- 1 and further 
water testing may not be required or the numbers and frequency of samples collected 
may be reduced. Any additional requirement would depend on local circumstances 
and will be at the discretion of the delegated person. 
However, it was recognised that ground application was not always appropriate in 
some areas and aerial application may still be the best option to take by the agency 
conducting the operation (Ministry of Health 1995b). Thomas (1994) suggested that 
effective and safer control of possums could be achieved using bait stations containing 
1080. Several advantages of using bait stations include, but are not limited to, 
• the actual amount of 1080 used can be reduced by over 90% from the amounts 
currently used in aerial application; 
• baits can be placed at selected locations so that waterways and public-use areas 
such as roads can be avoided; 
• bait stations are designed specifically for possums, making it difficult for non-
target species to eat toxic bait by placing bait stations in trees out of their reach; 
• unused toxic baits can be removed from the forest. 
7.9 Monitoring 
Water tests 
The agency conducting the operation is responsible for ensuring that water intended 
for human consumption has been tested by a reputable laboratory, such as a laboratory 
recognised by the Ministry of Health for the purposes of examining whether drinking 
water complies with the DWS NZ. This requirement should be included as a condition 
of the permit. 
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The Landcare Research Ltd has prepared a set of guidelines for water sample 
collection and handling (Wright 2007) and it is recommended that these guidelines be 
consulted for demonstration of compliance with the DWS NZ. In addition, NIWA has 
published a report (Suren and Lambert 2004) stating that water samples should be 
collected within 8-12 hours after 1080 operation. 
Because the possibility of run-off into drinking water supply could not be eliminated, 
monitoring would need to be repeated following rainfall. If the level in the water 
supply exceeds the proposed PMA V of 0.60 µgL- 1, an alternative supply may be 
required to be provided. The agency conducting the operation may need to address 
levels of concern from the general public in such circumstances. For example, the 
public should be advised of any forthcoming 1080 operation and that they should store 
drinking water for their use or (free) bottled water could be provided until the 
monitoring results are available to demonstrate the safety of the drinking water supply. 
These requirements would be at the discretion of the delegated person to suit local 
circumstances. 
Figure 14 illustrates the decision flowchart when water sampling would be required. 
However, water sampling would be at the discretion of the delegated person after 




Is 1080 bait proposed to be applied in 
area where water is drawn for human 
consumption? 
Is 1080 bait proposed to be applied by 
aerial or manual techniques? 
no 
manual 
Is it a public or private water 
supply? 
Will bait be applied within 20m of a 
watercourse or abstraction point? 
private 
Is alternative water supply available 
or provided? 
no 
Is historical data available in the 
same or neighbouring catchment 
which demonstrates that similar 
previous poisoning operations did 
not result in any water sample with 
1080 content >0~60µg/L? 
no 
Is 1080 proposed to be applied to 
less than 10% of the catchment 
contributing to the water at the 
abstraction point? 
no 
Is the abstraction point more than 








Guide to water sampling requirements where 1080 is proposed to be applied 
Source: Modified from Ministry of Health 2006 
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The water sampling protocol prepared by Wright (2007) is still recommended for use. 
The protocol states that "samples should be taken immediately after 1080 poisoning 
operations and continue daily until after the first significant rainfall water reaches the 
sampling site. Samples may also be taken before poisoning and from adjacent sites, to 
provide a check on the sampling process." 
The recent study carried out by Suren and Lambert (2004) suggested that water should 
be collected within 8-12 hours after 1080 poisoning operations to detect the presence 
of 1080. This has implications for water sampling programmes that commonly sample 
water 24 hours after an operation. The study showed that the 1080 concentrations 
detected during a fish experiment were "within" the 2 ppb recommended by the 
Ministry of Health. Data extrapolation demonstrated that all the 1080 would have 
leached from the baits by 18 hours (Suren and Lambert 2004). Based from this 
information and on the assumption that drinking water has been contaminated with 
1080, it can be assumed that the 1080 peak concentration occurred is within 24 hours. 
It was also reported by Suren (2006) that the potential number of baits falling into a 
stream cannot be calculated from the bait application rate and the stream size. 
Furthermore, the· distribution of baits in most of the stream was non-uniform. 
Therefore, assessing 1080 water contamination should be done on a case by case basis. 
The findings from previous monitoring programmes (Wright 2007) showed that water 
samples above 1 ppb have occurred in the first two days ( 48 hours) of sampling which 
appeared to be inconsistent with the findings by Suren and Lambert (2004) which 
stated that water samples should be collected within 8-12 hours for 1080 to be 
detectable. It is emphasised that advice should be sought from the local regional 
council hydrologist or a water quality scientist with respect to the choice of water 
sampling times when designing the water monitoring programme. 
Others (meat and milk) 
Contaminated samples would be tested and monitored (if required) as the need arises. 
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7.10 Future research 
From the gaps in information identified, it is considered that additional toxicology 
studies are required to meet the definition of a 'complete database' (Beck et al. 2001) 
( see section 5 .1.1.4) to provide a more sound basis for reviewing or updating the health 
risk assessment as discussed in chapter 5 of this study. This would provide more 
comprehensive data and be the basis of a review of the PMA V of 1080 in the DWS NZ 
and provide a more defensible TDI. These studies should include two systemic 
mammalian studies in two different species, one mammalian multigeneration 
reproductive study and two mammalian developmental toxicity studies in two different 
species. A 14-day teratogenic study has already been carried out by Eason et al. 
(1998, 1999), and it is proposed that another species be tested since two species are 
required for standard toxicology tests. 
An epidemiological study also appears to be warranted to ascertain whether or not 
humans are susceptible to the toxic effects of 1080 at environmental exposure levels. 
An important limitation of epidemiological studies is the difficulty in both detecting 
adverse health effects at low level of exposures and characterising the general 
population. The difficulty in conducting such epidemiological studies is 
acknowledged. 
Laboratory animal data may still be the only available data for extrapolation to 
calculate the human threshold, since a policy that is based on evidence alone, such as 
epidemiological studies, may take decades to be established. Both animal and human 
data (if available) should be carefully analysed and both sets of data may need to be 
used where appropriate. 
The need for additional studies has been supported by Fleury (1995) who has 
suggested that longitudinal studies of any long-term impact of 1080 on communities 
are uncommon despite the fact that this has been an area of public concern voiced by 
protesters and others. If repeated and robust studies can demonstrate that 1080 does 
not give rise to a public health risk, current restrictions imposed by Health authorities, 
for example, may be able to be relaxed. Although the views expressed in the Fluery 
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article have in part been overtaken by events in that additional toxicology studies have 
already been carried out which confirmed that 1080 is a teratogenic, 
testicular/epididymis and myocardial toxin (Eason et al. 2001; Eason and Turck 2002), 
the recommendations remain valid because additional studies are indeed required. 
The challenge in this context is to enable the design of policies that would protect the 
general population, specifically children, against environmental exposures to 1080, to 
improve research and other initiatives whose purpose is to protect children, and to 
ensure that new safeguards consider special risks to children. 
7.11 Discussion 
7.11.1 Key Findings 
The study found that the adult PMAV for 1080 in drinking water is 0.60 µg L-1 which 
is 6-fold lower than the current PMAV in the DWS NZ (in children the derived PMAV 
was 0.23 µg L-1 which is 15-fold lower than the current PMAV in the DWS NZ). The 
Ministry of Health previously recommended that if 1080 is present at 50% of the 
PMA V then continuous monitoring should be carried out until the level of 1080 meets 
2 ppb from drinking water to be considered as permissible for human consumption at 
this concentration (Durham 1998b ). Since the database for 1080 is incomplete, it is 
not possible to develop a policy directly using the available scientific information, i.e., 
arrows 1 and 2. Therefore, it is suggested that the development of policy will be 
derived from the model developed by Hansson (2002), i.e., from scientific data to 
policy (arrow 3) as illustrated in Figure 13. 
Based on the adult PMA V derived from the actual 1080 present ( see section 5 .1.1.3 ), 
the proposed PMAV is 0.60 µg L-1 and 50% of the proposed PMAV equates to 0.30 µg 
L-1• It would be prudent for the Ministry of Health's earlier interim policy to be 
reviewed in light of the findings from this study and utilise 0.30 µg L-1 as the trigger 
requirement for the monitoring for 1080 in drinking water source that may have been 
contaminated. Although it is recognised that exposure to drinking water contaminated 
with 1080 is extremely unlikely to be lifetime (see "tolerable intake" for short-term 
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exposure on page 126), this should be treated with caution due to the fact that 
teratogens exert their biologic damage after only short durations of exposure and also 
on the assumption that it could manifest even after a single exposure (US EPA 1991 ), 
and that the health effects can be lasting and serious. In addition, since the derivation 
of the TDI and PMA V were based from an incomplete database it is of utmost 
importance that this factor should be accounted for in the risk management process. 
It would be prudent to apply a risk management process that will minimise the 
exposure of the susceptible population. The risk management should always include 
the precautionary approach, which is well recognised by a number of authors, such as 
Bodansky (1991), Kriebel et al. (2001), Raffensperger and Tickner (2001) and 
Harremoes et al. (2001 ). At present, it is hardly possible to estimate accurately the risk 
to humans from the data that are currently available on 1080. Case studies by 
Harremoes et al. (2001) have demonstrated that there are valid reasons to adopt the 
precautionary approach and acknowledge and respond to the uncertainty and potential 
risk that may result. In this case, these are the adverse toxic effects of 1080, which 
should be taken into account in policy decision-making process. 
It would appear, therefore, that the findings from this study might have implications 
for public health since the PMA V estimated was 6-fold lower than the current PMA V 
in the DWS NZ. The findings may also have significant impact in relation to the risk 
management process in the context of a lower permissible level of 1080. However, it 
appears that only a small proportion of the population may be affected by this finding. 
People whose drinking water source comes from a reticulated water supply or in any 
drinking water supply where, historically, no detectable levels of 1080 were measured 
because of significant water dilution that has occurred may not be affected and this 
group accounts for the majority of the population. 
However, it is acknowledged that there are some rural households that draw drinking 
water from local streams or personal reservoirs, and are not connected to domestic 
reticulated systems. People on unreticulated surface water, e.g., personal reservoirs 
will need to be accounted for since they could potentially access higher concentrations 
than any other group, because the water dilution factor would be much lower (see 
exposure scenarios in 5.1.1.2). 
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The risk management process proposed in this study was not considered onerous and 
is, in fact, very similar to the risk management protocols currently in place as 
recommended by the Ministry of Health (see sections 7.7.2 and 7.8). Mandatory water 
sampling may need to be required after 1080 aerial application or in any 1080 
operation where drinking water may have been contaminated. The monitoring should 
continue until the 1080 concentrations found from the water tests are below the 
requirement for Priority 2 determinands in the DWS NZ. The recommendations are 
consistent with the Ministry of Health's precautionary approach until additional 
information is made available and further health risk assessment is carried out and the 
proposed PMA V can later be reviewed. The proposed actions are already in place 
(with minor modifications) at the discretion of the delegated person. 
7.11.2 Water monitoring 
Fisher and Eason (2003) reported that previous water monitoring programmes carried 
out in New Zealand between 1990 and 2003 after 1080 aerial applications showed that 
1080 concentrations complied with the 2 ppb recommended by the Ministry of Health 
as suitable for human consumption. No detectable levels of 1080 were found in 
reticulated water while significant and prolonged 1080 contamination was not evident 
in surface waters. Only five percent of over 1450 water samples tested found 1080 
close to the limit of detection (Eason 2002a; He Korero Paihama 2001) and these 
levels were transient and associated with the visible presence of baits in small streams. 
The 1080 levels ranged from 0.2 to 9 µg L-1 (see Appendix 1). 
In certain areas, 1080 levels were above the 2 ppb, such as, in Marlborough Sounds, 
Erua State Forest, Te Whaiau Spillway, Toko, and Te Kopia Scenic Reserve 
(Appendix 1 ). The report did not specify which water samples (if any) were collected 
from drinking water catchments. It appears that since there were water samples where 
1080 residues were higher than others, it would not be appropriate to use the mean 
level in the exposure assessment, because using the mean value would underestimate 
the likely exposure of those who live in areas where 1080 water levels were high. 
Hence in line with the precautionary approach, 4 ppb was used in the exposure 
assessment. 
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The number of samples taken in each operational area was unclear (Appendix 1). For 
example, there were 125 water samples taken in 1993 in Mt. Taranaki resulting in 15 
samples that contained 1080 residues but only four samples taken in 1995 in the 
Waimakariri with only one sample showing 1080 residues at 0.2 ppb; and four water 
samples in the Waitohu Stream taken in 1996 with no detectable levels of 1080. It 
appeared that from the water data, the limited number of water samples taken in some 
areas as described above may not provide sufficient data to establish conclusively that 
a specific drinking water catchment had historical water 1080 data that meet the 
Ministry of Health's interim policy measure of 2 ppb. It should be borne in mind that 
water contamination should be assessed on a case by case basis. 
In the early 1990s, the analytical limit of detection for 1080 was 0.3 ppb (this value is 
50% of the proposed PMA V) which means that some of the water samples tested may 
have had levels of 1080 that may have required monitoring as required for Priority 2 
determinands had the proposed PMA V of 0.60 ppb from this study been the basis of 
such a requirement. The limit of detection improved to 0.1 ppb from 1995 when 
advances in instrumentation provided much improved sensitivity (G.Wright pers. 
comm. 2005). 
The water sampling from 1990 to 2002 may have also been based on a 24-hour 
sampling period acqwding to the protocol written by Wright (1998). Suren and 
Lambert (2004) reported that water sampling should be carried out within 8-12 hours 
after 1080 operation but not later than 24 hours to be able to test for the presence of 
1080. Therefore, the time difference may explain the reason why 95% of the water 
samples showed no detectable levels of 1080. 
It can be argued that despite the fact that water samples were tested within the 24-hour 
period, 1080 levels were still detected. The highest level found in surface water was 4 
ppb (Fisher and Eason 2003) suggesting that 1080 does not biodegrade within such a 
short period of time as suggested by Suren and Lambert (2004). In fact, Wright (1998) 
stated that water samples containing above 1 ppb occurred during the first two days 
(i.e., 48 hrs) of sampling. 
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Results of water testing could be used to reassure the public of the safety of the 
programme, as well as individual householders of the safety of their water supply. 
Monitoring 1080 in water supplies also provides benefits for regional councils and 
other agencies, particularly from a public risk perception approach. Appendix 9 shows 
the survey carried out by this author (NF) in relation to public perception of risk from 
the use of pesticides and 1080. Over time, the monitoring records can be used to 
evaluate whether there needs to be the same level of ongoing monitoring in the future 
(G. Durhampers. comm. 1999). 
To demonstrate compliance, the agency conducting the operation must provide the 
delegated person with water monitoring data showing compliance with the Ministry of 
Health's interim policy measure on 1080 of 2 ppb. Samples must have been analysed 
by a laboratory recognised by the Ministry of Health for the purposes of examining 
drinking water. Compliance can be demonstrated by the following factors and it 
would be at the discretion of the delegated person. 
• continued monitoring8 is required if the level of 1080 is more than 50% of 
thePMAV; 
• water dilution is so great that the level of 1080 is at or below the limits of 
detection; 
• based on historical information of a particular water supply as complying 
with the Ministry of Health's interim policy measure of 2 ppb. 
The PCE report (1994) considered that 1080 was a contaminant. However, DoC has 
taken the view that the scientific evidence of the effects of 1080 when it enters water 
does not support classifying 1080 as a "contaminant" for the purpose of RMA because 
the impact is so minimal as to be outside the scope of the definition (PCE 1994). 
Based on the assumption that the PCE's interpretation is correct, then discharge 
permits must be obtained if 1080 could enter water sources unless there are rules made 
8 Continuous compliance monitoring is defined as the process of measuring and recording a defined chemical 
property by taking frequent measurements, using an electronic monitoring device specifically designed for the 
purpose, to prove the values of the measured property meet the requirements of the DWS NZ. 
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under the regional plans classifying the use of 1080 as a permitted activity. This 
activity is particularly relevant in cases where 1080 baits are aerially applied. 
However, if 1080 aerial application is a permitted activity in the resource consent of a 
local authority, then this poisoning operation is not notifiable. This non-notifiable 
activity has raised concerns to the general public living in the vicinity of 1080 aerial 
application (M. Molloy pers. comm. 2003). 
Definition of Water Supplies 
Public water supply 
The working definition of public water supplies for the purposes of the Hazardous 
Substances.(Vertebrate Toxic Agents) Transfer Notice 2004 and Hazardous Substances 
(Sodium Fluoroacetate) Transfer Notice 2004, is: 
"all water supplies that are not to self-supplied buildings are classed as public water 
supplies". 
According to the Water Supply Protection Regulations 1961, a "public water supply" 
means any mode, system, or works for the collection, supply, and distribution of 
wholesome drinking water in any district by a local authority or by any person or 
persons authorised by any enactment to undertake the supply of such water to the 
public. The WSP Regulations definition effectively means that the only water supplies 
that are public supplies are ones owned by local authorities. However, using the WSP 
Regulations definition would leave a significant portion of the population unprotected 
by the provisions of the vertebrate toxic agent consent conditions. It is suggested that 
a public drinking-water supply serving 25 people or more should give written 
permission/s. However this is up to the discretion of the delegated person/s. 
Private water supply 
A private water supply is simply one that is privately owned (i.e., it is not used for 
profit). The Ministry understands that identifying private water supply sources is 
standard practice for more rural operations. 
188 
7.11.3 1080 model permit conditions 
The Ministry of Health published the model permit conditions (Appendix 6) initially to 
provide assistance to the Medical Officers of Health. The Ministry of Health has not 
established rigid guidelines for the conditions applied by the Medical Officers of 
Health as such conditions need to take account of the local situations relating to use of 
the land and surface water in the area, the nature and control of the operations and 
consultation with interested parties locally. There are many factors affecting the 
concentrations of 1080 along the pathway to the consumer which will reduce the 
likelihood· of 1080 reaching drinking water or will reduce the final concentration of 
1080 in drinking water. Some of these factors could depend, for example on its water 
solubility or biodegradation, significant water dilution, and weather conditions. 
It is recognised in the 1080 model permit conditions (Ministry of Health 1995b, 
Appendix 6) that during wet and warm conditions the bait may disintegrate rapidly. 
Bait breakdown is dependent on the amount of rainfall as 1080 is highly soluble in 
water. Biodegradation takes longer under dry and cold conditions because there will 
be little biological activity to breakdown the structure of the bait. Since 1080 
operations are carried out during the winter months, 1080 baits may disintegrate at a 
slower rate especially during dry conditions. 
Delegated persons are expected to use their specialist professional judgment and local 
community knowledge in deciding what conditions are appropriate for each individual 
application. The model permit conditions are still applicable and can be used as 
appropriate (Appendix 6). The requirements under the Pesticides (VPC) Regulations 
were deleted as they have been superseded by the requirements under the HSNO Act. 
There is still considerable concern regarding potential danger to non-target species, 
either directly or through secondary poisoning. It is known that secondary poisoning 
occurs with 1080 but it remains a poorly understood problem, largely because of lack 
of an appropriate laboratory analysis for 1080 or its toxic metabolites in animal tissue 
where background fluoride readings may be high (Calver and King 1986). To reduce 
secondary poisoning, the model permit conditions require that the agency conducting 
the operation is required to inspect all rural/domestic water supply streams and 
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publicly visible sites in the area of the operation and where feasible collect all 
carcasses from places where they may put public health at risk. 
7.11.4 Implications for the Medical Officer of Health 
Under the HSNO Act, the Medical Officers of Health retain their role in granting 1080 
permits. In addition, the delegation has been extended to include qualified Health 
Protection Officers. However, in addition to granting permits when 1080 is applied in 
,drinking water catchments the Medical Officers of Health's role has been broadened 
covering "any other area where public health risk may be created". This requirement 
applies whether or not the land is being managed by DoC9• As a guiding principle, 
"any other area where.public health·risk may be created" may include those restricted· .· 
areas specified under the Pesticides (VPC) Regulations such as a public road, or places 
where the public are entitled to have access. The delegated person would have to use 
their professional judgment· to · establish what other areas would fall under this 
category. 
Given that the delegated person is empowered to amend, add or waive conditions to a 
permit that has been previously granted, any problems or issues that may have been 
encountered by them during 1080 operations can be dealt with by incorporating 
additional or modify existing conditions to protect public health. In addition, this 
power also gives them the flexibility to address local needs. 
Amending the HSNO Act giving the ERMA the power to delegate certain functions to 
Medical Officers of Health and qualified Health Protection Officers was an important 
step towards improving the workability of the HSNO Act. 
7.11.5 Susceptible population 
Living in areas where dilution of water is not so great, pregnant women or women of 
childbearing age, or the general public, including children because of their unique 
susceptibility may be potentially exposed to the adverse effects of 1080. Children may 
9 DoC was also delegated by the ERMA to grant 1080 permits on DoC land. 
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also be at greater risk of accidental poisoning despite warning signs because they are 
still unable to read and understand the hazards of 1080. Parents or caregivers need to 
be vigilant in not letting children gain access in areas where 1080 baits have been 
applied. Regular washing of children's hands is also important. Contamination of 
surfaces or toys may arise from parents or any member of the household handling 
1080, e.g., in preparation of baits or directly involved in 1080 operations. 
7.11.6 Exposure due to contaminated meat and milk 
Exposures from contaminated meat and milk were rare events but may still be 
considered as a public health issue especially in situations where exposures of animals 
concerned were unknown. In New Zealand where the use of 1080 is extensive, there is 
need for strict supervision during its use, and livestock should not be allowed access to 
grazing land known to contain 1080 baits. Responsible management is necessary to 
reduce risks likely to arise from 1080 poisoning. 
The risks which milk may impose would be manifested in areas where cows, for 
instance were milked and consumed by the general public. In this scenario, the milk 
remains undiluted and the concentration of 1080 would be high and may be of public 
health significance. This exposure pathway must also be taken into account although it 
may not affect a significant number of the population. Farmers must be notified and 
their consent be sought if their farm would be affected by the poisoning operation. If 
the owner agreed that such operation could take place, adequate precautionary 
measures should be taken to avoid any poisoning taking place. 
To avoid residues in food, it would be prudent to impose a minimum withholding 
period of five days to achieve an adequate margin of safety. In cases of death 
attributed to 1080, the withholding period should be doubled to ten days for the 
surviving stock and the livestock be moved to pasture that has not been treated with 
1080 (Rammell 1993). Similarly, it would appropriate to ensure that residues are not 
present in meat harvested for human consumption (Eason et al. 1996) and that a 
similar margin of safety of at least ten days applies. This source of exposure could be 
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relevant to hunters and other members of their household who sourced their meat from 
hunting and others to whom they may have given the meat. 
NZFSA (2005a) has also advised that wild or game estate animals should not be taken 
from an area where 1080 has been laid until four months after 1080 aerial poisoning 
operation or two months after the operation has completed and after 100 mm of rain. 
7.12 Conclusion 
Policy makers should consider developing and implementing strategies to manage and 
protect public health from the potential adverse effects of 1080. If public health 
strategies can be designed and implemented to reduce overt exposure to 1080 to a level 
that is tolerable for most vulnerable subgroups in a population, the entire population 
will be protected. Through these ineans, health risk assessment can reduce, although 
not entirely eliminate, the uncertainties involved and it can aid decision makers in 
identifying those areas where research is most needed. The data gaps identified in this 
study represent the main barrier to the advancement of the common understanding of 
the consequences of 1080 to human health. Hence, filling these data gaps is crucial to 
be able to develop sound policy advice. 
There are currently regulatory systems and guidelines in place but New Zealand is not 
yet in a position to confidently conclude that there is negligible risk involved and that 
the health effects described by concerned members of the public, such as fetal 
malformations, increase in miscarriages (see Appendix 7) are not in any way related to 
1080 exposures. 
The PMAV for 1080 in the DWS NZ is currently 3.5 ppb and from the findings of this 
study it could be considered that a lower PMA V is appropriate, reflecting concerns 
about the causal link between 1080 and teratogenicity, testicular/epididymis and 
myocardial effects in toxicological studies. Because there are no epidemiological 
studies to date and the toxicology data are inadequate, as discussed in previous 
chapters, a lower PMA V appears to be warranted as a precautionary approach. The 
PMA V may be revised in the future based on fmdings that decrease uncertainties in 
quantifying risk for the drinking water route of exposure. 
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This precautionary measure may involve compliance costs as the agency conducting 
the operation is required to sample water catchments that have been contaminated with 
1080. However, this requirement is already in place, and hence there are no 
additional/new costs to the agencies involved. Hood et al. (1992) stated that forecasts 
would only be of relevance if they can be communicated to those who are in a position 
to take action to avoid or mitigate the risk. 
The findings from this study do not suggest the complete restriction of 1080 use as it 
recognises the importance to agricultural and environment sectors of the need for 
sustained efforts in controlling possums in New Zealand. However, the protection of 
the health and sa;fety of the general public must be of paramount importance in light of 
the adverse effects of this compound. In the absence of data to the contrary, it is 
prudent to assume that humans and animals are equally sensitive to 1080. 
7.13 Recommendation 
• Since the Provisional Maximum Acceptable Value for 1080 found in this study 
is lower than the current Provisional Maximum Acceptable Value in the 
Drinking Water Standards New Zealand 2005, it would be prudent for the 
Provisional Maximum Acceptable Value for 1080 in drinking water to be 
reviewed. This study does not recommend that the Provisional Maximum 
Acceptable Value should be derived from child parameters data without 
carrying out any further investigation. 
• The precautionary approach should be adopted until a more comprehensive 
data set are made available and in turn, to reduce the uncertainties in 
developing the Tolerable Daily Intake and consequently the Provisional 
Maximum Acceptable Value. The difficulty in conducting proper 
epidemiology studies is acknowledged. However, it is inappropriate to 
conclude that such adverse effects may be irrelevant to humans as no such 
study has been carried out to refute the conclusions made in animal toxicology 
studies. 
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• A national geocoded record of drinking-water catchments treated with 1080 
should be developed. To accomplish this, the local public health units should 
keep a record of all the drinking-water catchments where a permit has been 
granted and this information collected at the national level by the Ministry of 
Health. This information would be important, for any future enquiry 
concerning 1080 drinking-water contamination. 
• Further research should be carried out with respect to 8-12 hours sampling as 
suggested by Suren and Lambert (2004) as their results are inconsistent with 
the findings of Wright (1998) where water samples above 1 ppb 1080 were 
detected in the first two days ( 48 hours) of sampling. 
• The use of Digital Global Positioning System should be made mandatory as 
part of permit conditions. 
• The water sampling criteria should be clearly defined in the water protocol, 
e.g., the number of water samples that should be collected for analyses. In 
addition, Digital Global Positioning System readings should be recorded where 
water samples were taken. 
• Modelling studies, similar to Wright et al. (2002) would be useful in estimating 
1080 contamination arising from bait laying operations and could therefore 
provide information with respect to reducing 1080 contamination for future 
1080 operations. 
• It has been found that 1080 workers contain urine 1080 levels exceeding the 
Biological Exposure Index and this finding was supported by the postal survey 
conducted by this author (NF) that vehicle contamination may potentially be a 
likely route of exposure (see Appendix 8a). Monitoring could include wipe 
samples of the vehicles. Because members of their household could be 
potentially exposed to 1080 they should also be included as part of the 
biological monitoring. The biological monitoring could be incorporated as part 
of the Department of Labour's study on 1080. 
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• An epidemiological study examining health parameters including reproductive 
and cardiac effects of 1080 in workers and their families would be useful in 
adding to the human health profile of 1080. 
• There has been an inconsistency ~etween the Parliamentary Commissioner for 
the Environment's and the Department of Conservation's interpretation on 
what would constitute a "contaminant" with respect to 1080 aerial application 
under the Rerource Management Act. The Ministry for the Environment 
should clarify this situation to avoid any dispute in future. 
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Appendix 1. Water analysis after major 1080 operations 1990-2002 
Location Date Total no. of samples No. with Highest 
taken in operation residues concentrations (µg/L 
area or nub) 
Waipoua 1990 36 0 -
Rangitoto 1991 20 0 -
Blackstone Hill 1992 23 11 0.6 
Mt Taranaki 1993 125 15 <0.3 
Woodside 1993 55 0 -
HunuaRange 1994 136 7 0.7 
MtTaranakj 1994 63 0 -
Marlborough 1994 26 5 3.4 ,. 
Sounds 
Wairarapa 1994 31 0 -
Hawke'sBav 1994 15 0 -
Ohak:une 1994 6 1 0.2 
Whangarei 1994 18 0 -
Karioi 1994: 10 1 0.8 
Manawatu 1994 21 0 -
w aimakariri 1995 4 1 0.2 
Manawatu 1995 · 48 0 -
Hawke'sBay 1995 8 1 0.3 
Ohak:une Erua 1995 3 0 -
Forest 
Tongariro 1995 8 0 -
National Park 
Northland 1995 11 0 -
Tararua Ranges 1995 11 0 
Hawke'sBay 1995 9 0 -
Waimarino 1995 4 0 -
Forest 
Wairarapa 1996 7 0 -
Pirongia 1996 7 0 -
Rauk:umara 1996 37 1 0.2 
Ranges 
Waikato 1996 4 0 -
Levin Buffer 1996 8 0 -
Erua State Forest 1996 3 1 3.5 
Waitohu Stream 1996 4 0 -
Wairokau Stream 1997 4 0 ... 
Rauk:umara 1997 12 0 -
Ranges 
Ohak:une 1997 10 0 -
Pareroa River, 1997 2 0 -
Timaru 
Rangataua Forest 1997 40 0 -
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Appendix 1. Continued 
Location Date Total no. of No. with Highest 
samples taken in residues concentrations 
operation area (u.g/L or nub) 
Te Whaiau Spillway 1997 3 1 2.4 
Rauk:umara Ranges 1997 9 1 0.5 
East Cape 1997 12 0 -
Warawara Forest 1997 4 0 -
Mt Bruce/Mikimiki 1998 10 0 -
Mawheraiti, West Coast 1998 1 0 -
Kuharua 1998 1 0 -
Manawatu-Wanganui 1998 6 0 -
Toko 1998 3 2 9* 
Wairarapa 1998 8 0 -
Manawatu-Wanganui 1998 8 0 -
West Taieri Stream 1998 4 0 -
Hook Bush, Timaru 1998 2 0 -
Haurangi Crown 1998 6 0 -
Northland 1998 9 0 -
Otorohanga, te Tahi 1998 3 0 -
Ahuroa/Maungatoroto 1998 2 0 -
Levin Buffer 1998 2 0 -
Lawrence/W aitahuna 1998 8 0 -
Northland 1998 5 0 -
Masterton 1998 6 0 -
Richmond 1998 9 0 -
Porangahau 1999 3 0 -
Northland 1999 7 0 -
Waipoua Forest 1999 1 0 -
WaipaRiver 1999 2 0 -
Holdsworth/Woodside 1999 3 0 -
Manawatu-Wanganui 1999 2 0 -
Hawke Hills 1999 2 0 -
Warawara Forest 1999 1 0 -
Waima 1999 2 0 -
Riwaka Forest 1999 2 0 -
Eastern Tararua R. 1999 7 0 -
Takaka 1999 6 0 -
AmuriRange 1999 1 0 -
Hawkins River 1999 1 0 -
Wakamarama 1999 15 0 -
Northland 1999 8 0 -
Wainuiomata 1999 26 0 -
Aorere 1999 2 0 -
Hauturu/Honikiwi 1999 2 0 -
Otorohanga 1999 1 0 -
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· Appendix 1. Continued 
Location Date Total no. of No. with Highest 
samples taken in residues concentrations 
operation area (u2/L or ppb) 
W ainuiomata 1999 25 0 -
Pembroke Wilderness 1999 6 0 -
Aorere 1999 6 0 -
Rotomanu 1999 2 0 -
Kaiiwi 1999 4 0 -
htland Paparoa 1999 12 0 -
Te Kopia Scenic Res. 1999 10 2 4.0 
Marlborough 1999 1 1 0.2 
Tapu River/Te Mata Str. 1999 7 0 -
Te Kopia Scenic Res. 1999 1 0 -
Benhopai 1999 1 0 -
Eastern Tararua R 1999 4 0 -
Hauhungaroa Range .1999 8 0 -
Hampden, Herbert 1999 14 0 -
Manawatu-Wanganui 1999 2 0 -
Waingawa 1999 1 0 -
Tapanui 1999 1 0 -
Murupara 1999 1 0 -
Manawatu-Wanganui 1999 1 0 -
Wairarapa 1999 20 0 -
Rotorua 2000 1 0 -
Northland 2000 9 0 -
Tapanui 2000 1 0 -
Manawatu-Wanganui 2000 2 0 -
Kaikoura 2000 7 0 -
Marlborou!!h 2000 2 0 -
Banks Peninsula 2000 1 0 -
Gisbome 2000 3 0 -
Copland 2000 1 0 -
Richmond 2000 5 0 -
Greymouth 2000 2 0 -
Manawatu-Wanganui 2000 2 0 -
Aorere 2000 7 0 -
Tak.aka 2000 7 0 -
Richmond 2000 2 0 -
Richmond 2000 2 1 0.5 
Manawatu-Wanganui 2000 6 0 -
Napier 2000 2 0 -
Taupo 2000 1 0 -
OmakaRiver 2000 2 0 -
Copland Valley 2000 1 0 -
Tak.aka 2000 1 0 -
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Appendix 1. Continued 
Location Date Total no. of No. with Highest 
samples taken in residues concentrations 
operation area (u~/L or ppb) 
Whirinaki 2000 1 0 -
Ohara Stream 2000 1 0 -
Waitohu 2000 4 0 -
Waiotemarama 2001 1 0 -
Wanganui National P. 2001 1 0 -
Kapitea Creek, Westland 2001 2 0 -
Otira 2001 5 0 -
Waihopai Valley 2001 8 0 -
Mt. Thomas 2001 6 1 0.3 
Wairarapa; 2001 1 0 -
Taupo 2001 1 0 ·-
Northland 2001 5 0 -
Hokitika 2001 2 0 -
Wairarapa 2001 3 0 -
Taupo 2001 1 0 -
Hokitika 2001 2 0 -
Tennyson Inlet 2001 2 0 - ,.· 
Aorere 2001 3 1 0.2 
Buller 2001 9 0 -
Takaka 2001 3 0 -
Mangarakau 2001 2 0 -
South Motueka 2001 8 0 -
Kahurangi National P. 2001 2 0 -
Marlborough 2001 1 0 -
Mid-Motueka Valley 2001 2 0 -
Waihopai Dam 2001 2 0 -
Canaan, Golden Bay 2001 2 0 -
Uooer Takaka 2001 7 0 -
Canaan, Upper Takaka 2001 11 0 -
Levin 2001 3 0 -
Waihopai Dam 2001 2 0 -
Mangatawhiri Stream 2001 1 0 -
Canaan 2001 4 0 -
Rangiora 2001 2 0 -
Takaka 2001 1 0 -
Pureora Forest 2001 4 0 -
Manawatu-Wanganui 2001 6 0 -
Masterton 2001 4 0 -
Gisbome 2001 4 0 -
Waingawa River 2001 2 0 -
Cobb Valley 2001 2 0 -
Waiohine, Waingawa 2001 7 0 -
Greymouth 2002 1 0 -
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Appendix 1. Continued 
Location Date Total no. of No. with Highest 
samples taken in residues concentrations 
operation area (u.g/L or nub) 
Masterton 2002 4 0 -
Waikato River 2002 6 0 -
Wanganui 2002 1 0 -
Taupo 2002 1 0 -
Trilby Creek, West 2002 1 0 -
Coast 
Taupo 2002 1 0 -
West Coast 2002 8 0 
Whisky Gulley, Otago 2002 1 0 
Palmerston North 2002 1 0 
Taupo 2002 1 0 
Herbert/Hampden 2002 8 1 0.8 
Waipori Falls, Otago 2002 2 0 
Motuihe Island 2002 5 0 
Pleasant Flat, West 2002 1 0 
Coast 
MtTaranaki 2002 8 0 
Golden Bay 2002 8 0 
Mt Grey 2002 12 2 1.0 
Hamilton 2002 1 0 
.Nelson 2002 1 0 
Hamilton 2002 3 0 
Waiohine River 2002 2 0 
Golden Bay 2002 10 0 
Totals 1465 57 
Source: Eason (2002) 
* Enquiries by Landcare Research's senior chemist identified that the sample had been collected by 
a worker with 1080 dust on his overalls and hands 
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(1080) using dichotomous toxicity data 
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Abstract 
The use of a benchmark dose (BMD) as an alternative to a no-observed-adverse-effect-level (NOAEL) approach was investigated as a 
means to improve current risk assessment values of sodium monofluoroacetate ( 1080). The feasibility of implementing the two approach-
es was investigated for three critical toxicological end points, namely cardiomyopathy, testicular toxicity and teratogenic effects identified 
from the few available critical studies. The BMD provides better representation of the dose-response relationship, offering an advantage 
over the current NOAEL approach. The calculated BMDs and lower-bound confidence limits (BMDLs) for the three end points were 
estimated using the Weibull, pro bit and quantal linear models for each end point. All models passed the x2 test statistics (p ;?- 0.1) for all 
three toxicity endpoints tested. A benchmark response (BMR) of 10% (extra risk) was chosen and the Akaike's information criterion 
(AIC) was used in selecting the appropriate model. The BMDL estimates derived were found to be generally slightly higher but compa-
rable to the NOAEL for those same endpoints. The BMD10 and BMDL10 for cardiomyopathy and testicular effects were 0.21 mg kg- 1 
bw and 0.10 mg kg-1 bw, respectively. These values are proposed for use in the eventual determination of the tolerable daily intake (TOI) 
for 1080. 
© 2006 Elsevier Inc. All rights reserved. 
Keywords: Benchmark dose; NOAEL; 1080; Cardiomyopathy; Testicular; Teratogen; TDI 
1. Introduction 
It has been suggested by Crump (1984) that dose-re-
sponse modelling, i.e., the benchmark dose (BMD) 
methodology rather than the traditional no-observed-
adverse-effect-level (NOAEL) approach should be generally 
applied to systemic toxicity. Dose-response modelling is a 
commonly accepted method of estimating the response asso-
ciated with a given exposure. However, not all human obser-
vations (if available) or animal experiments are amenable to 
BMD modelling (Crump, 1995), forinstance, if there is a bio-
• Corresponding author. Fax: +64 4 495 4479. 
E-mail address: Natalia_foronda@moh.govt.nz (N.M. Foronda). 
0273-2300/$ - see front matter © 2006 Elsevier Inc. All rights reserved. 
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logically significant increase in a rare malformation where it 
was found to be not statistically significant. 
It is well-known that the NOAEL does not necessarily 
show that there is a zero risk dose below a threshold dose. 
Gaylor (1992) showed, for example, in a review of develop-
mental toxicity studies, that the estimated risk of stillborn 
or resorbed or malformed fetuses ranged from 0% to 
4.5% at the NOAEL. The true risk of exposure at the 
NOAEL can often vary from 0% to >20%, depending on 
the background variability of endpoints, spacing of doses, 
and numbers of animals used, or alternatively it could be 
manyfold lower than a true population threshold (Leisen-
ring and Ryan, 1992; Gaylor, 1992; Renwick and Walker, 
1993). This could particularly be the case if the effect mod-
elled was an adaptive change and not necessarily adverse. 
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Therefore, the NOAEL is not the same as the biological 
threshold and may underestimate or overestimate the true 
no-effect level (Renwick and Walker, 1993). 
The BMD approach has been used in recent years as an 
alternative approach for calculating the tolerable daily 
intake (TDI) to avoid the shortcomings associated with 
the NOAEL (Crump, 1984). It has gained wide acceptance 
in carrying out health risk assessment and has been fre-
quently used by various regulatory agencies, such as the 
US EPA and the WHO (Fowles et al., 1999). The BMD 
approach uses all of the experimental data to fit one or 
more dose-response curves. In using the NOAEL 
approach to calculate a TDI, the only data point used is 
the NOAEL (Gaylor et al., 1998). The BMD approach is 
not restricted to experimental NOAELs/LOAELs but also 
makes use of dose-response data and sample size. The TDI 
is similar in definition and intent to terms such as the ref-
erence dose (RID) or reference concentration (IPCS, 
1994) and uses the same uncertainty factors as are used 
in the derivation of the TDI/RfD. 
The BMD is the dose (Barnes et al., 1995) calculated to 
be associated with an increase in the response ( called the 
BMR) (Gaylor, 1992) for a given incidence (e.g., 5% or 
10% incidence) of effect estimated from all toxicity data 
on that effect within the study (Crump, 1995). The BMD 
is assigned a lower confidence limit (BMDL) and is used 
as the point of departure in determining the TDI. The 
use of the BMDL has encouraged more statistically rigor-
ous experiments to be conducted to obtain tighter confi-
dence limits resulting in higher TDI values (Gaylor, 1996) 
and is therefore more accurate. 
The BMR is a response level used to define a BMD. For 
quanta! responses, the BMR is expressed in terms of a per-
cent increase in risk of adverse outcome compared with 
background. The BMR is typically set at the lower end 
of the range of responses (e.g., 10% or 5% change) that 
can be detected experimentally. Currently, there is no scien-
tific rationale for preferring a 5% or 10% effect level, and it 
appears that selection of one over the other would have 
minimal effect on the derived TDI in most cases (Barnes 
et al., 1995). For the purposes of this study, a BMR of 
10% was used in calculating the BMD. This 10% value is 
consistent with the 10% BMR suggested by the US EPA 
(2003). 
The purpose of this paper is to evaluate and use the 
BMD approach in the context of the adverse effects of 
1080. 1080 is one of the most toxic vertebrate agents known 
and it has been proven to be effective in controlling pos-
sums (Trichosurus vulpecula). It has been used in New Zea-
land for several decades and its use continues to cause 
controversy to the general public. New Zealand is the only 
country in the world with a "possum problem". Uncon-
trolled possum populations are a direct threat to vulnerable 
areas of the conservation estate and the diversity of New 
Zealand's flora and fauna. In addition, possums are the 
major wildlife host of bovine tuberculosis which is New 
Zealand's main animal health problem. New Zealand is 
the largest user of 1080 in the world using approximately 
80% of the world's production of manufactured 1080 
(PCE, 1994). A clear understanding of possible risks to 
the environment was suggested by Parfitt et al. (1994) as 
being essential, since more than 3.2 tonnes of 1080 is 
applied annually. In other countries, 1080 is also being 
used, but in relatively small quantities. 
In this study, the BMD approach, which involves fitting 
a mathematical model to toxicological dose-response data, 
is examined as an alternative to the use of a NOAEL. The 
BMD and BMDL estimates are calculated from pivotal 
studies available in published literature. In this analysis, 
three models are used and the fits of the models to each 
of the critical toxicity end points are determined. BMD 
estimates providing the best model fit are compared to cor-
responding NOAELs using statistically derived uncertainty 
factor. Conclusions with respect to the use of these models 
for BMD calculations for 1080 are provided. 
2. Methods 
A thorough literature review of relevant published articles was under-
taken. The data collected were subsequently analysed to determine 
whether or not the studies were relevant for the purposes of health risk 
assessment. Only studies characterising a non-lethal effect in appropriate 
test species were considered for further analysis. 
A comprehensive review of the relevant animal data revealed that the 
studies of Eason et al. (1999) and Eason and Turck (2002) provide the 
most appropriate studies for risk assessment and were chosen as the piv-
otal studies. Sprague-Dawley rats, about 6 weeks of age, were dosed with 
1080-treated water at 0.025, 0.075 and 0.25 mg kg-1 by oral gavage for 90 
days. Findings at necroscopy ( date of terminal sacrifice not specified) 
included severe hypospermia of the epididymis and severe degeneration 
of the seminiferous tubules of the testes in male rats dosed with 
0.25 mg kg- 1 day- 1• It was confirmed that recovery from testicular dam-
age did not occur even after 56 days without treatment. Increases in heart 
weight when compared with controls were reported. No effects were noted 
in the lower dose groups. Cardiomyopathy was only seen in 50% ( 10/20) of 
males dosed with 1080 at 0.25 mg kg- 1 day-1 and 5% (1/20) female rat, 
suggesting a gender difference. The NOAEL for both the testicular and 
cardiomyopathy was 0.075 mg kg-1 day-1. For the teratogenic effects, 
the critical study (Eason et al., 1999) confirmed that 1080 caused develop-
mental defects in rats when pregnant females were exposed to 0.10, 0.33 
and 0.75 mg kg-1 day- 1 of 1080 diet by the oral route on a daily basis dur-
ing the period of organogenesis (from days 6 through to 17 of gestation). 
The highest dose (0.75 mg kg-1 day-1) showed irreversible limb abnormal-
ities and the next highest dose (0.33 mg kg-1 day- 1) showed reversible rib 
defects. A NOAEL was reported at 0.10 mg kg- 1 day-1. 
The toxicological end points for which the dose-response relationship 
was best characterised were the developmental (Eason et al., 1999), repro-
ductive, and myocardial toxicities observed in the subchronic study in rats 
by Eason and Turck (2002). Whittem and Murray (1963) drew a similar 
conclusion that the heart was the most susceptible organ to pathologic 
lesions, while Sullivan et al. ( 1979) considered testis as the organ most vul-
nerable to the toxic effects of 1080. 
Table 1 shows the critical effects, the NOAELs and the LOAELs, and 
experimental doses of I 080 in experimental animal tested for the critical-
toxicity end points. 
For the data investigated, three models were employed to provide a 
range of BMD estimates using the US EPA BMDS version 1.3 software 
(2001). The models were used to calculate the BMDLs for the quanta! 
response variables at the 95% lower confidence limit and 10% level of extra 
risk. These models are summarised with their respective mathematical 
equation below as adopted from the US EPA (1995). 
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Table I 
Summary of critical quanta! end points and effects arising from 1080 exposure in rats 
Critical Endpoint Parameter Experimental dose Critical Effect 
Teratogenicity" NOAEL 0.10 mg kg-1 bw day-1 Malformations-irreversible forelimb malformations 
LOAEL 0.33 mg kg-1 bw day-1 
Testicular toxicity b NOAEL 
LOAEL 
0.075 mg kg-1 bw day-1 
0.25mgkg-1 bwday-1 
Severe hypospermia in epididymis, severe degeneration 
of seminiferous tubules of the testes 
Myocardial toxicitl NOAEL 
LOAEL 
0.075 mg kg-1 bw day-1 
0.25 mg kg-1 bw day-1 
Cardiomyopathy 
a Eason et al. (1999). 
b Eason and Turck (2002). 
Quanta! linear P(d) = c + (I -c) x {1 - exp[-ql x d]} 
Weibull P(d) = c + (I - c) x {1 - exp[-ql x dk]} 
Logprobit P(d) = c + (1 - c) x F(a +bx ln(d)), 
where F(x) is the cumulative normal density function, 
F(x) = 1/2[1 +erf(x/sqrt(2))] 
US EPA (2003) recommended a minimum goodness of fit p value of 
p = 0.1 for model acceptance. The goodness of fit of the model was deter-
mined using the chi-square (x2) test. For the purposes of this investigation, 
a p value from the chi-squared test of <0.1 was set as the rejection level for 
the test hypothesis of adequate modelling. p values from chi-squared test 
for each model were obtained using the US EPA BMDS software. Models 
that met the default statistical criteria for adequacy and visually fit the 
data were retained in determining the BMD10s and the BMDL10s. 
Akaike's information criterion (AIC) was considered for comparison 
among models and selection of the model for BMD and BMDL calcula-
tions. The AIC values were obtained using the US EPA BMDS software. 
AIC can be calculated using the equation 
AIC = -2logL+2p, 
where L is the value of the likelihood function at the maximum-likelihood 
estimates (MLE) for the parameters, and p is the number of parameters 
estimated in the model (Sand et al., 2002). Although the AIC does not 
reach a conclusion about "statistical significance" and does not "reject" 
any model, it determines how well the data supports each model. Lower 
AIC values were preferred according to this procedure for estimating 
the BMD and the BMDL (Sand et al., 2002). The model with the smallest 
AIC value was selected among all plausible models and this criterion was 
used for final model selection. 
The BMDL1oS calculated for each model were compared to one anoth-
er and to the statistically defined NOAELs. 
3. Results 
3.1. Test of goodness-of-fit 
All models used in the analyses met the x2 test criterion 
as shown in Table 2 and no model was rejected, except for 
the Weibull model of cardiomyopathy in female rats. 
3.2. Model performance 
The AIC values for the dose-response models used in 
the study are listed in Table 3. Analysing the overall model 
performance of various models, the three models gave 
comparable AIC values. If the BMDL estimates were with-
in a factor of 3, they were considered indistinguishable, and 
the model with the lowest AIC was selected to provide the 
BMDL (US EPA, 2003). Since the BMD was chosen within 
Table 2 
Goodness-of-fit tests for quanta! models for various toxicity end points at 
95% confidence limit with BMR of 10% 
Toxicity end point Probit Quanta! linear Weibull 
p value0 
Epididymisb 0.5211 0.5495 0.3213 
Testicularb 1.0 0.4105 1.0 
Cardiomyopathl 
Male 1.0 0.4105 1.0 
Female 0.5929 0.5971 d 
Teratogenic effects8 0.9337 0.1297 0.9892 
a Eason et al. (1999). 
b Eason and Turck (2002). 
c p vali.Je from x2 test at <0.1 is the rejection level. 
d Rejected model (unable to run the data using the Weibull model). 
Table 3 
Model performance for quanta! ·models for various toxicity end points 
Akaike's information criterion (AIC)0 
Toxicity end point Probit Quanta! linear Weibull 
Epididymisb 51.5434 51.773 53.2315 
Testicularb 31.7259 34.6013 31.7529 
Cardiomyopathyb 
Male 31.7259 34.6013 31.7259 
Female 21.4352 21.4528 d 
Teratogenic effects8 48.125 53.3508 47.9442 
a Eason et al. (1999). 
b Eason and Turck (2002). 
c AIC is the statistical measure of how well the model fit the data. 
d Rejected model. 
or near the experimental dose range, it was relatively insen-
sitive to the choice of the dose-response model, and an ade-
quate fit to the most of the experimental data was achieved 
with all models (Gaylor et al., 1998). 
The parameters of the dose-response models were esti-
mated by the maximum likelihood estimates. Details of 
the AICs are shown in Table 3. 
3.3. Calculation of BMD10s and BMDL10s 
As can be seen, the BMD10s were typically only slightly 
higher than the BMDL10s (Table 4). For the purposes of 
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Table 4 
Modelling results with quanta! endpoints at a 10% response rate (BMD) and its lower 95% confidence limit (BMDL} 
Critical end point BMD mg kg-1 BMDL mg kg-1 
Weibull Quanta! linear 
Forelimb malformations8 0.45 0.23 
Testicular effectsb 0.22 0.05 
Epididymisb O.o7 0.04 
Cardiomyopathyb 
Male 0.22 0.05 
Female C 1.83 
a Eason et al. (1999). 
b Eason and Turck (2002). 
0 Rejected model. 
this study, the point of departure for BMD modelling for 
quanta! end points is the BMDL associated with 10% 
BMR. 
The BMD approach generates a slope term, which is a 
new parameter not available in the NOAEL approach. It 
has been recognised that the slope could provide significant 
information to the assessor. Most likely the threshold is 
more quickly approached with steep dose response curves 
than shallow slopes, all other items being equal. 
For the purpose of this investigation, the slope was tak-
en to be the slope term ql, where the x-axis is the dose and 
the y-axis corresponds to the number of animals respond-
ing adversely. A dose-response curve is fitted to the exper-
imental data and the lower confidence limit on the dose 
corresponding to the BMR10 is obtained. This dose repre-
sents the estimate of the dose that produces a 10% increase 
in risk in the context of this paper. Thus, the BMDL10 is 
the lower confidence limit of the dose that gives a 10% 
excess in abnormal responses above the spontaneous back-
ground level. 
The NOAELs and LOAELs, and BMD10s and 
BMDL10s slopes for various critical quanta! end points 
are shown in Table 5. The probit model was used in deriv-
ing the BMD10s and the BMDL10s for testicular, epididy-
mis, male and female cardiomyopathy, and the Weibull 
model for teratogenicity based on AIC criteria. Fig. 1 dem-
onstrates the dose-response curves for 1080 and the models 
chosen to fit the data at 95% confidence limit and BMR of 
10% on various critical effects identified. 
Table 5 
---------------
Probit Weibull Quanta! linear Probit 
0.48 0.30 0.15 0.36 
0.21 0.07 O.o3 0.11 
0.09 0.03 0.03 0.06 
0.21 0.07 0.03 0.10 
0.89 C 0.20 0.21 
The BMD10s and BMDL10s calculated for each model 
were compared to one another and to the NOAELs (Table 
5). The BMDL10s for all quanta! end points, using the best 
fit models, were about three times higher than the NOA-
ELs for female cardiomyopathy and teratogenicty; and 
almost the same for the other end points. Given that the 
BMDL10 estimates from the three models were within a 
factor of 3, except for epididymis which had the lowest 
BMDL10 (Table 4), they were considered to show no 
appreciable model dependence and were considered to be 
indistinguishable in the context of the precision of the 
methods. The results were consistent with that of Gaylor 
et al. (1998). 
For all critical end points a dose-response trend was 
observed. The probit model demonstrated steeper slopes 
for testicular and male cardiomyopathy while shallower 
slopes were observed for epididymis, female cardiomyopa-
thy and teratogenicity compared with the other toxic effects. 
The NOAELs established for critical end points were 
0.075 mg kg-1 bw day-1 for testicular effects and cardio-
myopathy and 0.1 mg kg-1 bw day-1 for teratogenicity 
(Table 5). 
4. Discussion 
Based on a comprehensive review of literature consid-
ered to be relevant to human health risk assessment, this 
study found that the critical effects arising from 1080 
exposure were testicular/epididymis, myocardial toxicity 
NOAEL and LOAEL values and dose-response slopes with corresponding BMD10 and BMDL10 values from various quanta! end points 
Toxicity end point NOAEL mg kg-1 LOAEL mg kg-1 ql Slope term BMD10 mg kg-1 BMDL10 mg kg-1 BMD Model (best fit) 
Epididymisb O.o75 0.25 6.83 0.09 0.06 Probit 
Testicularb 0.o75 0.25 31.73 0.21 0.11 Probit 
Cardiomyopathy b 
Male 0.o75 0.25 31.73 0.21 0.10 Probit 
Female 0.o75 0.25 0.88 0.89 0.21 Probit 
Teratogenicity" 0.10 0.33 1.42 0.45 0.30 Weibull 
a Eason et al. (1999). 
b Eason and Turck (2002). 
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Fig. 1. Illustration of benchmark dose BMD) with corresponding models for 1080 critical data (A) Testicular and male cardiomoypathy (Probit model). 
(B) Epididymal effects (Probit model). (C) Female cardiomyopathy (Probit model). (D) Teratogenic effects (Weibull model). 
and teratogenicity. The BMD approach utilised in the 
study demonstrated that the BMDL10s for the quantal 
end points were generally slightly higher (but comparable) 
to the corresponding NOAELs for those same endpoints. 
In the pivotal studies, test animals were exposed via the 
oral route and NOAELs were established for all the critical 
toxicity end points. All of the studies have at least one dose 
level above the NOAEL. In comparing the three quantal 
models (Table 2), all models passed the goodness of-fit-test 
although in most cases the Weibull and probit models gen-
erally provided a better fit to the data. A difference noted 
between the first two models and that of quantal linear 
was with the latter usually producing the more conservative 
BMD10/BMDL10, i.e., two to fourfold lower in all end 
points investigated (Table 4). The probit model provided 
the best fit to testicular and male cardiomyopathy data 
and was chosen in estimating the BMDL10 for the determi-
nation of TDI. The quanta! linear model was not chosen, 
although it provided the lowest BMDL10, because it pro-
vided the worst fit among the models tested. 
Model performance (Table 3) was analysed and the AIC 
values obtained for the three models were comparable. 
Gephart et al. (2001) suggested that the strength of the 
BMD methodology is that different models that properly 
fit the data should give similar BMD estimates for the same 
data set. The findings from this study generally concur with 
this notion, as the choice of dose response model had little 
effect on the estimated BMD10. There was a little difference 
in BMD10s results between models with a similar fit. Fur-
thermore, the same authors· claimed that if models were 
of equally good fit, then different models should give simi-
lar BMD estimates for the quanta! data. Again, this notion 
was supported by this study (Table 4). In this sense, the 
results of this investigation support the argument made 
by Crump (1984) that model choice is not a critical factor 
for BMD estimation because model-based extrapolation to 
low doses is not required. 
The BMD is dependent upon the slope of the dose-re-
sponse. For effects that have the same NOAEL, the effect 
with the steeper dose-response will have a higher BMD 
(Gephart et al., 2001). Given that the data have the same 
NOAEL and different slopes, the BMD is likely smallest 
with shallower slope (M. Dourson, personal communica-
tion, 2005). This statement is particularly true in relation 
to epididymis exhibiting a shallower slope and a lower 
BMD10 compared with testicular and male cardiomyopa-
thy with steeper slopes and higher BMD10s (Table 5). How-
ever, the statement conflicts with the observation that the 
slopes of the dose-response curves for cardiomyopathy in 
females are smaller than that of cardiomyopathy in males 
and testicular effects, but the BMD10s for cardiomyopathy 
in males and testicular effects are smaller than those for 
cardiomyopathy in females. The reason for this apparent 
discrepancy is that the relationship between the slopes 
and BMDs for different effects with similar NOAELs 
depends on the location of the BMR. If the BMR is below 
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the response at the LOAELs, then the effect with the steep-
est slope will likely have a higher BMD, while if the BMR 
is above the response at the LOAEL, the shallower slope 
will likely yield a higher BMD. 
Fowles et al. (1999) indicated that less severe and frank 
effects tended to exhibit shallower and steeper probit 
slopes, respectively. This statement concurs with this inves-
tigation where testicular and male cardiomyopathy showed 
steeper slopes and shallower slopes for less critical effect, 
namely epididymal pathology. A major difference was also 
observed with respect to the susceptibility of males and 
females with the myocardial toxicity of 1080, males being 
more susceptible. 
Gaylor et al. (1998) pointed out that when no clear dose 
response is obtained and/or the BMD is calculated to be 
above the highest experimental dose level, use of the 
NOAEL might be more appropriate for setting a TDI. 
The BMD 10 for female cardiomyopathy was higher than 
the LOAEL, 0.89 mg kg-1 bw and 0.25 mg kg-1 bw, 
respectively so it may be more appropriate to use the 
NOAEL as a point of departure in this particular situation 
(Table 5). Fowles et al. (1999) and Gaylor (1996) suggested 
that the BMD should be below the observable LOAEL if it 
is to represent a point of departure for risk assessment. The 
BMDL10 was 0.21 mg kg-
1 bw which was lower than the 
LOAEL. The BMD10 for teratogenicity (0.45 mg kg-
1 
bw) was also higher than the LOAEL in the study 
(0.33 mg kg- 1 bw). Although the BMD10 exceeds the 
LOAEL for female cardiomyopathy, the BMDL10s are 
consistently below the LOAELs for the other toxic end 
points, and the BMDL10 is recommended in deriving the 
TDI for health risk assessment. Also, Barnes et al. (1995) 
suggested that it was not realistic to assume that implemen-
tation of the BMD approach would end the use of the 
NOAEL approach because there will always be data sets 
that cannot be evaluated using the BMD approach. Hence, 
the NOAEL approach should be used where appropriate. 
In summary, for quantal end points the BMDL10s gen-
erated were generally slightly higher but comparable points 
of departure to the NOAEL approach. The BMD10 and 
BMDL10 for male cardiomyopathy and testicular effects 
of 0.21 mg kg- 1 bw and 0.10 mg kg-1 bw, respectively pro-
vide more meaningful and more statistically sound bases 
for establishing a TDI for the human health risk assess-
ment for 1080. 
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Abstract 
This paper presents the development of a tolerable daily intake (TDI) for sodium monofluoroacetate (1080) using the quanta! myocar-
dial and testicular toxicity end points derived from the traditional NOAEL and newer benchmark dose (BMD) methods. 1080 is a highly 
toxic vertebrate pesticide that has been proven to be effective in controlling possums and other pests. By convention, the TD Is are derived 
using the traditional no-observed-adverse-effect-level (NOAEL) and applying appropriate default uncertainty factors (UF). In addition 
to the default UF, a statistically derived UF was also employed in deriving the TDI. The TDis derived from the NOAEL and BMD 
approach, 0.075 and O.lOmg/kg bw/day, respectively, were compared. The resulting TDI estimates using the BMDL, a statistical lower 
confidence bound on the BMD, were generally consistently slightly higher than those derived using the NOAEL approach. Based on the 
best fit of modelled dose-response data, a TDI of0.03 µg/kg bw/day is proposed for human health risk assessment of 1080. 
© 2006 Elsevier Inc. All rights reserved. 
Keywords: Sodium monofluoroacetate (1080); Tolerable daily intake (TDI); Cardiomyopathy; Testicular effects; BMDL; NOAEL 
1. Introduction 
Compound 1080 (sodium monofluoroacetate) is one of 
the most toxic vertebrate agent known. Its principal use in 
New Zealand is to control possums (Trichosurus vulpecula), 
and to contain the spread of tuberculosis to livestock such 
as cattle and deer herds. However, despite its effectiveness, 
over several decades in New Zealand, its ·iise continues to 
cause controversy amongst the general public reflecting the 
uncertainty associated with its use and potential for long-
term effects on human health. 
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In one notable instance, the Mangapeka Educational 
Trust and 1080 Action Group in Golden Bay expressed 
concern about the teratogenic/reproductive effects of 1080. 
In addition, Takaka Area residents were angry when 1080 
was mistakenly dropped in an area where they source their 
drinking water. Eason et al. (1993) suggested that the long-
term use of 1080 needs to be further studied because of the 
continuing controversy concerning its use, fate in water, 
and effects on non-target species, especially livestock and 
invertebrates. 
An extensive published database exists on the fate of 
1080 in the environment and effects on non-target species. 
However, some of the toxicological and metabolic data 
generated between the 1950s and the 1970s are out of date 
and would not meet current registration standards. Of note, 
one of the major gaps in knowledge surrounding 1080 is its 
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potential toxicity upon chronic low-dose exposure, and 
subsequent long-term effects on human health. 
New Zealand uses approximately 80% of the world's 
production of manufactured 1080 (PCE, 1994) amounting 
to 3.2 tonnes of raw product in the period 1 July 200 I to 30 
June 2002 (DoC and AHB, 2003). 
The majority of public concerns about possum control 
operations relate to the possible contamination of drinking 
water supplies with 1080, resulting from aerially sown baits 
falling into streams. This route of contamination fuels an 
ongoing debate concerning the potential toxicological 
effects of the use of this chemical in the environment. Inter-
est in the potential toxic effects of 1080 has resurfaced as a 
result of the latest findings from the animal toxicology 
studies commissioned by the DoC and the AHB, where 
1080 was found to be teratogenic, a male reproductive toxin 
and a myocardial toxin in rats (Eason et al., 1999; Eason 
and Turck, 2002). 
This paper evaluates available relevant toxicological 
data that may assist in human health risk assessment. 
Except for acute poisonings, no human data are known to 
date and the derivation of TDls in this study is based on 
subchronic studies due to the absence of chronic studies. 
Pivotal studies with critical toxicological endpoints are 
selected from a comprehensive literature review. TDls are 
derived using the traditional NOAEL approach and the 
BMD methodology and applying the conventional deriva-
. tion of uncertainty factors (UF) and a statistically derived 
UF. The TDls developed are compared and conclusions 
made with respect to the appropriateness of the TDI for 
human health risk assessment. 
2.Methods 
Relevant laboratory studies were analysed with respect to their ade-
quacy for human health· risk assessment. Studies on the possible adverse 
effects of 1080 from repeated exposures were limited, and the few chronic 
studies done have employed relatively high doses (e.g., sub-lethal doses), 
and/or unusual routes of administration, such as intraperitoneal injection 
and therefore may not be applicable to human exposures via ingestion, 
inhalation or dermal absorption. However, Chenoweth (1949) suggested 
that there was no striking difference between non-percutaneous routes of 
exposures on the resulting toxic effects of 1080, i.e., whether it was adminis-
teyed orally, subcutaneously, intramuscularly, intraperitoneally or intrave-
nously, noting Chenoweth (1949) that this phenomenon was uncommon in 
the field of pharmacology. It is unknown whether this observation would 
Table 1 
Summary of data used to calculate benchmark doses 
Endpoint 
Teratogenesis (irreversible forelimb malformations)" 




• Eason et al. (1999). 







apply to humans and therefore, studies of any route directly relevant to 
human exposures, were reviewed and assessed. 
The TDI is similar in definition and intent to terms such as reference 
dose (RID), reference concentration (RfC) and acceptable daily intake 
(IPCS, 1994). TDI is an estimate of the daily exposure to humans that is 
likely to be without appreciable risk of deleterious effects during a lifetime 
of continuous exposure. The derivation of a TDI involves identifying the 
critical effect(s), and selecting the pivotal study, the point of departure, and 
appropriate uncertainty factors (UFs). 
Traditionally, the no-observed-adverse-effect-level (NOAEL) is the 
primary basis for the scientific evaluation of the risk posed to humans 
from systemic toxicity (Barnes and Dourson, 1988). The BMD approach 
has been proposed as an alternative approach for calculating TDis to 
avoid the shortcomings associated with the NOAEL (Crump, 1984, 1995). 
A BMD is the dose (Barnes et al., 1995) calculated to be associated with an 
increase in the response, called the Benchmark Response (BMR) (Gaylor, 
1992) (e.g., 5% or I 0% incidence of the critical effects identified). The BMD 
is assigned a lower confidence limit (called the BMDL) when used to 
determine the TDI. The parameters used to estimate the benchmark doses 
are shown in Table 1. 
3. Results 
3.1. Identification of critical effect 
3.1.1. Effects on testes 
Reduction in plasma testosterone concentrations and 
degeneration of seminiferous tubules were observed in liz-
ards exposed to repeated sublethal doses equivalent to 100 
and 200mgkg-1 day-1 for 15 days (Twigg et al., 1988). 
Savarie (1984) and Eisler (1995) also observed that 1080 
exposures resulted in testicular damage. Sullivan et al. 
(1979) considered that the testis was the organ most vulner-
able to 1080 poisoning. Overt signs of toxicity were 
observed in rats after 7 days exposure to 1080. These effects 
included decreased testicular weight, morphological dam-
age to the testes, degeneration of seminiferous tubules, and 
altered spermatogenesis. 
Severe damage of the testes, characterised by massive 
disorganisation of the seminiferous tubules, nearly total 
loss of functional cells, absence of sperm, and damage to 
the Sertoli cells were reported by Smith et al. (1977) in rats 
exposed for a period of approximately four months to 
26 ppm of 1080 in drinking water. Regressive modifications 
of the seminiferous tubules were observed by Mazzanti 
et al. (1965) in the testes of albino rats. Minks suffered 
severe impaired reproduction presumed to be due to oligo-
or aspermia, or spermatopathy after dietary exposure to 
Doses (mg/kg bw/day) 
0.025 O.D75 0.10 0.25 0.33 0.75 
0/26 1/26 11/26 
0/10 0/10 10/20 
0/10 2110 10/20 
0/10 0/10 10/20 
0/10 0/10 1/20 
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0.80 ppm of 1080 for two months (Hornshaw et al., 1986). 
Necrosis in spermatids, probably resulting from rapid and 
severe adenosine triphosphate (ATP) depletion, and apop-
tosis in spermatogonia from gradual and partial ATP 
depletion, was observed in Sprague-Dawley rats after a sin-
gle oral dose of l.Omgkg-1 (Shinoda et al., 2000). Severe 
hypospermia of the epididymis and severe degeneration of 
the seminiferous tubules of the testes in male rats dosed 
with 0.25mgkg-1 day by oral gavage for 90 days were 
reported by Eason and Turck (2002). It was confirmed that 
recovery from testicular damage did not occur even after 56 
days without treatment. 
3.1.2. Myocardial toxicity 
Rammell (1993) and Eason et al. (1994) claimed that 
cumulative damage to the heart or other organs from 
repeated exposure to large sublethal doses of 1080 can 
occur in sheep (Ovis aries). Smaller doses of 1080 given at 
regular intervals produced cumulative effects (Annison 
et al., 1960) and resulted in myocardial damage in sheep, 
probably due to increased accumulation of citrate in the 
heart. The cumulative effect of 1080 has been noted in other 
species, such as the mouse and the rat. This has been attrib-
uted largely to slow renal clearance of fluoroacetate 
(Chenoweth, 1949). Sheep were affected differently from 
rats in that further doses following the initial administra-
tion of 1080 proved to be fatal. Rats were able to tolerate 
non-fatal dose of 1080 for the next 24-36 h following fur-
ther administration of 1080. This finding appeared to sug-
gest that larger animals are affected differently than smaller 
animals. However, there has been little reliable information 
on 1080's action and toxicity in the larger domestic animals 
(Annison et al., 1960) and therefore the observed differences 
could not be directly compared. Whether or not elimination 
mechanisms in larger animals, such as sheep, are relevant to 
humans has remained unknown. 
Acute multifocal injury to the myocardium, after 
1080 doses as low as 0.11 mgkg- 1 day for 3-7 days, were 
observed in several research studies carried out in Aus-
tralia (Eason et al., 1994). Whittem and Murray (1963) 
demonstrated mild but characteristic cardiac histopa-
thology in sheep dosed with 0.055 mg kg-1 day of fluoro-
acetate by stomach tube, and typical cardiac 
histopathology at 0.11 mg kg-1 day. Similar acute myo-
cardial lesions were found in the hearts of sheep and 
guinea pigs treated with potassium fluoroacetate. Whit-
tern and Murray (1963) suggested that the most suscepti-
ble target organ is the myocardium as revealed by the 
pathologic lesions. 
Eason and Turck (2002) noted increases in heart weight 
in both male and female Sprague-Dawley rats when com-
pared with controls. The test animals were treated with 
1080 in drinking water at doses of 0.025, 0.075, and 
0.25 mg kg-1 day by the oral route for a period of 90 days. 
No effects were noted in the lower dose groups. Cardiomy-
opathy was seen in 50% (10/20) of males dosed with 1080 at 
0.25mgkg-1 day-1 and 5% (1/20) female rat, suggesting a 
gender difference. The NOAEL for rats was reported to be 
0.075mgkg-1 day-1 by the same authors. 
3.1.3. Developmental toxicity ( teratogenic effects) 
De Meyer and De Plaen (1964) found that 1080 adminis-
tered intraperitoneally on the 9th day of pregnancy in rats 
at a dose of 600 µg had caused eye anomalies, syndactylia, 
and evisceration. A more recent study by Eason et al. (1999) 
confirmed that 1080 caused teratogenic effects in rats. The 
highest dose (0.75mgkg-1 day-1) showed irreversible limb 
abnormalities and the next highest dose (0.33 mg kg-1 
day-1) showed reversible rib defects. A NOAEL was 
reported at O.lOmgkg-1 day-1. 
Whittem and Murray (1963) concluded that the heart 
was the most susceptible organ to pathologic lesions while 
Sullivan et al. (1979) considered the testes as the organ most 
vulnerable to the toxic effects of 1080 poisoning. Eason 
et al. (1999) and Eason and Turck (2002) reported well 
characterised dose-response relationships for developmen-
tal (short-term exposure), reproductive, and myocardial 
toxicities after subchronic exposures. Testicular and myo-
cardial effects are considered the most critical effects arising 
from 1080 exposures and represent the basis for the TDI. 
3.2. Selection of pivotal study 
A review of the few available critical studies revealed 
that the studies of Eason et al. (1999) and Eason and Turck 
(2002) provided the most appropriate studies for risk 
assessment as they were more recent, of good scientific 
quality, followed international OECD Guidelines, used 
recognised Good Laboratory Practice (GLP) and were able 
to establish NOAELs for critical effects in sensitive target 
organs. Therefore, these studies were chosen as the pivotal 
studies. 
There were no available chronic exposure studies for any 
route of exposure in any species. Therefore, potential toler-
able concentrations for exposures were calculated using 
subchronic studies with application of appropriate uncer-
tainty factors. 
3.3. Point of departure 
The dose-response relationship provides a basis to infer 
a point of departure. Systemic (non-cancer) toxicity is usu-
ally assumed to have thresholds below which no effects 
occur (IPCS, 2000). For these toxicities, safety assessments 
are carried out with the establishment of TDis seen as 
doses below these thresholds. The threshold concept led to 
the logical conclusion that exposure to substances at doses 
below the threshold was safe and therefore acceptable. 
From this concept, guidelines and standards to protect 
public health were developed. 
The use of the BMDL has lead to improved experiments 
conducted to obtain tighter confidence limits, resulting in 
higher TDI values (Gaylor, 1996). In benchmark analysis, 
the BMDL is used as the principal criterion for regulatory 
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purposes. Therefore, the use of the BMDL as the point of 
departure was also explored in this study. 
3.3.1. Estimation of BMDs and BMDLs 
Foronda et al. (2006) investigated the use of a BMD as 
an alternative to a NOAEL approach to improve current 
risk assessment for 1080. The calculated BMD 10s and 
lower-bound confidence limits (BMDL10s) at 95% lower 
confidence bound on dose for cardiomyopathy, testicular, 
and teratogenic effects were estimated using the Weibull, 
probit and quantal linear models based on their model 
performances for each end point. The Pearson X2 test 
(U.S. EPA, 1995) was used to assess the fit of the models 
to the observed dose-response data. All models met the 
X2 test except for Weibull model for the cardiomyopathy 
in female rats since this model could not use these data. 
Analysing the overall model performance of various mod-
els, the three quantal models gave comparable Akaike's 
information criterion (AIC) and the model with the low-
est AIC was chosen to estimate the BMD. The probit 
model was used in deriving the BMD10s and BMDL10s for 
all the end points except for the teratogenic effects, while 
the Weibull model was chosen using the AIC criterion. 
The BMD10s and the BMDL10s were estimated using the 
US EPA BMDS version 1.3 software (U.S. EPA, 2001) for 
the corresponding models chosen according to the AIC. 
BMDL10s were calculated using the maximum likelihood 
method. The BMD10s were typically only slightly higher 
than the BMDL10s. A BMDL10 at its lower 95% confidence 
limit of O.lOmgkg-1 bw-1 had been used to derive the TDI 
for 1080 (Foronda et al., 2006) and this value was adopted 
for the purposes of this study. 
3.4. The use of uncertainty factors (VF) 
An UF is a mathematical expression of uncertainty that 
is used to protect populations from hazards which cannot 
be assessed with high precision [International Programme 
on Chemical Safety (IPCS, 1992)]. Dourson et al. (1996) 
believed that the use of the UF approach to risk assessment 
was justified on the rationale that low dose risks remain 
largely unknown for both carcinogens and non-carcino-
gens. The application of an UF is also seen as a use of scien-
tific judgment about low-dose exposures and risks. 
3.4.1. Rationale of UFs applied in estimating the TD! 
• A default factor of 10 (VA) is used to take into account 
the interspecies variation. For example, the toxicokinetic 
and toxicodynamic differences between humans and rats 
(the test species used in the pivotal study) are not known 
as no relevant data exist for 1080 in humans, although 
based on lethal effects, rodents might be as sensitive, or 
perhaps more sensitive, than other mammals such as 
humans. 
• An uncertainty factor of 10 (U8 ) is used to account for 
intraspecies differences (i.e., human variability) in 
response to toxic chemicals. This UF was introduced to 
protect sensitive individuals within a population. Age, 
sex, genetic composition, nutritional status, and pre-
existing diseases may all alter susceptibility to toxic 
chemicals. To be assigned a factor of less than 10, a 
chemical must have more than just an adequate, peer 
reviewed human database (Abernathy et al., 2003). 
Information on toxicokinetics and toxicodynamics 
variability in humans would also be useful for consid-
ering an uncertainty factor other than the default value 
of 10. 
• An UF of 10 (Us) was used to account for the use of 
data from a subchronic study as a surrogate for results 
from a chronic study. This UF appears to be warranted 
based on the evidence that prolonged exposure (21-126 
days) to 1080 in the drinking water of laboratory rats 
caused depletion of spermatids, formation of spermatid 
and spermatocyte giant cells, and seminiferous tubule 
atrophy (Smith et al., 1977). Exposure to 1080 for two 
months severely impaired the reproduction of mink, 
which was presumed to be due to oligo- or aspermia 
(Hornshaw et al., 1986). 
In addition, subchronic 90-day tests still have their limi-
tations with regard to human health hazard assessment 
since exposure takes place only for a certain period 
[approximately 10% of the lifetime (Kroes, 1995)]. The 
length of this period may not necessarily be sufficiently long 
enough to reveal chronic effects, since the substance may 
produce different toxic responses when administered 
repeatedly over a long period of time, and the ageing pro-
cess may alter tissue sensitivity, metabolism or physiologi-
cal capability. Moreover, spontaneously occurring diseases 
may also influence the degree and nature of the effect of the 
substance. 
3.4.2. Database uncertainty factor ( Un) 
In relation to completeness of the overall database, the 
Beck et al. (2001) definition of a "complete database" was 
applied. Beck et al. (2001) suggested that when the database 
is limited, there is uncertainty as to whether the identified 
NOAEL might be significantly lower if other studies were 
performed, or whether a different NOAEL might have been 
identified if additional health endpoints had been evalu-
ated. A complete database was defined by Beck et al. (2001) 
as having: 
• two systemic toxicity mammalian studies in different 
species; 
• one mammalian multigeneration reproductive study; 
and 
• two mammalian developmental toxicity studies in differ-
ent species. 
(This is also consistent with the registration require-
ments of agrichemicals in the USA, Canada, Europe, and 
Japan). 
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If these five studies are available, and if clear thresholds 
can be identified from them, then there is a high degree of 
confidence that one has approximated an appropriate point 
of departure. Unfortunately, no mammalian multigeneration 
reproductive toxicity study on 1080 exists to date. Moreover, 
only one species has been tested (i.e., rats) with regard to tera-
togenicity whereas two species are normally required for tox-
icological evaluation. In this case, professional judgment is 
required to determine the appropriate value taking into 
account the scientific uncertainties of the studies and the 
overall database. A U0 of 3 is judged to be reasonable based 
on the availability of part of, but not the "complete data-
base". The use of a 3-fold factor here, instead of a default 
value of 10, is also consistent with current practice (Dourson, 
1994) in that the use of more than 3 areas of uncertainty with 
default values of 10 leads to overly conservative estimates of 
TDI (or RfDs). The common practice is to use only a 3-fold 
factor for the 4th area of uncertainty and an additional 3-
fold factor for a 5th area of uncertainty. Alternatively, the 
uncertainty factors other than for interspecies and intraspe~ 
cies variability can be viewed as all related to general data-
base deficiencies and the overall factor for this area is 
between 1- and 100-fold (IPCS, 1994). 
The U.S. Food Quality and Protection Act (FQPA) pro-
vides a new extra IO-fold safety factor to be added after the 
determination of the TDI to fully ensure that infants and 
children are protected (U.S. EPA, 1996). The additional 
safety factor under the FQPA is largely policy-based and 
not driven by scientific findings (Scheuplein et al., 2002). It 
has been recognised by both U.S. EPA and others (U.S. 
EPA, 2002; Fenner-Crisp, 2001; Dourson et al., 2002), that 
part of this safety factor overlaps with the database uncer-
tainty factor discussed earlier, and that when the database 
factor is employed properly, no need exists for the toxicity 
component of the FQPA factor. Based on this rationale, no 
additional safety factor is proposed to be incorporated for 
children's increased susceptibility beyond that already 
incorporated to account for human variability. 
Combined, the overall UFs and U0 that are proposed to 
be used in deriving the TDI for 1080 is 3000 (i.e., 
10*10*10*3). The USEPA is currently using a cumulative 
maximum of 3000 UF in its risk assessment (Kodell and 
Gaylor, 1999; U.S. EPA, 2002). 
Table2 
Estimated upper percentiles of distributions of uncertainty factors 
The IPCS (1994) have recognised the imprecision of the 
cumulative default factors and in order to maintain credi-
bility of the risk assessment process, IPCS has suggested 
that the total default UF should not exceed 10,000. If the 
risk assessment leads to a higher factor, then the resulting 
TDI would be so imprecise as to lack meaning. 
3.4.3. Use of statistically derived UF 
The objective of combining UFs is to provide a way to 
obtain an estimate of an upper percentile, say 95th, of the dis-
tribution of the response to the product TDI, 
UH x U A x Us x U0 , that will be sufficiently protective of the 
general population but not overly conservative (Kodell and 
Gaylor, 1999). Table 2 provides the estimated upper percen-
tiles of distributions of the individual UFs compiled from 
information in Kodell and Gaylor (1999) with some unknown 
and/or unspecified rationale for the distribution function. 
The formula for UHAS gives a combined UF that is less 
conservative (but almost similar) than the conventional 
approach of simply multiplying together a set of UFs. 
Kodell and Gaylor (1999) stated that it is appropriate to 
use a larger percentile than the 95th percentile, but to still 
use a point estimate. Due to the limited information avail-
able, in particular the relevance of severe toxic end-points 
to humans, a more conservative approach appears to be 
warranted. Hence, the 99th percentile is proposed for the 
purposes of this study. 
As can be seen in Table 2, the default maximum factor of 
3000 recommended by the U.S. EPA for four factors 
approaches the estimated 99th percentile. There were three 
UFs (UHAS= 998) in this study plus an extra factor of 3 to 
take into account the incompleteness of the database. Since 
Kodell and Gaylor (1999) did not include database uncer-
tainty factors in their analysis, Ui:1As will simply be multi-
plied by the U0 of 3, bringing the total UF to 2994. 
3.5. Derivation ofTDis using the NOAEL approach and the 
BMD methodology 
In general, TDis are used to provide information on 
potential long-term toxic effects (Bender, 2002). Toxicity 
risk assessment currently relies on the estimation of TDls 
based on the use of the NOAEL or BMDL divided by the 












• Maximum conventional value for two uncertainty factors. 













1000 X 3 = 3000c 
d Maximum value for three uncertainty factors [with some unknown and/or unspecified rationale for the distribution function] (Kodell and Gaylor, 
1999). 
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Table3 
Comparative TD Is from NOAEL and BMDL10 values 
Quanta! toxicity endpoint NOAEL NOAELTDI BMDL10 BMDLTDI 





























• Maximum conventional value for four uncertainty factors as derived in Section 3.4. 
b Maximum conventional value for uncertainty factors as suggested by the U.S. EPA. 
UFs (Allen et al., 1994). However, the TDI value is not an 
absolute certainty as there is a low probability that adverse 
effects might occur and the absence of all risk to all people 
cannot be assured at this level (Barnes and Dourson, 1988). 
The existence of different TDis need not imply that anyone 
of them is more "wrong" or "right" than the rest. It is more 
a reflection of the difference in scientific judgement of risk 
assessors (Barnes and Dourson, 1988). 
The calculation of a TDI by applying a UF to a NOAEL 
will be referred to as a 'NOAEL approach' since the point 
of departure was the NOAEL for the critical adverse 
effects. The estimation of TDis based on the use of the 
BMDL based on these same effects and divided by UFs will 
be called the 'BMD approach'. 
For the purposes of this investigation, the assessments 
and calculations ofTDI were done according to the WHO 
recommendations as described in the International Pro-
gramme on Chemical Safety's "Environmental Health Cri-
teria 104, Principles for the Toxicological Assessment of 
Pesticide Residues in Food" (IPCS, 1990). To derive the 
TDI, this can be represented mathematically using the fol-
lowing formula: 
Tolerable Daily Intake (TDI) = NOAEL or BMDL/ 
(UA*UH*Us*U0 *UJ, 
where: U A= interspecies extrapolation 
UH= intraspecies extrapolation 
Us= using subchronic data 
U0 = using incomplete database 
UL= extrapolation from LOAEL to NOAEL (if 
needed), not used with BMDL 
In this case, both the statistical and usual UFs have the 
same value, i.e., 3000. This figure was used in the final deri-
vation of the TDI. 
Thus, comparing the NOAEL and the BMDL10 TOI 
derived values demonstrated that the TOis from the BMD 
approach were generally slightly higher than the NOAEL 
approach and therefore less conservative values (Table 3). 
Several BMDLs could be used to establish the TDI. The 
BMDL10 of O.lOmgkg-1 bw day-1 for cardiomyopathy in 
male rats and testicular effects in estimating the risks from 
1080 exposures was chosen because these were the most 
critical effects considered for 1080 by Sullivan et al. (1979), 
Eason et al (1999), Eason and Turck (2002), and Whittem 
and Murray (1963). This value is considered a scientifically 
sound option and is therefore recommended for use in 
human health risk assessment (Foronda et al., 2006). This 
value may be considered as conservative (i.e., protective) 
and errs on the side of caution due to the incomplete infor-
mation available, as already discussed. 
4. Discussion 
Non-cancer risk assessment is currently based on the 
assumption that a biologic threshold dose must be 
exceeded before exposure to chemical causes effects. Under 
this view, if a person is exposed to a dose below their 
threshold of response, no effect is experienced and thus no 
risk is involved. However, there is variability in the sensitiv-
ity of individuals to chemicals and thus in order to assess 
population risks the responses of sensitive individuals must 
be taken into account. Unfortunately, human epidemiol-
ogic data are very rare, and even when they are available, 
the data may be inadequate to determine with any precision 
the threshold for particularly sensitive individuals. Epide-
miological studies are less often available and of reduced 
value because of the lack of quantitative information on the 
concentrations to which the people have been exposed or to 
what else the populations have been simultaneously 
exposed (Ministry of Health, 1995). Hence, the human 
threshold dose is typically extrapolated from animal data. 
Animal test data provide an estimate of the subthreshold 
dose, or NOAEL. Because true relationship between this 
animal threshold dose and the human threshold are 
unknown, uncertainty is inherent in the extrapolation. 
Interspecies UF is intended to adjust for two quite distinct 
concems-{i) any genuine differences in susceptibility 
between laboratory animals and humans, and (ii) the limi-
tations in the statistical power of laboratory bioassays 
involving relatively small number of animals (Baird et al., 
1996). 
The derivation of the TOI for 1080 was based on sub-
chronic studies due to the absence of chronic studies. 
Higher UFs were utilised to take into account the uncer-
tainties involved in the inter and intraspecies differences, 
the use of subchronic studies and the incompleteness of the 
overall database. In addition, critical information on the 
conditions of human exposure is lacking. Exposures to the 
general population are less well documented than occupa-
tional exposures due to limited availability of systems capa-
ble of measuring the exposures to specific risk agents 
N.M. Foronda et al. I Regulatory Toxicology and Pharmacology 47 (2007) 29-36 35 
actually experienced by people (Covello and Merkhofer, 
1993). 
The statistically derived UF of 2994 (rounded to 3000) 
proposed in this study represents a viable alternative to the 
use of a product of default factors to establish the TDI. The 
UF provides a known level of confidence in health protec-
tion, without unnecessarily compounding the conservatism 
built into each individual factor. The same UF of 3000 was 
used for the BMD approach and the resulting TDis for 
most end points were slightly higher than those calculated 
using the NOAEL approach. The BMD can provide a more 
consistent approach that avoids the occasional extreme 
behaviour of the NOAEL (Gaylor et al., 1998). 
The NOAEL of 0.075 mg kg- 1 bw day- 1 for testicular 
and cardiomyopathy from Eason and Turck (2002) might 
provide the most appropriate and relevant basis for 1080 
TDI. A complementary study was also carried out with a 
NOAEL of O.IOmgkg-1 bw day-1 based on severe malfor-
mations as the toxic end point (Eason et al., 1999). As dis-
cussed earlier, teratogenic effects were also considered as a 
critical end point for the purposes of this study. However, 
the BMDL10s generated by the probit model arising from 
the most critical end points, i.e., male cardiomyopathy and 
testicular effects of 0.10mgkg-1bw day-1 were ultimately 
chosen to estimate the TDI, because the use of this model 
was able to capture more of the available data. 
The TDI derived from the BMDL10 was slightly higher 
than the TDI derived from the NOAEL value. TDI of 
0.03 µg kg-1 bw day-1 is proposed to be used for 1080 
health risk assessment until additional studies are carried 
out since these studies may likely reduce the UF in deriving 
the TDI and thereby likely raise the value of the TDI. Two 
systemic toxicity mammalian studies in different species, 
one-multigeneration reproductive study, and two mamma-
lian developmental toxicity studies in different species are 
the criteria used to define a "complete database". There is a 
lack of toxicology studies relating to chronic 1080 expo-
sure, and this hinders the determination of an appropriate 
TDI and results in higher UFs. The UFs can be reduced if 
additional studies are carried out to generate a "complete 
database" providing a better understanding of the interspe-
cies and intraspecies variability of I 080. 
The TDI may be considered conservative, as the general 
population may not be exposed to 1080 throughout their 
entire life, whereas this methodology has been widely used to 
develop TD Is based on the assumption that the general popu-
lation may be exposed to the chemical in question for lifetime. 
An attempt to estimate population threshold for 
humans is fraught with uncertainty because of poorly stud-
ied toxicokinetics and toxicodynamics between the test spe-
cies and humans, and because of heterogeneity in these 
processes among human populations. In addition, the pau-
city of information about the toxicokinetics of 1080 in 
humans indicates the need to carefully limit and monitor 
occupational and environmental exposures to achieve a 
better understanding and management of human toxicity 
(Temple and Edwards, 1985). 
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Appendix 4. Application for a Permission for the Use of Vertebrate 
Toxic Agent(s) 
Application for a Permit 
For the Use of Vertebrate Toxic Agent(s) 
Hazardous Substances and New Organisms Act 1996 (HSNO) 
This application is to be used when applying for a Permit to use any HSNO approved vertebrate 
toxic agent (VT A) for ~hich a permission is required under section 95A of the HSNO Act. This 
includes the VTAs listed in Schedules 1 of the Hazardous Substances (Vertebrate Toxic Agents) 
Transfer Notice 2004 and the Hazardous Substances (Sodium Fluoroacetate) Transfer Notice 2005. 
A Permit is issued by a person acting under powers delegated by the Environmental Risk 
Management Authority ("the delegated person"). 
Attachments 
The application form contains a series of attachments requesting information necessary for issuing 
permit. Complete all the attachments that apply to this operation. If an attachment is not relevant, 
return the attachment as part of the completed application form and write "not applicable" across it. 
Return this application to the contact person below. 
LOCAL PUBLIC HEAL TH CONTACT 
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Application for Permit to use a Vertebrate Toxic Agent 
(Pursuant to section 95A of the Hazardous Substances and New Organisms Act 1996) 
Name of applicant and/or organisation on whose behalf vertebrate toxic agent is to be applied. 
Explanatory Note: A Permit may be issued to the applicant or to a person holding a controlled substance 
license. If the permit is granted to a controlled substance licensee give his/her name and provide a copy of 
the controlled substance licence. If the operation is "contracted out", the agency conducting the operation 
must complete the application form, including Attachment E. 
Contact details: (address, postal address, telephone, cell phone, facsimile, e-mail): 
Start Date: I Finish ~ate: 
Give reasons if a permit is required to continue an operation over an extended period ( e.g., 12 months). 
Vertebrate toxic· Strength, e.g., Form, e.g., pellets Application rate Purpose, e.g., for 
agent, e.g. 800g/kg (for aerial possum control 
potassium cyanide operations) 
, Application frequency/Number of applications: If more than one VTA or different forms of the same VTA 
are to be used, specify which product the information below refers to, and use p.3 for other VT As. 
Specify all strategies for the VTA to be used: If more than one VTA is involved, use the boxes on p.3. 
Strategies to be used: (Tick applicable box) 
Yes No Yes No 
Aerial 0 0 Bait stations 0 0 
Broadcast 0 0 State heights of bait stations: 
Turf spits 0 0 Types of bait stations: 
Traps 0 0 
Other control methods 0 0 
(Describe briefly below) 
Operation Name/ Locality: 
Operation Size (ha): 
If the applicant has carried out an earlier operation in this area, report: 
Date of Operation: Application Identification Code: --
Name (print): Signature: Date: Application 
identification code: 
(Office use only) 
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VTA Information (Cont) 
Vertebrate Toxic Agent to be Used: 
Application frequency/Number of applications: 
Specify all strategies for the VT A 
Strategies to be used: (Tick applicable box) 
Yes No Yes No 
Aerial D D Bait stations .D D 
Broadcast· D D State heights of bait stations: 
D D 
.; 
Turf spits Types·ofbait stations: 
Traps D D 
Other control methods D D 
(Describe briefly below) 
Vertebrate Toxic Agent to be Used: 
Application frequency/Number of applications: 
Specify all strategies for the VT A 
Strategies to be used: (Tick applicable box) 
Yes No Yes No 
Aerial D D Bait stations D D 
Broadcast D D State heights of bait stations: 
Turf spits D D Types of bait stations: 
Traps D D 
Other control methods D a 
(Describe briefly below) 
Add new entries if more than four VT As are involved in the operation. 
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ATTACHMENTS-ATOP 
Complete the attachments that apply to this application. Tick the "yes/no" boxes below. 
If an attachment is not relevant, write "not applicable" across it. Return all attachments. 
Note that different VTAs may require varying levels of detail to be provided with the 
attachment. Similarly aerial and ground operations will have different information 
requirements. 
_., ·; ..... }Ff:'P.t:/' ····,r··t?c·;·:ytf,'. ·:~\ffi', 




























Consultation with Maori 
Operation Delivered by Subcontractor 
Transport, Storage and Disposal ofVTAs 
Excluded Areas: Mark clearly on map(s) 
G Drinking Water Supply Catchments and Intakes 
(Public and Private Commercial) 
H Dwellings, Adjacent Landowners/Occupiers 
I Areas That Are Easily Accessible 
J Tramping Huts and Shelters 
K Walking Tracks and Roads 
L Other Excluded Areas 
+::< ,Risk Communication 
M Schools and Early Childhood Centres 
N Notifications 
0 Warning Notices and Information Boards 
Special Requirements 



































Ensure you return all attachments with this application. If an attachment is not relevant, write "not 
applicable" across it. 
Office use 


















ATTACHMENT A: OPERATIONAL MAPS 
The use of the maps is to provide sufficient specific information for this operation. 
• Provide a description of the operational area. Include here the name of the area/reserve, and the name(s) 
of the landowner(s), clearly noting public and private land ownership. 
• Operational maps should provide an adequate level of detail INCLUDING LOT NUMBERS WHERE 
APPROPRIATE. A number of map options are available e.g., topographical {e.g., NZS 260 series), GIS 
(geographic information systems), aerial photos, etc. 
• Include: - area ground control ha ----
- area aerial control ha ----
- territorial local authority 
• If using more than one VTA, show on the map where each VTA will be stored and where it will be 
applied. · 
• : Identify where the helicopter loading zones will be and bait processing sites for carrot 1080 operations. 
If there is more than one loading zone or processing site, ensure all are clearly identified. (With carrot 
operations, one or more processing sites e.xist and also perhaps one or more loading zones). This · 
information may also be recorded in Attachment F. 
• Attach operational map(s): More than one map may be needed to include all the information.· Use 
maps of different scales if necessary. · 
Identify the following on your map( s) by using a colour code, a number code or similar: 
- Drinking Water Catchments and Intakes 
(Public and Private Commercial Water Supplies) 
- Dwellings, Adjacent Landowners/Occupiers 
- Areas Easily Accessible to Public 
- Tramping Huts and Shelters 
- Walking Tracks and Roads 
- Other Excluded Areas 
- Schools and Early Childhood Centres 
- Warning Notices and Information Boards 
(Letters in brackets refer to corresponding attachments) 










ATTACHMENT B: RISK ASSESSMENT 
Do people take drinking water from water supplies originating in the operational area? 




Refer Attachments C, D and G 
If no, on. what is this assessment based? 
Do members ofthe public live within or adjoini~g the operational boundary? 
Yes D 
No D 
Refer Attachments H 
If no, on what is this assessment based? 
Do the public have access to the area? 
Think about areas reached by walking tracks, roads and boating access, which can be used by the public. 
Yes D 
No D 
Refer Attachments C, D, I, J, K, L and 0 
If no, on what is this assessment based? 
Are there any schools or early childhood centres within or near the operational boundary? 
Yes D Refer Attachment M 
No D If no, on what is this assessment based? 
Is the operational area used for outdoor pursuits, groups/clubs such as hunters, camp~rs, trampers, mountain 
bikers, scouts, schools, etc? 
Yes D 
No D 
Refer Attachments C, D, I, J, K, N and 0 
If no, on what is this assessment based? 
Is the operational area close to a village, town, other residential area, educational centre, marae or camping 
ground? If yes, describe. 
Yes D No D 
Refer Attachments C and D 
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ATTACHMENT C: COMMUNITY CONSULATION 
Do you expect any public concern about this operation? 
If yes, describe the nature of the concern: 
What is the source of your information? 
If no, on what is this assessment based? 
Consultation with community groups 
. What community groups did you consult with in relation to this application? 
Name the individuals/groups consulted: 
Detail what, if any, concerns these individuals/groups identified. 
Yes D No D 
How are you planning to avoid, mitigate or remedy any adverse effects identified by these 
individuals/groups? 
Attach any evidence of the consultation ( correspondence, minutes of meetings, record of phone calls, etc). 
Jfyou have not consulted any community groups about this application, ask the resource consent planner at 
your local council to help ideritifj, the appropriate groups to contact. 
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ATTACHMENT D: CONSULTATION WITH MAORI 
When consulting with Maori, you need to take into . account Section 6(d) of the HSNO Act: "The 
relationship of Maori and their culture and traditions with their ancestral lands, water, sites, waahi tapu, 
valued flora and fauna, and other taonga ". 
What Maori groups (iwi/hapu/whanau) did you consult with in relation to this application? 
Name the individuals/groups consulted: 
Identify what, if any, concerns these individuals/groups identified: 
How are you planning to avoid, mitigate or rerriedy any adverse effects identified by these 
individuals/groups? 
Attach any evidence of the consultation ( correspondence, minutes of meetings, record of phone calls, etc): 
If you have not consulted the Maori community about this application, ask the resource consent planner at 
your local council to help identify the appropriate groups to contact. 
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ATTACHMENT E: OPERATION DELIVERED BY 
SUBCONTRACTOR 
Name of subcontractor: Controlled Substance Licence Number: 
Date of Issue: 
List the work experience the subcontractor has with the VTAs to be used: 
Contact details of the subcontractor (address, postal address, telephone, cell phone, facsimile, e-:mail): 
Name of principal agency: 
Signature: 
Chain of responsibility - Complete as applicable to this operation .. 
It is now common practice for pesticide operations to be subcontracted to other agencies. All agencies involved 
have responsibilities to ensure the safe use ofVTAs. Any subcontracting arrangements must be documented. 
Example 
Agency/ Authority 
Principal Agency (AHB, DoC) 
Contractor (Local Authority) 
Subcontractor (Name of approved operator) 




Area of Responsibility 
e.g. Control of Bovine TB. Conservation etc 
e.g. Contracted by AHB Possum Control 
e.g. Field operations 
Area of Responsibility 
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ATTACHMENT F: TRANSPORT, STORAGE and DISPOSAL OF 
VTAs 
Give the name and address ofVTA suppliers: 
Name: 
Address: 
Estimate the quantity ofVTAs required for the operation for which this permit is sought. 
Where will the VTAs be stored prior to the operation: 
Describe storage security (locked secure compound, electronic surveillance etc): 
How will the VT As be transported to the operation site (land, sea or air): 
Note that you must comply with the requirements of the Land Transport Rule: Dangerous Goods 1999 and 
any air/sea regulatory requirements that apply. 
Where and how will any unused VT As be stored or disposed of: 
Where and how will empty containers be disposed of: 
Record any resource consents held for the disposal of toxic waste from the operation: 
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ATTACHMENT G: DRINKING WATER SUPPLY CATCHMENTS 
(Public and Private Commercial Water Supplies) 
The intent of this section is to minimise the risk of people drinking water contaminated with VT As. 
A drinking water catchment is an area from which water is likely to be taken for use as drinking water for 
human consumption. This includes surface water and ground water catchments. There may be public and 
private commercial water supplies such as camping grounds, hotels and pack packers to identify as well as 
domestic supplies to individual properties. 
A drinking water catchment is defined as "Any area from which rainfall flows into a body of water, that is 
proximate enough to an abstraction point which supplies water for human consumption, that it can be said that 
the water is drawn from that area". Public water supply means "All water supplies that are not to self-
supplied buildings". [Note: These two definitions apply only to their use for the purposes of issuing 
permissions· for VTAs under the HSNO Act and its regulations, including the Hazardous Substances 
(Vertebrate Toxic Agents) Transfer Notice 2004 and the Hazardous Substances (Sodium Fluoroacetate) 
Transfer Notice 2005.] 
Locations of intakes of drinking water for VT A aerial operations 
Provide topographical NZMS Grid below. References for water supply intakes you have marked on your 
attached operational map (Attachment A). All locations shall be obtained using at least a GPS unit set up for use 
in New Zealand and using the following Map Datum:-New Zealand Geodetic Datum 1949. All GPS locations 
recorded in the field shall be plotted out on a NZS 260 series map prior to submission, and plotted points assessed 
against field knowledge gained from site visits to ensure correctness. 
Intake _(insert your map code) 
Name of Supply: _______________ _ 
NZSM Grid Ref. of intake: E ______ _ N ______ _ 
Type of Supply: _______________ _ 
Intake 
Name of Supply: _______________ _ 
NZSM Grid Ref. of intake: E ______ _ N -------
Type of Supply: ______________ _ 
Intake 
Name of Supply: _______________ _ 
NZSM Grid Ref. of intake: E ______ _ N -------
Type of Supply _______________ _ 
Add new entries if there are more than three drinking water intakes. 
List or mark on the topographical map (Attachment A) all public and private drinking water supplies, including 
catchments, reservoirs etc. 
Has the applicant physically inspected all water supply intake locations with the landowner/supply operator to 
ensure that location of the supply as detailed in this application form is correct? 
Yesa Noa 
Has the applicant sought written permission from the authorities ( e.g., TLAs) that operate public drinking water 
supplies? 
Yesa Noa 
Send a copy of the completed application form, accompanying location maps and attachments to the authorities 
which have drinking water catchments and/or intake structures within the operational area. 
A copy of each written permission given by the authority that operates a public drinking water supply must be 
forwarded to the Public Health Unit having jurisdiction over the operational area. 
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Attachment G (Cont.) 
For aerial and broadcast operations: Dairy Farms 
Are there any dairy farms within 3 km of the operational area? 
YesO No 0 
Attach copies ofrelevant hydrogeogical and hydrological reports and letters from consumers where needed. 
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ATTACHMENT H: DWELLINGS, ADJACENT 
LANDOWNERS/OCCUPIERS 
Specify ( or identify on a map) all dwellings within or adjacent to the boundary of the operational area. 
Note: This requirement may be covered by Attachment A (Operational Maps). 
In areas where there are more than 30 adjacent residential properties/landowners involved, the identification of 
the properties on a map may be sufficient. 
How will you tell the occupiers, adjacent residents and landowners about this operation? 
How will you ensure that VT A baits are not applied near occupied dwellings? 
Has the occupier, adjacent residents and landowners list attached or described on the operational map 
(Attachment A) been checked and updated by the applicant? 
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ATTACHMENT I: AREAS THAT ARE EASILY ACCESSIBLE 
The intent of this attachment is to identify the potential for exposure of young children and others who cannot 
read or who do not understand the dangers of poisoned baits. 
Note: In some circumstances it may be possible and necessary to close any high use area. 
Give the sources of your information: 
List areas used by the public; including lay-bys for-'motorists ( or identify on operational map: 'Attachment A): 
List private land which has a high public use ( or identify on operational map: Attachment A): 
Estimate the number of people visiting the operational area. In particular, is it a high use area or will the number 
of people using it during the operation, increase for specific events or according to the season. Circle the 
appropriate response. 
HIGH 
(more than 50 people per day) 
List any areas to be closed to the public: 
MEDIUM 
(fewer than 50 people per day) 
LOW 
(fewer than 10 people per day) 
Are there likely to be people who are at risk of poisoning who may visit the operational area e.g., children or 
venturesome tourists? 
List high use areas which will receive mid-week baiting strategy (or identify on operational map): 
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ATTACHMENT J: TRAMPING HUTS, BIVVIES/SHELTERS, TENT 
CAMPING SITES, PICNIC AREAS, PUBLIC ROAD LAY-BYS and 
WATERCRAFT LANDING POINTS 
The intent of this section is to cover those places where the public may be gathered temporarily. 
Are there any tramping huts, bivvies/shelters, tent camping sites, picnic areas, public road lay-bys and 
watercraft landing points within the operational area? 
Yes D No D 
If yes, list tramping huts, bivvies/shelters (or identify clearly on operational map: AttachmentA): 
Give the source(s) of your information: 
Describe the baiting plan in areas near huts, shelters etc: 
Name of the person who provided the information: ------------
Signature: ---------------
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ATTACHMENT K: WALKING TRACKS and ROADS 
Where it is necessary to carry out baiting on walking tracks and roads that are likely to receive high use, 
consideration should be given to closing the operational area to the public until it is deemed to be safe. 
Obtain the following information from a knowledgeable third party ( e.g., the landowner) and have this party 
sign off the information as being up to date and correct. 
List all public walking tracks and their level ofuse: 
Use the criteria below to assess the level of use of the track. 
HIGH MEDIUM LOW 
(more than 50 people per day) (fewe~ than 50 people per day) (fewer thanl O people per day) 
List all public roads and walking tracks within ilie area (or identify on operational map: Attachment A): 
Give the source(s) of your information: 
Name of the person who provided the information: ------------
Signature: _________ _ 
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ATTACHMENT L: OTHER EXCLUDED AREAS 
The intent of this attachment is to identify any other place not listed in this application where the use of VT As 
may directly or indirectly harm human health e.g., where the toxin could enter the food chain by 
contaminating animals, fish or food crops. 
List any other excluded areas not recorded elsewhere in the application ( or identify on operational map; 
Attachment A): 
Describe the control methods for this area: 
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ATTACHMENT M: PRIMARY SCHOOLS, SECONDARY 
SCHOOLS, KINDERGARTENS and OTHER EARLY CHILDHOOD 
CENTRES (ECCs) 
(ECCs are facilities attended by pre-school children) 
The intent of this attachment is to help to protect young children (and others who are unable to understand 
notices) from the risk of contact with VTAs. For example, young children walking or cycling to school may 
visit friends, explore or take short cuts through operational areas (therefore their parents/caregivers need to 
receive warnings of the whereabouts ofVTAs in the area). 
Explanatory Note - "Appropriate Distance" 
This applies to the size· of a circle around an operational area in which schools and early childhood centres 
may be found. Urban schools are likely to have pupils coming from shorter distances than those in rural areas, 
whichhave children coming from further afield. For example, a 2 km-radius circle area around an operational 
area may be suitable in an urban setting, but a 10 km radius may be more suitable in a rural area. The 
appropriate distance should be identified after consultation with school staff and with the delegated person. 
List all schools and early childhood centres located within 150 metres of the operational area: 
List all schools and early childhood centres located within an "appropriate distance" of the operational area: 
Provide a copy of the information that will be supplied to these schools and early childhood centres: 
260 
ATTACHMENT N: NOTIFICATIONS 
Notification is required to ensure that the general public is aware of any poisoning operation scheduled to take 
place. 
Hunting permits for the general area of operation are required to carry a warning to hunters that poisoning is 
planned for certain localities. The appropriate authorities (DoC, Regional Local Authorities or Unitary Local 
Authorities, or Forest Managers) must be notified in advance of the operation to ensure that this happens. 
Attach a copy of the information to be provided to groups and agencies. 
A record or list of names/addresses of contacts is to be maintained by the applicant. This record is to be kept by 
the applicant for 12 months from the date of issue of the Permit and shall be made available to the delegated 
person on request. 
Local health/medical services/police: 
Veterinary clinics: 
Hunting/kennel clubs/game packing houses, out door pursuits/clubs: 
Any other known groups that are likely to have access to the area: 
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ATTACHMENT 0: WARNING NOTICES, INFORMATION 
BOARDS, PUBLIC INFORMATION CENTRES, KIOSKS etc 
The intent of this attachment is to ensure that a clear warning is given to people of the presence and danger of 
the VT A. Where foreign tourists frequently visit an area, it may be useful to provide signage in the 
appropriate language. As a minimum, warning notices must be erected at every place where people normally 
obtain access to the treatment area, including beaches and other landing points from waterways. 
Explanatory Note: The term "regular" should be interpreted to suit local conditions. Where vandalism is to · 
be expected, notices will need to be checked daily. If vandalism is not expected in the operational area, longer 
periods may be allowed to elapse between inspections. 
List locations of warning notices arid information boards ( or identify on operational map: Attachment A): 
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ATTACHMENT P: AERIAL OPERATIONS USING VTAs 
Explanatory Note: The log is a summary report of operations. The log may include summaries of several 
operations providing they occur within the same approval period. 
It is acknowledged it is not always physically possible to inspect all boundaries. If this is the case, discuss with 
the delegated person. 
List drinking water supply reservoirs or storage facilities and waterways (and identify on operational map; 
Attachment A): · 
List areas to be inspected (and identify on operational map; Attachment A): 
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Appendix 5. Permission for use of Vertebrate Toxic Agent(s) 
PERMIT FOR USE OF VERTEBRATE TOXIC AGENT(S) 
Pursuant to section 95A of the Hazardous Substances and New Organisms Act 1996 
To (name of applicant): 
Of (postal and physical address of applicant: 
Application Identific~tion Code: 
Purpose of Application* ,. ------------'--------
Application Location/ Area* 
Start date:------------ Finish date: 
I ···································•·········· a person acting under powers delegated by the 
Environmental Risk Manageril~nt Authority (the Authority), GRANT PERMISSION 
for the use of the following vertebrate toxic agent(s): 
...................................................................................................... . . 






Appeals: Section 125 (IA) of the Hazardous Substances and New Organisms Act 1996 
(HSNO Act): A person may appeal to the District Court against a decision of the Authority, 
under section 95A about the terms and conditions of a permission held by the person. 
Notice of appeal: Section 127 of the HSNO Act: Before or immediately after the filing and 
service of a notice of appeal, the appellant shall serve a copy of the notice on the Authority, 
and every other party to the proceedings, and any other person who made a submission to the 
Authority. 
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SCHEDULE 1 - PERMIT CONDITIONS 
Application Identification Code: 
Application Location/ Area: 
In addition to requirements specified under the Hazardous Substances and New Organisms 
(HSNO) Act and i~s regulations, including the Hazardous Substances (Vertebrate Toxic Agents) 
Transfer Notice 2004 and the Hazardous Substances (Sodium Fluoroacetate) Transfer Notice 
2005, the following conditions shall apply: 10 . 








(Note to officer: check there is a page number on each page, and initial each page of 
conditions at the bottom) 
10 The requirements under HSNO are minimum requirements, which must be met. A person acting under a 
delegation from the Authority may impose additional (stricter) conditions. 
265 
MODEL CONDITIONS that may be imposed 
by a person acting under delegation of the Authority 
when granting permission/s 
FOR USE OF VERTEBRATE TOXIC AGENT(S) 
Under the Hazardous Substances and New Organisms Act 1996 
The requirements under HSNO are minimum requirements, which must be met. A person acting 
under a delegation from the Authority may impose additional (stricter) conditions. 
The following are model conditions for a vertebrate toxic agent (VTA) operation, which may be set 
from time to time to meet local conditions within the operational area and surrounds. The conditions 
of a permit may be selected from these model conditions, depending on the delegated person's 
assessment of the local circumstances. The model conditions may also be modified or new conditions 
imposed at the discretion of the delegated person. All conditions should be listed under Schedule 1 
(Permit Conditions) of the permit. 
Model conditions are in standard type; comments in italics indicate where additional information is to 
be inserted. 
For all operations using vertebrate toxic agents 
l (Insert contact name person from page I) of (insert name of PHU issuing the permit) is to 
be notified by telephone and/or in all instances confirmed in writing before the vertebrate 
toxic agent(s) phase of the operation begins. 
2 All incidents and complaints relating to the operation that may impact on public health 
shall be documented and notified to (contact name person from page I) of (insert name of 
PHU issuing the permit). · 
3 If any circumstances relating to the application or the operation change, the person issuing 
this permit (insert contact name person from page I) shall be informed immediately and 
they retain the right to modify or withdraw the permission. 
4 Hand-laid bait or paste shall not be laid near specified walking tracks, formed public roads, 
or any areas used by the public (lay-bys, parks, etc) where the bait or paste is within sight 
of or easily accessible to the public from those areas. 
(If PHUs wish to stipulate a particular distance, they can still do so). 
5 The applicant must specify the maximum and minimum time period during which the 
majority of the bait may be toxic, after application. The applicant must advise in writing 
the Public Health Unit issuing this permit (insert contact name person from page I) when 
baits have ceased to be toxic. 
6 Any vehicle used to transport vertebrate toxic agent(s) or its wastes shall be kept locked 
when the vehicle is left unattended for any period of time. 
7 Prior to commencing the operation, the applicant shall notify persons who take drinking-
water downstream from the operational zone (i.e., water supplies with catchments and 
intakes inside the operational area or on adjoining properties) of the operation and its 
duration. 
8 Residents and landowners adjacent to the operational area shall be identified by the 
applicant and shall be provided with information on safety and precautions with respect to 
the vertebrate toxic agent(s) being used. 
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9 All reasonable steps shall be taken to prevent contamination with the vertebrate toxic 
agent(s) of all areas within 150 metres (or within a distance mutually agreed in writing 
with occupiers) of the dwellings (including stock and drinking water supply) identified. 
10 All places where the public may stay, camp, play, exercise or assemble (including any 
approved camping ground, tramping huts, bivvies/shelters, tent camping sites, picnic areas, 
public road lay-bys and watercraft landing points) shall be identified and must be excluded 
from the operation by way of a (specify distance) metre buffer zone around each place in 
which no vertebrate toxic agent s.hall be laid. · 
11 No vertebrate toxic agent(s) shall be applied to land that receives high public use (whether 
it is public or privately owned) . during school holidays or public holidays, unless that area 
is closed to the public. 
"High public use" means that there are more than 50 people visiting the operatioridl area 
per day. 
12. . Land that receives high public use (whether it is public or privately owned) shall be made 
safe· from vertebrate 'toxic ::agent(s) before the beginning of school or public holiday 
periods, unless the area is closed to the public. · 
13 For areas that receive high public use, a mid.:week vertebrate toxic agent baiting strategy 
. shall be used, unless limited use is expected due to seasonal or climatic conditions, or due 
to closure of the area. 
14 The· applicant shall notify local health services of the poisoning operation and provide 
appropriate safety information. Local health services include: GPs and other primary 
health services,. ambulance services, Police, hospitals and emergency clinics ( e.g., 
Emergency Departments at local.hospitals), and veterinary clinics in the operational area. 
. 15 The public shall be given notice, e.g., by advertisements in the local newspaper, (specify 
time} prior to the proposed application of a vertebrate toxic agent. 11 
16 . Warning signs shall be checked at regular intervals, and must be repaired/replaced within 
24 hours of discovery or notification of damage or theft. Where warning signs are located 
some distance from the operational zone these signs shall include a map showing the 
operational zone and the location of the sign(s). 
17 The warning signs must include an international symbol for toxic substances ( e.g., skull 
and crossbones) and a statement advising that children.should not be allowed to wander 
(e.g., WATCH CHILDREN at all times). 
18 No vertebrate toxic agent is to be applied where it is accessible by grazing stock. 
19 The applicant must provide a copy of this permit and its conditions to the Person in Charge 
of the operation. 
For aerial operations using vertebrate toxic agents 
20 Vertebrate toxic agent(s) shall not be aerially applied within (specify distance) metres of 
any approved camping ground, formed public road currently in use, lay-bys, picnic areas, 
tramping huts, bivvies/shelters, tent camping sites, watercraft landing points, streams, 
rivers, lakes, ponds and reservoirs specified by the delegated person. 
11 This condition does not to be specified if the operation is only using 1080 bait for aerial application, as the 
Hazardous Substances (Sodium Fluoroacetate) Transfer Notice 2005 already imposes such a requirement. 
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21 The bait must be hand laid if it is to be applied closer than the distance specified in 
condition 20 with respect to those areas specified in that condition. 
22 All toxic baits must be cleared from the walking tracks and roads listed within 48 hours 
from the time the vertebrate toxic agent was applied, unless the tracks or roads are closed 
to the public. 
23 High use tracks must be checked and cleared of baits within 24 hours from the time the 
vertebrate toxic agent was applied, unless the high use tracks are closed to the public. 
24 If any such walking track or road listed is closed to .the public, it must be scrutinised for 
baits and cleared before re-opening. 
25 Following initial clearance, walking tracks and roads are to be regularly inspected for toxic 
baits that may have fallen from the tree canopy. For high use tracks, this will be on a daily 
basis. 
26 An operator's log (report) must be compiled of activities associated with the aerial 
application and a copy of this log is to be forwarded to the Public Health Unit issuing this 
permit (insert contact name person from page I) within four weeks of the date of the 
vertebrate toxic agent being laid. 
As a minimum, the log shall include: 
(a) time, date and place of the application 
(b). amount of vertebrate toxic agent applied and its formulation 
( c) list of supervising operators 
( d) names of subcontractors with services provided 
(e) name, address and rating number ofpilot(s) 
(f) any incidents that occurred and problems that arose during the operation, 
including the investigation undertaken and where necessary the remedial actions 
taken 
(g) any involuntary transgressions of the conditions in this approval, including an 
explanation of each transgression and the remedial actions taken 
(h) copy ofGPS printouts of toxic flight lines 
(i) a completed copy of the Aerial Operation Form. 
27 Differential Global Positioning System (DGPS) shall be used at all times for aircraft 
carrying bait-sowing equipment. 
28 After aerial application of a vertebrate toxic agent, any areas that are required to be 
inspected shall be inspected. This may include any boundaries which adjoin the land of a 
different tenure, or, any nearby areas in which aerial application of the vertebrate toxic 
agent is not permitted (specify all areas that are to be inspected). 
For operations (aerial and hand-laid) where 1080 is laid in a drinking water catchment 
29 Water testing is required for all public water supplies (specify named supply/location). 
Water samples must be collected within (person issuing permit to specify time) hours after 
a 1080 poison operation. 
30 Water testing is required for all private water supplies (specify named supply/location). 
Water samples must be collected within (person issuing permit to specify time) hours after 
a 1080 poison operation. 
If you impose a condition for water testing under conditions 29 and/or 30, the applicant 
must seek advice from the local regional council hydrologist/water quality scientist when 
designing the water monitoring programme, including the sampling periods. 
268 
31 An alternative drinking water supply shall be provided and water testing shall be carried 
out to show that the supply contains less than 2 parts-per-billion (ppb) 1080 before the 
reopening of the water supply ,except when one or more of the following applies: 
(a) Where test results gathered from previous operations, covering the same 
catchment or groundwater supply and at the same or greater application dose, 
show that the 2 ppb level was not exceeded in any test. 
(b) Where drinking-water comes from a secure bore supply (hydrogeological report). 
( c) Where the water from the water catchment in the treatment area is sufficiently 
diluted by other water sources (hydrological n;port). 
(d) Where there is sufficient distance between the 1080 treatment area and the draw-
off point for the water supply from that water catchment (in most cases 3 km). 
(e) Where another source of water is available (such as a separate catchment, roof 
tank or reservoir) that is not subject to possible 1080 contamination, and the 
consumer is advised in writing to use that alternative supply. 
(f) Where baits are not laid in any place where they can fall or be washed into water 
sources or drinking-water supplies. 
(g) Where the 1080 is applied using bait stations. 
(h) Where consumers state in writing that they do not want an alternative drinking-
water supply and that the operator has advised them in writing of the risks. 
If any of exceptions (a) to (h) apply, the applicant must have provided the relevant 
documentation as part of their application for a permit. 
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Appendix 6. Model Permit Conditions for the use of sodium 
monofluoroacetate (1080) issued by the Medical Officer of Health 
Additional conditions which may be imposed at the Medical Officer of Health's (MOH) 
discretion to meet local needs. 
The following are model conditions which may be set from time to time to meet different local 
needs and may be selected from, or added to, depending on the MOH's assessment of local 
circumstances. 
1. For All Operations 
1.1 The agency conducting the operation shall notify the Medical Officer of Health if 
there is any alteration to the intended date of the application. 
1.2 All schools, play centres and child care centres specified by the Medical Officer of 
Health within an appropriate area shall be provided with information on safety 
precautions ( e.g., 1080 information kit) by the agency conducting the operation. 
Generally the "appropriate area" will be 10 km, however, this may vary from one 
locality to another. Therefore, the "appropriate area" should be established by 
the local Medical Officer of Health following appropriate consultation. 
1.3 Notification of the poisoning operation and appropriate safety information is to be 
provided by the agency conducting the operation to GPs, ambulance services, 
Police, hospitals and emergency clinics ( e.g., Accident & Emergency 
Departments), and veterinary clinics in the operational area of the operation. 
This requirement is a precautionary measure so that these agencies/bodies can 
make themselves aware of what should be done in the event of an emergency relating to 
1080. 
1.4 Loss of the toxic material and other incidents that may pose a hazard to the public 
must be notified to Medical Officer of Health as soon as possible but at least 
within 24 hours. 
1.5 All complaints relating to possible impacts on public health (e.g., contamination 
of public water supplies) during a 1080 operation should be documented and 
notified to the Medical Officer of Health who will maintain a record. 
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1.6 Notices that are stolen or obscured should be repaired/replaced by the agency 
conducting the operation within 24 hours of notification of loss. 
1.7 No baits are to be present during school and public holidays in areas to which the 
public have ready access. 
Although the Ministry of Health understands that there is a legal requirement for 
signs to be displayed showing I 080 has been applied, its main concern is young 
children who cannot read so don't understand the danger of poisoned baits. 
This condition depends upon the discretion of the Medical Officer of Health 
after discussion with the applicator and interested parties. Consideration should 
be given to ensuring that toxic bait laying operations do not occur when a large 
number of children are likely to be using the area. Some schools are moving to a 
four-term year, and in areas where a three-term year also occurs, application of 
this condition would preclude control work from a significant portion of the 
control season. It should be noted that areas where control work is occurring will 
be closed to the public. 
1.8 Hunting permits for the general area of operation shall carry a warning to hunters 
that 1080 poisoning is planned for certain localities. 
2. For Aerial Operations 
2.1 An inspection is to be made of boundaries which adjoin land of a different tenure 
after an aerial application of baits and of areas in which aerial application of bait 
is not permitted, i.e., roads, major waterways. If bait is in the wrong area, 
arrangements should be made to clear the area of stock or toxic bait. 
It is noted that it is not always physically possible to inspect all boundaries. 
2.2 All walking tracks and formed public roads specified by the Medical Officer of 
Health must be cleared of toxic baits within 48 hours of the completion of the 
operation. 
2.3 The contractor applying the bait must keep a log for one year of activities 
associated with the aerial application, i.e., time, date, place, weather, flight paths, 
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wind direction and amount dropped. The log must be made available to the 
Medical Officer of Health, on request. 
a) No aerial application of 1080 is to be made within 20 metres of any 
camping ground (as defined in the Camping Ground Regulations 1985), formed 
public road currently in use, picnic areas, lake, pond, water supply intake or 
stream/river spe,cified by the Medical Officer of Health. 
Applications near streams and rivers should be discussed with the Medical Officer 
of Health before the permit is issued. 
Consideration should be given to provide the residents with an alternative 
drinking-water source if 1080 has been allowed to be applied in any drinking 
water catchment. 
The provisional Maximum Acceptable Value (MA.VJ for 1080 in the New Zealand 
Drinking-Water Standards 2005 is 3.5mg/L (3.5 ppb). 
b) Bait applied within 60 metres of the areas in (a) must be applied by 
helicopter either with a competent observer in the aircraft, or by an aircraft fitted 
with and using a recording Differential Global Positioning System (DGPS). 
A DGPS is a satellite and computer-based aircraft navigation system which can 
accurately record bait application in aerial poisoning operations. It enables 
auditing of flight paths and the area targeted and improves the targeting of bait 
coverage. However, the use of DGPS cannot be imposed in all cases because of 
the limited number of DGPS available in the country. 
c) The bait must be hand laid if it is to be applied closer than 20 metres to 
the areas specified in (a). 
2.4 No aircraft carrying 1080 for aerial application is to fly in transit over a water 
supply (dams, reservoirs, or public water supply intakes) and flight paths must not 
cross a waterway within 100 metres upstream of an intake. 
2.5 Where 1080 baits have been laid in a public water supply catchment, the Medical 
Officer of Health requires the agency applying the bait to monitor the water 
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quality during the operation and for a specified period thereafter. This shall 
include chemical analyses of public water supplies. 
2.6 All aircraft and loading equipment must be thoroughly decontaminated before the 
aircraft or equipment leaves the operational area following the Animal Health 
Board operational protocol. 
3. For Ground Operations (including 1080 paste): 
Please note that the MedicalOfficer of Health's approval is only required for ground 
applications within 'restricted areas' under regulation 12 of the VPC Regulations 
(now repealed). 
3.1. Hand-laid 1080 bait or paste shall not be laid within five metres of specified 
walking tracks and formed public roads. 
3.2 The Medical Officer of Health may require public notice by advertisements for 
hand laying of 1080. 
3.3 Rural/domestic water supply streams and publicly visible sites shall be inspected 
and all carcasses collected where feasible from places where public health could 
be at risk. 
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Appendix 7. Preliminary information collected by the Public Health 
Units (PHU) 
The purpose of this study was to obtain an overview of how 1080 was being used in each local 
PHU12• The findings from this study were intended to help address some of the questions raised 
regarding the perceived risk from the use of 1080. 
Methodology 
On 15 August 2002, the author (NF) requested each PHU to provide information on the way 1080 








Is 1080 ever used in your area? 
Approximately, how many 1080 operations occur annually in your area? 
In your permit conditions, has 1080 been permitted to be applied in any catchment 
area from which water is drawn from human consumption? 
What precautions do you usually require to. minimise the possibility of water 
contamination? 
Have you received any complaints relating to 1080 operations? 
If yes, briefly summarise each. 
PHUs replied directly to the author (NF) and responses were summarised for analyses (Table 1). A 
code was assigned to each PHU to ensure the anonymity of the respondents. The information 
provided by each PHU was summarised and analysed by this author (NF). Key findings were 
presented under the 'Results and Discussion' section. 
12 Designated officer in each PHU means a Medical Officer of Health, a Health Protection Officer or other 
officer designated by the Director-General of Health. The primary responsibility of a designated officer is to 
fulfill his or her statutory duties and responsibilities. 
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Results and Discussion 
A summary of the survey is shown in Table 1 and key findings are listed below: 
• In all areas covered by each PHU, 1080 was pennitted to be used in catchment areas from 
which water was drawn for human consumption. 
• 1080 has been or is being used in all areas covered by each PHU. 
• 1080 operations varied from each region with 1080 being used more frequently in some 
areas than others. 
• All PHUs received a number of complaints relating to 1080 operations except in one area 
(PHU 1) where none was received despite having a number of publicly notified 1080 pest 
control operations. PHU 5 commented that no complaints were received but they received 
"protests" prior to or during the operation. Protests and complaints may have been used 
interchangeably in this context, such as in PHU 8 where 1080 activists are present in thefr 
area. 
• Accidental dropping of 1080 baits in non-target areas cannot be ruled out as demonstrated 
in this survey. 
• There was a general lack of knowledge on legislative requirements and the risks involved 
when handling 1080 inappropriately. 
• Non-compliance appeared to be a major issue and the agency conducting the operation 
should ensure that contractors were familiar and complied, with such requirements. 
• The results of the survey suggested that in water catchment areas where 1080 was 
pennitted to be applied, one of the conditions imposed was consultation with affected 
homeowners and that alternative drinking water supplies should be provided to affected 
people until such time that the drinking water met the Ministry of Health's 
recommendation that the levels of 1080 did not exceed 2 ppb. 
Complaints of public health significance were: 
• Possible contamination of drinking water catchments after 1080 aerial application; 1080 
baits have fallen outside the operational zone; 
• Lack of notification that a 1080 operation is occurring at a certain date; 
• 1080 baits found in water supply catchment; too late for ( or the lack of) consultation prior 
to 1080 poisoning operation; 
• No signage used in walking tracks and baits found in a creek and picnic ground accessible 
by the public; 
275 
• Bait stations were visible and too close to a public road; 1080 baits were not removed from 
walking tracks; theft of 1080. 
It appears from the information provided by PHUs that there were legitimate reasons for the public 
to be concerned about the use of 1080. It has been acknowledged that there were contraventions 
made in some DoC 1080 operations (PHU 2; P. Reid pers. comm. 2005), i.e., 1080 baits were laid 
in exclusion zones. Also PCE (1998) reported that there has been an increiising trend for control 
agencies to contract out their possum control operations which has created implications for 
monitoring the performance of their operators. 
Preliminary information from PHU 
In relation to conditions imposed by the PHU, response from the PHUs suggested that standard 
conditionsl3 were applied (Appendix 5). Some PHUs, such as PHU 2 and 4, have included 
additional controls to complement the standard conditions, i.e., 
• warning signs were translated into foreign languages; 
• high use walking tracks were closed until staff could safely walk through these areas; 
• water intake was disconnected from other intake/s; and 
• provision of alternative drinking water. 
Because dogs are very susceptible to the toxic effects of 1080, most of the complaints received 
were about dog deaths. Dog owners have been warned to keep their dogs away during 1080 
operations using leaflets, such as that produced by the NPCA, "1080 Is Not Kid's Stuff' (undated), 
has been distributed. 
There was the possibility of accidental ingestion occurring, especially in the case of young 
children. A young child found some 1080 baits in an urupa (Maori cemetery) (PHU 3). The 
parents apparently found the child with a broken 1080 pellet and some green material in her mouth. 
The child was rushed to the hospital where following examination she was found to be well with no 
evidence of having actually consumed any bait material. Investigation showed that the urupa was 
indeed baited during an aerial 1080 operation. The area was identified by the operator of the local 
iwi during public consultations planning phase. 
PHU 8 reported that trampers, who were unaware that a 1080 operation was to be carried out, 
entered an operational zone. They were showered with 1080 baits the following day. There was a 
legal requirement under the Pesticides (VPC) Regulations (now repealed) to erect warning notices 
13 Conditions specified in the Medical Officer of Health permit form. 
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at every place where people normally obtain access to the baited area including the intended date 
on which it is to be applied. 
There was also an incident where a farmer's property was dropped with 1080 baits without the 
farmer's knowledge (PHU 3). Another complaint received by PHU 3 concerned forestry crew 
being showered with baits during aerial operation. Apparently, the company employing the crew 
did not pass on vital infqrmation concerning the commencement of the baiting operation. 
As can be seen, only PHU 1 has suggested that they did not receive any complaints although the 
number of 1080 operations was comparable with other PHUs receiving complaints. On average, it 
appears that PHU 10 granted the highest number of 1080 operations while PHU 9 granted fewer 
permits butthe Minister's office has received a number of complaints/concerns from this region (S. 
Gilbert pers. comm. 2004). In PHU 6, concerns were addressed by sending relevant 1080 
information to the public and stating that they could be contacted if they wish to discuss the 
information. 
There were local iwi oppositions received in relation to the possible contamination of water (PHU 
7). Water is taonga (treasure) to Maori and the application of 1080 may likely to be of concern to 
local iwi and hapu. The PHU had dealt with this issue by requesting that the water be tested to 
ensure that the drinking water met the Ministry of Health's recommendation that the levels of 1080 
did not exceed 2 ppb. 
PHU 8 stated that if 1080 is allowed to be dropped in drinking water catchment areas, the water 
treatment facility supplied by two catchments was to be closed down. Strict controls were also 
required in relation to private water supplies, including: 
• The regional council involved was required to ensure that the water tank supply was 
replenished as needed. Bottled water was supplied if reserve tank was not available. 
• Operators were asked to inform all those affected to fill reserve tanks before the operation 
and disconnect water intake/s before 1080 aerial operation. 
• Users of drinking water will only be advised to collect water from the affected area/s when 
the Medical Officer of Health has been satisfied that the drinking water complies with the 
Ministry of Health's recommendation, as confirmed by water laboratory analysis. 
In PHU 2, operators appeared to understand how high levels of concern should be addressed as 
they themselves suggested special precautions to be included in the permit conditions to alleviate 
the concerns from the community. In addition, if there were conditions that the PHU considered 
appropriate for inclusion these were discussed in the first instance with the operators to determine 
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whether or.not these were achievable and/or practical, before such conditions were added as part of 
the permit conditions. The PHU still received complaints over the use of 1080 in spite of earlier 
comment that they communicate well with the operators. In addition, major oversights concerning 
1080 operations have seen a complete rethink by DoC about their contracting of sensitive tasks in 
the area. 
PHU 3 has claimed that 1080 baits were found in a popular walking track following 1080 aeria~ 
application. In this particular situation, the operator apparently believed that 48 hours were 
allowed to check the track following bait application in accordance with the standard approval 
conditions. Theft was also mentioned as one of the complaints received by PHU 3. Investigation 
revealed that the 25 kg bag of 1080 pellets stolen was part of a consignment of bait material 
ordered 12 months previously by DoC. The consignment had apparently been stored at a 
contractor's warehouse and the theft has been detected at the time. 1080 was classified as "Deadly 
Poison" under the Toxic Substances Regulations. Although, people who are engaged in 1080 
commercial activities can legally use 1080, it is legally required that this product should be strictly 
kept out of reach of unauthorised individuals and must be stored under lock and key and not 
ordinarily stored in a warehouse accessible to the public. 
Unforeseen circumstances could occur in aerial operations. PHU 8 claimed that in a DoC 1080 
operation, 2-3 baits were thought to have fallen from a bait bucket while flying over an area outside 
the operational zone. A child picked up a bait but the child's mother was able to intercept the bait 
before the child was able to do anything with the bait. Unfortunately, the child's dog ate the bait 
and subsequently died. The child could have been poisoned had the mother not seen her child pick 
up the bait. This incident clearly illustrates that accidental dropping of 1080 in public areas outside 
the operational zone has indeed occurred. In the model permit conditions (Ministry of Health 
1995b), the use ofDGPS cannot be imposed in all cases because of its limited availability in New 
Zealand. Only four firms have DGPS available which is considered to be inadequate to cater for all 
the aerial operations by both the DoC and AHB (PCE 1994). This information appears to be out of 
date as the number of DGPSs has increased since these documents were published (M Kennedy 
pers. comm. 2007) 
Unsubstantiated claims were also reported, includings: 
• A father reported that his son had picked up a bait and a dog died after eating some baits in 
the same incident and that this track was outside the operational zone. There was a 
suspicion that the baits in question were deliberately placed after having been stolen from 
an earlier operation and the Police have investigated this incident. 
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• There were also claims that baits were dropped outside the operational zone, although 
some incidents may have related to windfall baits being deposited on paths some days after 
the aerial operation. DGPS records indicated no breaches of the operational zone occurred 
during aerial bait operations. 
Summary and Conclusion 
The information provided by the PHU s suggests that there were genuine reasons for the general 
public to be concerned from 1080 usage as demonstrated on a number of occasions, for instance, 
1080 baits have fallen outside the operational zone, lack of notification that a 1080 operation is 
occurring at a certain date, 1080 baits found in water supply catchment, baits stations were found in 
areas where the public have ready access, and baits not removed from walking tracks. 1080 
hazards in places where people expect to be safe, e.g., public places, are hazards that will be 
perceived by the public in a context wider than that of scientific risk assessment. 
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Table 1. Preliminary information on the way 1080 is used involving Public Health Units 
PHU Ql Q2 Q3 Q5 
1 Yes Approx 6 Yes No 
2 Yes 25 average Yes Yes 
3 Yes 10 aerial Yes Yes 
14 ground 
4 Yes 2-3 Yes, but only private supplies Yes 
5 Yes Average 4 Yes No (PHU 1) 
6 Yes 8 aerial; 5 ground Yes 
7 Yes 15 average Yes 
8 Yes 2-3 aerial Yes 
2-3 hand-laid 
9 Yes 30-35 average Yes 
10 Yes 78 average Yes 
11 Yes 40 average Yes 
Data were collected in 2002 
PHU (number.)- code assigned to each PHU to keep anonymity ofrespondent 
Q 1 - Is 1080 ever used in your area? 
Q2- Approximately, how many 1080 operations occur annually in your area? 
Q3 - In your permit conditions, has 1080 been permitted to be applied in any catchment area from which water is drawn from human consumption? 
Q4 - What precautions do you usually require to minimise the possibility of water contamination? 
Q5 - Have you received any complaints relating to 1080 operations? 








Table 1. Continued 
PHU Q4 Q6 
1 Conditions imposed were based on the Ministry of Health's model None 
permit conditions for 1080 and Medical Officer of Health's permit 
conditions 
2 Standard conditions14 plus: Few complaints. None that have been substantiated. Complaints about the 
Exclusion of school holidays/long weekends/duck shooting season death of dog and sending abusive letters to the PHU. 
for areas where people pressure will be higher, particularly when 
people from outside the area may be visiting. Requirements for 
warning signs to be translated to foreign language where 
appropriate. 
Inclusion of a request for operators to have a very low threshold for 
notification of incidents in areas where there are sensitive for any 
reason. 
Closure of high use walking tracks until staff can safely walk 
through these areas. 
3 Conditions listed in Section H of the Medical Officers of Health Off target application of 1080 which is purported to have killed a dog. 
conditions. Secondary poisoning resulting to dog's death. 
Green material purported to be 1080 bait found on public road following a 
1080 operation. Analysis of material found no 1080 present. 
Aerial application of 1080 to a popular walking track. 
Discovery by Police of an unopened 25kg bag 1080 pellets while exercising a 
search warrant in a house. The finding of 1080 bahs on a urupa by a young 
child. 
Forestry crew showered with baits during aerial operation. 
4 Water tests include potable water extraction points. Asked Signs not removed after an operation. A forestry worker complained that he 
applicants to communicate within all water users. was being poisoned three years after the application took place. 
Secondary poisoning of dogs. 
5 Exclusion of the immediate intake zone and upstream 200m; if No complaints are received but "protests" prior to or during operations. 
practical the intake was disconnected; contingency emergency plans Operators are required to record complaints sometimes these are audited. 
for aerial applications; liaison with water supplier; audit of bait 
placement for ground operations. 
14 Conditions specified in the MOH permits 
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6 Section Hof the Medical Officer of Health's model conditions Call mainly from adjacent landowners or deerstalkers that were concerned 
applied. about upcoming operations. 
Alternative water supplies. 
7 Standard conditions are imposed. Dog poisoning. 1080 paste ( confirmed) found by children in a detergent 
Waterways used for water supply to be inspected after the operation bottle. 
any wayward baits were removed. Complaint re 1080 application that did not have approval. 
Water supply monitoring to be carried out. Complainant concerned that they (including neighbour) were not informed re 
upcoming 1080 operation. Operator did not follow own guidelines or read the 
approval. 
1080 poisoned possum carcasses disposed in offal fits and may affect 
groundwater. 
Possible 1080 contamination of spring/stream/river supplying water. Iwi 
opposition to 1080 operation re water contamination. 
8 Attachment Hof the Application for Permission imposes strict 1080 activists group is by far the largest group of complaints received. 
conditions on the applicant to protect the quality of drinking water. A child picked up a bait outside the operational zone. 
Any accident is to be immediately reported to the MOH to enable Trampers entered the aerial zone the night before the operation before signs 
remedial action. were erected on the morning of the operation. They were unaware that they 
Water supplies are switched off if necessary. had entered a "closed area" and baits falling from the helicopter struck them. 
A number of dog deaths complaints followed the RC's operation. 
Claims that baits were dropped outside operational zone. 
9 Standard conditions apply Community opposed to 1080, especially aerially applied. Concerns include 
possible water and environmental contamination, human and animal health 
Homeowners are consulted and alternative water supplies are risks, community stress. 
instituted upon request by affected people and this remains until the 1080 baits found in water supply catchment. 
water is tested as free from 1080. Signed permission forms from 1080 baits found in water supply catchment and intake. 
affected persons are sought before permission is granted. No consultation until 2 days prior to the aerial application of 1080. 
Baits ended up in a creek and picnic ground accessible by the public. The 
picnic area was however closed by the Council for the operation, but anti 
1080 groups went into area and found the baits in the creek bed. 
Baits were found on walking racks along with dead possums, and an absence 
of signage. 
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10 Standard conditions apply Deer hunters not wanting 1080 to be aerially dropped as they kill whitetail 
deer. 
A farmer concerned about an aerial operation and that the baits should not be 
dropped to his property. 
Objections raised relating to air and waterways being polluted by 1080 
during public meetings regarding possum control by the local iwi. 
Complaints from the public that bait stations were visible and too close to a 
public road. 
Complaint received from the local DOC staff regarding bait being laid too 
close to a public walking track. 
Local residents were concerned about the hand laying of 1080 within the 
vicinity of their town's water supply. 
A complaint made by deerstalkers about dead animals in a water catchment 
area and also comments about carrot bait in a water supply zone. 
11 Condition 1-4 sect H of the application form for all baiting 1080 baits not being removed from some areas of walking tracks in DOC 
operations; Condition 5 for aerial application where water supply is Forest Park prior to tracks being reopened to the public. 
from surface or gallery source. Inadequate cleanup of farm airfield loading site ( fall of snow covered some 
bait residues which were then discovered a few days later after snow melt). 
Depending on the catchment type, a minimum distance from the Opposition to an aerial 1080 operation on to a water catchment area. 
water edge. A number of complaints relate to dogs deaths. 
Often notices were removed or defaced. 
283 
Appendix Sa. Postal survey on work characteristics of 1080 workers 
Less is known about the patterns of exposure of children and other individuals living in households 
with 1080 workers. No study has been carried out to address whether these individuals may have 
been potentially exposed through this route of exposure. 
This survey aimed to determine the likely exposure of members of the public that may arise from 
associating with people directly involved in handling 1080. This involved personal behaviours, 
and their interaction with people living in the same household. Although occupational exposures 
were excluded from this study, their inclusion in this part of the survey was to identify working 
habits that may affect the exposure of people living in the same household. Because there is 
considerable scientific interest in the manner in which workers were exposed to 1080, these 
findings may potentially be important in informing policy and programmes that are aimed to train 
workers in 1080 safety. 
Selected studies reviewed 
The "take-home" exposure pathway was shown to be a significant contributor to residential 
contamination in the homes of agricultural workers (Hood 2002). Since there are no studies that 
are available relating to 1080 "take-home" exposure, "take-home" exposure pathways arising from 
the use of pesticides relevant to this study were reviewed. In addition, studies which may not be 
due to "take-home" exposures (studies were not described as "take-home') but were due to 
contamination of their homes because of their proximity to the treated area were also included in 
the review for information and interest. 
Curl et al. (2002) reported that "take-home" exposure among families of farm workers in 
Washington State found that azinphos-methyl was the most commonly detected pesticide in both 
house dust and vehicle dust. Azinphos-methyl was found in 85% of the household dust samples 
and 87% of the vehicle dust samples above the limit of detection which showed a significant 
correlation between pesticide concentrations in house dust and vehicle dust. Furthermore, urine 
sample analysis showed that one of the metabolites of azinphos-methyl was present in the urine of 
88% of the children and 92% of the adults. This evidence supported the likelihood that the 
pesticide was transported from the clothing or skin of workers into the vehicles and eventually into 
their homes. In another study, Zahm and Ward (1998) investigated "take-home" exposures of 
parents occupationally exposed to pesticides and childhood cancer. Although the research was 
limited by non-specific pesticide exposure information, small numbers of exposed subjects, 
potential for recall bias, and a small number of studies for most cancers, the magnitude of the risks 
was often greater than adults, indicating greater susceptibility of children to the carcinogenic 
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effects of pesticides. Of concern were leukaemia, neuroblastoma, Wilm's tumour, soft tissue 
sarcoma, Ewings sarcoma, non-Hodgkin's lymphoma, and cancers of the brain, colorectum, and 
testes. 
Lu et al. (2000) found that concentrations of azinphos-methyl and phosmet in the house dust of 
agricultural workers were elevated above concentrations of these pesticides in the house dust of 
non-agricultural workers. This occurred regardless of proximity to the farmland. Residues of 
agricultural pesticides were detected on the work boots, vehicle steering wheels, and children's 
hands of many of the agricultural families, but not of the reference families. Moreover, children 
whose parents reported garden use of insecticides had higher levels of organophosphate pesticide 
metabolite than did children whose parents did not use garden insecticides. Workers who were 
involved in mixing, loading, or applying pesticide formulations had detectable levels of pesticide 
residues in their house or vehicle dust, compared to those who did not perform these job tasks 
(Coronado et al. 2004). It was found that workers who thinned crops appeared to have greater 
levels of pesticide residues in their homes and vehicles than workers who did not thin crops. This 
probably contributed to the levels of pesticides to which children in the households were exposed. 
It would appear that pesticides brought home on workers' bodies, clothing and shoes accumulated 
in the home environment, thus potentially exposing children and other family members. The 
presence of a "take-home" pathway of pesticide exposure was also demonstrated in Oregon by 
McCauley et al. (2001) who showed a direct correlation between the number of agricultural 
workers living in a household and the concentration of azinphosmethyl found in dust collection 
from the home. It was estimated by the authors that the median levels would increase by 
approximately 40% for each additional person living in the house. 
Data from a preliminary study conducted by Hernandez-Valero (2001) showed that children of 
migrant farm workers who were exposed to pesticides in utero or through breast-feeding were at 
high risk of developing associated health problems. Garry et al. (2002a) compared the frequencies 
of birth defects among live-born male and female children according to paternal fungicide use. 
More male children were born to families whose male partner did not apply fungicides than those 
who applied these products. Regarding birth defects, more male children were born with birth 
defects than female children. Comparing birth defect frequencies during the first year of life 
showed a 1.5 fold or more increase in the frequency of most birth defects compared with an earlier 
cohort study conducted by the same authors. Spouses of pesticide applicators who used herbicides, 
insecticides, and fungicides had more miscarriages than any other pesticide application group 
(Garry et al. 2002b). The age at menarche between rural and urban women was also investigated 
in the same study. Authors suggested that the reproductive life span (menarche to natural 
menopause) among women who live on farms or rurally (36.5 yr) was somewhat shorter than for 
women currently living in an urban setting (38.9 yr). This 2.4-yr difference in reproductive life-
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span was significantly different. It appears that women who live on farms or in rural areas where 
pesticides may be used are at greater risk than women living in urban areas. In the same study, 
significant reductions in male births in relatively small populations were observed. The 25% 
reduction in male births in the children of applicators that apply herbicides, insecticides, and 
fungicides was significant, but subject to question on biological grounds. Paternal exposure and 
use of dithiocarbamate pesticides and combinations of other pesticides led to significant increases 
in the spontaneous abortion rate among farm women (Savitz et al. 1997). 
The population of greatest potential risk of exposure to pesticides found in carpet dust are infants 
and toddlers (ages 0.5 -5 years) who may ingest dust through mouthing of hands, toys and other 
objects (Whitmore et al. 1994). It was concluded in this study that dust ingestion could constitute a 
substantial proportion of a child's exposure to pesticides in some homes. The data also suggested 
that a child may be exposed to a greater number of pesticides in the home by ingestion of house 
dust than by inhalation. Dermal absorption of pesticides from house dust may also be a potential 
route of exposure for small children. Loewenherz et al. (1997) suggested that 44% of children of 
pesticide applicators were found to have detectable levels of organophosphate residues. 
Simcox et al. (1995) studied 59 families involved in farming, families residing on farms, and non-
agricultural families in the Yakima Valley, and levels of four organophosphate pesticides were 
compared. Chlorpyrifos was detected in 95% of the homes. House dust concentrations were 
consistently higher for agricultural families than for non-agricultural families. Pesticide applicators 
tended to have higher house dust concentrations compared to nonapplicators. There was a 3-fold 
difference in median chlorpyrifos house dust concentration between farm workers who did not 
directly handle pesticides and reference families of nonfarm workers who lived in agricultural 
communities. 
Methodology 
A statistician (G. Purdie) was consulted concerning the survey instrument, the sample size, and 
whether th.e answers ( e.g, coding) results were statistically analysable. The outcome of this 
consultation is summarised below: 
Sample size 
The names and addresses of individuals who were accredited members of the NPCA were provided 
to the researcher (NF) through the assistance of that organisation. The NPCA also provided a letter 
endorsing the survey and seeking for the support of their members (Appendix 8a). The NPCA 
members included workers who were directly or indirectly involved with 1080. Since the intent of 
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this survey was only to include workers directly involved in handling 1080, a request was made to 
the NPCA for a list of 1080 workers. However, the NPCA was unable to identify who were 
actually handling 1080 and/or contractors carrying out 1080 work. In addition, the NPCA also 
raised privacy issues regarding the willingness of the contractors providing names of 1080 users. 
Therefore, the survey questionnaire was sent to all the NPCA accredited members (total= 531 ). 
Survey instrument 
A simple postal questionnaire (Appendix 8b) consisting of 15 questions relating to whether or not 
the respondent is using 1080, job tasks, protective practices and demographic characteristics was 
developed to gauge the public's exposure to 1080 workers and their families and close contacts. A 
copy of the questionnaire was sent to the NPCA for any comments/suggestions. The NPCA found · 
the questionnaire acceptable. 
Ethical approval (Departmental level) was obtained from the University of Otago Ethics 
Committee before the survey was conducted. As a requirement of the Ethics approval the 
completed questionnaires were to be stored at the University of Otago for a period of five years. 
Mailing labels of study participants were printed and these were numbered to match numbers on 
the questionnaires. In this way, responders and non-responders could be tracked down. The 
questionnaire was sent with a covering letter, endorsement from NPCA, and an addressed stamped 
envelope. The covering letter highlighted that the results from the survey were strictly confidential 
and anonymity of replies was ensured in that respondent names would not be recorded for the 
purposes of data analysis. 
Follow-up 
The researcher made two telephone calls to two non-respondents, five weeks after the 
questionnaires were sent out, reminding them to submit their questionnaires prior to the follow-up 
survey. The follow-up call provided an opportunity to determine that the survey questionnaire was 
not returned because the participants were not directly handling 1080. It may have been possible 
that other participants may have also thought the same way, even though the questionnaire 
requested participants to return the questionnaire and that they should tick the 'NO' box on the 
questionnaire if they were not handling 1080. 
Due to the low response rate (35%) follow-up letters were sent to non-respondents, six weeks after 
the first mail out. Follow-up letters highlighted an instruction to tick the 'NO' box if they were not 
handling 1080 and return the questionnaire to the researcher. 
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Bias 
Bias was minimised by sending questionnaires to all NPCA members (see Sample size) as 
members would represent those who are directly and indirectly handling 1080. The samples would 
be sufficient to represent the behaviour of 1080 handlers' population. The questionnaires were 
coded (see Appendix Sb) and encoding was developed with the statistician (G. Purdie) and the 
validity of the codes was tested by verifying whether or not the codes were statistically analysable. 
This was done by taking few samples and entering the codes on the data entry programme (see 
Data entry). The interviewers were trained how to enter the codes on the data entry programme. 
Response rate 
The follow-up survey increased the response rate to 74% (excluding participants with wrong 
addresses, total N=474) and a 66% response rate based on the total number of participants (total 
N=53 l ). The total number of respondents related to those who were directly handling 1080 or not. 
Among the total number ofrespondents, 127 respondents were identified as directly handling 1080. 
Eligibility criteria 
All respondents who were directly handling 1080 were eligible for inclusion in this study. 
Therefore, only the responses from 127 workers directly handling 1080 were included in the final 
data analysis. 
Data entry 
A data entry programme was developed using Microsoft Access 2000. The programme was 
developed with the assistance of a statistician (G. Purdie) to ensure that the correct coding was 
entered into each question. 
Contractors were trained to enter the data on the data entry programme. During the data entry 
process, it was found out that there was no field created for "other" for protective clothing. 
Interviewers provided the data as "write ins", and these were later entered on by the author (NF) to 
the database prior to statistical analysis. 
Validation of data 
It was intended to validate data by generating 30 random numbers using Microsoft Excel. 
However, the survey questionnaires which should have been kept in a secure location in the 
Department, as a requirement of the Ethics approval, could not be located. It was assumed, 
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therefore, that the data entered were accurate representation of the data from the survey 
questionnaires. 
Statistical method 
Ideally, a power test should be done a priori, in order to determine the sample size. A post-hoc 
power analysis could have been done to determine the test's power to detect differences of 
magnitudes that were scientifically meaningful, at the alpha rate employed. However, the sample 
size had already been constrained by practical issues related to recruiting subjects, i.e., the sample 
size could not be increased whether or not a power test was carried out, hence a power analysis 
post-hoc was not performed. 
Results from this survey were analysed statistically using the Statistical Analysis System (SAS). 
The Chi-square test ( exact) was the method employed to determine the statistical significance of 
the data because this test is often used to analyse categorical data (Downie 1983; Harraway 1992). 
Data analysis 
Ethnicity was categorized as European, Maori/Pacific and Asian/Others, consistent with how the 
data in the telephone survey (Appendix 9c) were handled. Age groups were formed (as for 
groupings in the telephone survey) with the added category of "less than 18 years" as there were 
fourteen respondents in this category. 
The sample was small producing even smaller subgroups. However, statistical tests to determine 
significance of the differences were conducted by forming new variables. Groups were combined 
in order to perform statistical tests with small subgroups. On their own, some subgroups could not 
have any analysis done on them. But since the relative proportions of the subgroups pre and post 
combination are intact, this should not be an issue. 
These were: 
• A new q 11 variable called 'nq 11 ', was formed to have two categories: "Living with 
others" and "Not living with others"; 
• Similarly, a new q12 variable referred to as 'nq12' was formed with categories: "Living 
with children" and ''Not living with children"; 
• Questions 4 and 7 were combined to form a variable with categories: "Brings home 
contaminated equipment" and "Does not bring home contaminated equipment"; 
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• Questions 8 and 9 were combined to form a variable with categories: "Contaminated 
vehicle" and "Not contaminated"; 
• A new q3 variable was formed with categories: "Wears protective clothing" and "Does not 
wear". A respondent who wears any of the choices listed under question 3 was classified 
under the first category. 
• Similarly for question 5: "Careful with contaminated personal equipment" and "Not 
careful" (if yes to any of choices 3, 5, 7); 
• Same for question 6: "Takes precaution" and "Does not take precaution" (Yes to choice 5). 
• Significance tests were performed on each of nq3, nq4_7, nq6, nq8_9 vs. each of nqll, 
nql2, nql4, andnq15. 
• There was no analysis of gender as there were only 6 female respondents. 
Results and Discussion 
A number of studies have demonstrated that pesticides brought home on worker's bodies, clothing 
and shoes accumulate in the home environment, thus potentially exposing children and other family 
members. This statement could potentially apply to 1080 and the likely exposures of people living 
with them would depend on their working behaviour. A study conducted, for instance by Lu et al. 
(2000), Simcox et al. (1995), and Curl et al. (2002) suggested that the "take-home" pathway has 
been a significant contributor to residential contamination in homes of agricultural workers. 
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. Table2 
Description of protective clothing applied by 1080 workers 
Protective clothing Percentage* 
Disposable overalls 32 
Non-disposable overalls 65 
Disposal gloves 60 




* same respondents listed > 1 protective clothing 
The respondents were asked what types of protective clothing they used when handling 1080 or 
1080 baits. The 1080 workers applied one or more of the protective clothing listed in Table 2. 
Other protective clothing employed but not listed on the Table (frequency =1 or 2) included 
earmuffs and hardhats/helmets, eye protection, face shield, goggles, raincoat and legging, and wet 
weather gear. · 
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Table 3 
Demographic characteristics of 1080 workers and their work practice of using 
protective clothing 
Characteristic Uses protective Does not use 
clothing protective clothing Chi-Square 
(%) (%) 
N= 115 P= 0.49 
Living with others 76 10 
Not living with others 13 1 
N= 113 P= 0.90 
Living with children 47 6 
Not living with children 42 5 
Ethnicity N=l12 P= 0.36 
Maori/Pacific Islander 12 0 
NZ European 68 10 
Asian/Others 9 1 
Age (years) N= 125 P= 0.70 
Less than 18 10 1 
18 to 24 3 0 
25 to 34 24 4 
35 to 44 19 2 
45 to 54 24 4 
55 and up 9 0 
There were no associations observed between ''uses protective clothing" and "does not use 
protective clothing" and "living with others" or "not living with others", "living with children" or 
"not living with children", age and ethnicity (Table 3). No significant associations implied that 
whether or not there were other people or children living with the respondents did not affect their 
behaviour regarding use of any protective clothing ( they may or may not use protective clothing). 
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Table 4 
Percentage of 1080 workers with respect to bringing home contaminated materials 
Work Practice Percentage 
Bring home contaminated materials 24 
Does not take home 76 
N= 125 
Table 4 illustrates the number of 1080 workers who took or did not take home-contaminated 
materials with them. .As can be seen, only a small proportion of 1080 workers took hoine-
contaminated materials, suggesting good work practice. 
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Table 5 
Demographic characteristics of 1080 workers and their work practice of bringing 
home contaminated materials 
Characteristic Bring home Does not bring 
(%) home Chi-Square 
(%) 
N= 115 P= 0.75 
Living with others 19 3 
Not living with others 67 11 
N= 113 P= 0.81 
Living with children 11 11 
Not living with children 42 36 
Ethnicity N= 112 P= 0.80 
Maori/Pacific Islander 4 9 
NZ European 17 61 
Asian/Others 1 8 
Age (years) N= 125 P = 0.12 
Less than 18 4 7 
18 to 24 1 2 
25 to 34 5 23 
35 to 44 3 18 
45 to 54 6 22 
55 and up 5 4 
There were no associations observed between "bringing home" and "does not bring home 
contaminated materials" and "living with others" or not "living with others", "living with children" 
or "not living with children", age, and ethnicity (Table 5). 
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Table 6 
Behaviour of 1080 workers with their personal equipment that have been 
contaminated with 1080 
Work Habits Percentage* 
Leave at work 43 
Wash/ clean boots 59 
Wash separately 61 
Wash with other clothes 8 
Dry clean 8 
Mixed with clean material 3 
N=l15 
* same respondents listed > 1 work habits 
Respondents demonstrated various working habits with respect to what they did with their 
contaminated personal equipment (Table 6). There were 61% respondents who washed their 
clothes separately, followed closely by wash/clean boots before re-entering the work vehicle 
(59%), and 43% for those who left their items at work to be cleaned. A small percentage appeared 
to be not taking precautionary measures, for example, those who washed work clothes with other 
clothes (8%) and mixed them with clean materials (3%). 
Other working habits (Frequency = 1) mentioned were: 
• protective clothing carried in special container/separately 
• rinse and clean all gear on job 
• boots changed before entering vehicle/ change footwear 
• contaminated clothes on rear of ute in locked box 
• disposable gear or contaminated clothing destroyed by company or hazchem unit or 
goes to landfill 
• don't leave contaminated site until it has been fully decontaminated 
• lunch is packed separately 
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Demographic characteristics of 1080 workers and their work practice of being 
careful with contaminated personal equipment 
Characteristic Careful Not careful Chi-Square 
(%) (%) 
N= 115 P= 0.98 
Living with others 81 5 
Not living with others 13 1 
N= 113 P= 0.79 
Living with children 48 4 
Not living with children 45 3 
Ethnjcity N= 112 P= 0.88 
Maori/Pacific Islander 12 0.5 
NZ European 74 4 
Asian/Others 9 0.5 
Age (Years) N= 125 P= 0.70 
Less than 18 10 1 
18 to 24 3 0 
25 to 34 26 2 
35 to 44 20 3 
45 to 54 26 1 
55 and up 8 0 
Significance tests were performed between "careful with contaminated personal equipment" and 
the "not so careful" respondents vs. the various demographic characteristics used in the survey. No 
significant associations were noted in all cases as demonstrated in Table 7. 
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Table 8 
Precautionary measures of 1080 workers to minimise the possibility of 
contaminations 
Precautions Percentage* 
Wash hands 96 
Wash face 67 
Wash arms 61 
Take a shower 34 
Wash boots 55 
Remove work clothes 61 
N= 115 
* same respondents listed > 1 precautions 
When asked what precautionary measures were applied to minimise the possibility of 
contamination of other materials,. all of the respondents appeared to perform one or more of the 
precautionary measures listed in Table 8. Only one respondent answered that no washing was 
being undertaken. Other precautionary measures not listed in Table 8, accounting for one response 
each, include "change boots before leaving", "burn", and "packaged and stored in plastic". 
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Table 9 
Demographic characteristics of 1080 workers and precautions employed to minimise 
the possibility of contamination of other materials 
Characteristic 
Living with others 
Not living with others 
Living with children 






Less than 18 
18 to 24 
25 to 34 
35 to 44 
45 to 54 
55 and up· 
** Significant at 1 % level 
* Significant at 5% level 
Take precautions Does not take 
(%) precautions Chi-Square 
(%) 
N= 115 P = 0.01 * 
86 0 
13 1 
N= 113 P= 0.29 
53 0 
46 1 











Note: No statistics computed for the ethnicity data as the row or column sum is zero. 
It was found from this survey that those who "live with others" appeared to be "more careful" 
(86%) than if they lived by themselves (13%) (Table 9). However, when the question was focussed 
primarily on children, the answers of the respondents changed dramatically. It was observed that 
there was an almost equal proportion of them "being careful" whether they "live with children" 
(53%) or have "no children living with them" (46%) (Table 9). It appears that children were not 
treated in a special way as with others living in the same household. This finding was inconsistent 
with the question relating to "living with others" as respondents were careful irrespective of 
whether or not children are living with them. The 25-34 (28%), 35-44 (21 %), and 45-54 (28%) age 
298 
groups were found to be more the "careful" group compared with the other age groupings (Table 
9). Age appeared to have a significant effect on the working habits of the respondents. 
Children should not be treated as "little adults" (Olin and Sonawane 2003) as they are likely to be 
more vulnerable to the toxic effects of 1080 because they breathe more air and consume more food 
and water in proportion to their body weight, 1080 workers should be more vigilant with respect to 
their decontamination practices. One respondent (not directly handling 1080) commented that 
"little effort is made to prevent contamination and workers just get on with bagging and throwing 
up". 
With respect to ethnicity, New Zealand Europeans accounted for 77% of the "careful" group. 
However, the New Zealand Europeans comprised 77% of the respondents and so this may not 
necessarily imply that the New Zealand Europeans tend to be more "careful" th3? the_ other 
ethnicities. The high percentage may reflect the predominance of New Zealand Europeans in the 
1080 workforce .. 
A strong association (P<0.0001) was observed between ''taking" or ''not taking precautions" and 
age while an association at 5% level of significance (P=0.01) was observed with "living or not 
living with others". No association was noted between ''taking" and ''not taking precautions" and 
with "living or not living with children" (Table 9). 
Table 10 
Responses of 1080 workers with respect to "vehicle contamination" 
Vehicle Contamination Percentage 
Contaminated vehicle 50 
Not contaminated vehicle 50 
N= 125 
In Table 10 there was an equal split between respondents who answered that their service vehicle 
was being used for personal purposes or that their private vehicle was used to go to work and may 
have been contaminated with 1080 (50%) and those who "do not contaminate" (50%). It would 
appear that a large proportion of 1080 workers could be potentially contaminating clean personal 
belongings and also other people or passengers when the contaminated vehicle is being used for 
personal purposes. This finding concurs with Curl et al. (2002) and Coronado et al. (2004) where 
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the vehicle used for travel to and from work was a vector of chemical transmission, and that the 
residues found in the vehicle were markers of contamination from worker clothing or skin. 
Applying these findings to those of the 1080 survey suggests that measures should be taken to 
minimise vehicle contamination from exposed workers. 
Table 11 
Demographic analysis of 1080 workers and their attitude towards vehicle 
contamination 
Characteristic Contaminated (%) Not contaminated 
(%) Chi-Square 
N= 115 P = 0.46 
Living with others 45 41 
Not living with others 9 5 
N= 113 P=0.07 
Living with children 24 28 
Not living with children 30 18 
Ethnicity N= 112 P = 0.03* 
Maori/Pacific Islander 10 2 
NZ European 40 38 
Asian/Others 4 6 
Age ('{ears) N= 125 P=0.87 · 
Less than 18 2 9 
18 to 24 1 1 
25 to 34 13 16 
35 to44 11 10 
45 to 54 17 12 
55 and up 6 2 
* Significant at 5% level 
Whether or not children are living with respondents appeared to not change the worker's behaviour 
in relation to ''vehicle contamination". Similarly, this finding appeared to apply with respect to 
age, although the 45-54 age group comprised the highest proportion involved with ''vehicle 
contamination" (17%) while for those who "did not contaminate" the 25-34 age group were most 
frequent (16%). It should be noted that the overall pattern between the 25-34, 35-44, and the 45-54 
age groups was the same for these age groups (Table 11 ). 
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At the 5% level of significance (P=0.03), an association was detected between "contaminated" or 
"not contaminated vehicle" and ethnicity. However, no such associations were observed between 
"contaminated" or "not contaminated vehicle" and "whether or not living with others", ''whether or 
not living with children", and age (Table 11 ). 
When respondents were asked what precautions they applied to minimise the possibility of 
contaminating other passengers or users of their vehicles, 4 7% answered that they did not transport 
contaminated materials, 4% answered that they did not take precautions, 44% pack separately 
contaminated materials, and other precautions accounted for 5 %. 
Table 12 
Protective practices of 1080 workers and relationship with their work activities 
Activities Baiting only (%) Factory and 
baiting Chi-Square 
(%) 
N= 129 P = 0.18 
Does not use protective clothing 8 -
Use protective clothing 79 13 
N= 119 P = 0.19 
Bring home contaminated 23 1 
clothing 
Does not bring home 63 13 
contaminated clothing 
N= 119 P= 0.54 
Careful 83 14 
Not careful 23 1 
N= 119 P=0.86 
Does not take precaution 4 1 
Take precautions 82 13 
N= 119 P=0.23 
Contaminated vehicle 42 9 
Not contaminated vehicle 44 5 
There were no associations observed between 1080 activities (baiting or factory and baiting) and 
''whether or not respondents use protective clothing", and ''whether or not they bring home 
contaminated materials", and ''whether or not they are careful", and ''whether or not they take 
precaution", and "whether or not their vehicle is contaminated" (Table 12). 
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The mode of 1080 activities the responders were engaged with did not appear to have affected their 
working habits. Of respondents who were involved in baiting operations, 79% used protective 
clothing, 63% did not take home-contaminated materials, 83% were careful, and 82% took 
precautions. With respect to "vehicle contamination", 42% have answered that they "contaminate 
their vehicle" while 44% did not appear to contaminate their vehicle (Table 12). Although it 
appears that a majority of the respondents have exercised some form of precautionary measures, a 
moderate proportion of the respondents may not be applying precautionary measures thus 
increasing or potentially putting the health of people living with them at risk. 
· The PCE report (1994) noted that the possum control industry spent insufficient time and resources 
developing quality control standards and this attitude has resulted with the public distrust of 
poisons. 
Some comments from those who were not using 1080 are summarised below: 
• Most of the work in their area is contracted out now which has created implications for 
monitoring the performance of their operations (this was also mentioned in the PCE 1998). 
• Odd 1080 pellets were seen on the ground. 
• Interested in doing work on the effects of land, micro fauna, micro flora, etc. 
• Do not work directly with 1080 but on occasion come close to those that do and have 
noticed that little effort is made to prevent contamination. "Workers just get on with 
bagging and throwing up". 
Summary and Conclusion 
This study found several interesting results that would warrant further investigation. Risk 
perception studies could, in principle, provide information which, together with other kinds of 
information, such as complaints raised by the general public, would constitute a useful background 
against which policy can be formed. 
1080 workers may be routinely exposed to 1080 as part of their occupation. Many of these workers 
perform job tasks that have high risk for direct exposure to 1080, such as mixing, loading, or 
applying 1080 formulations. Under the Health Safety in Employment Act employers are required 
to ensure that their employees wear personal protective equipment and training be provided to these 
workers. The workers need to be well informed about risks and appropriate actions that need to be 
taken. 
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Respondents appeared to use precautionary measures while engaged in 1080 activities. A minority 
of respondents had poor working habits which may result in contamination of the people living 
with them, in particular children. Of great concern was the behaviour of 1080 workers with respect 
to the use of their vehicles, where half of the respondents appeared to be not taking precautions to 
prevent their vehicle from being contaminated and may be potentially exposing the people who are 
in contact with the vehicle to the risk of contamination. 
Of particular interest are children and how they may be at greater risk of being exposed to 1080. 
Cleaning activities at home play a major role in reducing children's exposure. Since, the home 
environment is not subject to degradative environmental processes such as sun, rain, and soil 
microbial activity (Simcox et al. 1995), the biodegradation of 1080 could occur at a slower pace, 
on the assumption that the house has been contaminated, than in outdoor soil. Children may be 
uniquely susceptible to this exposure because they spend greater amounts of time on carpets and 
floors (where 1080 may accumulate), and they engage in hand to mouth behaviour (increasing their 
likelihood of ingesting 1080 contaminated materials) (Mills and Zahm 2001 ). 
The findings also suggested that the working behaviours of 1080 workers were not altered 
according to whether or not they lived with others, including children. Since other studies of 
pesticides (e.g., Curl et al. 2002; Lu et al 2000,) have demonstrated "take-home" exposures, 1080 
workers also need to be more vigilant with respect to their working behaviour to not only to keep 
themselves safe but also the people around them. 
Studies commissioned by DoC and AHB showed 1080 levels in the urine of 1080 workers, for 
instance by O'Connor et al. (2000, 2001) where there were some samples showing levels above the 
BEi set by the Department of Labour (Workplace Services). Since biological monitoring was 
outside the scope of this study, urine samples of those people living with 1080 workers were not 
determined. However, evidence has suggested that 1080 workers were indeed exposed to 1080 
while carrying out 1080 activities. The possibility that 1080 workers may be contaminating people 
living with them and thus potentially putting them at risk cannot be ruled out. Adequate 
precautionary measures must be employed at all times when workers are involved with 1080 
activities. 
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Appendix 8b. Endorsement letter from NPCA 
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Level 5, Agriculture House, 12 Johnston St, PO Box 11 461, WELLINGTON 6034 
Telephone +64 4 499 7559 Facsimile +64 4 473 1603; 
Email npca@.xtra.co.nz Web www.npca.org.nz 
Survey into Pesticide Related Issues 
A survey being carried out by the University of Otago on issues related to the use of 
pesticides is commended for your support. 
Details on the aims and process to be used are contained in the enclosed letter. 
Research into public attitudes on pesticide use should improve our understanding on 
the safe use of toxins and assist associated public awareness programmes with the 
challenge of maintaining a supportive climate for pesticide use. 
For these reasons we are happy to endorse this survey and your co-operation will be 
appreciated. 
If you have any queries then please direct them to Natalia Foronda, Environmental 
Health Team, Ministry of Health, Wellington. Refer to the enclosure for contact 
details. 
Yours sincerely~,. / 
~
. / 
1,1 :~ ~-~1, (/l' .. 
Maurice Kennedy 
National Co-ordinator - NPCA 
Appendix 8c. 1080 workers postal survey questionnaire 
QUESTIONNAIRE 
Q.1 Are you using or working with1080? 
DYes ONo 
~ GotoQ.2 Please return the questionnaire 
Q.2 Which of the following activities are you involved? (PLEASE TICK ALL THAT 
APPLY.) 
D Factory exposure: 
D Mixing & handling 1080 concentrate solution 
D Manufacturing of 1080 cereal baits 
D Baiting operations using 1080 
D Aerial, carrot 
D Preparation of 1080 baits, i.e. spraying of diced 
carrots 
D Loading & handling 1080 carrot baits 
D Aerial, cereal 
D Loading & handling 1080 baits 
D Ground application 
D Application of 1080 baits, e.g. bait stations 
D Loading & handling 1080 baits 
Q.3 What types of protective clothing do you use when handling 1080 or 1080 baits? 
(PLEASE TICK ALL THAT APPLY.) 
D Disposable overalls 
D Disposable gloves 
DMask 
D Non-disposable overalls 
D Non-disposable gloves 
D Boots 
D Other (specify): ______ _ 
Q.4 Do you bring home contaminated clothes/overalls, shoes/boots, and other personal 
equipment from your place of work? (PLEASE TICK ONE BOX.) 
DYes DNo 
Q.5 What do you do with your contaminated personal equipment? (PLEASE TICK ALL 
THAT APPLY. 
D Leave at work to be cleaned 
D Wash/ clean boots before re-entering the work vehicle 
D Place with uncontaminated materials such as clean clothes 
D Wash work clothes separately 
D Wash with other clothes 
D Dry clean 
D Pack together with lunch bag 
D Other 
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Q.6 What precautions do you apply to minimise the possibility of contamination of other 
materials? (PLEASE TICK ALL THAT APPLY.) 
D Wash hands 
D Wash face 
D Wash arms 
D Take a shower 
D No washing undertaken 
D Wash boots thoroughly before leaving place of work 
D Remove work clothes before leaving work 
D Other 
Q:7 Do you take home-contaminated equipment other than personal items from your place of 
work? (PLEASE TICK ONE BOX.) 
D All the time D Some of the time D Never 
Q.8 Do you use your service vehicle (if any) for personal purposes other than 1080 related 
activities? (PLEASE TICK ONE BOX.) 
D All the time D Some of the time D Never 
Q.9 Does your private vehicle used to go to work get contaminated with 1080? e.g. loading 
contaminated equipment and/or personal belongings? (PLEASE TICK ONE BOX.) 
D All the time D Never 
D Some of the time D Use public transport instead 
Q .10 What precautions do you apply to minimise possibility of contaminating other passengers 
or users of your vehicle? (PLEASE TICK ONE BOX.) 
D Pack separately contaminated materials 
D No precautions 
D Not applicable ( don't transport contaminated materials home) 
D Other 
Q.11 How many people are living with you? PLEASE SPECIFY __ _ 
Q.12 How many children are living with you? PLEASE SPECIFY __ _ 
Q.13 Your Gender 
D Male D Female 
Q.14 Your Age (Please specify) __ years 
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Q.15 Your Ethnicity. (PLEASE TICK ONE OR MORE IF APPROPRIATE). 
D European 
D Maori 
D Pacific People 
D Asian 
D Other (Specify) __________ _ 
Thank you. Please return your survey using the envelope provided. 
D 
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Appendix 9a. Telephone survey on public perception of risk from the 
use of pesticides and 1080 
Disclaimer: This telephone survey was conducted by contractors. This survey was excluded from 
the main text of the thesis because of some issues raised with respect to the 100% reported 
response rate in the regions surveyed by the contractors in comparison with about 50% or more 
response rates generally achieved in such surveys, and found in the survey conducted by the author 
(NF). Apparently, there has been a miscommunication between the contractors and NF and the 
number of non-respondents were not recorded. The analyses were based on the data provided, and 
· the author does not make any watranty for the accuracy of the data. This Appendix is attached for 
readers' information and interest; and the data have been used for comparison purposes only 
because of reservations around the response rate. 
Public perception of risk from the use of pesticides and 1080 
In June 1990, . the Department of Health (now the Ministry of Health) commissioned a study 
describing the public attitudes to the use of chemicals (Department of Health 1990). A sample of 
800 respondents was randomly selected from the 18 regional telephone directories (White Pages). 
The survey was conducted by telephone. The survey findings indicated a significant level of public 
concern over the risk from pesticides. There was little support for an absolute ban on these 
products and there appeared to be a considerable support for more regulatory control. . . 
The 1990 report recommended conducting a similar survey in 1995 to check if public attitudes 
have changed (Department of Health 1990). However, no follow-up study was carried out which 
may likely be due to changes in the health sector. Therefore, this study has included a follow-up 
telephone survey with respect to risk perception from the current use of pesticides with emphasis 
on 1080. 
Selected studies reviewed 
An attempt was made to carry out a literature search on the risk perception of pesticides, with 
emphasis on 1080. Only the most relevant research studies were reviewed for the purposes of this 
study. Other subjects, such as electromagnetic field were also included, for example, for interest. 
People respond to hazards that they perceive (Slovic et al. 1981). Environmental threats, such as 
for instance drinking water contamination, air pollution, hazardous waste disposal, can have a 
tremendous impact on the public. Classic examples were the Love Canal15 and the Three Mile 
Is1and16, which created intense community concern, e.g., potential health (Schwartz et al. 1985) 
15 Love Canal was a landfill for chemical waste disposal and subsequently converted to residential properties. 
16 Accident happened when a nuclear reactor suffered a partial core meltdown. 
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and the confidence of the public with respect to the ability of the government in protecting its 
constituents (Bruhn 1992). In New Zealand, 1080 aerial application has been challenged by the 
community because it involved high environmental risks, particularly contamination of drinking 
water and impacts on non-target animals (Morgan 1998). 
Attitudes to "pest seriousness" tend to vary according to the age and sex of the person concerned. 
In general, older respondents were more concerned about pests than were younger people. Nearly 
65% of the respondents thought that not enough was being done to control possums, with a higher 
proportion of older people and males perceiving this (Sheppard and Urquhart 1991). For possums 
control, 70% of the rural people supported the use of trapping while the urban populati9n 
accounted for 54%. ·Males appear to support the use of cyanide more than women, accounting for 
58% and 33%, respectively. Over 50% of males found the use of 1080 for possum control "very 
suitable" or "suitable" while only 38% of the females supported its use. There were 56% females 
who considered the use of 1080 "very unsuitable" or "unsuitable" vs 39% of the male respondents. 
In a telephone survey conducted by Fitzgerald et al. (2000), respondents were asked to rate their 
acceptability to manual (shooting and trapping), poisoning (aerial and ground baiting), and 
biological methods for killing possums. Females were found to be less accepting of all the 
technologies mentioned than males. The most acceptable methods for killing possums were 
shooting (82%) and trapping (67%). The poisoning method included ground application of 1080 
poisoned bait, aerial application of 1080 poisoned bait, other poisons, and a hypothetical poison 
that kills only possums. Of these, a poison that kills only possums was considered the most 
acceptable, and was rated the most acceptable of all the technologies used in the study. Aerial 
application of 1080 and use of other poisons were the least acceptable of all the control methods 
listed. An apparent growing concern over the use of poisons, especially the use of 1080 was 
confirmed by the public focus group included in the study. Aerial use of 1080 was seen as of 
greater risk by respondents as opposed to biological controls, with males rating the risks lower than 
females. Participants, especially the females did not trust experts, despite reassurances about the 
safety of 1080. 
A study carried out by Horn and Kilvington (2002) suggested that Maori opposed to 1080 use were 
of the view that the risk to human health and the environment was "worse" when 1080 was 
dropped aerially because they felt that this was a less uncontrollable operation that when bait 
stations are used. Dog owners were concerned about their animals because of the proven 1080 
toxicity to dogs. The same authors also mentioned that respondents considered 1080 as a problem 
because it was most commonly used in large-scale aerial operations. 
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Several characteristics of individuals, such as gender, race, and sociopolitical attitudes, were related 
to differing levels of risks. Flynn et al. (1994) found that perceptions of risk were higher for 
women for every hazard studied which included a diverse set of technologies ( e.g., nuclear power, 
commercial air travel), lifestyle risks ( e.g., cigarette smoking, drinking alcohol), and environmental 
conditions (e.g., ozone depletion, radon). The concern about technological and environmental 
health risks shown by people of colour ( e.g., Hispanic, Asian, Black, American Indian) was also 
clearly documented in the same s_tudy. The percentage of high-risk responses was greater among 
people of colour on every item. This study showed that "non-white" males and females were much 
more similar in their perceptions of risk than were white males and females. Finucane et al. (2000) 
studied the perceptions on a wide variety of environmental and health hazards, including blood 
transfusions, motor vehicles, nuclear power plants, and vaccines. The study showed gender 
differences in risk perception on eve1y item, more females had high-risk responses than males. 
Racial differences were also reported, the percentage of high-risk responses was greater for "non-
whites" (e.g., African-Americans, Hispanic, Asia, American Indian) on every item. White males 
differed from others in their ratings of perceived risks to individuals and the public, a finding that 
has come to be known as the "white-male effect". In New Zealand context, "non-whites" will 
include Maori, Asians, Pacific Islander, Africans, etc. 
Concern about contamination of a public drinking water supply was highest among the younger 
respondents, among women, and among those whose children were under 18 (Hamilton 1985). 
Similarly, toxic waste problems were particularly alarming to women with young children 
(Hamilton 1985). Howe (1990) investigated the relationship between regional differences and 
public health concern about chemicals. The results showed that women were "more concerned" 
than men about exposures, pollution, and related health effects regardless of region. Sex was 
modestly but significantly correlated to overall attitudes on pesticide use, with women being more 
"anti-pesticide" than males (Dunlap and Beus 1992). 
In a study of the perception of risks of prescription drugs, Slavic et al. (1989) has failed to find 
gender differences but detected some age-related influence. An American study (Anon 1978) 
which reviewed the attitudes of Americans towards predator control suggested that people opposed 
to predator control were most likely to be urban; aged 18-29 years; white females; students or those 
with a college education; single; and bird watchers, backpackers or anti-hunting advocates. 
Conversely, people in favour of control tended to be rural, to be associated with the livestock or fur 
trapping industries, and to have less than eighth grade education. 
A research study by Dunlap and Beus (1992) found that responses to three general items (i.e., 
safety of pesticides for the human food supply; safety of pesticides for the environment; and 
possible pesticide contamination of groundwater), indicated a "moderately high level of public 
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concern" over the safety of pesticides for the food supply, a "higher level of concern" over the 
safety for their environment, and a "very high level of concern" over pesticide contamination of 
water supplies, even when pesticides "are used according to approved directions." Results from the 
same study, concluded that sex, age, and education were found to be modestly but significantly 
correlated to overall pesticide attitudes. Women, younger adults, and the well-educated were more 
anti-pesticide than their counterparts. When the safety of pesticides was examined, women were 
significantly more likely to be more concerned about safety than men and younger adults were 
slightly more concerned about safety. For the perceived necessity of pesticide use, education was 
found to be significantly related, with the more educated being more likely to see pesticide use as 
necessary (Dunlap and Bues 1992). Younger respondents, the well-educated, and those in higher 
income levels were found to be more likely than their counterparts to express "distrust" in the food 
industry in protecting consumers from pesticides (Dunlap and Bues 1992). McStay and Dunlap 
(1983) suggested that women were more likely to express their concern than men for 
environmental quality through everyday decisions regarding personal behaviour, whereas men are a 
bit more likely to express their concern by attempting to influence the decisions and behaviours of 
others. 
Risk perceptions relating to "hazardous waste site" showed that concern was "extremely high" 
before clean up was carried out and "moderately high" after cleanup (Bord and O'Connor 1992). 
Respondents or someone close to them were asked about their own level of concern arising from 
exposure to toxic chemicals. Over 80% expressed "high concern" for adult and childhood cancers, 
birth defects, and leukemia. Over 70% expressed "high concern" for liver, kidney, and bladder 
problems, lung problems (not cancer), miscarriages, skin problems, and other serious childhood 
diseases. As supported by previous studies mentioned, e.g., McStay and Dunlap (1983), females 
tend to make higher health risk estimates than males. The pattern for education was found 
interesting as it was suggested that concern was not significantly linked with education. It may be 
possible that education improves people's risk estimates, but may not lower their levels of concern. 
Most often, expert and lay views of environmental health risks were found to be inconsistent. 
Judgements of lay people of risk were related more to other hazard characteristics, for instance, 
catastrophic potential or threat to future generations (Slovic 1987). Slovic et al. (1981) suggested 
differences in risk judgements between lay people and experts, and reported many similarities 
between the lay people's groups while the views expressed by the experts differed markedly from 
them. For example, the experts viewed electric power, surgery, swimming and X-rays as "more 
risky" than did the other groups and they judged nuclear power, police work and mountain 
climbing to be much "less risky". Lay people sometimes lack certain information about hazards. 
However, their basic conceptualisation of risk was much richer than that of the experts and 
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reflected legitimate concerns that were typically omitted from expert risk assessments (Slovic 
1987). 
The extent and nature of the risks posed by pesticides have been clarified by several risk perception 
studies which compared the perceived risks of pesticides to those of range of technologies and 
activities (Dunlap and Beus 1992). For example, results of a survey of three Northern California 
communities survey showed that 63 percent of respondents were ''very concerned" over "pesticide 
residue in food," and ranked fourth in a list of ten potential hazards (Pilisuk et al. 1987). The 
findings of Slovic (1987) generally concur with these results, which demonstrated that the risks 
posed by pesticides were ranked "relatively high" (generally in the top third) among a wide range 
of 30 potential risks by both citizen groups and experts. "Unknown risks" and "dread risk" (i.e., 
nuclear power and nuclear war) were consistently found to produce high ratings of overall 
riskiness. The public tended to view pesticides as constituting a relatively major risk. This was not 
surprising as pesticides were viewed as a threat that was not well understood; that has delayed, 
long-term, and potentially fatal consequences; and therefore "dreaded" (Dunlap and Bues 1992). 
In the UK, issues that were associated with "popular concerns" and "outrage" were landfill sites, 
chemicals, food additives, dental amalgam and so on, and not smoking, obesity, poor diet, speeding 
and lack of exercise (W essely 2005). This demonstrates that voluntary risks were far more 
acceptable than involuntary ones. Risks under an individual's direct control were less threatening. 
Hazards considered to be voluntary tend to be judged as controllable, and hazards whose adverse 
effects were delayed tended to be seen as posing risks that were not well known (Slovic 1987). 
Potter and Bessin (2000) carried out a telephone survey to ascertain people's attitudes and 
understanding about termites and their control. Ninety three percent of respondents expressed 
"concern" about the application of termiticides inside their home while 75 percent indicated they 
were "very concerned". In their 1994 survey, there were only 36 percent who said that they would 
be "very concerned" about using pesticides in their home. This was an increase of 39 percent 
compared with the 2000 study. Women were found to be "more apprehensive" than men, where 
85% of female respondents expressed a "high level of concern" about termites vs 68% of males. 
Fischer et al. (1991) explored what risks laypeople were concerned about. Women mentioned 
"environmental risks" much more than men, whereas men were more likely to mention "safety and 
health risks". Women were, however, more likely to mention "environmental risks", (e.g., 
conventional pollution, exotic pollution), and respondents were more likely to mention "mundane 
risks" to "health, safety, and personal and social well-being". 
More women were concerned about risks than were men in all the items describing "technological 
risks" used in a study conducted by Pilisuk et al. (1987). Contaminated drinking water ranked first 
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(79%) in the "very concerned" group. In contrast to the gender differences, age ofrespondents was 
not significantly associated with expression of concern on any item. While males and people with 
higher levels of income and education were "less concerned" than lower status females, concerns 
were, however, expressed by major percentages among every category of respondents. Those who 
expressed "nonconcern" on one or more of the items tended to be males, with more years of 
education, less religious, and with higher incomes. Thirty five percent of the respondents felt that 
people living in the affected communities had little or no influence on risk decision outcomes, 
while a majority (65%) responded in the "great influence" category. 
There was a wide perception that the quality of the environment was deteriorating and this 
deterioration was seen as posing a direct threat to the health and well-being of humans (Dunlap 
1991). Three significant correlations were found among the 25 hazards (e.g., water pollution, 
storms, pesticides and herbicides) listed in the Environmental Appraisal Inventory (EAI) and 
demographic variables (Schmidt and Gifford 1989). Females "perceived slightly" more threat to 
the environment from the hazards listed in the EAI than males. Males perceived "higher levels of 
controls" than females, and "perceived control" increased with age. Water pollution was ranked 4th 
as a "threat to the individual" and 5th as a "threat to the environment". Close ranks were seen in 
pesticides and herbicides, 7th as a "threat to the individual" and 5-6 as a "threat to the 
environment". Although the "perceived threats" were high, respondents "perceived water 
pollution, pesticides and herbicides" as more controllable than the other hazards being 4th and 11th 
in rank, respectively. 
The public concerns among three New York regions with respect to sociodemographic 
characteristics (i.e., gender, age, education, race, urbanisation, and home ownership) and 
"perceived proximity" to potential exposure sources were explored by Howe (1990). Regional 
differences were observed and most concerns were noted in the Long Island residents, followed by 
western New York. In all three regions, "concern about exposure" was significantly higher for 
women, among persons with 9 to 11 years of education. Exposure concerns were highest among 
respondents who believed that they "lived either close or very close to a toxic dump site or to an 
area of high pesticide use". 
The difference between the opinion of French and Belgian public with respect to risk was 
investigated by Carle et al. (2004). The data for the two populations were rather similar with 
respect to perception of "nuclear risk" as compared to perception of "chemical risks". French 
people considered the "chemical risk" to be more important than the "risk of nuclear power 
stations", which could probably be due to the chemical plant disaster that occurred in Toulouse17 in 
2001. This difference was much smaller in Belgium. When asked whether the truth has been told 
17 Explosion of a warehouse that stored ammonium nitrate. 
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to them, most of the people thought they have not been told the truth about risks. In France, the 
number of people that assumed that they were not informed correctly about the fallout of 
Chernobyl 18was remarkably high. 
Whitford (1993) suggested that farmers were inclined to positive attitudes about pesticides because 
they were familiar with the risks and benefits of preventing crop destruction from pests that can be 
observed easily and immediately. While the non-agricultural population was more inclined to 
focus negatively on the ''potential risks of pesticides" because they have no control over other 
pesticide applications, don't understand or were doubtful of the value of pesticides in the 
agricultural system:, and were concerned about unknown or delayed health problems. 
The association between social equity and risk was investigated by Zimmerman (1993). The 
question of whether or not "hazardous waste sites" were disproportionately located in communities 
that may have fewer financial and political resources to alleviate such conditions showed that for 
more than 600 communities housing over 800 hazardous waste disposal sites on the National 
Priority List (NPL) sites, Black populations were approximately 50% higher than the equivalent 
proportions in the nation as a whole. When the weighted average percentage of Blacks, Hispanics 
and persons be1ow the poverty level were compared, taking into account concentrations of 
minorities in large communities, communities with NPL sites had a larger proportion of Blacks 
than was typical of the nation (18.7% vs 12.1% or about 50% or more). A similar pattern was 
found for Hispanics, while no pronounced difference appeared for percentages of the populations 
below the poverty level. 
A small survey (N = 43) was conducted by Hammitt (1990) relating to risk perceptions and 
consumer choice between organically (without pesticides) and conventionally grown produce. 
Consumers perceived residual pesticides and other synthetic chemicals as creating a "significant 
health risk". Respondents who purchase organic produce were willing to pay a substantial 
premium to avoid pesticide residues. They also said they were fearful of a broad range of ill effects 
due to pesticide residues, growth stimulants, and fertiliser. The adverse effects arising from these 
substances were believed to be cumulative and delayed. 
Maderhaner and Guttmann (1978) reported the hazard perceived by the respondents in relation to 
the distance of seven types of public facilities, i.e., nuclear reactor, oil refinery, airport, gas works, 
prison, district heating facility, and mental hospital. The study suggested that frequent contact with 
a nuclear reactor "reduces the perceived hazard". The study group living 1.4 km from the reactor 
has perceived to be "riskier" than the nearer group (0.5 km) and the control. 
18 Explosion of Chernobyl nuclear power plant. 
314 
Cultural and environmental features may affect the element of perceived risks. Australia and New 
Zealand may perceive risks differently from people of other nationalities because of the differences 
in real risks (Rohrmann 1994). Australia and New Zealand have unique climates and environments 
and also unique lifestyles, which may heighten or attenuate real risks and be reflected in risk 
perceptions. For instance, Rohrmann (1994) found that, compared with Germans, Australians and 
New Zealanders gave lower risk ratings for "conventional" technologies such as airports (which 
were more likely to seem. essential to Australians given their relative isolation from other countries) 
and coal power plants (also essential because of Australia's less advanced industrialisation). 
However, Australians and New Zealanders gave higher risk ratings than Germans to environmental 
pollution and large-scale technology such as nuclear power. Given that no nuclear power plants 
existed in Australia and New Zealand, perceptions of nuclear power may be reflecting fears of the 
unknown and of catastrophic consequences. 
The risk perception before and after reading the brochure on electromagnetic fields (EMF) was also 
investigated by MacGregor et al. (1994). The findings suggested that the naive beliefs about the 
potential of EMF exposure to cause harm were highly influenced by specific content elements of 
the brochure. Concerns were relatively low for most sources of exposure to fields prior to reading 
the brochure. Respondents expressed the following concerns after the brochure: "higher perceived 
risks" from sources of EMF exposure; "greater dread", particularly regarding power line risks; 
"greater perceived control" over these risks; "less perceived" equity; and "greater concerns" 
regarding health effects of EMF. 
Methodology 
A statistician (G. Purdie) has been consulted concerning the survey instrument, selection criteria 
and the sample size and advised the following: 
Sample size 
There were a total of 500 participants to this survey. Aside from the number of people surveyed, 
the response rate is important. A method giving a higher response rate with a smaller number of 
respondents might be better than one with a lower response rate with a higher number of 
respondents (G. Purdie pers. comm. 2004). The gain in accuracy between 200 responders 
(confidence limits for a proportion was not more than+/- 7.1%) and 300 responders (confidence 
limits for a proportion was not more than +/- 5.8%) was not great. Therefore, based on the 
assumption that the survey would have at least a 50% response rate, telephone survey of about 500 
would be adequate to obtain approximately 250 respondents. The aim was to have reasonable 
number of respondents that would be statistically analysable, within budget and would not 
compromise the results of the survey. It is worth noting that the survey was carried out at a time 
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when marketing companies were making use of telephone promotions and surveys, which may 
have lessened people's willingness to participate, as experienced in the Wellington region. 
Another major consideration that was taken into account in determining the number of participants 
was the budget allotted for the survey. 
Selection criteria 
The total number of participants to be called in each region was calculated by roughly counting the 
number of people in each directory (business addresses excluded) and proportionately calculating 
how many people would be called in each area to provide a total of 500 participants. The numbers 
of people called for each region were: 
Northland = 15 
Auckland = 144 
Waikato, King Country, Thames Valley= 44 
Bay of Plenty= 36 
Gisbome = 6 
Hawkes Bay = 20 
Taranaki = 15 
Wanganui= 7 
Manawatu = 15 
Wellington= 58 
Nelson= 14 
West Coast = 5 
Blenheim= 7 
Christchurch= 59 
Oamaru/Timaru = 13 
Dunedin= 22 
Invercargill = 13 
W airarapa = 7 
The participants were randomly selected from the regional telephone directories (white pages). 
One number was selected on every fourth page of the directory. Using Excel, a random number 
between 1 and 4 pages was generated and a name (number) was drawn from the page chosen, e.g., 
page 2. Because a phone book has four columns in each page, a random number was generated 
between columns 1 and 4 of the page chosen. Based on 50 names per column, a random number 
was generated between 1 and 50 and the name (number) was chosen accordingly. The process was 
repeated until enough names (numbers) had been generated. 
Survey instrument 
The interview tool comprised a structured questionnaire based on Department of Health 1990 
study. The questionnaire was modified and divided into two parts. The first part included risk 
perceptions questions involving pesticides only. The second part prescribed specific questions 
relating to 1080. The second part repeated many of the questions in the first part but the reference 
to 1080 was changed to pesticides (see Appendix 9c). The revised questionnaire took 
approximately 10 minutes to read. 
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Ethical approval (Departmental level) was obtained from the University of Otago Ethics 
Committee before the survey was conducted. The completed questionnaires have been stored at 
the University of Otago for a period of five years as a requirement of the Ethics approval. The 
revised questionnaire was pilot tested in the Wellington region. There were no problems 
encountered in understanding the questions asked, although one respondent found the questionnaire 
long and decided to stop before finishing the interview. 
Interview process 
A screening sheet (see Appendix 9b) for the telephone interviewers was also developed. Two 
contractors were trained to make the calls in all the non-Wellington regions and experiences 
encountered in the Wellington region, e.g., how to politely introduce yourself to the participants, 
not to use the word 'survey', if necessary, but instead use alternative words, such as "study", were 
shared to the interviewers to give them some general ideas on the nature of the survey. 
The instruction sheet developed for the interviewers contained the following information. Each 
survey form was prepared and the telephone number called. People aged 18 and over within the 
dwelling were eligible for interview. If there was no answer, the number being called was written 
on the box allotted on the first page of the survey form. One call back was made to telephone 
numbers where no contact was made. The call back was made on a different day in a different time 
period. Up to two call backs were made to the selected respondent if the interview was not 
completed on the first call. The call back was made on a different day in a different time period. If 
unsuccessful, this call was recorded as "no contact". All people called who refused to participate 
were recorded "refused to participate". The telephone directories used in making the calls were 
listed in the telephone survey form (Appendix 9c). 
Bias 
The likelihood of bias was reduced by random sampling. Each person was chosen entirely by 
chance (see Selection criteria). The questionnaire was trialled in the Wellington region to ensure 
that participants understood the questions. The questionnaires were coded (see Appendix 9c) and 
encoding was develbped with the statistician (G. Purdie) and the validity of the codes was tested by 
verifying whether or not the codes were statistically analysable. This was done by taking few 
samples and entering the codes on the data entry programme (see Data entry). The interviewers 
were trained how to enter the codes on the data entry programme. 
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Response rate 
There was a 94.8% response rate to this survey. A 100% response rate was achieved in all regions 
with the exception of Wellington (59%) and Manawatu (87%). The response rate in the Wellington 
region was lower when compared with the other regions. Reasons for this were varied, such as 
participants refused to participate, very busy, not interested at all, and unavailability. This author 
(NF) noted that the word "survey" appeared to be unattractive to participants. Few participants 
said that they were not interested on any type of survey, while those who answered that they were 
busy and asked what would be the convenient time to call back said they were not interested. 
Data entry 
A data entry programme was developed using Microsoft Access 2000. The programme was 
developed with the assistance of a statistician (G. Purdie) to ensure that the correct coding is 
entered into each question. Questions 9 and 20 were not answerable by 'yes' or 'no' and were 
coded as free text. 
Contractors were trained to enter the data. Responses were recorded initially on the survey form 
and then the data were entered on the programme. During the data entry process, it was found out 
that there was no field created for 'main 1080 concern'. Interviewers provided the data as 'write 
ins', and these were later entered on to the database by the researcher (NF) prior to statistical 
analysis. 
Validation of data 
One hundred samples were randomly selected using Microsoft Excell. These samples were 
compared with the data entered on to the data entry package and were considered to be accurate 
representation of the data obtained from the survey questionnaires. 
Statistical method 
Full analysis of the data was undertaken using the Statistical Analysis System (SAS). The Chi-
square test was utilised in determining the statistical significance of the data. The Chi-square test 
was appropriate because it is often used to analyse categorical data (Downie 1983; Harraway 1992) 
and the samples were independent for testing association in between samples in a two-way table. 
For a similar reason, the Chi-square test was used for the one-way tables. 
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Data analysis 
Unanswered questions were not analysed because only frequencies of responses were computed for 
the variables. 
Answers coded as free text (Q9 and Q20) were further grouped as follows for further analysis. 
Answers on Q9 "who was spraying" were coded as Council - 1; Neighbour - 2; Others - 3 and Q9 
"what was being sprayed" were coded as 1 for weed killer, general spray, including garden and 
domestic sprays; 2 for orchard, vineyard and farm; and 3 for others. There were no answers for 
"where was being sprayed". For Q20, answers were coded as 1 - human health effects including 
long-term effects, birth defects; 2 - environmental effects including soil; 3 - animal effects; and 4 -
others. Non-response for these free text questions was too high (93% of the data are missing) to 
allow for any meaningful analysis tb be further carried out. 
Among the demographic variables used in the study, only age and gender were compared against 
the 2001 Census of Population and Dwellings (Department of Statistics 2001) to see if respondents 
have projected the actual population or a random selection of participants was achieved. Analysis 
showed that males, 18-24 years were relatively higher than the other age groups compared with 
what should have been actually sampled. As suggested by the statistician (R. Namay), ethnicity 
and region were not included because based on expert opinion, for some variables such as Maori 
and regional benchmarks, there was considerable bias observed (more than 15%) in the survey 
estimates. Potential issues raised were the number of benchmark variables and what can be done to 
lessen the non-sampling error of source. 
Aggregation was performed on some of the variables to carry out meaningful analyses. Those who 
were aware that they have issues/concern with pesticides were categorised as having "pesticides 
concern". All other responses ("no opinion", "no concern", "don't know") have been aggregated to 
form a second group of respondents. The same aggregation method was used in relation to those 
having "1080 concern". 
Multiple ethnicities were a problem. Without aggregation of ethnicities, some ethnic group counts 
are too low to allow for a meaningful statistical significance analysis. Ethnicity was aggregated to 
form the following groups: Maori/Pacific Islander, NZ European and Asian/Others. 
Furthermore, a "domicile" variable with two categories was created. The categories were 
"City/Suburb" dwellers and "Town/Country" dwellers. Also a new variable pertaining to 
"knowledge of 1080 usage" in the area was formed. Two groups defined the variable formed as 
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· those "aware" that 1080 is used in their area and those who "don't know" or "claim that it was not 
used". 
The number of respondents of "among those with 1080 concern" (N=171) has been filtered from 
among those "1080 aware" as it is logical to assume that only those who were "1080 aware" would 
have some "1080 concern" (Table 13). 
Table 13 
"1080 Concern" and Knowledge of 1080 Usage 
Knowledge of usage 
"1080 Concerns" Aware(%) No/don't know(%) 
With concerns 8 46 
N= 171 
Results and Discussion 
According to the definition of the Food and Agriculture Organisation (PAO) International Code of 
Conduct on the Distribution and Use of Pesticides, a pesticide is "any substance or mixture of 
substances intended for preventing, destroying, or controlling any pests, including vectors of 
human or animal disease, unwanted species of plants or animals causing harm during or otherwise. 
interfering with production, processing, storage, transport or marketing of food, agricultural 
commodities, wood and wooden products or animal feedstuffs, or which may be administered to 
animals for the control of insects, arachnids or other pests in or on their bodies. The term includes 
substances intended for use as a plant-growth regulators, defoliant, desiccant, or fruit tinning agent 
for preventing of premature fall of fruit and substances applied to crops either before or after 
harvest to protect the commodity from deterioration during storage and transport." (Kaloyanova 
and El Batawi 1991: 1). 
Based on the FAO definition, 1080 is classified as a pesticide. However, from a layperson's point 
of view, pesticides would generally mean those substances which, for instance, are being used as . 
weed killer, or home garden sprays. Hence, from this survey, specific questions were asked 
relating to 1080 to obtain the public perception with respect to this compound. 
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Table 14 
Distribution of Biggest/Main Pesticide Concern 
"Biggest/Main Concern" Percentage Chi-Square 
Animal effects 63 P <0.0001* 
Environmental effects 16 
Long-term effects 21 
N=281 
** Significant at 1 % level 
As shown in Table 14, there was a strong association (p<0.0001) noted when respondents were 
asked about their "biggest/main concern" with regard to the use of pesticides in the environment. 
The majority of the respondents ( 63 % ) claimed that their ''biggest/main concern" about the use of 
pesticides relates to danger to animals. This was followed by concerns due to its long-term effects 
(21 % ) and from a public health point of view was considered to be of direct relevance to this study. 
The views expressed by Dunlap and Beus (1992) that threat from pesticides are in agreement with 
this study that threat from pesticide use was not well understood, has delayed, long term and 
potentially fatal consequences. However, what specific pesticides respondents' were worried about 
cannot be identified from this survey. 
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Table 15 
Public's opinion with a selection of statements about pesticide usage 
Statements 
a) "The public knows enough about the 
health risks of pesticides". 
b) "There is not enough available 
information about the health risks of 
using pesticides." 
c) "The controls on the use of pesticides 
are adequate". 
d) "Not enough care is taken when 
people use pesticides." 
e) "There is too much fuss made about 
the risk from pesticides". 
f) ·"All pesticides should be banned." 
g) "The long term health risks of 
pesticides are worrying." 
N = 4 76 except statement (g) where N = 475 











(%) Opinion Chi-Square 
(%) 
65 4 P<0.0001* 
43 8 P<0.0001* 
43 22 P<0.0001* 
19 12 P<0.0001* 
70 5 P<0.0001* 
82 10 P<0.0001* 
24 9 P< 0.0001* 
The survey results are in agreement with the 1990 study where 89% of the respondents disagreed 
with an absolute ban of all pesticides while there was a split between whether respondents "agree" 
(35%) or "disagree" (43%) that the controls on the use of pesticides were adequate (Table 15). 
For each statement asked with respect to pesticide usage in Table 15, a significant difference 
(p<0.0001) was observed among the "agree", "disagree", and "no opinion" respondents. People 
who think that "too much fuss is made about the risk of pesticides" accounted for about 25% of the 
respondents while 67% of the respondents were of the opinion that "the long-term effects of 
pesticides were worrying." A high proportion (65%) of respondents disagreed that "the public 
knows enough about the health risks of pesticides". Similarly, a majority of respondents tend to 
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agree that "not enough care is taken when people use pesticides" (69%) while 49% were of the 
view that "not enough available information about the health risks of using pesticides" and 82% 
disagreed "that all pesticides should be banned." 
Table 16 




** Significant at 1 % level 
N=320 
"1080 Concerns" Chi-Square 
With concerns (%) No/don't know(%) 
44 19 P <0.0001* 
10 27 
It can be deduced from Table 16 that those with "pesticide concern" were those of "l 080 c.oncern" 
as well. A strong association (P <0.0001) was observed between the ways the respondents 
answered the question on "1080 concern" vs the way they answered the "pesticide concern" 
question. · A high percentage (82%) of those with "1080 concern" also had ''pesticide concern". 
Conversely, around 70% of those with "pesticide concern" have "1080 concern" as well. 
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Table 17 
Demographic analysis of groups who are concerned about pesticides 
Characteristics "Pesticide concern" 




1 - 2 years school 10 6 
Qualification ' 8 6 
School Certificate 17 9 
University Degree 25 11 
University 1 year 4 4 
Domicile N=477 
City & Suburbs 6 3 
Town & Countrv 56 35 
Ethnicity N=477 
Maori/Pacific Islander 5 5 
NZ European 50 31 
Asian/Others 6 3 
Age (years) N=474 
18-24 3 4 
25-34 9 6 
35 -44 15 7 
45-54 14 6 
55 and up 22 14 
Gender N=469 
Male 23 19 
Female 40 18 
1 Trade qualification, technical qualification or some other qualifications 
** Significant at 1 % level 
Chi-Square 
P = 0.17 
P=0.73 
P=0.28 
P < 0.0001 ** 
P=0.0013** 
The concerns of the different population subgroups were generally quite similar. It appears that 
those who obtained a University degree have much more "1080 concern" than those who finished 
lower qualifications (Table 18), who tended to have less concerns. A similar trend was noted to 
respondents who have a "pesticide concern" (Table 17). Bord and O'Connor (1992) and Dunlap 
and Beus (1992) suggested that the well educated appeared to be more anti-pesticide than their 
counterparts. This statement appears to concur with the findings of this survey. 
324 
There was a modest gender difference found in this survey with respect to their belief about 1080 
concerns (significant at 5% level, P=0.0286). Females were likely to be more concerned (32%) 
than males (22%) (Table 18). This finding was supported by a survey carried out where women 
were more opposed to the use of cyanide than men (Sheppard and Urquhart 1991 ). Of the general 
sociodemographic variables that have been studied, there was some evidence that gender and age 
may influence evaluations of risk, although the precise interpretation to be placed upon such 
findings_ was uncertain. Several studies found that women perceived more threat to the 
environment than men (Schmidt and Gifford 1989; Pilisuk et al. 1987; Fischer et al. 1991). 
Respondents aged 55 and above were "more concerned" with 1080 (18%) than their younger 
counterparts (Table 18). Similarly, the same trend was observed in relation to those who were 
"pesticide concerned" with respect to gender and age (Table 17). 
The findings from this current survey appear to be consistent with the findings by Anon (1978) and 
Dunlap and Beus (1992) that those living in "city and suburbs" have low percentage of 1080 
concerns (5%) (Table 18) and because they are less 1080 .concerned, they may favour the use of 
1080. Those who were classed as "town and country dwellers" (49%) were more concerned and 
would probably not support the use of 1080. This rationale is consistent with Nelkin (1989) and 
Howe (1990) that people's distance from the source ofrisk and the consequences also appeared to 
influence risk perception. Pesticides followed a similar profile where those living in "town and 
country" were more of concerned than those living in "city and suburbs" (Table 17). This finding 
is inconsistent with Whitford (1993) where the author has concluded that the non-agricultural 
population was more inclined to focus negatively on the potential risks of pesticides. Pesticides 
followed a similar profile as shown in Table 17. 
Respondents from this study who suggested that they have "no/don't know 1080 concerns" (41 %) 
live in "town and country" and the "city and suburbs" dwellers (5%) were the groups that were 
accounted for (Table 18). The same trend was observed in "no/don't know pesticide concerns" as 
shown in Table 17. The findings may concur with Whitford (1993) on the assumption that those 
living in "town and country" may engage in some form of farming activities. Farmers were 
inclined to form a positive attitude about pesticides because they are familiar with risk and because 
the benefits of preventing crop destruction from pests can be observed easily and immediately. 
When the respondents were filtered to only those who are aware of 1080, no association was noted 
between "1080 concern" and all the demographic variables, namely age, educational qualification, 
ethnicity and domicile (Table 18). It is interesting to note that the educational qualification, 
domicile, age and ethnicity do not play a critical factor about the level of "1080 concern" among 
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the respondents. However, gender does matter as demonstrated by the 5% level of significance 
(P=0.0286) observed between them although the association was modest (Table 18). 
Table 18 
Demographic analysis of groups who are concerned about 1080 
Characteristic "1080 Concerns" 
With concerns No/don't know 
(%) (%) 
Educational Qualification N=284° 
1 - 2 years school 7 6 
Qualification a 9 9 
School Certificate 11 9 
University Degree 23 17 
University 1 year 4 5 
Domicile N=320° 
City & Suburbs 5 5 
Town & Country 49 41 
Ethnicity N= 305 ° 
Maori/Pacific Islander 3 3 
NZ European 45 38 
Asian/Others 6 5 
Ages N=317° 
18-24 3 3 
25-34 6 6 
35 -44 12 8 
45-54 15 10 
55 and up 18 19 
Gender N= 312 ° 
Male 22 25 
Female 32 21 
a Trade qualification, technical qualification or some other qualifications 
* Significant at 5% level 




P = 0.8851 




How "1080 Concern" affects the knowledge of 1080 usage in local area 
Knowledge of usage 
"1080 Concerns" "Aware"(%) ''No/don't know"(%) Chi-Square 
With concerns 8 46 P = 0.6504 
No/don't know 6 40 
N= 320 ("1080 aware") 
No association was noted between having or no "1080 concern" and knowledge of whether or not 
1080 is.being used in their locality (Table 19). It appears from this finding that the level of1080 
concern among respondents was not · affected by whether or not they were aware of 1080 being 
used .in their. area. As can be seen, those who were aware of knowledge of 1080 use has only 
accounted for 8% (with "1080 concern") as opposed to 6% for the "no/don't know" respondents. 
Table 20 






** Significant at 1 %level 
N = 320 ("1080 aware") 
"1080 Concern" 
"Aware"(%) "No/don't know"(%) 
Chi-Square 
15 25 P <0.0001** 
39 21 
There was a strong association (P<0.0001) noted between "aware" or ''no/don't know" and the way 
the respondents perceived whether or not controls on the use of 1080 were adequate and whether or 
not enough care was being taken when people use 1080 (Table 20). The significant association has 
demonstrated that respondents' awareness of 1080 being used in their locality affects their 
perception on 1080 use. 
Moreover, an association (P = 0.0003) was also noted between having or not having "1080 
concern" and the way respondents feel about whether or not the public knows enough about the 
health risks of 1080 and whether or not there is not enough available information about the health 
risks of using 1080 (Table 21 ). These two factors play a significant role in affecting the way 
respondents expressed their view as being "1080 concerned". 
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Table21 




** Significant at 1 % level 
N = 320 ("1080 aware") 
"1080 Concern" Chi-Square 
"With concerns"(%) "No/ don't know"(%) 
20 28 P=0.0003** 
33 19 
A strong association (P<0.0001) was found between the "biggest/main concern" and those who 
expressed "1080 concern" about the use of 1080 in the environment (Table 22). The small P-value 
means that the people do not evenly have the same main concern. Close examination of those with 
"1080 concern" shows that the major concern that stands out from this group was the effect of 1080 
on animals (49%) (Table 22) .. Long-term effects (20%) and environmental effects (15%) were the 
next major concerns. Acute effects were relatively ofless concern (10%). 
The set of concerns evoked by the questionnaire suggested that danger to animals clearly topped 
the list accounting for 49% and 63% for 1080 and pesticides, respectively. It is known that 1080 is 
very toxic to dogs as only a tiny amount is sufficient to produce a lethal effect as mentioned in 
section 4.1.1. A number of PHUs have reported complaints about dogs' deaths (Appendix 7). 
Table 22 







** Significant at 1 % level 
Among "1080 concern"= 137 
Percentage Chi-Square 













** Significant at 1 % level 
Among "1080 concern"= 171 
Percentage Chi-Square 




There was also a strong association (P<0.0001) noted between the "1080 concern" group and their 
source. of drinking water (Table 23) which illustrates that people do not evenlY. have the same 
concern. For the same group, the main source of water was the town supply (87%). The other . . . 
sources .were proportionally small compared to the biggest source of drinking water. Ground 




Public's opinion with a selection of statements about 1080 usage 
Statements 
a) "The public knows enough about the 
health risks of 1080''; 1 
b) "There is not enough available 
information about the health risks of 
using 1080." 1 
c) "The controls on the use of 1080 are 
adequate". 1 
d) ''Not enough care is taken when 
people use 1080." 2 
e) "There is too much fuss made about 
the risk from 1080". 2 
t) " 1080 should be banned.",. 
g) "The long term health risks of 1080 
are worrying." 2 
1 N = 318 ("1080 aware") 
2 N = 317 ("l 080 aware") 










"Disagree" "No Chi-Square 
(%) Opinion" 
(%) 
66 7 P<0.0001** 
43 12 P<0.0001** 
P< 0.8203 
32 34 
30 39 P< 0.0918 
62 14 P<0.0001** 
48 26 P<0.0001** 
22 30 P<0.0001** 
When a specific question was asked about 1080, there were 34% of the respondents who "agreed" 
that there were adequate controls on the use of 1080 while 32% "disagreed", and 26% of the 
respondents "agreed" that 1080 should be banned as opposed to 48% who "disagreed" (Table 24). 
It appears from this survey that although there were people who were opposed to its use, almost 
half of people surveyed have supported its continued use. 
The group of respondents with "1080 concern" (N = 171) was further investigated. There were 
only 17 people who said they get ( or sometimes get) their meat from the farm and only two of these 
respondents thought that the meat was contaminated, hence no further analysis was done on this 
group. Only 13 of those with "1080 concern" get ( or sometimes get) their meat from hunting so 
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this group was also not further investigated. Only one respondent said he/she gets milk from the 
farm so no further investigation was done either. 
Long-term effects of both pesticides and 1080 (Tables 14 and 22, respectively) were the next most 
common category that concerned the respondents followed by environmental effects. Long-term 
effects of 1080 was the primary focus of this study as there were no known studies to date as to 
whether or not humans are susceptible to the overt effects of this compo~d.· A 1990 poll indicated 
that 75% of the American public now share the perception that pesticides posed serious hazard to 
humans and the environment (Whitford 1993). 
Each statement was analysed statistically and p-values were based on whether respondents "agree", 
''.disagree", and "no opinion" expressed on specific statements asked during the survey (Table 24). 
Across the three categories, the differences were statistically significant (P<0.0001) showing strong 
associations between the ways the respondents answered the question on 1080 usage. · A high 
proportion disagreed that 1080 should be banned ( 48%) while a high proportion ( 48%) agreed that 
the long-term effects of 1080 were worrying. A low proportion (27%) agreed that "the public 
knows enough about the health risks of 1080", 45% agreed that "there is not enough available 
information about the health risks of using 1080". When asked whether "the controls on the use of 
1080 are adequate", there was an almost even split between those who "agreed" (34%), "disagreed" 
(32%), and the "no opinion" accounted for 34%. Similarly, the same trend was noted with respect 
to "not enough care is taken when people use 1080". 
Table 25 
Summary of people's awareness about public protest about 1080 usage 
Protests 
Danger to animals 




** Significant at 1 % level 
N=48 
Percentage Chi-Square 





There were only 48 respondents who answered the statement with respect to their awareness of any 
public protest about the use of 1080 in their area. Public protest concerning danger to animals 
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accounted for 52% and long-term effects and harm to the environment were about 15% and 13%, 
respectively. A low percentage (8%) of public protests with respect to acute effects of 1080 was 
noted. A strong association (P<0.0001) was noted between "1080 usage" and public protests 
(Table 25). 
There was no further investigation carried out as only 23 respondents had "1080 concern" in 
relation to ethnicity and culture. Various opinions were expressed by respondents about this 
question including: 
• Untested over time/would like more research done on it 
• Danger to animals/living things and environment 
• Long-term effects on human health and environment 
• Harmful effects on pregnant women and birth defects 
• Stays long in soil and it does not breakdown 
• Harm/risks to health 
• Not enough care or control is taken/flagrant use 
• Whanau and heritage is at stake if 1080 is used 
Summary 
Risk perception studies examine the judgements people make when are asked to characterise and 
evaluate hazardous activities (Slovic 1987), as demonstrated in this survey. 
The long-term effects of 1080 and pesticides were consistently of major concern as raised by the 
respondents. Attitudes to "l 080 concerns" tend to vary according to the educational qualification, 
domicile, age and gender of the person concerned. The most concerned tends to be expressed by 
females, older people, those with University degrees and those living in town and country. The 
same trend was observed with regard to pesticides. 
A significant association was observed between "1080 and pesticides concern" and gender which 
indicates that males and females expressed their views differently with respect to their concerns 
about 1080 and pesticides use. A significant association was also noted in relation to age and 
'pesticides concern'. 
A large proportion of respondents disagreed that the public knows enough about the health risks of 
1080 and pesticides and almost an equal split between respondents who agree and disagree that not 
enough available information about the health risks of 1080 and pesticides. Despite of these 
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perceptions, the majority of respondents did not appear to support the ban of either 1080 or 
pesticides use. 
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Appendix 9b. Screening sheet 
"Good morning/afternoon, my name is from the University of Otago. We are 
carrying out a nationwide survey on people's attitudes towards the use of pesticides to control 
vermin. The results from this survey will update the findings of a similar survey done by the 
Ministry of Health in 1990. This project has been approved by the University of Otago Ethics 
Committee." 
.Q.A "My sampling requires me to-inter.view people aged 18 and over. Do you belong to this 
age group? 
IF YES, GO TO Q.B. 
··1F NOT OLD ENOUGH, ASK TO SPEAK TO A PERSON OVER 18. REINTRODUCE 
THE SURVEY IF NECESSARY. GO TO Q.B. 
IF NO ONE ELSE IS . ELIGIBLE, USE THE FOLLOWING THANK YOU AND 
TERMINATE. 
"Thank you very much for your time, but I can only interview people aged 18 years and over. 
Goodbye." 
Q.B 
SAY: ''The questions I am going to ask will take about 
10 minutes or less to answer. Could you spare me that 
time now?" 
IF BUSY OR RELUCTANT, SAY: "If you cannot spare that 
time right now, I would very much like to make a time to call 
you back. It is important that we talk to a good cross-section 
of people on these issues. 
FOR PERSEASION IF NECESSARY: ''People who have taken 
part so far have found it an interesting survey to answer." 
IF NOT PRESENT 
"When would be the best time 
for me to call back to speak to 
him/her? 
RECORD ON THE 
SAMPLING SHEET 
TRY FOR AN APPOINTMENT 
AND RECORD DETAILS ON THE 
QUESTIONNAIRE, FOR TELEPHONING. 
PROCEED TO THE 
QUESTIONNAIRE 
If refused: Thank them for their time. 
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Appendix 9c. Public perception of risk from pesticides and 1080 
I I QUESTIONNAIRE 
Q.1 "In the last 12 months, have you personally come into contact with any pesticides?" 
( circle ONE only) 
Yes-I No-3 Don't know - 5 
Q.2 "Do you have any concerns about coming into contact with pesticides?" 
(circle ONE only) · 
T No:-3 Don'tknow-5 .. ,GO TO Q6 
. Q.3 "Whatis your biggest single main concern about the use of pesticides in the environment? 
(circle ONE only. Code to the best match answer given). 
Acute health effects from the use of pesticides - 1 
Long -term effects of pesticides- 2 
Harm to environment - 3 
Danger to animals - 4 
Q.4 "Have you personally suffered any illness that, in your opinion, was caused by pesticides?" 
(circle ONE only 
Yes-I No-3 Don't know - 5 
Q.5 "Have any members of your family suffered any illness that, in your opinion, was caused 
by pesticides?" (circle ONE only 
Yes-I No-3 Don't know - 4 
Q.6 ''Now I'm going to read out some statements and I'd like you to tell me whether you agree, 
disagree, or have no opinion with each one. Do you agree, or disagree that ... " (read out 
for each statement, and circle the answer as you go). 
Agree Disagree No 
opinion 
a) "The public knows enough about the health risks of 1 3 5 
pesticides". 
b) "There is not enough available information about the 1 3 5 
health risks of using pesticides." 
c) ''The controls on the use of pesticides are adequate". 1 3 5 
d) ''Not enough care is taken when people use 1 3 5 
pesticides." 
e) "There is too much fuss made about the risk from 1 3 5 
pesticides". 
f) "All pesticides should be banned." 1 3 5 
g) "The long term health risks of pesticides are 1 3 5 
worrying." 
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Q.7 "Which of these four best describes the place where you live?" 
(read al/four options before circling the one option chosen) 
"Outside a city or large town" ............... 1 
"Within a city or large town" ................ 2 
"In a small town" .............................. 3 
"In the country" ................................ 4 
DO NOT READ OUT: Other (Specify) ............................................. . 
Don't' know = Y Refused= Z 
Q.8 "Please tell me which of these four statements best describes your knowledge of pesticide 
spraying carried out where you live, or near where you live, by people outside of your household? ' 
(read all four options before circling the one option chosen) 
"YOU know that other people have used pesticide sprays . r 
where you live or near where you live" .................. 1 -, GO TO Q.9 
"or.you think that other people may have used pesticide sprays: ........ 2 
"or you're not sure if other people have used pesticide sprays or not" .. 3 
"or you know that other people have not used pesticide sprays 
where you live or near where you live" ..................................... .4 
DO NOT READ OUT: ......... Don't know ............. 5 
Refused ................. 6 
Q.9 ~'Can you describe who was spraying, what was being sprayed and where was being 
sprayed?" (Write down answer) 
Q .10 "Do you have any idea, how often these pesticides are being used?" 
(circle ONE only) 
Monthly = 1 Quarterly = 2 Every 6 months = 3 Other (Specify) .......... .4 
No/Not sure= 5 
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Q.11 "Is there anything else you want to say about pesticide or sprays?" (circle ONE only) 
Yes = 1 ..................................................... . 
Nothing else= 2 Don't know= 5 
"I'm now going to ask you specific questions relating to 1080, a known pesticide." 
Q.12 "Can you tell me what 1080 is used for?" (Tick AU that apply) 
0 Kill possums 
0 Don't know 
0 Kill rabbits 0 Kill wallabies 
Other: ....................................... . 
Q.13 "Is 1080 being used in your area?" (circle ONE only) 
Yes-1 Notsure-2 No...:...3 Don't know- 4 
Q.14 "How is it used in your area?" (circle ONE only) 
Aerial application - 1 Ground application - 2 Dtm'tknow- 3 
Q.15 Do you have any concerns about the use of 1080?" (circle ONE only) 
! 
Notsure-2 No-"3 Don't know:~ 4 
J. 
GO toQ17 
Q.16 "What is your biggest single main concern about the use of 1080 in the environment? 
Acute effects from the use of 1080 = 1 
Long -term effects of 1080 = 2 
Harm to environment = 3 
Danger to animals = 4 
Other= 5: ---
Q.17 "Are you aware of any public protest about the use of 1080 in your area?" 
(circle ONE only) 
I 1-11 Not sure-2 No-3 Don't know - 4 
J. 
GO to Q19 
Q.18 "Can you please briefly summarise what people are protesting about?" (circle ONE only) 
Acute effects from the use of 1080 - 1 
Long -term effects of 1080 - 2 
Harm to environment - 3 
Danger to animals - 4 
Other 
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Q.19 "In relation to your ethnicity and culture, do you have any specific concerns regarding the 
use of 1080?" (circle ONE only) 
T Notsure--'-2 No-3 Don't know - 4 J. GO toQ21 
Q.20 "Can you please briefly tell me your concerns?" (write down answer) 
. Q.21 "In the last 12 months, have you personally been exposed to 1080?" 
Q.22 
No-3 Don'tknow-4. 
"Please tell me how you were exposed." 
(circle ONE only) 
J. 
GOtoQ23 
Drinking water= 1 Food =2Air borne dust = 3 
Other (Specify) ____ = 4 
''Now I'm going to ask you specific questions relating to your sources of drinking water 
and food". 
Q.23 "Where does your drinking water supply come from? (circle ONE only) 
Town drinking-water supply =l Tank water (not treated)= 2 
Ground (bore) water= 3 Other= 4 Don't know= 5 
Q.24 "Do you collect your milk from a farm?" (circle ONE only) 
I y~c I No=2 Sometimes = 3 Don'tknow=3 
Q.25 "Is there a possibility that cows in area that have been contaminated with 1080?" 
(circle ONE only) 
Yes= 1 Notsure-2 No-3 Don't know - 4 
Q.26 "Do you obtain your meat supply from a farm?" (circle ONE only) 
No=2 Sometimes = 3 Don't know= 4 
Q.27 "Is there a possibility that the animal's meat were contaminated with 1080?" 
(circle ONE only) 
Yes= 1 Notsure-2 No-3 Don't know - 4 
Q.28 "Do you obtain your meat supply from hunting?" (circle ONE only) 
No=2 Sometimes = 3 Don'tknow=4 
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Q.29 What sort of animals do you hunt? (tick ALL that apply) 
D Rabbit DDeer D Pigeon D DuckD Pig D Goat 
Other: .......... . 
Q.30 "Is there a possibility that these hunted animals have been contaminated with 1080?" 
Yes= 1 Not sure-2 No-3 Don'tknow-4 
Q.31 ''Now I'm going to read out some statements and I'd like you to tell me whether you agree, 
disagree or no opinion with each one. These questions are similar to an earlier question. 
The only difference is that the reference to pesticides has been changed to 1080. Do you 
agree, or disagree that ... '' (read out for each statement, and circle the answer as you go). 
Agree Disagree No opinion 
a) "The public knows enough about the health risks 1 3 5 
of 1080". 
b) "There is not enough available information about 1 3 5 
the health risks of using 1080." 
c) "The controls on the use of 1080 are adequate". 1 3 5 
d) ''Not enough cate is taken when people use 1080." 1 3 5 
e) "There is too much fuss made about the risk from 1 3 5 
1080". 
f) "1080 should be banned." 1 3 5 
g) "The long term health risks of 1080 are worrving." 1 3 5 
Q.32 "And finally,just a few questions about yourself to help us analyse the data. I am going to 
read out a list of age groups. Please stop me when I get to the age group you fall into." 
(READ OUT & CIRCLE ONE ONLY). 
"18 - 24 years?" --- 1 
"25 - 34 years?" ----2 
"35 - 44 years?" ----3 
"45 - 54 years?" ----4 
"55 or over?"----------5 
DO NOT READ OUT: Refused= 6 
Q.33 "What kind of work do you do?" -----------
Q.34 "Does this work involve handling 1080?" 
D Yes 0No~GOTOQ37 
Q.35 "in what industry is that? (write down answer) 
(IF IT IS IS RELATED TO 1080, e.g., MIXING & HANDLING OF 1080 CONCENTRATE 
SOLUTION, MANUFACTURING OF 1080 BAITS, APPLICATION OF BAITS, LOADING & 
HANDLING OF TOXIC BAITS, ETC, ASK THE NEXT QUESTIONS 36 a) -c). Tick the ONE 
box that applies in each question. IF NOT RELATED TO 1080 GO TO Q37 
Q .36 a) "Do you wash your hands and other parts of the body that you think have been exposed to 
1080 before going home?" 
D Yes D No D Sometimes 
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Q 36 b) "Do you take your working clothes with you at home?" 
0 Yes O No: GO TO Q 36 d) 
D Sometimes 
Q 36 c) "If yes or sometimes, how are they washed? 
D Wash separately D Wash with other clothes 
D Dry clean D Other __ _ 
Q 36 d) "Are there any children staying with you?" 
DYes ONo 
Q.37 "About your schooling and education. Did you pass: 
(Tick ONE box that applies) 
D School Certificate or its overseas equivalent 
D One or two full years at school after your School Certificate year 
D One fully year of university study after leaving school" 
D University degree or diploma 
D Trade qualification, technical qualification or some other qualification 
Q.38 "Are there any children under the age 16 living in your household? 
( circle ONE only) 
Yes-1 No-2 
Q.39) "To which of these groups do you consider you most belong?" 
(read out all answers and tick as many that apply) 
D Maori 
D New Zealand European 
D Samoan 





D Other (such as Dutch, Japanese, Tokelauan). Please specify ___ _ 
Don't know - Y 
Q.40) (circle sex of respondent) 
Refused= Z 
Male-1 
Q. 41) ( circle telephone book you are using) 
Northland= 01 
Auckland = 02 
Waikato, King Country 
Thames Valley= 03 
Bay of Plenty = 04 
Gisbome = 05 
Hawkes Bay = 06 
Taranaki = 07 
Wanganui = 08 
Manawatu = 09 
Wairarapa = 10 
Wellington = 11 
Nelson= 12 
West Coast= 13 
Female-2 
Blenheim = 14 
Christchurch = 15 
Oamaru/Timaru = 16 
Dunedin= 17 
Invercargill = 18 
Thank you for participating to this survey. Your participation is most appreciated and will help us 
update our information on how the public perceives pesticides. 
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